0001437749-23-031987.txt : 20231114 0001437749-23-031987.hdr.sgml : 20231114 20231114161952 ACCESSION NUMBER: 0001437749-23-031987 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 81 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: WRAP TECHNOLOGIES, INC. CENTRAL INDEX KEY: 0001702924 STANDARD INDUSTRIAL CLASSIFICATION: ORDNANCE & ACCESSORIES, (NO VEHICLES/GUIDED MISSILES) [3480] IRS NUMBER: 980551945 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-38750 FILM NUMBER: 231406665 BUSINESS ADDRESS: STREET 1: 1817 W 4TH STREET CITY: TEMPE STATE: AZ ZIP: 85281 BUSINESS PHONE: 800-583-2652 MAIL ADDRESS: STREET 1: 1817 W 4TH STREET CITY: TEMPE STATE: AZ ZIP: 85281 10-Q 1 wrap20230930_10q.htm FORM 10-Q wrap20230930_10q.htm
Q3 2023 --12-31 false 0001702924 1 3 1 3 3 2 33 0 5 0 0 1 00017029242023-01-012023-09-30 thunderdome:item utr:sqft 0001702924wrap:OfficeSpaceInMiamiFloridaMemberus-gaap:SubsequentEventMember2023-11-01 utr:M utr:Y 0001702924us-gaap:SubsequentEventMemberwrap:ExecutiveChairmanMember2023-10-122023-10-12 xbrli:pure iso4217:USD 0001702924us-gaap:SubsequentEventMemberwrap:ExecutiveChairmanMember2023-10-12 0001702924us-gaap:RestrictedStockUnitsRSUMemberus-gaap:SubsequentEventMemberwrap:ExecutiveChairmanMember2023-10-122023-10-12 0001702924wrap:IntrensicLLCMember2023-08-09 0001702924wrap:IntrensicLLCMember2023-08-092023-08-09 0001702924wrap:IntrensicLLCMemberus-gaap:TrademarksAndTradeNamesMember2023-08-09 0001702924wrap:IntrensicLLCMemberus-gaap:CustomerRelationshipsMember2023-08-09 0001702924wrap:IntrensicLLCMemberus-gaap:TechnologyBasedIntangibleAssetsMember2023-08-09 00017029242022-01-012022-09-30 00017029242022-07-012022-09-30 00017029242023-07-012023-09-30 0001702924srt:AsiaPacificMember2022-01-012022-09-30 0001702924srt:AsiaPacificMember2023-01-012023-09-30 0001702924srt:AsiaPacificMember2022-07-012022-09-30 0001702924srt:AsiaPacificMember2023-07-012023-09-30 0001702924wrap:EuropeMiddleEastAndAfricaMember2022-01-012022-09-30 0001702924wrap:EuropeMiddleEastAndAfricaMember2023-01-012023-09-30 0001702924wrap:EuropeMiddleEastAndAfricaMember2022-07-012022-09-30 0001702924wrap:EuropeMiddleEastAndAfricaMember2023-07-012023-09-30 0001702924srt:AmericasMember2022-01-012022-09-30 0001702924srt:AmericasMember2023-01-012023-09-30 0001702924srt:AmericasMember2022-07-012022-09-30 0001702924srt:AmericasMember2023-07-012023-09-30 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2022-01-012022-12-31 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2022-01-012022-12-31 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2023-01-012023-09-30 0001702924us-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2023-01-012023-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2022-01-012022-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2022-01-012022-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2023-01-012023-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2023-01-012023-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2022-07-012022-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2022-07-012022-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorTwoMember2023-07-012023-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorOneMember2023-07-012023-09-30 0001702924us-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberwrap:DistributorsMember2023-07-012023-09-30 xbrli:shares 0001702924wrap:ExecutiveChairmanMember2023-06-292023-06-29 0001702924wrap:ExecutiveChairmanMember2023-06-29 0001702924wrap:ExecutiveChairmanMemberus-gaap:SeriesAPreferredStockMember2023-06-292023-06-29 0001702924wrap:ConsultantMemberwrap:MrElwoodNorrisMember2022-01-012022-09-30 0001702924wrap:ConsultantMemberwrap:MrElwoodNorrisMember2023-01-012023-09-30 0001702924wrap:ConsultantMemberwrap:MrElwoodNorrisMember2023-07-012023-09-30 0001702924wrap:MrElwoodNorrisMember2023-01-012023-09-30 00017029242023-09-30 0001702924wrap:ProfessionalServicesAndTechnologyAcquisitionAgreementMember2022-11-222022-11-22 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2023-09-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2022-01-012022-09-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2022-07-012022-09-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2023-01-012023-09-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2023-07-012023-09-30 0001702924wrap:RelatedPartyTechnologyLicenseAgreementMemberwrap:SyzygyLicensingLLCMember2016-09-30 00017029242022-01-012022-12-31 0001702924us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-09-30 0001702924us-gaap:RestrictedStockUnitsRSUMember2023-09-30 0001702924us-gaap:EmployeeStockOptionMember2023-01-012023-09-30 0001702924us-gaap:EmployeeStockOptionMember2023-09-30 0001702924us-gaap:ResearchAndDevelopmentExpenseMember2022-01-012022-09-30 0001702924us-gaap:ResearchAndDevelopmentExpenseMember2023-01-012023-09-30 0001702924us-gaap:ResearchAndDevelopmentExpenseMember2022-07-012022-09-30 0001702924us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012023-09-30 0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-01-012022-09-30 0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-09-30 0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2022-07-012022-09-30 0001702924us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-30 0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMember2022-01-012022-09-30 0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMember2022-07-012022-09-30 0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMember2023-01-012023-09-30 0001702924us-gaap:RestrictedStockUnitsRSUMemberwrap:The2017StockIncentivePlanMember2023-07-012023-09-30 iso4217:USDxbrli:shares 0001702924us-gaap:RestrictedStockUnitsRSUMember2022-01-012022-12-31 0001702924us-gaap:RestrictedStockUnitsRSUMember2022-12-31 0001702924us-gaap:EmployeeStockOptionMemberwrap:The2017StockIncentivePlanMember2022-01-012022-09-30 0001702924us-gaap:EmployeeStockOptionMemberwrap:The2017StockIncentivePlanMember2022-07-012022-09-30 0001702924us-gaap:EmployeeStockOptionMemberwrap:The2017StockIncentivePlanMember2023-01-012023-09-30 0001702924us-gaap:EmployeeStockOptionMemberwrap:The2017StockIncentivePlanMember2023-07-012023-09-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMember2023-07-012023-09-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMembersrt:MaximumMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMembersrt:MinimumMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMemberus-gaap:ShareBasedCompensationAwardTrancheThreeMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMemberus-gaap:ShareBasedCompensationAwardTrancheTwoMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMemberus-gaap:ShareBasedCompensationAwardTrancheOneMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-30 0001702924us-gaap:EmployeeStockOptionMember2022-01-012022-09-30 0001702924us-gaap:PerformanceSharesMemberwrap:ChiefExecutiveOfficerAndPresidentMember2022-04-012022-04-30 0001702924us-gaap:PerformanceSharesMemberwrap:The2017StockIncentivePlanMember2023-09-30 0001702924wrap:ServicebasedOptionsMemberwrap:The2017StockIncentivePlanMember2023-09-30 00017029242022-12-31 0001702924wrap:The2017StockIncentivePlanMember2022-01-012022-01-31 0001702924wrap:The2017StockIncentivePlanMember2022-04-012022-04-30 0001702924wrap:The2017StockIncentivePlanMember2023-09-30 0001702924wrap:The2017StockIncentivePlanMember2022-06-30 0001702924wrap:The2017StockIncentivePlanMember2022-06-012022-06-30 0001702924wrap:The2017StockIncentivePlanMember2021-06-012021-06-30 0001702924wrap:The2017StockIncentivePlanMember2020-06-012020-06-30 0001702924wrap:The2017StockIncentivePlanMember2019-05-012019-05-31 0001702924wrap:The2017StockIncentivePlanMember2017-03-31 00017029242023-07-292023-07-29 0001702924us-gaap:SeriesAPreferredStockMemberwrap:RegisteredDirectOfferingMember2023-07-292023-07-29 0001702924us-gaap:SeriesAPreferredStockMemberwrap:RegisteredDirectOfferingMember2023-07-29 00017029242023-07-29 0001702924us-gaap:SeriesAPreferredStockMemberwrap:RegisteredDirectOfferingMember2023-07-032023-07-03 0001702924us-gaap:SeriesAPreferredStockMemberwrap:RegisteredDirectOfferingMember2023-07-03 0001702924wrap:RegisteredDirectOfferingMember2023-07-032023-07-03 0001702924wrap:WarrantsIssuedInRegisteredDirectOfferingMember2023-06-29 00017029242022-09-30 00017029242021-12-31 0001702924wrap:CommissionsPayableMember2022-12-31 0001702924wrap:FormerCeoPayableMember2023-09-30 0001702924wrap:SyzygyLicensingLLCMember2022-12-31 0001702924wrap:SyzygyLicensingLLCMember2023-09-30 0001702924us-gaap:ComputerSoftwareIntangibleAssetMember2022-12-31 0001702924us-gaap:ComputerSoftwareIntangibleAssetMember2023-09-30 0001702924us-gaap:TrademarksMember2022-12-31 0001702924us-gaap:TrademarksMember2023-09-30 0001702924us-gaap:PatentsMember2022-12-31 0001702924us-gaap:PatentsMember2023-09-30 0001702924us-gaap:FurnitureAndFixturesMember2022-12-31 0001702924us-gaap:FurnitureAndFixturesMember2023-09-30 0001702924us-gaap:ComputerEquipmentMember2022-12-31 0001702924us-gaap:ComputerEquipmentMember2023-09-30 0001702924wrap:ToolingMember2022-12-31 0001702924wrap:ToolingMember2023-09-30 0001702924wrap:ProductionAndLabEquipmentMember2022-12-31 0001702924wrap:ProductionAndLabEquipmentMember2023-09-30 0001702924us-gaap:MeasurementInputExercisePriceMember2022-12-31 0001702924us-gaap:MeasurementInputExercisePriceMember2023-09-30 0001702924us-gaap:MeasurementInputExpectedTermMember2022-12-31 0001702924us-gaap:MeasurementInputExpectedTermMember2023-09-30 0001702924us-gaap:MeasurementInputExpectedDividendRateMember2022-12-31 0001702924us-gaap:MeasurementInputExpectedDividendRateMember2023-09-30 0001702924us-gaap:MeasurementInputRiskFreeInterestRateMember2022-12-31 0001702924us-gaap:MeasurementInputRiskFreeInterestRateMember2023-09-30 0001702924us-gaap:MeasurementInputPriceVolatilityMember2022-12-31 0001702924us-gaap:MeasurementInputPriceVolatilityMember2023-09-30 0001702924us-gaap:FairValueInputsLevel3Member2022-12-31 0001702924us-gaap:FairValueInputsLevel3Member2023-09-30 0001702924us-gaap:FairValueInputsLevel3Member2022-01-012022-12-31 0001702924us-gaap:FairValueInputsLevel3Member2023-07-012023-09-30 0001702924us-gaap:FairValueInputsLevel3Member2021-12-31 0001702924us-gaap:FairValueInputsLevel3Member2023-06-30 0001702924us-gaap:FairValueInputsLevel1Member2022-12-31 0001702924us-gaap:FairValueInputsLevel1Member2022-01-012022-12-31 0001702924us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Member2022-12-31 0001702924us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Member2022-01-012022-12-31 0001702924wrap:USTreasurySecuritiesInShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2022-12-31 0001702924wrap:USTreasurySecuritiesInShortTermInvestmentsMemberus-gaap:FairValueInputsLevel1Member2022-01-012022-12-31 0001702924us-gaap:FairValueInputsLevel1Member2023-09-30 0001702924us-gaap:FairValueInputsLevel1Member2023-01-012023-09-30 0001702924us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Member2023-09-30 0001702924us-gaap:CertificatesOfDepositMemberus-gaap:FairValueInputsLevel1Member2023-01-012023-09-30 0001702924wrap:ExtendedProductWarrantiesMember2022-12-31 0001702924wrap:TrainingMember2022-12-31 0001702924wrap:VirtualRealityTrainingMember2022-12-31 0001702924wrap:ExtendedProductWarrantiesMember2023-09-30 0001702924wrap:TrainingMember2023-09-30 0001702924wrap:VirtualRealityTrainingMember2023-09-30 0001702924wrap:DeferredRevenueMember2023-09-30 0001702924wrap:CustomerDepositsMember2023-09-30 0001702924wrap:DeferredRevenueMember2023-01-012023-09-30 0001702924wrap:CustomerDepositsMember2023-01-012023-09-30 0001702924wrap:DeferredRevenueMember2022-12-31 0001702924wrap:CustomerDepositsMember2022-12-31 0001702924us-gaap:ConvertiblePreferredStockMember2022-01-012022-09-30 0001702924us-gaap:ConvertiblePreferredStockMember2023-01-012023-09-30 0001702924wrap:IntrensicLLCMember2022-01-012022-09-30 0001702924wrap:IntrensicLLCMember2023-01-012023-09-30 0001702924wrap:IntangiblesOtherThanPatentsAndTrademarksMember2022-01-012022-09-30 0001702924wrap:IntangiblesOtherThanPatentsAndTrademarksMember2023-01-012023-09-30 0001702924wrap:PatentsAndTrademarksMember2022-01-012022-09-30 0001702924wrap:PatentsAndTrademarksMember2023-01-012023-09-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-09-30 0001702924us-gaap:RetainedEarningsMember2022-09-30 0001702924us-gaap:AdditionalPaidInCapitalMember2022-09-30 0001702924us-gaap:CommonStockMember2022-09-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-01-012022-09-30 0001702924us-gaap:RetainedEarningsMember2022-01-012022-09-30 0001702924us-gaap:AdditionalPaidInCapitalMember2022-01-012022-09-30 0001702924us-gaap:CommonStockMember2022-01-012022-09-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2021-12-31 0001702924us-gaap:RetainedEarningsMember2021-12-31 0001702924us-gaap:AdditionalPaidInCapitalMember2021-12-31 0001702924us-gaap:CommonStockMember2021-12-31 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-07-012022-09-30 0001702924us-gaap:RetainedEarningsMember2022-07-012022-09-30 0001702924us-gaap:AdditionalPaidInCapitalMember2022-07-012022-09-30 0001702924us-gaap:CommonStockMember2022-07-012022-09-30 00017029242022-06-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-06-30 0001702924us-gaap:RetainedEarningsMember2022-06-30 0001702924us-gaap:AdditionalPaidInCapitalMember2022-06-30 0001702924us-gaap:CommonStockMember2022-06-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-30 0001702924us-gaap:RetainedEarningsMember2023-09-30 0001702924us-gaap:AdditionalPaidInCapitalMember2023-09-30 0001702924us-gaap:PreferredStockMember2023-09-30 0001702924us-gaap:CommonStockMember2023-09-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-09-30 0001702924us-gaap:RetainedEarningsMember2023-01-012023-09-30 0001702924us-gaap:AdditionalPaidInCapitalMember2023-01-012023-09-30 0001702924us-gaap:PreferredStockMember2023-01-012023-09-30 0001702924us-gaap:CommonStockMember2023-01-012023-09-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-31 0001702924us-gaap:RetainedEarningsMember2022-12-31 0001702924us-gaap:AdditionalPaidInCapitalMember2022-12-31 0001702924us-gaap:PreferredStockMember2022-12-31 0001702924us-gaap:CommonStockMember2022-12-31 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-30 0001702924us-gaap:RetainedEarningsMember2023-07-012023-09-30 0001702924us-gaap:AdditionalPaidInCapitalMember2023-07-012023-09-30 0001702924us-gaap:PreferredStockMember2023-07-012023-09-30 0001702924us-gaap:CommonStockMember2023-07-012023-09-30 00017029242023-06-30 0001702924us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-30 0001702924us-gaap:RetainedEarningsMember2023-06-30 0001702924us-gaap:AdditionalPaidInCapitalMember2023-06-30 0001702924us-gaap:PreferredStockMember2023-06-30 0001702924us-gaap:CommonStockMember2023-06-30 0001702924us-gaap:ConvertiblePreferredStockMember2022-12-31 0001702924us-gaap:ConvertiblePreferredStockMember2023-09-30 00017029242023-11-13
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _________ to _________

 

Commission File Number: 000-55838

 

wrap20230930_10qimg001.jpg

 

 

Wrap Technologies, Inc.

(Exact name of registrant as specified in its charter)

 

Delaware

 

98-0551945

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification Number)

1817 W 4th Street

Tempe, Arizona 85281

(Address of principal executive offices) (Zip Code)

 

(800) 583-2652

(Registrant’s Telephone Number, Including Area Code)

 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, par value $0.0001 per share

WRAP

Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

 

Indicate by check mark whether the registrant has submitted every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large Accelerated Filer

 

Accelerated filer

Non-accelerated filer

 

Smaller reporting company

   

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No ☒

 

As of November 14, 2023 a total of 44,214,169 shares of the Registrant’s common stock, par value $0.0001, (“Common Stock”) were issued and outstanding.

 

 

  

 

WRAP TECHNOLOGIES, INC.

 

INDEX

 

PART I. FINANCIAL INFORMATION

Page

   

Item 1.

Financial Statements:

1
 

Condensed Consolidated Balance Sheets as of September 30, 2023 (unaudited) and December 31, 2022

1
 

Condensed Consolidated Statements of Operations and Comprehensive Loss for the three and nine months ended September 30, 2023 and 2022 (unaudited)

2
 

Condensed Consolidated Statements of Stockholders’ Equity for the three and nine months ended September 30, 2023 and 2022 (unaudited)

3
 

Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2023 and 2022 (unaudited)

5
 

Notes to Unaudited Condensed Consolidated Interim Financial Statements

6

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

18

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

29

Item 4.

Controls and Procedures

29
     

PART II. OTHER INFORMATION

 
     

Item 1.

Legal Proceedings

30

Item 1A.

Risk Factors

30

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

30

Item 3.

Defaults Upon Senior Securities

30

Item 4.

Mine Safety Disclosures

31

Item 5.

Other Information

31

Item 6.

Exhibits

31
     

SIGNATURES

32

 

 

 
 

  

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Wrap Technologies, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except par value and share amounts)

 

   

September 30,

2023

   

December 31,

2022

 

ASSETS

               

Current assets:

               

Cash and cash equivalents

  $ 4,934     $ 5,330  

Short-term investments

    10,000       13,949  

Accounts receivable and contract assets, net

    4,321       2,830  

Inventories, net

    5,816       3,975  

Prepaid expense and other current assets

    762       775  

Total current assets

    25,833       26,859  

Property and equipment, net

    533       758  

Operating lease right-of-use asset, net

    205       285  

Intangible assets, net

    3,319       2,569  
Goodwill, net     1,611       -  

Other assets

    166       100  

Total assets

  $ 31,667     $ 30,571  
                 

LIABILITIES AND STOCKHOLDERS' EQUITY

               

Current liabilities:

               

Accounts payable

  $ 1,546     $ 1,419  

Accrued liabilities

    1,128       1,463  

Customer deposits

    2       -  

Deferred revenue- short term

    189       166  

Operating lease liability - short term

    116       108  
Warrants – short term     7,834       -  

Total current liabilities

    10,815       3,156  
                 

Long-term liabilities:

               

Deferred revenue- long term

    176       167  

Operating lease liability - long term

    105       193  

Total long-term liabilities

    281       360  

Total liabilities

    11,096       3,516  
                 

Commitments and contingencies (Note 12)

           
                 

Stockholders' equity:

               
Preferred stock - 5,000,000 authorized; par value $0.0001 per share     -       -  

Convertible Preferred Stock– 10,000 authorized, par value $0.0001 per share; 10,000 and 0 issued and outstanding at September 30, 2023 and December 31, 2022, respectively

    2,036       -  

Common stock - 150,000,000 authorized; par value $0.0001 per share; 43,289,236 and 41,175,993 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively

    4       4  

Additional paid-in capital

    97,919       94,333  

Accumulated deficit

    (79,388

)

    (67,376

)

Accumulated other comprehensive loss

    -       94  

Total stockholders' equity

    20,571       27,055  

Total liabilities and stockholders' equity

  $ 31,667     $ 30,571  

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

 

1

 

 

 

Wrap Technologies, Inc.

Condensed Consolidated Statements of Operations and Comprehensive Loss

(in thousands, except share and per share amounts)

(unaudited)

 

   

Three Months Ended

September 30,

   

Nine months Ended

September 30,

 
   

2023

   

2022

   

2023

   

2022

 

Revenue:

                               

Product sales

  $ 3,248     $ 1,612     $ 4,897     $ 4,042  

Other revenue

    383       89       647       422  

Total revenue

    3,631       1,701       5,544       4,464  

Cost of revenue

    1,454       790       2,347       2,430  

Gross profit (loss)

    2,177       911       3,197       2,034  
                                 

Operating expense:

                               

Selling, general and administrative

    4,317       3,586       12,604       11,952  

Research and development

    610       1,236       2,683       4,210  

Total operating expense

    4,927       4,822       15,287       16,162  

Loss from operations

    (2,750 )     (3,911

)

    (12,090 )     (14,128

)

                                 

Other income (expense):

                               

Interest income

    90       34       413       36  
Change in fair value of warrant liabilities     (117 )     -       (117 )        

Other

    (6 )     12       (25 )     10  

Total other income (expense)

    (33 )     46       271       46  

Net loss

  $ (2,783 )   $ (3,865

)

  $ (11,819 )   $ (14,082

)

                                 
Less: Convertible preferred stock dividends     (193 )     -       (193 )     -  
Net loss attributable to common stockholders   $ (2,976 )   $ (3,865 )   $ (12,012 )   $ (14,082 )
                                 

Net loss per basic and diluted common share

  $ (0.07 )   $ (0.09

)

  $ (0.29 )   $ (0.34

)

Weighted average common shares used to compute net loss per basic and diluted common share

    42,652,481       41,086,285       41,914,512       40,955,234  
                                 
Comprehensive loss:                                

Net loss

  $ (2,783 )   $ (3,865

)

  $ (11,819 )   $ (14,082

)

Net unrealized gain on short-term investments

    -       73       -       62  

Comprehensive loss

  $ (2,783 )   $ (3,792

)

  $ (11,819 )   $ (14,020

)

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

 

2

 

 

 

Wrap Technologies, Inc.

Condensed Consolidated Statements of Stockholders' Equity

(in thousands, except share amounts)

(unaudited)

 

Three Months Ended September 30, 2023

 

   

Common Stock

   

Convertible

Preferred

Stock

   

Additional Paid-In

    Accumulated    

Accumulated

Other Comprehensive

    Total Stockholders'  
   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Equity

 

Balance at July 1, 2023

    41,910,687     $ 4             $ -     $ 96,182     $ (76,411

)

  $ -     $ 19,775  

Share-based compensation expense

    -       -       -       -       (201

)

    (1

)

    -       (202

)

Dividends on convertible preferred stock

    -       -       -       -       -       (193

)

    -       (193

)

Convertible preferred stock issued, net of offering costs

    -               10,000       2,036       -       -       -       2,036  

Common shares issued upon vesting of restricted stock units

    128,549       -       -       -       -       -       -       -  

Issuance of common stock for acquisition

    1,250,000       -       -       -       1,938       -       -       1,938  

Net loss for the period

    -       -       -       -       -       (2,783

)

    -       (2,783

)

Balance at September 30, 2023

    43,289,236     $ 4       10,000     $ 2,036     $ 97,919     $ (79,388

)

  $ -     $ 20,571  

 

Nine Months Ended September 30, 2023

 

   

Common Stock

   

Convertible

Preferred

Stock

   

Additional Paid-In

   

Accumulated

   

Accumulated

Other Comprehensive

   

Total

Stockholders'

 
   

Shares

   

Amount

   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Equity

 

Balance at January 1, 2023

    41,175,993     $ 4       -     $ -     $ 94,333     $ (67,376

)

  $ 94     $ 27,055  

Common shares issued upon exercise of stock options

    250       -       -       -       -       -       -       -  

Share-based compensation expense

    -       -       -       -       1,648       -       -       1,648  

Dividends on convertible preferred stock

    -       -       -       -       -       (193

)

            (193

)

Convertible preferred stock issued, net of offering costs

    -       -       10,000       2,036       -       -       -       2,036  

Common shares issued upon vesting of restricted stock units

    862,993       -       -       -       -       -       -       -  

Issuance of common stock for acquisition

    1,250,000       -       -       -       1,938       -       -       1,938  

Settlement – US Treasury bills

    -       -       -       -       -       -       (94

)

    (94

)

Net loss for the period

    -       -       -       -       -       (11,819

)

    -       (11,819

)

Balance at September 30, 2023

    43,289,236     $ 4       10,000     $ 2,036     $ 97,919     $ (79,388

)

  $ -     $ 20,571  

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

 

3

 

Three Months Ended September 30, 2022

 

                                   

Accumulated

         
                   

Additional

           

Other

   

Total

 
   

Common Stock

           

Paid-In

   

Accumulated

   

Comprehensive

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Equity

 

Balance at July 1, 2022

    40,992,161     $ 4     $ 92,856     $ (59,976

)

  $ (17

)

  $ 32,867  

Common shares issued upon exercise of stock options

    5,500       -       8       -       -       8  

Share-based compensation expense

    -       -       872       -       -       872  

Common shares issued upon vesting of restricted stock units

    127,917       -       -       -       -       -  

Net unrealized gain on short-term investments

    -       -       -       -       73       73  

Net loss for the period

    -       -       -       (3,865

)

    -       (3,865

)

Balance at September 30, 2022

    41,125,578     $ 4     $ 93,736     $ (63,841

)

  $ 56    

$

29,955  

 

Nine Months Ended September 30, 2022

 

                                   

Accumulated

         
                   

Additional

           

Other

   

Total

 
   

Common Stock

           

Paid-In

   

Accumulated

   

Comprehensive

   

Stockholders'

 
   

Shares

   

Amount

   

Capital

   

Deficit

   

Income

   

Equity

 

Balance at January 1, 2022

    40,851,945     $ 4     $ 91,025     $ (49,759

)

  $ (6

)

  $ 41,264  

Common shares issued upon exercise of stock options

    55,500       -       83       -       -       83  

Share-based compensation expense

    -       -       2,628       -       -       2,628  

Common shares issued upon vesting of restricted stock units

    218,133       -       -       -       -       -  

Net unrealized gain on short-term investments

    -       -       -       -       62       62  

Net loss for the period

    -       -       -       (14,082

)

    -       (14,082

)

Balance at September 30, 2022

    41,125,578     $ 4     $ 93,736     $ (63,841

)

  $ 56    

$

29,955  

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

 

4

 

 

Wrap Technologies, Inc.

 

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

 

   

Nine months Ended September 30,

 
   

2023

   

2022

 

Cash Flows From Operating Activities:

               

Net loss

  $ (11,819 )   $ (14,082

)

Adjustments to reconcile net loss to net cash used in operating activities:

               

Depreciation and amortization

    675       574  

Share-based compensation

    1,648       2,628  

Warranty provision

    (8 )     55  
Change in fair value of warrant liabilities     117       -  

Non-cash lease expense

    80       75  

Provision for doubtful accounts

    (48 )     61  

Changes in assets and liabilities:

               

Accounts receivable

    (1,353 )     1,576  

Inventories

    (1,780 )     (1,396

)

Prepaid expense and other current assets

    13       268  

Accounts payable

    (67 )     (834

)

Operating lease liability

    (80 )     (65

)

Customer deposits

    2       (43

)

Accrued liabilities and other

    (322 )     175  

Warranty settlement

    (8 )     (63

)

Deferred revenue

    32       35  

Net cash used in operating activities

    (12,918 )     (11,036

)

                 

Cash Flows From Investing Activities:

               

Purchase of short-term investments

    (6,145 )     (23,119

)

Proceeds from maturities of short-term investments

    10,000       33,300  

Capital expenditures for property and equipment

    (133 )     (201

)

Investment in patents and trademarks

    (277 )     (133

)

Purchase of intangible assets

    (60 )     -  
Net cash paid for acquisition of Intrensic     (551 )     -  

Cash outlay for deposits

    (66 )     (3

)

Net cash provided by investing activities

    2,768       9,844  
                 

Cash Flows From Financing Activities:

               

Proceeds from exercise of stock options

    -       83  

Proceeds from issuance of warrants and convertible preferred stock, net of offering costs

    9,754       -  

Net cash provided by financing activities

    9,754       83  
                 

Net decrease in cash and cash equivalents

    (396 )     (1,109

)

Cash and cash equivalents, beginning of period

    5,330       4,937  

Cash and cash equivalents, end of period

  $ 4,934     $ 3,828  
                 

Supplemental Disclosure of Non-Cash Investing and Financing Activities:

               

Change in unrealized gain on short-term investments

  $ (94 )   $ 62  
Issuance of common stock for acquisition   $ (1,938 )   $ -  
Net assets acquired from acquisition   $ 147     $ -  
Convertible preferred stock issued, net of offering costs   $ (2,036 )   $ -  
Warrant liabilities   $ (7,834 )   $ -  
Dividends on convertible preferred stock   $ (193 )   $ -  

Right-of-use asset and liability recorded during period

  $ -     $ 260  

 

See accompanying notes to unaudited condensed consolidated interim financial statements.

 

5

 

 

Wrap Technologies, Inc.

Notes to Unaudited Condensed Consolidated Interim Financial Statements

(in thousands, except per share and share amounts)

 

 

1.                ORGANIZATION, SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT DEVELOPMENTS

 

Organization and Business Description

 

Wrap Technologies, Inc., a Delaware corporation (the “Company”, “we”, “us”, and “our”), is a publicly traded company with our Common Stock, par value $0.0001 per share (“Common Stock”), listed on the Nasdaq Capital Market (“Nasdaq”) under the trading symbol “WRAP”. The Company is a developer and supplier of public safety products and training services for law enforcement and security personnel. The Company’s primary product is the BolaWrap® remote restraint device. The principal markets for the Company’s proprietary products and services are in North and South America, Europe, Middle East and Asia.

 

Basis of Presentation

 

The Company’s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. In management’s opinion, the accompanying financial statements reflect adjustments necessary to present fairly the financial position, results of operations, and cash flows for those periods indicated, and contain adequate disclosure to make the information presented not misleading. Adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the footnotes. The condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2022, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “Annual Report”), as filed with the SEC on March 2, 2023. The accompanying condensed consolidated balance sheet at December 31, 2022 has been derived from the audited consolidated balance sheet at December 31, 2022, contained in the Annual Report. Results of operations for interim periods are not necessarily indicative of the results of operations for a full year.

 

Where necessary, the prior year’s information has been reclassified to conform to the current year presentation.

 

Principles of Consolidation

 

The Company has two wholly owned subsidiaries, Wrap Reality, Inc. formed in December 2020 that sells a virtual reality (“VR”) training system primarily targeting law enforcement agencies and Intrensic, LLC which the Company acquired in August 2023 which specializes in Body Worn Camera and Digital Evidence Management solutions. The consolidated financial statements include the accounts of these subsidiaries after elimination of intercompany transactions and accounts.

 

Business Combinations

 

The Company accounts for its business combinations under the provisions of Accounting Standards Codification ("ASC") Topic 805-10, Business Combinations ("ASC 805-10"), which requires that the purchase method of accounting be used for all business combinations. Assets acquired and liabilities assumed, including non-controlling interests, are recorded at the date of acquisition at their respective fair values. The estimated fair value of net assets acquired, including the allocation of the fair value to identifiable assets and liabilities, was determined using established valuation techniques. ASC 805-10 also specifies criteria that intangible assets acquired in a business combination must meet to be recognized and reported apart from goodwill. Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from the business combinations and are expensed as incurred.

 

The estimated fair value of the acquired intangible assets was determined using a method which reflects the present value of the operating cash flows generated by this asset after taking into account the cost to realize the revenue, and an appropriate discount rate to reflect the time value and risk associated with the invested capital.

 

Certain adjustments to the assessed fair values of the assets and liabilities made subsequent to the acquisition date, but within the measurement period, which is up to one year, are recorded as adjustments to goodwill. Any adjustments subsequent to the measurement period are recorded in income.

 

Goodwill

 

Goodwill represents the difference, if any, between the aggregate consideration paid for an acquisition and the fair values of the underlying net assets and liabilities assumed from an acquired business. Goodwill is not amortized, but instead is tested for impairment. The Company tests goodwill for impairment on an annual basis during the fourth quarter, or more frequently if conditions indicate that such impairment could exist. The Company evaluates qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying value and whether it is necessary to perform goodwill impairment process.

 

Definite-lived Intangible Assets 

 

Definite-lived intangible assets represent certain trade names, patents, licenses, software, acquired technology and customer relationships. Definite-lived intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses, if any. Definite-lived intangible assets acquired through the business combination are measured at fair value at the acquisition date. The Company amortizes these acquired definite-lived intangibles assets with a finite life on a straight-line basis, over 6 years for technology; 7 years for customer relationships; and 8 years for trademarks and trade names.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions (e.g., stock-based compensation valuation, allowance for doubtful accounts, valuation of inventory and intangible assets, warranty reserve, accrued expense and recognition and measurement of contingencies) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenue and expense during the reporting period. Actual results could materially differ from those estimates.

 

6

 

Warrants

 

The Company accounts for warrants as liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

For issued warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company accounts for the warrants issued in accordance with the guidance contained in ASC 815-40-15-7C, under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statement of operations.

 

Convertible Preferred Stocks

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 480 and ASC 815 to determine if those instruments or embedded components of those instruments qualify as derivatives and are subject to bifurcation accounting. The Company determines that the economic characteristics and risks of the embedded derivative instrument are clearly and closely related to the economic characteristics and risks of the host contract. The convertible instruments are accounted for as a single hybrid instrument. Additionally, the convertible instruments do not have any redemption features that would preclude permanent equity classification in accordance with the guidance contained in ASC 480-10-S99.

 

The Company issued the Warrants, which are classified as liabilities and measured at fair value on a recurring basis, and Convertible Preferred Stocks in one transaction. The issuance proceeds were allocated by using the with-and-without method. Under this method, The Company first allocated the issuance proceeds to the Warrants based on their initial fair value measurement, and then allocated the remaining proceeds to the Convertible Preferred Stocks.

 

Loss per Share

 

Basic loss per share (EPS) is computed by dividing net loss, less any dividends, accretion or decretion, redemption or induced conversion, if any, on our Series A Convertible Preferred Stock, by the weighted average number of shares outstanding during the reported period.

 

In computing diluted EPS, we adjust the numerator used in the basic EPS computation, subject to anti-dilution requirements, to add back the dividends (declared or cumulative undeclared) applicable to the Series A Convertible Preferred Stock. Such add-back would also include any adjustments to equity in the period to accrete the Series A Convertible Preferred Stock to its redemption price, or recorded upon a redemption or induced conversion, if any. We adjust the denominator used in the basic EPS computation, subject to anti-dilution requirements, to include the dilution from potential shares resulting from the issuance of the Series A Convertible Preferred Stock, restricted stock units, and stock options. Stock options and restricted stock units exercisable or issuable for a total of 2,668,750 and 6,396,277 shares of Common Stock were outstanding at September 30, 2023, and 2022, respectively. These securities are not included in the computation of diluted net loss per common share for the periods presented as their inclusion would be antidilutive due to losses incurred by the Company.

 

Recent Issued Accounting Guidance

 

The Company has reviewed recently issued, but not yet effective, accounting pronouncements and does not believe the future adoptions of any such pronouncements will be expected to cause a material impact on its financial condition or the results of operations.

 

In July 2023, the SEC adopted the final rule under SEC Release No. 33-11216, Cybersecurity Risk Management, Strategy, Governance, and Incident Disclosure, requiring disclosure of material cybersecurity incidents on Form 8-K and periodic disclosure of a registrant’s cybersecurity risk management, strategy and governance in annual reports. Regulation S-K Item 6 disclosure requirements under this rule will be effective for us in the fourth quarter of 2023. Incident disclosure requirements in Form 8-K will be effective for us on June 15, 2024. We are still evaluating for any impact on our financial statement disclosures from the adoption of this final rule.

 

Recent Developments

 

On August 9, 2023, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Intrensic, LLC, a Delaware limited liability company (“Intrensic”), and certain members of Intrensic, including Kevin Mullins, the Company’s Chief Executive Officer (collectively, “Sellers”). Under the terms of the Purchase Agreement, the Company agreed to purchase, and Sellers agreed to sell, 100% of the membership interests (the “Membership Interests”) of Intrensic for the following consideration upon the consummation of the sale of the Membership Interests (the “Intrensic Closing”): (i) $553,588 in cash, subject to adjustment based upon the outstanding indebtedness of Intrensic and Intrensic’s working capital as of the Intrensic Closing; and (ii) 1,250,000 shares of Common Stock of the Company (collectively, the “Purchase Price”) (the “Intrensic Acquisition”).

 

Kevin Mullins, a director of the Company and the Company’s Chief Executive Officer, owns approximately 9.53% of the Membership Interests, and as such, has a financial interest in the Intrensic Acquisition.

 

7

  

 

2.          REVENUE AND PRODUCT COSTS

 

Revenue consists of product revenue and other revenue. Product sales include BolaWrap products and accessories. Other revenue includes VR revenue, service, training and shipping revenue.

 

Periodically, certain customers request bill and hold transactions for future delivery as scheduled and designated by them. In such cases, revenue is not recognized until after control, title and risk of ownership has transferred which is generally when the customer has requested such transaction under normal billing and payment terms and has been notified that the product (i) has been completed according to customer specifications, (ii) has passed quality control inspections, and (iii) has been tagged and packed for shipment, separated from other inventory and ready for physical transfer to the customer. The value associated with custodial storage services is deemed immaterial in the context of such contracts and in total, and accordingly, none of the transaction price is allocated to such service.

 

The timing of revenue recognition may differ from the timing of invoicing to customers. The Company generally has an unconditional right to consideration when customers are invoiced, and a receivable is recorded. A contract asset is recognized when revenue is recognized prior to invoicing, or a contract liability (deferred revenue) when revenue will be recognized subsequent to invoicing. The Company recognizes an asset if there are incremental costs of obtaining a contract with a customer such as commissions. These costs are ascribed to or allocated to the underlying performance obligations in the contract. The Company may receive consideration, per terms of a contract, from customers prior to transferring goods to the customer. The Company records customer deposits as a contract liability. Additionally, the Company may receive payments, most typically for service and warranty contracts, at the onset of the contract and before the services have been performed. In such instances, a deferred revenue liability is recorded. The Company recognizes these contract liabilities as revenue after all revenue recognition criteria are met. The table below details the activity in our contract liabilities during the nine months ended September 30, 2023.

 

   

Customer

   

Deferred

 
   

Deposits

   

Revenue

 

Balance at January 1, 2023

  $ -     $ 333  

Additions, net

    2       229  

Transfer to revenue

    -       (197

)

Balance at September 30, 2023

  $ 2     $ 365  

Current portion

  $ 2     $ 189  

Long-term portion

  $ -     $ 176  

 

At September 30, 2023, the Company’s deferred revenue of $365 consisted of $199 related to VR, $6 related to training and $160 related to BolaWrap extended warranties and services. At December 31, 2022, the Company’s deferred revenue of $333 consisted of $198 related to VR, $11 related to training and $124 related to BolaWrap extended warranties and services.

 

Estimated costs for the Company’s standard warranty, generally one-year, are charged to cost of products sold when revenue is recorded for the related product. Royalties are also charged to the cost of products sold.

  

 

3.          FINANCIAL INSTRUMENTS

 

Assets and liabilities recorded at fair value on a recurring basis in the Condensed Consolidated Balance Sheets and assets and liabilities measured at fair value on a non-recurring basis or disclosed at fair value, are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The accounting guidance also establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows:

 

8

 

Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

 

Level 2—Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and

 

Level 3—Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.

 

The Company’s short-term investments consisting of U.S. Treasury bill securities and Certificate of Deposits are classified as Level 1 because they are valued using quoted market prices.

 

The following table shows the Company’s short-term investments by significant investment category as of September 30, 2023, and December 31, 2022.

 

   

As of September 30, 2023

 
   

Adjusted

   

Unrealized

   

Unrealized

   

Market

 
   

Cost

   

Gains

   

Losses

   

Value

 

Level 1:

                               

Certificate of Deposits

    10,000       -       -       10,000  

Total Financial Assets

  $ 10,000     $ -     $ -     $ 10,000  

 

   

As of December 31, 2022

 
   

Adjusted

   

Unrealized

   

Unrealized

   

Market

 
   

Cost

   

Gains

   

Losses

   

Value

 

Level 1:

                               

U.S. Treasury securities in short-term investments

    9,849       100       -       9,949  

Certificate of Deposits

    4,000       -       -       4,000  

Total Financial Assets

  $ 13,849     $ 100     $ -     $ 13,949  

 

Unrealized gains or losses resulting from our short-term investments are recorded in accumulated other comprehensive gain or loss as they are classified as available for sale. During the three and nine months ended September 30, 2023, no gain (loss) was recorded to other comprehensive gain (loss). During the three and nine months ended September 30, 2022, a $73 gain and $62 gain was recorded to other comprehensive gain (loss), respectively.

 

The warrant liabilities are measured at fair value on a recurring basis. The subsequent measurement of the warrant liabilities as of September 30, 2023, is classified as Level 3 due to the use of an observable market quote in a non-active market and the management’s assumption of the expected stock price volatility.

 

The following table presents the fair value in the beginning of the period, the changes in the fair value, and the fair value at the end of the period of warrant liabilities (in thousands):

 

Level 3:  

September 30,

2023

   

December 31,

2022

 

Fair value at inception or the beginning of the period

  $ 7,717       -  

Change in fair value of warrant liabilities

    117       -  

Fair value as of September 30, 2023

  $ 7,834       -  

 

9

 

The Company uses the modified Black-Scholes option pricing model to determine the fair value of warrant liabilities. The following table summarizes the assumptions used to compute the fair value of Warrants:

 

   

As of

September 30,

2023

   

As of

December 31,

2022

 

Expected stock price volatility

    100

%

    -

%

Risk-free interest rate

    4.49

%

    -

%

Dividends yield

    0

%

    -

%

Expected life of warrants

    4.75       -  

Exercise price

  $ 1.45     $ -  

 

Our other financial instruments also include accounts receivable, accounts payable, accrued liabilities and business acquisition liabilities. Due to the short-term nature of these instruments, their fair values approximate their carrying values on the balance sheet.

  

 

4.          INVENTORIES

 

Inventory is recorded at the lower of cost or net realizable value. The cost of substantially all the Company’s inventory is determined by the FIFO cost method. Inventories consisted of the following:

 

   

September 30,

2023

   

December 31,

2022

 

Finished goods

  $ 2,921     $ 2,293  

Work in process

    -       -  

Raw materials

    2,895       1,682  

Inventories - net

  $ 5,816     $ 3,975  

  

 

5.          PROPERTY AND EQUIPMENT, NET

 

Property and equipment consisted of the following:

 

   

September 30,

2023

   

December 31,

2022

 

Production and lab equipment

  $ 536     $ 513  

Tooling

    505       448  

Computer equipment

    587       531  

Furniture, fixtures and improvements

    190       181  
      1,818       1,673  

Accumulated depreciation

    (1,285 )     (915

)

Property and equipment, net

  $ 533     $ 758  

 

Depreciation expense was $122 and $358 for the three and nine months ended September 30, 2023, respectively, and $121 and $359 for the three and nine months ended September 30, 2022, respectively.

 

10

  

 

6.          INTANGIBLE ASSETS AND GOODWILL

 

Intangible Assets, net

 

Intangible assets, net consisted of the following:

 

   

September 30,

2023

   

December 31,

2022

 

Amortizable intangible assets:

               

Patents

  $ 841     $ 575  

Trademarks

    241       150  

Purchased software and technology

    2,452       1,962  
Customer Relationships     160       -  
      3,694       2,687  

Accumulated amortization

    (778 )     (462

)

Total amortizable

    2,916       2,225  

Indefinite life assets (non-amortizable)

    403       344  

Total intangible assets, net

  $ 3,319     $ 2,569  

 

Amortization expense was $150 and $317 for the three and nine months ended September 30, 2023, respectively, and $72 and $215 for the three and nine months ended September 30, 2022, respectively.

 

At September 30, 2023, future amortization expense is as follows:

 

2023 (3 months)

  $ 164  

2024

    655  

2025

    650  

2026

    427  

2027

    180  

Thereafter

    840  

Total estimated amortization expense

  $ 2,916  

 

 

Goodwill

 

The table below summarizes the changes in the carrying amount of goodwill:

 

Balance at January 1, 2023   $ -  
Acquired goodwill     1,611  
Balance at September 30, 2023   $ 1,611  

  

 

7.          ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

Accounts payable includes $122 and $127 due to related party Syzygy Licensing, LLC (“Syzygy”) as of September 30, 2023, and December 31, 2022, respectively. See Note 11 for additional information on this related party.

 

Accrued liabilities consist of the following:

 

   

September 30,

2023

   

December 31,

2022

 

Patent and legal costs

  $ 61     $ 135  

Accrued compensation

    786       1,100  

Warranty costs

    109       125  

Taxes and other

    172       103  

Total

  $ 1,128     $ 1,463  

 

Accrued compensation includes $139 and $1,022 in employee bonuses and commissions payable at September 30, 2023 and December 31, 2022, respectively.

 

Changes in our estimated product warranty costs were as follows:

 

   

Nine Months Ended

September 30,

 
   

2023

   

2022

 

Balance, beginning of period

  $ 125     $ 96  

Warranty settlements

    (8 )     (63

)

Release of warranty provision

    (8 )     55  

Balance, end of period

  $ 109     $ 88  

 

11

  

 

8.          WARRANTS

 

On June 29, 2023, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain directors of the Company and certain accredited and institutional investors (collectively, the “Investors”), pursuant to which it agreed to sell to the Investors in a private placement (the “Offering”): (i) warrants to acquire up to an aggregate of 6,896,553 shares of Common Stock (the “Warrants”) and (ii) Series A Convertible Preferred Stock (Note 9). The warrants are exercisable six months after issuance at an exercise price of $1.45 per share, subject to adjustment, and expire five years from the date of issuance. The closing of the Offering occurred on July 3, 2023. The aggregate gross proceeds from the Offering were $10,000. $7,717 of $10,000 was allocated to the Warrants.

  

 

9.          STOCKHOLDERS' EQUITY

 

The Company’s authorized capital consists of 150,000,000 shares of Common Stock and 5,000,000 shares of preferred stock, par value $0.0001 per share (“Preferred Stock”).

 

On July 3, 2023, the Company filed a Certificate of Designations (the “Series A COD”) with the State of Delaware, designating 10,000 shares of its Preferred Stock as Series A Convertible Preferred Stock, $0.0001 per share (the “Series A Preferred”). Shares of Series A Preferred are convertible into Common Stock (the “Conversion Shares”) at an initial conversion price of $1.45 (the “Conversion Price”), subject to customary adjustments and price-based as defined in the Series A COD. Holders of Series A Preferred Shares are entitled to dividends of 8% per annum, payable quarterly, subject to adjustment upon the occurrence of certain events in accordance with the terms of the Series A COD. The holders of Series A Preferred have no voting rights on account of the Preferred Shares, other than with respect to certain matters affecting the rights of the Preferred Shares.

 

On June 29, 2023, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain directors of the Company and certain accredited and institutional investors (collectively, the “Investors”), pursuant to which it agreed to sell to the Investors in a private placement (the “Offering”): (i) the Warrants Note 8 and (ii) an aggregate of 10,000 shares of the Company’s newly designated Series A Convertible Preferred Stock, with par value $0.0001 per share and a stated value of $1,000 per share, initially convertible into up to 6,896,553 shares of the Company’s common stock, par value $0.0001 per share at a conversion price of $1.45 per share, subject to customary adjustments and price-based as defined in the Series A Certificate of Designations (the “Convertible Preferred Stocks”). The customary adjustments include: (i) additional amounts related to declared and unpaid Dividends and any other unpaid amounts due and payable and (ii) make-whole amounts related to the accrual of any additional dividends that would have accrued up to the date of conversion including the one-year anniversary from the date of conversion. Each preferred stock has a stated value of $1,000 per share, and holders thereof are entitled to cumulative dividends of 8% per annum on the stated value, payable quarterly in arrears, subject to adjustment upon the occurrence of certain events in accordance with the terms of the Convertible Preferred Stocks. The holders of Convertible Preferred Stocks have no voting rights on account of the Convertible Preferred Stocks, other than with respect to certain matters affecting the rights of the Convertible Preferred Stocks. $2,036 of the aggregate gross proceeds was allocated to the Convertible Preferred Stocks. In September 2023, the Company authorized and declared $193 dividend which was an accrued in accounts payable as of September 30, 2023.

  

 

10.          SHARE-BASED COMPENSATION

 

On March 31, 2017, the Company adopted, and the stockholders approved, the 2017 Stock Incentive Plan (the “Plan”) authorizing 2,000,000 shares of Common Stock for issuance as awards to employees, directors or consultants. In May 2019, the stockholders ratified an increase in the Plan authorizing an additional 2,100,000 shares of Common Stock; in June 2020 ratified an additional 1,900,000 shares of Common Stock; in June 2021 ratified an additional 1,500,000 shares of Common Stock; and in June 2022 ratified an additional 1,500,000 shares of Common Stock; for a total of 9,000,000 shares subject to the Plan. At September 30, 2023, there were 4,438,539 shares of Common Stock remaining available for grant under the Plan.

 

The Company generally recognizes share-based compensation expense on the grant date and over the period of vesting or period that services will be provided. In April 2023 the Company recognized severance acceleration of $178 of share-based compensation expense resulting from the resignation of the Company’s Chief Executive Officer and Chief Operating Officer due to a reduction in force that resulted in changes in the composition of the executives of the Company. In January 2022 the Company recognized severance acceleration of $242 of share-based compensation expense resulting from the resignation of the Company’s Chief Executive Officer as part of a management transition plan.

 

12

 

Stock Options

 

The following table summarizes stock option activity for the nine months ended September 30, 2023:

 

           

Weighted Average

         
   

Options on

Common

Shares

   

Exercise

Price

   

Remaining

Contractual

Term

   

Aggregate

Intrinsic

Value

 

Outstanding January 1, 2023

    5,491,399     $ 3.72       5.96     $ 92  

Granted

    60,000     $ 1.34                  

Exercised

    (250

)

  $ 1.50                  

Forfeited, cancelled, expired

    (3,329,476

)

  $ 5.54                  

Outstanding September 30, 2023

    2,221,673     $ 3.56       7.65     $ 10  

Exercisable September 30, 2023

    1,033,504     $ 4.37       7.02     $ -  

 

At September 30, 2023, there were 1,529,275 service-based stock options outstanding, and 692,398 performance-based stock options outstanding, which performance-based stock options were granted in April 2022 to the Company’s former Chief Executive Officer and President, subject to future market capitalization targets. 1,207,698 of the 2,221,673 stock options granted included in the table above were granted in April 2022 outside the Plan as an employment inducement grant but are subject to the terms and conditions of the Plan.

 

The Company uses the Black-Scholes option pricing model to determine the fair value of service-based options granted. The following table summarizes the assumptions used to compute the fair value of options granted to employees and non-employees:

 

   

For the Nine Months

 
   

Ended September 30,

 
   

2023

   

2022

 

Expected stock price volatility

    49

%

    49

%

Risk-free interest rate

    3.64

%

    1.17

%

Expected dividend yield     0 %     0 %

Expected life of options

    6.66       3.46  

Weighted-average fair value of options granted

  $ 0.55     $ 1.25  

 

Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of awards. The Company’s estimated volatility was based on an average of the historical volatility of peer entities whose stock prices were publicly available. The Company’s calculation of estimated volatility is based on historical stock prices of these peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price. The Company records forfeitures as they are incurred.

 

The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the options. The dividend yield of zero is based on the fact that the Company has never paid cash dividends and has no present intention to pay cash dividends. The Company calculates the expected life of the options using the Simplified Method for the employee stock options as the Company does not have sufficient historical exercise data.

 

The Company used the Monte Carlo Simulation Model to value at the grant date the aggregate of 1,614,230 market condition performance options granted in April 2022 to the Company’s former Chief Executive Officer and President. The assumptions used in the Monte Carlo Simulation were stock price on date of grant of $2.89, contract term of 10 years, expected volatility of 49% and risk-free interest rate of 2.9%. Vesting is based on sustained market capitalization of $250 million, $500 million and $1 billion and resulted in implied service periods ranging from approximately 4 to 7 years. At September 30, 2023, 921,832 of the 1,614,230 market condition performance options granted in April 2022 were cancelled.

 

Stock option expense was $(169) and $399 for the three and nine months ended September 30, 2023, respectively, and $308 and $1,448 for the three and nine months ended September 30, 2022, respectively.

 

13

 

Restricted Stock Units

 

The Plan provides for the grant of restricted stock units (“RSUs”). RSUs are settled in shares of the Company’s Common Stock as the RSUs become vested. The following table summarizes RSU activity for the nine months ended September 30, 2023:

 

   

Service-Based

RSU's

   

Weighted

Average

Grant Date

Fair Value

   

Weighted

Average

Vesting

Period

(Years)

 

Unvested at January 1, 2023

    922,057     $ 2.88       2.11  

Granted - service based

    686,394     $ 1.33          

Vested

    (862,993

)

  $ 2.87          

Forfeited and cancelled

    (298,381

)

  $ 2.47          

Unvested at September 30, 2023

    447,077     $ 2.00       1.74  

 

RSU expense was $(33) and $1,249 for the three and nine months ended September 30, 2023, respectively, and $564 and $1,180 for the three and nine months ended September 30, 2022, respectively.

 

Share-Based Compensation Expense

 

The Company recorded share-based compensation for options and RSUs in its statements of operations for the relevant periods as follows:

 

   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
   

2023

   

2022

   

2023

   

2022

 

Selling, general and administrative

  $ (149 )   $ 700     $ 1,404     $ 2,180  

Research and development

    (53 )     172       244       448  

Total share-based expense

  $ (202 )   $ 872     $ 1,648     $ 2,628  

 

As of September 30, 2023, total estimated compensation cost of stock options granted and outstanding but not yet vested was $1,168 which is expected to be recognized over the weighted average period of 2.73 years.

 

As of September 30, 2023, total estimated compensation cost of RSUs granted and outstanding but not yet vested was $757 which is expected to be recognized over the weighted average period of 1.61 years.

 

 

11.          DEFINED CONTRIBUTION PLAN

 

The Company has a defined contribution savings plan for all eligible U.S. employees established under the provisions of Section 401(k) of the Internal Revenue Code. This plan was formed on January 1, 2022. Eligible employees may contribute a percentage of their salary subject to certain limitations. The Company’s contributions for each of the three and nine months ended September 30, 2023, and year ended December 31, 2022, was $0.

  

 

12.          COMMITMENTS AND CONTINGENCIES

 

Related Party Technology License Agreement

 

The Company is obligated to pay royalties and development and patent costs pursuant to an exclusive Amended and Restated Intellectual Property License Agreement dated as of September 30, 2016, with Syzygy, a company owned and controlled by stockholder/consultant Mr. Elwood Norris and stockholder/consultant Mr. James Barnes. The agreement provides for royalty payments of 4% of revenue from products employing the licensed ensnarement device technology up to an aggregate of $1,000 in royalties or until September 30, 2026, whichever occurs earlier. The Company recorded $122 and $185 for royalties during the three and nine months ended September 30, 2023, respectively, and $61 and $147 for royalties during the three and nine months ended September 30, 2022, respectively. The maximum payout still available under this arrangement is $95 as of September 30, 2023.

 

Service Provider Agreement

 

Pursuant to the Professional Services and Technology Acquisition Agreement (the “Agreement”) entered into with Lumeto, Inc. and Spatial Industries Group, Inc. (collectively, “Service Provider”) on November 22, 2022, as amended on April 2, 2023, the Service Provider provided to the Company certain technology, services, and perpetual licenses for use within the Company’s Wrap Reality virtual simulation training platform (the “Technology, Services, and License”) in consideration for a cash payment of $700 to the Service Provider, which was completed as of June 30, 2023. The Company has no ongoing or future commitments, responsibilities, or obligations related to this matter.

 

14

 

Purchase Commitments

 

At September 30, 2023, the Company was committed for approximately $1,690 for future component deliveries that are generally subject to modification or rescheduling in the normal course of business.

 

Indemnifications and Guarantees

 

Our officers and directors are indemnified as to personal liability as provided by the Delaware law and the Company’s articles and bylaws. The Company may also undertake indemnification obligations in the ordinary course of business related to its operations. The Company is unable to estimate with any reasonable accuracy the liability that may be incurred pursuant to any such indemnification obligations now or in the future. Because of the uncertainty surrounding these circumstances, the Company’s current or future indemnification obligations could range from immaterial to having a material adverse impact on its financial position and its ability to continue in the ordinary course of business. The Company has no liabilities recorded for such indemnities.

 

Regulatory Agencies

 

The Company is subject to oversight from regulatory agencies regarding firearms that arise in the ordinary course of its business.

 

Litigation

 

The Company is subject to litigation and other claims in the ordinary course of business. The Company records a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed and adjusted to include the impacts of negotiations, estimated settlements, legal rulings, advice of legal counsel, and other information and events pertaining to a particular matter. At September 30, 2023, we had no provision for liability under existing litigation.

 

13.          RELATED PARTY TRANSACTIONS

 

Commencing in October 2017 the Company began reimbursing Mr. Elwood Norris, a former officer, current 10% stockholder and consultant of the Company, $1.5 per month on a month-to-month basis for laboratory facility expense, for an aggregate of $4.5 and $13.5 during the three and nine months ended September 30, 2023, and 2022, respectively. Mr. Norris retired as the Company’s Chief Technology Officer effective September 30, 2021, and commencing July 1, 2021, was engaged as a month-to-month consultant. Mr. Norris was paid a monthly fee of $7.5 per month for aggregate consulting payments of $22.5 and $67.5 during each of the three and nine months ended September 30, 2023, and 2022.

 

On June 29, 2023, we entered into the Purchase Agreement with certain investors, including Mr. Scot Cohen, the Executive Chairman of the Company, and V4, an entity over which Mr. Cohen exercises control and whose securities are beneficially owned by Mr. Cohen (the “Affiliated Offering”), pursuant to which the Company issued to Mr. Cohen and V4 an aggregate of 3,000 Series A Preferred and warrants to purchase up to an aggregate of 2,068,966 shares of Common Stock for aggregate gross proceeds of $3,000,000 (excluding the proceeds the Company may receive from the exercise of the warrants issued in the Affiliated Offering) (the “Affiliated Proceeds”). The Certificate of Designation for the Series A Preferred provides that Series A Preferred held by a holder who serves as a director, officer or is an employee of the Company shall only be convertible into shares of Common Stock following receipt of approval of a majority of the Company’s stockholders (“Stockholder Approval”). Similarly, any warrant issued to one of our directors may not be exercised prior to date that is the later of (x) the date on which the Company received Stockholder Approval and (y) the date that is six months from the date of issuance). Stockholder Approval was attained at a special meeting of stockholders held on September 19, 2023. 

 

On August 9, 2023, the Company entered into the Purchase Agreement with Intrensic and the Sellers, including Kevin Mullins, a director of the Company and its Chief Executive Officer. Under the terms of the Purchase Agreement, the Company agreed to purchase, and Sellers, including Mr. Mullins, agreed to sell, 100% of the Membership Interests of Intrensic for the following consideration: (i) $554 in cash, subject to adjustment based upon the outstanding indebtedness of Intrensic and Intrensic’s working capital; and (ii) 1,250,000 shares of Common Stock of the Company. Kevin Mullins owns approximately 9.53% of the Membership Interests, and as such, has a financial interest in the sale of Intrensic to the Company.

 

See Notes 1, 7 and 12 for additional information on related party transactions and obligations.

 

14.          MAJOR CUSTOMERS AND RELATED INFORMATION

 

For the three months ended September 30, 2023, revenue from two distributors accounted for approximately 62% and 12% of revenue with no other single customer accounting for more than 10% of total revenue. For the three months ended September 30, 2022, revenue from one distributor accounted for approximately 59% of revenue with no other single customer accounting for more than 10% of total revenue.

 

15

 

For the nine months ended September 30, 2023, revenue from one distributor accounted for approximately 41% of revenue with no other single customer accounting for more than 10% of total revenue. For the nine months ended September 30, 2022, revenue from one distributor accounted for approximately 39% of revenue with no other single customer accounting for more than 10% of total revenue.

 

At September 30, 2023, accounts receivable from one distributor accounted for 51% of net accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance. At December 31, 2022, accounts receivable from one distributor accounted for 70% of net accounts receivable.

 

The following table summarizes revenue by geographic region. Revenue is attributed to countries based on customer’s delivery location:

 

   

For the Three Months

   

For the Nine Months

 
   

Ended September 30,

   

Ended September 30,

 
   

2023

   

2022

   

2023

   

2022

 

Americas

  $ 1,347     $ 1,478     $ 3,225     $ 3,484  

Europe, Middle East and Africa

    2,284       220       2,320       435  

Asia Pacific

    -       3       (1 )     545  
Total revenues   $ 3,631     $ 1,701     $ 5,544     $ 4,464  

  

 

15.          BUSINESS COMBINATION

 

The Company entered into the Purchase Agreement with Intrensic and the Sellers with an effective date of August 9, 2023 (the (“Closing”).  The Closing was consummated on August 16, 2023.  Under the terms of the Purchase Agreement, the Company agreed to purchase, and Sellers agreed to sell the  Membership Interests for the following consideration at Closing: (i) $554 in cash, subject to adjustment based upon the outstanding indebtedness of Intrensic and Intrensic’s working capital as of the Closing; and (ii) 1,250,000 shares of Common Stock of the Company valued at approximately $1,938.

 

The Company assessed the historical financial information of Intrensic to determine if it would materially impact Wrap's historical financial statements for the purposes of disclosing proforma financial information. The Company determined that in the current or prior reporting periods the acquired business contributed immaterially to the Company’s financial statements . Therefore, a pro forma disclosure of the Company as if the business combination had occurred is not warranted under ASC 805.

 

The preliminary purchase price is not finalized. The Company is still evaluating the impact of the income tax provision related to the acquisition and assessing the assumed contracts related to deferred revenue.

 

The table below sets forth the preliminary allocation of the fair value of Intrensic’s net assets acquired and the corresponding line item in the Company’s consolidated balance sheet at the date of acquisition.

  

Cash and cash equivalents

  $ 3  

Accounts receivable

    90  

Inventory

    61  

Net property, plant and equipment

    -  

Technology

    490  

Customer relationships (included in Intangibles)

    160  

Trademarks and trade names (included in Intangibles)

    80  

Goodwill

    1,611  

Total assets

  $ 2,495  
         

Liabilities

    3  

Equity

    2,492  

Total liabilities and equity

  $ 2,495  
         

Purchase Price:

       

Cash

    554  

Equity

    1,938  

Liabilities assumed

    3  

Total

  $ 2,495  

 

Legal fees incurred in connection with the transaction totaled approximately $38 and have been expensed as incurred.

 

16

  

 

16.          SUBSEQUENT EVENTS

 

Appointment of Executive Chairman

 

On October 12, 2023, the Board of Directors (the “Board”) appointed Scot Cohen, the Company’s current Chairman of the Board, to the position of Executive Chairman, effective October 12, 2023 (the “Effective Date”). Mr. Cohen cofounded the Company in March 2016, and has previously served as the Executive Chairman of the Company from July 2017 until June 2021.

 

In connection with Mr. Cohen’s appointment as Executive Chairman, the Company and Mr. Cohen entered into an agreement on October 12, 2023 (the “Agreement”). Pursuant to the Agreement, unless earlier terminated pursuant to the terms therein, Mr. Cohen will serve as the Company’s Executive Chairman for an initial term of two years from the effective date of his appointment. As compensation for Mr. Cohen’s services to the Company, the Agreement entitles Mr. Cohen to an annualized base salary of $200,000 (the “Base Salary”) and eligibility to participate in customary benefits offered to other executives of the Company.

 

The Agreement further provides for:

 

A grant of that number of restricted shares (“RSAs”) of the Company’s Common Stock equal to $675,000 divided by $1.40, representing the closing price of Common Stock as reported on the Nasdaq Capital Market on October 12, 2023 (the “Closing Price”) for the date of grant (the “Grant Date”), which RSAs are subject to certain vesting conditions based on the achievement of certain targets based on total market capitalization of the Company.

 

A nonqualified option to purchase up to that number of shares of Common Stock with a Grant Date fair value equal to $675,000 divided by the Closing Price (the “Option”), an exercise price equal to the Closing Price, and a term of 10 years, which Option vests based on Mr. Cohen’s continued employment with the Company and the achievement of certain budgeted revenue targets established by the Board; and

 

A nonqualified option to purchase up to 2.25% of the number of shares of the Company’s Common Stock that are issued and outstanding (determined on a fully-diluted basis, including, without limitation, any shares issuable upon the conversion or exercise of any outstanding warrants or preferred stock) as of the Effective Date (the “Performance Option”), at an exercise price equal to the Closing Price, and a term of 10 years, which Performance Option vests, subject to Mr. Cohen’s continued employment with the Company through each vesting date, in accordance with the same vesting conditions as provided for in the RSAs.

 

The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by the full text of the Agreement, a copy of which is filed as Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on October 16, 2023.

 

Resignations of Michael Parris and Wayne Walker

 

Effective October 11, 2023 (the “Mr. Parris Resignation Date”), and October 12, 2023 (the “Mr. Walker Resignation Date”), Michael Parris and Wayne Walker, respectively, resigned from their positions as members of the Board. Neither director’s decision to resign was the result of any dispute or disagreements with the Company on any matter relating to the Company’s operations, policies or practices.

 

Appointment of Rajiv Srinivasan and Timothy Szymanski

 

On October 12, 2023, Rajiv Srinivasan and Timothy Szymanski were appointed to serve as members of the Board to fill the vacancies created as a result of the resignations of Messrs. Parris and Walker, until the Company’s next annual meeting of stockholders or until their respective successors are duly elected and qualified.

 

Miami Office Lease

 

The Company has entered into an 89-month lease for 4,487 square feet of office space in Miami, Florida, starting from November 1, 2023. This leasing arrangement aims to enhance the Company's footprint on the East Coast and in international markets.

 

In accordance with the Subsequent Events Topic of the FASB ASC 855, we have evaluated subsequent events through the filing date and determined that no additional subsequent events occurred that were reasonably expected to impact the consolidated condensed financial statements presented herein.

 

17

 

 

 

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

 

You should read the following discussion in conjunction with the financial statements and other financial information included elsewhere in this Quarterly Report on Form 10-Q (this Report) and with our audited financial statements and other information presented in our Annual Report on Form 10-K for the year ended December 31, 2022 (the Annual Report). The following discussion may contain forward-looking statements that reflect our plans, estimates and beliefs. Words such as expect, anticipate, intend, plan, believe, seek, estimate, continue, may, will, could, would, or the negative or plural of such words and similar expressions or variations of such words are intended to identify forward-looking statements but are not the only means of identifying forward-looking statements. Such forward-looking statements are subject to a number of risks, uncertainties, assumptions and other factors that could cause actual results and the timing of certain events to differ materially from future results expressed or implied by the forward-looking statements. Factors that could cause or contribute to these differences include, but are not limited to, those discussed below and elsewhere in this Report and in our other filings with the Securities and Exchange Commission (SEC), including particularly matters set forth under Part I, Item 1A (Risk Factors) of the Annual Report. Furthermore, such forward-looking statements speak only as of the date of this Report. Except as required by law, we undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements. For purposes of Management's Discussion and Analysis within this Report, all monetary amounts are stated in thousands except for par values and per share amounts, unless otherwise stated.

 

Overview

 

We are a global public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. We are leading the movement for safer outcomes by equipping law enforcement with safe, non-pain compliance tools and immersive training for the modern world. We began sales of our first public safety product, the BolaWrap 100 remote restraint device, in late 2018. In late 2020 we added a new solution to our public safety technologies, which is our virtual reality (“VR”) training platform – Wrap Reality. Wrap Reality is now sold to law enforcement agencies for simulation training as well as corrections departments for the societal reentry scenarios. In Q1 2022 we delivered a new generation product, the BolaWrap 150. The BolaWrap 150 is electronically deployed and is more robust, smaller, lighter and simpler to deploy than the BolaWrap 100 that has been phased out.

 

Our target market for our solutions includes approximately 900,000 full-time sworn law enforcement officers in over 18,000 federal, state, and local law enforcement agencies in the U.S. and over 12 million police officers in more than 100 countries. Additionally, we are exploring opportunities in other domestic markets, such as military and private security. Our international focus is on countries with the largest police forces. According to 360iResearch, a market research consulting firm, our non-lethal products are part of a global market segment expected to grow to $16.1 billion by 2027.

 

We focus our efforts on the following products and services:

 

BolaWrap Remote Restraint Device – is a hand-held remote restraint device that discharges a seven and half-foot Kevlar tether to entangle an individual at a range of 10-25 feet. BolaWrap assists law enforcement to safely and effectively control encounters early without resorting to painful force options.

 

Wrap Reality – is a law enforcement 3D training system employing immersive computer graphics VR with proprietary software-enabled content. It allows up to two participants to enter a simulated training environment simultaneously, and customized weapons controllers enable trainees to engage in strategic decision making along the force continuum. Wrap Reality has 43 scenarios for law enforcement and corrections and 25 scenarios at this time for societal reentry. Wrap Reality is one of the most robust 3D Virtual Reality solutions on the market for law enforcement and societal reentry today.

 

Wrap Intrensic is a Body-Worn Camera (BWC) and Digital Evidence Management (DEM) solutions provider.  BWC and DEM play crucial role in capturing, storing, and managing digital evidence, such as video and audio recordings for various purposes, including criminal investigations and maintaining transparency in public interactions. The Wrap Intrensic X2 camera hardware and storage and data management capability, along with awareness of front-line operations, provides customers with a solution to meet the challenges.  Wrap Intrensic Evidence on Cloud provides an unlimited video storage platform that includes video and other evidence uploading, search, retrieval, redaction, and evidence sharing while reducing the need for resources required to manage this evidence.

 

In addition to the US law enforcement market, we have shipped our restraint products to 62 countries. We have established an active distributor network representing 50 states and one dealer representing the US territory of Puerto Rico. We have distribution agreements with 49 international distributors covering 54 countries. We focus significant sales, training and business development efforts to support our distribution network in addition to our internal sales team.

 

We focus significant resources on research and development innovations and continue to enhance our products and plan to introduce new products. We believe we have established a strong brand and market presence globally and have established significant competitive advantages in our markets.

 

18

 

Business Outlook and Challenges

 

We believe our Company's products and solutions are gaining global recognition and awareness through active use across multiple agencies and continued acceptance worldwide as well as various marketing channels such as demos, social media, trade shows, and media exposure, among others. In part, this recognition and awareness can be attributed to positive feedback from law enforcement agencies and the successful deployment of our products. As a result, our brand, Wrap, is becoming increasingly recognized on a global scale as a leader in remote restraint and non-lethal solutions.

 

In addition, we are focused on aggressive marketing and public relations efforts. We are confident in the potential market opportunities for our solutions in remote restraint, virtual reality solutions and digital evidence management in the law enforcement and security sectors worldwide. These opportunities are driven by the increasing demand for less-lethal policing, continued training, and transparency driven by community demands and local laws.

 

In the law enforcement sector, our BolaWrap product has been successfully deployed in the field, as reported by agencies worldwide. BolaWrap is now in use by almost 1,000 US law enforcement agencies and in 62 countries. Due to its safe remote restraint capabilities, many agencies do not deem its usage a categorical reportable use of force and rather place it underneath early use of force such as handcuffs. We train law enforcement agencies deploy BolaWrap when verbal commands breakdown but long before there is justifiable escalation to pain inducing tools such as: pepper spray, pepper ball, batons, bean bags, tasers or Conducted Electrical Weapons (CEW’s) or firearms.

 

Agencies voluntarily report usage to Wrap. In the usage reports we have been provided; officers have reported successful outcomes in 83% of the use cases. This percentage is higher than what is often seen with less lethal tools. From the information we have been provided, the most common BolaWrap use case is for individuals with behavioral health issues, and the second most common BolaWrap use case is during domestic violence calls. Twenty-six percent of the reported persons who are wrapped with the BolaWrap are thought to be under the influence of alcohol or drugs.

 

There are many reasons why we may not receive reports on all the use of the BolaWrap, including, when uses of BolaWrap are considered evidence in ongoing criminal cases, are controlled by local policy or regulation, or require officer and union and other released to be shared with us. However, many agencies have shared bodycam footage of successful field deployments with us, which we may use in our training and education efforts. We believe that as the reports of BolaWrap's effectiveness in de-escalation continue to increase, it will contribute to our future revenue growth.

 

Management anticipates that our portfolio of products has a strong and expanding pipeline of market opportunities in the law enforcement, military, corrections, and homeland security sectors both domestically and internationally. With the increasing demand for more humane and safer policing practices, continued need for ongoing training, and transparency for police encounters, we expect a continued surge in our global business. Currently, we are exploring major international business prospects while simultaneously seeking to establish relationships with large police agencies in the U.S. However, we acknowledge that it is challenging to predict the exact timeline for closing these deals, or whether they will ultimately materialize.

 

19

 

As part of our efforts to expand our sales and distribution operations, we provide a comprehensive training program for law enforcement officers and trainers in using the BolaWrap. This training equips them with knowledge about the appropriate use and limitations of BolaWrap in tandem with modern policing techniques for de-escalation of encounters. We now focus on also teaching when and why BolaWrap should be used, including the specific area of success (i.e., after verbal commands break down and before the law enforcement officer is ready to escalate to pain compliance tools). Management believes that law enforcement trainers and officers who have been trained to use our products, or have witnessed demonstrations, are more inclined to support the acquisition and deployment of our products by their respective departments to drive successful outcomes. As of September 30, 2023, over 1,480 agencies have received BolaWrap training with over 5,200 training officers at those agencies certified as BolaWrap instructors and qualified to train the rest of their departments, representing a 14% increase in agencies and a 14% increase in trained officers as compared to September 30, 2022. 

 

Operating expense for the third quarter of fiscal 2023 increased $0.1 million, or 2%, to $4.9 million from $4.8 million in the prior year period. The increase in operating expense was the result of one-time items associated with the Company’s finance offering and legal expenses associated with the acquisition of Intrensic.

 

Management is confident that implementing the strategic changes it made in April are leading to substantial sales growth and put us on a path towards sustainable profitability. Although geopolitical tensions and macroeconomic challenges have affected our quarterly results in the past and may in the future, we believe our firm is uniquely positioned to provide lifesaving technologies, training, and digital evidence management that enable law enforcement officers. If departments follow our Use of Force Guarantee requirements, we are confident enough to offer that in 12 months we would buy their BolaWrap devices back if they do not reduce their reportable use of force by 10%. With an increasing addressable market, Wrap offers a unique value proposition. Our improved pricing strategy, coupled with reduced operating expense and our growing sales outlook, is expected to help reduce losses and improve cash flow in the future. 

 

Looking ahead to the coming years, we plan to increase the number of product demonstrations and training sessions, both domestically and in the international markets. Our new focus on the when and why BolaWrap is used is already showing improved results. This is a departure of the hardware product only approach of the past. Our sales of the BolaWrap 150, Wrap Reality and Wrap Intrensic are expected to continue to rise, aided by our ongoing cost savings and cost control measures, which should lead to an overall reduction in cash burn.

 

At September 30, 2023, we had backlog of approximately $48 thousand expected to be delivered in the fourth quarter of 2023. Additionally, we had deferred revenue of $365 thousand expected to be recognized generally over the next five years. Our deferred revenue mostly is from Wrap Reality subscription and other revenue. Distributor and customer orders for future deliveries are generally subject to modification, rescheduling or in some instances, cancellation, in the normal course of business.

 

Since inception, we have generated significant losses from operations and anticipate that we will continue to generate significant losses from operations for the foreseeable future. We believe that we have adequate financial resources to sustain our operations for the next year. We reduced our net loss during the third quarter of fiscal 2023 by more than $1.1 million as compared to the third quarter of fiscal 2022. Net cash used in operations during the nine months ended September 30, 2023, was $2.1 million more than cash used in operations during the nine months ended September 30, 2022. This increase in net cash used during the first nine months of 2023 as primarily driven by changes in Account Receivable and Inventory.

 

We expect that we will continue to innovate new applications for our public safety technology, open new geographies, develop new products and technologies to meet diverse customer requirements and identify and develop new markets for our products.

 

Supply chain disruptions have affected our operations in the past and could negatively impact our ability to source materials, manufacture and distribute products in the future. Moreover, financial markets have continued to experience significant volatility, challenging the Company’s ability to access the capital markets to provide additional working capital to fund the Company’s growth. Despite these conditions, and following an analysis of our future capital needs, the Company consummated an offering of Series A Convertible Preferred Stock and Warrants (“Offering”), which Offering closed on July 5, 2023, resulting in gross proceeds to the Company of approximately $10.0 million of which $7.4 million was received on June 29, 2023. The $7.4 million received was recorded to cash with an offset to warranty liability. As a result, we had $14.9 million in cash and cash equivalents and short-term investments as of September 30, 2023. We therefore believe we have sufficient capital to fund our operations for the next twelve months. However, liquidity constraints and access to capital markets could still negatively affect our liquidity and require changes to our investment strategy.

 

Future global pandemics could potentially result in lost or delayed revenue for our Company, as occurred in the years ended December 31, 2021, and 2022 due to the global COVID-19 pandemic. These potential future events could include restrictions on our suppliers' ability to meet delivery requirements and commitments, employees' inability to perform their work due to illness caused by a pandemic or local, state, or federal mandates requiring employees to stay home. Delays in carriers' ability to deliver our products to customers, unforeseen deviations from customers or foreign governments restricting the ability to conduct business, and customers' inability to pay us on a timely basis, if at all, could also limit our revenue.

 

Our Company may be positively or negatively impacted by social unrest, riots, protests against racial inequality, and movements like "Defund the Police." Such unrest may be further fueled by misleading information or negative publicity about our solutions. We believe our solutions are actually the answer to reducing use of force and driving safer outcomes for officers and the citizens they interact with each day. We recently introduced our Protest Riot Pack aimed at equipping officers with an easy to grab no-harm solution for dealing with civil unrest. Although the intensity of these events may have subsided, some may still indirectly or directly influence police agency budgets and the funding available to current and potential customers. In addition, participants in these events may attempt to create the impression that our solutions are contributing to the perceived problems, potentially harming our business and operations, including our revenue, earnings, and cash flows from operations.

 

Changes in our management and other critical personnel have the potential to negatively affect our business. Such disruptions could have an adverse impact on our operations, programs, growth, financial condition, or results of operations. On the other hand, improvements in our operations, operating expense, and go-to-market approaches could positively influence the success of our business in the future.

 

20

 

Critical Accounting Policies and Estimates

 

The preparation of financial statements in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expense, and related disclosure of contingent assets and liabilities. We evaluate our estimates, on an on-going basis, including those estimates related to recognition and measurement of contingencies and accrued expense. We base our estimates on historical experience and on various other assumptions we believe to be reasonable under the circumstances. Actual results may differ from these estimates under different assumptions or conditions.

 

As part of the process of preparing our financial statements, we are required to estimate our provision for income taxes. Significant management judgment is required in determining our provision for income taxes, deferred tax assets and liabilities, tax contingencies, unrecognized tax benefits, and any required valuation allowance, including taking into consideration the probability of the tax contingencies being incurred. Management assesses this probability based upon information provided by its tax advisers, its legal advisers and similar tax cases. If later our assessment of the probability of these tax contingencies changes, our accrual for such tax uncertainties may increase or decrease. Our effective tax rate for annual and interim reporting periods could be impacted if uncertain tax positions that are not recognized are settled at an amount which differs from our estimates.

 

Some of our accounting policies require higher degrees of judgment than others in their application. These include share-based compensation and contingencies and areas such as revenue recognition, allowance for doubtful accounts, valuation of inventory and intangible assets, estimates of product line exit costs, warranty liabilities and impairments.

 

Revenue Recognition. We sell our products to customers including law enforcement agencies, domestic distributors and international distributors and revenue from such transactions is recognized in the periods that products are shipped (free on board (“FOB”) shipping point) or received by customers (FOB destination), when the fee is fixed or determinable and when collection of resulting receivables is reasonably assured. We identify customer performance obligations, determine the transaction price, allocate the transaction price to the performance obligations and recognize revenue as we satisfy the performance obligations. Our primary performance obligations are products/accessories and VR software licensing or sale. Our customers do not have the right to return product unless the product is found to be defective.

 

Share-Based Compensation. We follow the fair value recognition provisions issued by the Financial Accounting Standards Board (“FASB”) in Accounting Standards Codification (“ASC”) Topic 718, Stock Compensation (“ASC 718”) and we adopted Accounting Standards Update (“ASU”) 2018-07 for share-based transactions with non-employees. Share-based compensation expense recognized includes stock option and restricted stock unit compensation expense. The grant date fair value of stock options is determined using the Black-Scholes option-pricing model. The grant date is the date at which an employer and employee or non-employee reach a mutual understanding of the key terms and conditions of a share-based payment award. The Black-Scholes option-pricing model requires inputs including the market price of the Company’s Common Stock on the date of grant, the term that the stock options are expected to be outstanding, the implied stock volatilities of several publicly traded peers over the expected term of stock options, risk-free interest rate and expected dividend. Each of these inputs is subjective and generally requires significant judgment to determine. The grant date fair value of restricted stock units is based upon the market price of the Company’s Common Stock on the date of the grant. We determine the amount of share-based compensation expense based on awards that we ultimately expect to vest and account for forfeitures as they occur. The fair value of share-based compensation is amortized to compensation expense over the vesting term.

 

Allowance for Doubtful Accounts. Our products are sold to customers in many different markets and geographic locations. We estimate our bad debt reserve on a case-by-case basis and the aging of accounts due to a limited number of customers mostly government agencies or well-established distributors. We base these estimates on many factors including customer credit worthiness, past transaction history with the customer, current economic industry trends and changes in customer payment terms. Our judgments and estimates regarding collectability of accounts receivable have an impact on our financial statements.

 

Valuation of Inventory. Our inventory is comprised of raw materials, assemblies and finished products. We must periodically make judgments and estimates regarding the future utility and carrying value of our inventory. The carrying value of our inventory is periodically reviewed and impairments, if any, are recognized when the expected future benefit from our inventory is less than carrying value.

 

21

 

Valuation of Intangible Assets. Intangible assets consisted of (a) capitalized legal fees and filing expense related to obtaining patents and trademarks, (b) customer agreements, tradenames, software, non-solicitation and non-compete agreements acquired in business combinations and valued at fair value at the acquisition date, and (c) the purchase cost of indefinite-lived website domains. We must make judgments and estimates regarding the future utility and carrying value of intangible assets. The carrying values of such assets are periodically reviewed and impairments, if any, are recognized when the expected future benefit to be derived from an individual intangible asset is less than carrying value. This generally could occur when certain assets are no longer consistent with our business strategy and whose expected future value has decreased.

 

Accrued Expense. We establish a warranty reserve based on anticipated warranty claims at the time product revenue is recognized. This reserve requires us to make estimates regarding the amount and costs of warranty repairs we expect to make over a period of time. Factors affecting warranty reserve levels include the number of units sold, anticipated cost of warranty repairs, and anticipated rates of warranty claims. We have very limited history to make such estimates and warranty estimates have an impact on our financial statements. Warranty expense is recorded in cost of revenue. We evaluate the adequacy of this reserve each reporting period.

 

We use the recognition criteria of FASB ASC Topic 450-20, Loss Contingencies, to estimate the amount of bonuses when it becomes probable a bonus liability will be incurred and we recognize expense ratably over the service period. We accrue bonus expense each quarter based on estimated year-end results, and then adjust the actual in the fourth quarter based on our final results compared to targets.

 

Warrants. The Company accounts for warrants as liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

Business Combination. The Company accounts for its business combinations under the provisions of Accounting Standards Codification ("ASC") Topic 805-10, Business Combinations ("ASC 805-10"), which requires that the purchase method of accounting be used for all business combinations. Assets acquired and liabilities assumed, including non-controlling interests, are recorded at the date of acquisition at their respective fair values. The estimated fair value of net assets acquired, including the allocation of the fair value to identifiable assets and liabilities, was determined using established valuation techniques. ASC 805-10 also specifies criteria that intangible assets acquired in a business combination must meet to be recognized and reported apart from goodwill. Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from the business combinations and are expensed as incurred.

 

The estimated fair value of the acquired intangible assets was determined using a method which reflects the present value of the operating cash flows generated by this asset after taking into account the cost to realize the revenue, and an appropriate discount rate to reflect the time value and risk associated with the invested capital.

 

Certain adjustments to the assessed fair values of the assets and liabilities made subsequent to the acquisition date, but within the measurement period, which is up to one year, are recorded as adjustments to goodwill. Any adjustments subsequent to the measurement period are recorded in income.

 

Historically, our assumptions, judgments and estimates relative to our critical accounting policies have not differed materially from actual results. Other than the warrants and business combination described above, there were no significant changes or modification of our critical accounting policies and estimates involving management valuation adjustments affecting our results for the period ended September 30, 2023. Our accounting policies are more fully described in Note 1. Organization and Summary of Significant Accounting in the notes to our audited consolidated financial statements included in the Annual Report.

 

Recent Accounting Pronouncements

 

New pronouncements issued for future implementation are discussed in Note 1. Organization and Summary of Significant Accounting Policies of our financial statements.

 

Segment and Related Information

 

The Company operates as a single segment. The Company’s chief operating decision maker is its Chief Executive Officer, who manages operations for purposes of allocating resources. Refer to Note 13. Major Customers and Related Information, in our financial statements for further discussion.

 

Operating Expense

 

Our operating expense includes (i) selling, general and administrative expense, (ii) research and development expense, and in the most recent fiscal quarter, (iii) product line exit expense. Research and development expense is comprised of the costs incurred in performing research and development activities and developing production on our behalf, including compensation and consulting, design and prototype costs, contract services, patent costs and other outside expense. The scope and magnitude of our future research and development expense is difficult to predict at this time and will depend on elections made regarding research projects, staffing levels and outside consulting and contract costs. The future level of selling, general and administrative expense will be dependent on staffing levels, elections regarding expenditures on sales, marketing and customer training, the use of outside resources, public company and regulatory expense, and other factors, some of which are outside of our control.

 

We expect our operating costs will reduce from the first three fiscal quarters of 2023 as a result of the changes implemented in April 2023, and ongoing cost containment efforts. We may incur additional non-cash share-based compensation costs depending on future option and restricted stock unit grants that are impacted by stock prices and other valuation factors. Historical expenditures are not indicative of future expenditures.

 

22

 

Results of Operations

 

Three Months Ended September 30, 2023 Compared to Three Months Ended September 30, 2022

 

The following table sets forth for the periods indicated certain items of our condensed consolidated statement of operations. The financial information and the discussion below should be read in conjunction with the financial statements and notes contained in this Report.

 

   

Three Months Ended

September 30,

   

Change

 
   

2023

   

2022

   

$

   

%

 
   

(in thousands, except percentage change)

 

Revenues:

                               

Product sales

  $ 3,248     $ 1,612     $ 1,636       101

%

Other revenue

    383       89       294       330

%

Total revenues

    3,631       1,701       1,930       113

%

Cost of revenue

    1,454       790       664       84

%

Gross profit

    2,177       911       1,266       139

%

                                 

Operating expenses:

                               

Selling, general and administrative

    4,317       3,586       731       20

%

Research and development

    610       1,236       (626 )     (51

)%

Total operating expenses

    4,927       4,822       105       2

%

Loss from operations

  $ (2,750 )   $ (3,911

)

  $ 1,161       (30

)%

 

Revenue

 

We reported net revenue of $3.6 million for the three months ended September 30, 2023, as compared to $1.7 million for the quarter ended September 30, 2022, a 113% increase over the prior year. International revenue increased from $223 thousand for the three months ended September 30, 2022 to $2.3 million for the three months ended September 30, 2023. The increase in international revenue was driven by certain large orders and continued strong demand for our products in the EMEA region. We also incurred discounts of $68 thousand during the three months ended September 30, 2023, as a result of promotional programs designed to encourage customers to upgrade to the BolaWrap 150. Gross sales were $3.7 million for the three months ended September 30, 2023, before such discounts. The discounts compare to normal business discounts of $240 thousand in the comparable quarter of the prior year. We expect a decline to minimal discounts in 2024 as we have phased out our promotional upgrade offer.

 

International revenue generally consists of larger orders with the end user being large, centralized government agencies. These orders continue to be lumpy and difficult to predict as to both timing and amount. We believe that revenue during the fiscal year 2023 will increase overall compared to the revenue recorded during 2022 due to growth of domestic sales and anticipated international orders from a robust pipeline, although no assurances can be given. We believe based on pipeline that these larger international deals are more likely to book and ship in the final quarter of 2023.

 

We incurred product promotional costs of $61 thousand during the three months ended September 30, 2023, related primarily to BolaWrap 150 demonstration products and the cost of training products and accessories delivered to law enforcement agencies that were expensed as marketing costs. We are responding to increased demand for training as a result of expanded product and brand awareness and increased successful field use by agencies but due to awareness expect reductions in product promotional costs from the prior year.

 

23

 

Gross Profit

 

Our gross profit for the three months ended September 30, 2023, was $2.2 million, or a gross margin of 60%. Our gross profit for the three months ended September 30, 2022, was $0.9 million, or a gross margin of 54%. The increase in gross profit represented a 139% increase over prior year as a result of cost efficiencies with the BolaWrap 150 production, selling price adjustments implemented in September of 2022, and a reduction of promotional pricing.

 

As our revenue history is limited, historical margins may not accurately reflect future margins. However, we expect higher margins with the production of the BolaWrap 150 compared to previous production due to design changes and improved pricing. Our margins are also subject to variations based on the sales channels and product mix through which our products are sold. At present, our cassettes have lower margins than BolaWrap devices. As we scale cassette production, we will look to reduce our costs and drive higher cassette margins. Cassettes were a total of 21% of our overall revenue in the three months ended September 30, 2023, and will continue to grow as a recurring revenue base as more BolaWrap devices are in the field and the usage of BolaWrap increases due to the need of officers to de-escalate earlier to prevent injuries and use of higher levels of force.

 

We regularly introduce updates and revisions to our products, which may include changes to raw materials and components, and can impact our product costs. Given our limited experience with warranty costs, our estimated future warranty expense may affect our gross margins.

 

Our global supply chain has experienced notable component shortages, extended lead times, cost fluctuations, and logistical constraints, all of which have affected our product costs. Although we have seen these supply chain obstacles ease in 2023, we acknowledge that future supplier shortages, quality problems, and logistics delays could impact our production schedules and have a material negative impact on our financial condition, results of operation, and cash flows.

 

Selling, General and Administrative Expense

 

Selling, general and administrative (“SG&A”) expense of $4.3 million for the three months ended September 30, 2023 increased by $0.7 million, when compared to $3.6 million for the three months ended September 30, 2022. The increase in selling general and administrative expense was the result of one-time items associated with the Company’s financing and the acquisition of Intrensic.

 

Share-based compensation costs allocated to SG&A decreased to $(149) thousand compared to $700 thousand for the comparable prior quarter. This $849 thousand decrease resulted primarily from changes in management and one-time cost offsets associated with the management changes in April 2023.

 

Salaries and burden costs of $1.6 million for the three months ended September 30, 2023, was a decrease of $0.6 million, or a 25% decrease, due to change in headcount. During the three months ended September 30, 2023, as compared to same period during the prior year, we increased professional fees by $940 thousand, and increased consulting and contract services fees by $214 thousand. We expect expenditures for SG&A expense to be relatively in line with the third quarter of 2023 despite anticipated increases in Revenue.

 

Advertising and promotion costs were $224 thousand for the three months ended September 30, 2023, or a decrease of $32 thousand as compared to $256 thousand during the three months ended September 30, 2022. The changes in advertising costs were related to reductions in consultants and other cost containment efforts. However, the company expects advertising costs will increase in the future due to increased investment in strategic targeting and marketing campaigns as well as building brand awareness.

 

Research and Development Expense

 

Research and development expense decreased by $626 thousand for the three months ended September 30, 2023, when compared to the three months ended September 30, 2022. We incurred a $225 thousand period over period decrease in share-based compensation expense allocated to research and development expense as a result of personnel changes made in April 2023. Outside consulting costs decreased by $90 thousand and prototype related costs decreased by $120 thousand primarily due to reduced costs related to finalizing the BolaWrap 150 product and continued cost containment efforts.

 

24

 

Operating Loss

 

Loss from operations of $2.8 million during the three months ended September 30, 2023, was a reduction of $1.1 million compared to loss from operations of $3.9 million during the three months ended September 30, 2022, reflecting increased margin and the focus on reducing operating costs.

 

Nine months Ended September 30, 2023, Compared to Nine months Ended September 30, 2022

 

The following table sets forth for the periods indicated certain items of our condensed consolidated statement of operations. The financial information and the discussion below should be read in conjunction with the financial statements and notes contained in this Report.

 

   

Nine months Ended

September 30,

   

Change

 
   

2023

   

2022

   

$

   

%

 

Revenue:

                               

Product sales

  $ 4,897     $ 4,042     $ 855       21

%

Other revenue

    647       422       225       53

%

Total revenue

    5,544       4,464       1,080       24

%

Cost of revenue

    2,347       2,430       (83 )     (3

)%

Gross profit

    3,197       2,034       1,163       57

%

                                 

Operating expense:

                               

Selling, general and administrative

    12,604       11,952       652       5

%

Research and development

    2,683       4,210       (1,527 )     (36

)%

Total operating expense

    15,287       16,162       (875 )     (5

)%

Loss from operations

  $ (12,090 )   $ (14,128

)

  $ 2,039       (14

)%

 

Revenue

 

We reported net revenue of $5.5 million for the nine months ended September 30, 2023, as compared to $4.5 million for the nine months ended September 30, 2022, a 24% increase over the prior year. International revenue increased from $1.0 million for the nine months ended September 30, 2022 to $2.3 million for the nine months ended September 30, 2023. We incurred discounts of $132 thousand during the nine months ended September 30, 2023, as a result of promotional programs designed to encourage customers to upgrade to the BolaWrap 150. Gross sales were $5.7 million for the nine months ended September 30, 2023, before such discounts. The discounts compare to normal business discounts of $790 thousand in the comparable nine-month period of the prior year. We expect a decline to minimal discounts in 2023 as we have phased out our promotional upgrade offer.

 

International revenue generally consists of larger orders with the end user being large, centralized government agencies. These orders continue to be lumpy and difficult to predict as to both timing and amount. We believe that revenue during the fiscal year 2023 will increase overall compared to the revenue recorded during 2022 due to growth of domestic sales and anticipated international orders from a robust pipeline, although no assurances can be given. We believe based on pipeline that these larger international deals are more likely to book and ship in the latter half of 2023.

 

We incurred product promotional costs of $156 thousand during the nine months ended September 30, 2023, related primarily to BolaWrap 150 demonstration products and the cost of training products and accessories delivered to law enforcement agencies that were expensed as marketing costs. We are responding to increased demand for training as a result of expanded product and brand awareness and increased successful field use by agencies but due to awareness expect reductions in product promotional costs from the prior year.

 

We had $365 thousand of deferred revenue on September 30, 2023, of which $199 thousand related to VR, $6 thousand was related to training and $160 thousand related to BolaWrap extended warranties and services. As we potentially secure increased bookings for Wrap Reality, as well as BolaWrap extended warranties, we expect our deferred revenue to grow in future quarters. 

 

25

 

On September 30, 2023, we had backlog of $48 thousand expected to be delivered in the fourth quarter of 2023. Distributor and customer orders for future deliveries are generally subject to modification, rescheduling or in some instance’s cancellation in the normal course of business. 

 

Gross Profit

 

Our gross profit for the nine months ended September 30, 2023, was $3.2 million, or a gross margin of 58%. Our gross profit for the nine months ended September 30, 2022, was $2.0 million, or a gross margin of 46%. The increase in gross profit represented a 57% increase over prior year as a result of increased sales and continue cost containment efforts on production.

 

As our revenue history is limited, historical margins may not accurately reflect future margins. However, we expect higher margins with the production of the BolaWrap 150 compared to previous production due to design changes and improved pricing. Our margins are also subject to variations based on the sales channels and product mix through which our products are sold. At present, our cassettes have lower margins than BolaWrap devices. As we scale cassette production, we will look to reduce our costs and drive higher cassette margins. Cassettes were a total of 20% of our overall revenue in the nine months ended September 30, 2023, and will continue to grow as a recurring revenue base as more BolaWrap devices are in the field and the usage of BolaWrap increases due to the need of officers to de-escalate earlier to prevent injuries and use of higher levels of force.

 

We regularly introduce updates and revisions to our products, which may include changes to raw materials and components, and can impact our product costs. Given our limited experience with warranty costs, our estimated future warranty expense may affect our gross margins.

 

Our global supply chain has experienced notable component shortages, extended lead times, cost fluctuations, and logistical constraints, all of which have affected our product costs. Although we anticipate these supply chain obstacles to ease in 2023, we acknowledge that future supplier shortages, quality problems, and logistics delays could impact our production schedules and have a material negative impact on our financial condition, results of operation, and cash flows.

 

Selling, General and Administrative Expense

 

Selling, general and administrative (SG&A”) expense of $12.6 million for the nine months ended September 30, 2023 increased by $0.6 million, when compared to $12.0 million for the nine months ended September 30, 2022, due to cost one-time costs associated with severance, the Intrensic acquisition, and the Company’s financing.

 

Share-based compensation costs allocated to SG&A decreased to $1.4 million compared to $2.2 million for the comparable prior-year period. This $0.8 million decrease resulted primarily due to changes in management, one-time costs in the prior year period, and changes in the stock price.

 

Salaries and burden costs of $4.6 million for the nine months ended September 30, 2023, was a $2.2 million decrease compared to the prior year nine months ended September 30, 2022. During nine months ended September 30, 2023, as compared to same period during the prior year, we increased professional fees by $1.1 million, and increased consulting and contract services fees by $243 thousand. We expect expenditures for SG&A expense in 2023 to be slightly lower than 2022 despite expected revenue growth.

 

Advertising and promotion costs were $669 thousand for the nine months ended September 30, 2023, or a decrease of $246 thousand as compared to $915 thousand during the nine months ended September 30, 2022. The changes in advertising costs were related to reductions in consultants and other cost containment efforts.

 

Research and Development Expense

 

Research and development expense decreased by $1.5 million for the nine months ended September 30, 2023 when compared to the nine months ended September 30, 2022. We incurred a $204 thousand period over period decrease in share-based compensation expense allocated to research and development expense as a result of personnel changes made in April 2023. Outside consulting costs decreased by $342 thousand and prototype related costs decreased by $443 thousand for the nine months ended September 30, 2023, primarily due to reduced costs related to finalizing the BolaWrap 150 product.

 

26

 

Operating Loss

 

Loss from operations of $12.1 million during the nine months ended September 30, 2023 was a reduction of $2.0 million compared to loss from operations of $14.1 million during the nine months ended September 30, 2022, reflecting increased margin and the focus on reducing operating costs.

 

Liquidity and Capital Resources

 

Overview

 

Our primary source of liquidity to date has been funding from our stockholders from the sale of equity securities and the exercise of derivative securities, consisting of options and warrants. We expect our primary source of future liquidity will be from the sale of products, exercise of stock options and warrants and from future equity or debt financings.

 

We have experienced net losses and negative cash flows from operations since our inception. As of September 30, 2023, we had cash and cash equivalents of $4.9 million, short-term investments of $10.0 million, positive working capital of $15.0 million and had sustained cumulative losses attributable to stockholders of $79.4 million. Our working capital at September 30, 2023 was positively affected by an increase in inventories of approximately $1.8 million, which consisted of increases of inventory of the BolaWrap 150 in anticipation of future orders, and the receipt of $10.0 million from the Offering on June 29, 2023 that formally closed on July 5, 2023.  The Offering was consummated following an analysis of our future capital needs, resulting in the issuance of Series A Convertible Preferred Stock and Warrants.  The Offering generated gross proceeds to the Company of approximately $10.0 million.  As a result, we had $14.9 million in cash and cash equivalents and short-term investments as of September 30, 2023. We therefore believe we have sufficient capital to fund our operations for the next twelve months. However, liquidity constraints and access to capital markets could still negatively affect our liquidity and require changes to our investment strategy.

 

Capital Requirements

 

Our future liquidity requirements or future capital needs will depend on, among other things, capital required to introduce new products and the operational staffing and support requirements, as well as the timing and amount of future revenue and product costs. We anticipate that demands for operating and working capital may grow depending on decisions on staffing, development, production, marketing, training and other functions and based on other factors outside of our control, including the timing of receipt of revenue.

 

Our future capital requirements, cash flows and results of operations could be affected by, and will depend on, many factors, some of which are currently unknown to us, including, among other things:

 

 

Any future outbreaks pandemics or contagious diseases or fear of such outbreaks;

   

 

 

Decisions regarding staffing, development, production, marketing and other functions;

   

 

 

The timing and extent of market acceptance of our products;

   

 

 

Costs, timing and outcome of planned production and required customer and regulatory compliance of our products;

   

 

 

Costs of preparing, filing and prosecuting our patent applications and defending any future intellectual property-related claims;

   

 

 

Costs and timing of additional product development;

   

 

 

Costs, timing and outcome of any future warranty claims or litigation against us associated with any of our products;

   

 

 

Ability to collect accounts receivable; and

   

 

 

Timing and costs associated with any new financing.

 

Principal factors that could affect our ability to obtain cash from external sources including from exercise of outstanding warrants and options include:

 

 

Volatility in the capital markets; and

 

27

 

 

Market price and trading volume of our Common Stock.

 

On June 29, 2023, the Company entered into a Securities Purchase Agreement with a founder and director of the Company and certain accredited and institutional investors (collectively, the “Investors”), pursuant to which it agreed to sell to the Investors in a registered direct offering (the “Offering”) (i) an aggregate of 10,000 shares of the Company’s newly-designated Series A Convertible Preferred Stock, with a par value $0.0001 per share, and a stated value of $1,000 per share (“Series A Preferred”), initially convertible into up to 6,896,553 shares of the Company’s Common Stock, at a conversion price of $1.45 per share, and (ii) warrants to acquire up to an aggregate of 6,896,553 shares of Common Stock (“Warrants”). The Series A Preferred provide for the payment to holders thereof of cumulative dividends of 8% per annum, payable quarterly in arrears. The Warrants are exercisable six months after issuance at an exercise price of $1.45 per share, subject to adjustment, and expire five years from the date of issuance. The $1.45 per share conversion price of the Series A Preferred and exercise price of the Warrant represent the closing share price of the Company’s Common Stock on June 29, 2023. The Offering closed on July 5, 2023 (the “Closing”), resulting in aggregate gross proceeds from the Offering of approximately $10.0 million.

 

The Company received approximately $10.0 million in gross proceeds from the Offering. After payment of placement agent fees and costs of the Offering, the net proceeds from the Offering were approximately $9.0 million. Proceeds from the Offering are being used to scale the Company’s sales team, support marketing efforts, and fuel the evolution and diversification of the Company’s product offerings.

 

Off-Balance Sheet Arrangements

 

We have no off-balance sheet arrangements.

 

Cash Flow

 

Operating Activities

 

During the nine months ended September 30, 2023, net cash used in operating activities was $12.9 million. The net loss of $11.8 million was decreased by non-cash expense of $2.5 million consisting primarily of share-based compensation expense of $1.6 million. Other major component changes using operating cash included an increase of $1.8 million in inventories and an increase in accounts receivable of $1.4 million.

 

During the nine months ended September 30, 2022, net cash used in operating activities was $11.0 million. The net loss of $14.1 million was decreased by non-cash expense of $3.4 million consisting primarily of share-based compensation expense of $2.6 million. Other major component changes using operating cash included an increase of $1.4 million in inventories and a net reduction in accounts payable and accrued liabilities of $659 thousand. A decrease in accounts receivable of $1.6 million reduced the cash used in operating activities.

 

Investing Activities

 

During the nine months ended September 30, 2023, we used $6.1 million of cash to purchase short-term investments and we had proceeds from maturities of short-term investments of $10.0 million. During the nine months ended September 30, 2023, we used $60 thousand of cash for the purchase of intangible assets, $551 thousand of cash for the purchase of Intrensic, $133 thousand of cash for the purchase of property and equipment and invested $277 thousand in patents.

 

During the nine months ended September 30, 2022, we used $23.1 million of cash to purchase short-term investments and we had proceeds from maturities of short-term investments of $33.3 million. During the nine months ended September 30, 2022, we used $201 thousand of cash for the purchase of property and equipment and invested $133 thousand in patents.

 

Financing Activities

 

During the nine months ended September 30, 2023 we received $9.8 million in gross proceeds from the issuance of securities, which is reflected in cash and cash equivalents, with an offset to accrued expense, reflected in the Company’s Condensed Consolidated Balance Sheet at September 30, 2023. We did not receive any gross proceeds for the issuance of securities for the nine months ended September 20, 2022.

 

During the nine months ended September 30, 2022, we received $83 thousand in proceeds from the exercise of previously issued stock options. We did not receive any proceeds from the exercise of previously issued stock options for the nine months ended September 31, 2023.

 

28

 

Contractual Obligations and Commitments

 

Pursuant to that certain exclusive Amended and Restated Intellectual Property License Agreement dated September 30, 2016, by and between the Company and Syzygy Licensing, LLC (“Syzygy”), we are obligated to pay to Syzygy a 4% royalty fee on future product sales up to an aggregate amount of $1.0 million in royalty payments or until September 30, 2026, whichever occurs earlier.

 

Pursuant to the Professional Services and Technology Acquisition Agreement (the “Agreement”) entered into with Lumeto, Inc. and Spatial Industries Group, Inc. (collectively, “Service Provider”) on November 22, 2022, as amended on April 2, 2023, which Agreement, provided that the Service Provider provide to the Company certain technology, services, and perpetual licenses for use within the Company’s Wrap Reality virtual simulation training platform (the “Technology, Services, and License”), in consideration for a cash payment of $700 made to the Service Provider upon the execution of the Agreement.

 

In January 2022 we extended our facility lease for three years through July 2025 and we are committed to aggregate lease payments on the lease of $31 thousand for three months in 2023, $126 thousand in 2024 and $75 thousand in 2025.

 

At September 30, 2023, we were committed for approximately $1.7 million for future component deliveries and contract services that are generally subject to modification or rescheduling in the normal course of business.

 

On August 9, 2023, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Intrensic, LLC, a Delaware limited liability company (“Intrensic”), and certain members of Intrensic, including Kevin Mullins, a director of the Company and its Chief Executive Officer (collectively, “Sellers”).  Under the terms of the Purchase Agreement, the Company agreed to purchase, and Sellers agreed to sell, 100% of the membership interests (the “Membership Interests”) of Intrensic for the following consideration upon the consummation of the sale of the Membership Interests: (i) $553,588 in cash, subject to adjustment based upon the outstanding indebtedness of Intrensic and Intrensic’s working capital as of the closing; and (ii) 1,250,000 shares of Common Stock of the Company.  

 

Effects of Inflation

 

During the nine months ended September 30, 2023 and year ended December 31, 2022, we had experienced increased costs in labor and materials due to inflation. We believe in 2023 that low unemployment and higher salaries will create higher payroll costs and increased operating expense in the business. We have seen increases in costs from multiple suppliers for materials as well as labor.

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

 

Not applicable.

 

Item 4. Controls and Procedures.

 

We are required to maintain disclosure controls and procedures designed to ensure that material information related to us, including our consolidated subsidiaries, is recorded, processed, summarized and reported within the time periods specified in the SEC rules and forms.

 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, as of September 30, 2023, we conducted an evaluation of our disclosure controls and procedures as such term is defined under Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level.

 

29

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting during our fiscal quarter ended September 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Our process for evaluating controls and procedures is continuous and encompasses constant improvement of the design and effectiveness of established controls and procedures and the remediation of any deficiencies, which may be identified during this process.

 

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future period are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We may become subject to legal proceedings, as well as demands and claims that arise in the normal course of our business, including claims of alleged infringement of third-party patents and other intellectual property rights, breach of contract, employment law violations, and other matters and matters involving requests for information from us or our customers under federal or state law. Such claims, even if not meritorious, could result in the expenditure of significant financial and management resources. We make a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed and adjusted to include the impacts of negotiations, estimated settlements, legal rulings, advice of legal counsel, and other information and events pertaining to a particular matter. At September 30, 2023, we had no provision for liability under existing litigation.

 

An unfavorable outcome on any litigation matters could require payment of substantial damages, or, in connection with any intellectual property infringement claims, could require us to pay ongoing royalty payments or could prevent us from selling certain of our products. As a result, a settlement of, or an unfavorable outcome on, any of the matters referenced above or other litigation matters, or legal proceedings could have a material adverse effect on our business, operating results, financial condition and cash flows.

 

Item 1A. Risk Factors

 

Management is not aware of any material changes to the risk factors discussed in Part 1, Item 1A, of the Annual Report on Form 10-K for the year ended December 31, 2022.  In addition to the other information set forth in this Quarterly Report on Form 10-Q, you should carefully consider the risk factors discussed in Part 1, Item 1A, of the Annual Report on Form 10-K for the year ended December 31, 2022, and subsequent reports filed pursuant to the Exchange Act which could materially and adversely affect the Companys business, financial condition, results of operations, and stock price. The risks described in the Annual Report on Form 10-K and subsequent reports filed pursuant to the Exchange Act are not the only risks facing the Company. Additional risks and uncertainties not presently known to management, or that management presently believes not to be material, may also result in material and adverse effects on our business, financial condition, and results of operations.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

No unregistered securities were issued during the three months ended September 30, 2023, that were not previously reported.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

30

 

Item 4. Mine Safety Disclosures

 

Not Applicable.

 

Item 5. Other Information

 

None.

 

Item 6. Exhibits

 

Exhibit 3.1

Form of Certificate of Designations of Series A Convertible Preferred Stock, incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K, filed with the SEC on June 30, 2023.

Exhibit 4.1

Form of Warrant, incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K, filed with the SEC on June 30, 2023.

Exhibit 10.1

Form of Purchase Agreement, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on June 30, 2023.

Exhibit 10.2

Engagement Letter, dated June 29, 2023 by and between Wrap Technologies, Inc. and Katalyst Securities LLC, incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K, filed with the SEC on June 30, 2023.

Exhibit 10.3

Membership Interest Purchase Agreement, dated August 9, 2023, by and between Wrap Technologies, Inc., Intren Holdings Partners, LLC, Kevin Mullins, Marc Upton, Tre Mullins, Terry Nichols, Charles DeVita, Nick DeVita, David Stading, Peter Cavicchia, Timothy McAfee, Andon McAfee, Andon Dragomanov, John R. Sette, Matthew J. Dugas, and Ronald Hurley, incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K, filed with the SEC on August 22, 2023.**

Exhibit 31.1

Certification of Kevin Mullins, Principal Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

Exhibit 31.2

Certification of Chris DeAlmeida, Principal Accounting Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as amended, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

Exhibit 32.1

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Kevin Mullins, Principal Executive Officer, and Chris DeAlmeida, Principal Accounting Officer.*

 

Extensible Business Reporting Language (XBRL) Exhibits*

101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (embedded within the Inline XBRL Document and include in Exhibit 101)

 

* Filed concurrently herewith

**  Certain portions of this exhibit (indicated by “[***]”) have been omitted as the Company has determined (i) the omitted information is not material and (ii) the omitted information would likely cause harm to the Company if publicly disclosed.

 

31

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

 

 

WRAP TECHNOLOGIES, INC.

   
 

By:

/s/ CHRIS DEALMEIDA

November 14, 2023

 
   

Chris DeAlmeida

Chief Financial Officer and Treasurer

(Principal Accounting Officer)

 

32
EX-31.1 2 ex_591545.htm EXHIBIT 31.1

Exhibit 31.1

 

CERTIFICATION

 

I, Kevin Mullins, certify that:

 

1.         I have reviewed this quarterly report on Form 10-Q of Wrap Technologies, Inc.;

 

2.         Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.         Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.         The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.         The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2023

 

/s/ KEVIN MULLINS                           

Kevin Mullins

Chief Executive Officer

(Principal Executive Officer)

 

 

 

 
EX-31.2 3 ex_591544.htm EXHIBIT 31.2

Exhibit 31.2

 

CERTIFICATION

 

I, Chris DeAlmeida, certify that:

 

1.         I have reviewed this quarterly report on Form 10-Q of Wrap Technologies, Inc.;

 

2.         Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.         Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.         The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

 

a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

 

c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

 

d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.         The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

 

a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

 

b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

Date: November 14, 2023

 

/s/ CHRIS DEALMEIDA

Chris DeAlmeida

Chief Financial Officer and Treasurer

(Principal Accounting Officer)

 

 

 
EX-32.1 4 ex_591543.htm EXHIBIT 32.1

Exhibit 32.1

 

 

CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Each of the undersigned hereby certifies, in accordance with 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in his or her capacity as an officer of Wrap Technologies, Inc. (the “Company”), that, to his or her knowledge, the Quarterly Report of the Company on Form 10-Q for the period ended September 30, 2023, fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934, as amended, and that the information contained in such report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: November 14, 2023

 

/s/ KEVIN MULLINS                  

Kevin Mullins

Chief Executive Officer

(Principal Executive Officer)

 

Date: November 14, 2023

 

/s/ CHRIS DEALMEIDA

Chris DeAlmeida

Chief Financial Officer and Treasurer

(Principal Accounting Officer)

 

 

The foregoing certification is being furnished solely to accompany the Report pursuant to 18 U.S.C. Section 1350, and is not being filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and is not to be incorporated by reference into any filing of the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing. A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

 

 
EX-101.SCH 5 wrap-20230930.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) link:calculationLink link:definitionLink link:presentationLink 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) link:calculationLink link:definitionLink link:presentationLink 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) link:calculationLink link:definitionLink link:presentationLink 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) link:calculationLink link:definitionLink link:presentationLink 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) link:calculationLink link:definitionLink link:presentationLink 006 - Disclosure - Note 1 - Organization, Summary of Significant Accounting Policies and Recent Developments link:calculationLink link:definitionLink link:presentationLink 007 - Disclosure - Note 2 - Revenue and Product Costs link:calculationLink link:definitionLink link:presentationLink 008 - Disclosure - Note 3 - Financial Instruments link:calculationLink link:definitionLink link:presentationLink 009 - Disclosure - Note 4 - Inventories link:calculationLink link:definitionLink link:presentationLink 010 - Disclosure - Note 5 - Property and Equipment, Net link:calculationLink link:definitionLink link:presentationLink 011 - Disclosure - Note 6 - Intangible Assets and Goodwill link:calculationLink link:definitionLink link:presentationLink 012 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities link:calculationLink link:definitionLink link:presentationLink 013 - Disclosure - Note 8 - Warrants link:calculationLink link:definitionLink link:presentationLink 014 - Disclosure - Note 9 - Stockholders' Equity link:calculationLink link:definitionLink link:presentationLink 015 - Disclosure - Note 10 - Share-based Compensation link:calculationLink link:definitionLink link:presentationLink 016 - Disclosure - Note 11 - Defined Contribution Plan link:calculationLink link:definitionLink link:presentationLink 017 - Disclosure - Note 12 - Commitments and Contingencies link:calculationLink link:definitionLink link:presentationLink 018 - Disclosure - Note 13 - Related Party Transactions link:calculationLink link:definitionLink link:presentationLink 019 - Disclosure - Note 14 - Major Customers and Related Information link:calculationLink link:definitionLink link:presentationLink 020 - Disclosure - Note 15 - Business Combination link:calculationLink link:definitionLink link:presentationLink 021 - Disclosure - Note 16 - Subsequent Events link:calculationLink link:definitionLink link:presentationLink 022 - Disclosure - Significant Accounting Policies (Policies) link:calculationLink link:definitionLink link:presentationLink 023 - Disclosure - Note 2 - Revenue and Product Costs (Tables) link:calculationLink link:definitionLink link:presentationLink 024 - Disclosure - Note 3 - Financial Instruments (Tables) link:calculationLink link:definitionLink link:presentationLink 025 - Disclosure - Note 4 - Inventories (Tables) link:calculationLink link:definitionLink link:presentationLink 026 - Disclosure - Note 5 - Property and Equipment, Net (Tables) link:calculationLink link:definitionLink link:presentationLink 027 - Disclosure - Note 6 - Intangible Assets and Goodwill (Tables) link:calculationLink link:definitionLink link:presentationLink 028 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities (Tables) link:calculationLink link:definitionLink link:presentationLink 029 - Disclosure - Note 10 - Share-based Compensation (Tables) link:calculationLink link:definitionLink link:presentationLink 030 - Disclosure - Note 14 - Major Customers and Related Information (Tables) link:calculationLink link:definitionLink link:presentationLink 031 - Disclosure - Note 15 - Business Combination (Tables) link:calculationLink link:definitionLink link:presentationLink 032 - Disclosure - Note 1 - Organization, Summary of Significant Accounting Policies and Recent Developments (Details Textual) link:calculationLink link:definitionLink link:presentationLink 033 - Disclosure - Note 2 - Revenue and Product Costs (Details Textual) link:calculationLink link:definitionLink link:presentationLink 034 - Disclosure - Note 2 - Revenue and Product Costs - Contract Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 035 - Disclosure - Note 3 - Financial Instruments (Details Textual) link:calculationLink link:definitionLink link:presentationLink 036 - Disclosure - Note 3 - Financial Instruments - Instruments by Significant Investment Category (Details) link:calculationLink link:definitionLink link:presentationLink 037 - Disclosure - Note 3 - Financial Instruments - (Details) link:calculationLink link:definitionLink link:presentationLink 038 - Disclosure - Note 3 - Financial Instruments - Fair Value Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 039 - Disclosure - Note 4 - Inventories - Summary of Inventories (Details) link:calculationLink link:definitionLink link:presentationLink 040 - Disclosure - Note 5 - Property and Equipment, Net (Details Textual) link:calculationLink link:definitionLink link:presentationLink 041 - Disclosure - Note 5 - Property and Equipment, Net - Summary of Property and Equipment (Details) link:calculationLink link:definitionLink link:presentationLink 042 - Disclosure - Note 6 - Intangible Assets and Goodwill (Details Textual) link:calculationLink link:definitionLink link:presentationLink 043 - Disclosure - Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details) link:calculationLink link:definitionLink link:presentationLink 044 - Disclosure - Note 6 - Intangible Assets and Goodwill - Future Amortization Expense (Details) link:calculationLink link:definitionLink link:presentationLink 045 - Disclosure - Note 6 - Intangible Assets and Goodwill - Schedule of Goodwill (Details) link:calculationLink link:definitionLink link:presentationLink 046 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities (Details Textual) link:calculationLink link:definitionLink link:presentationLink 047 - Disclosure - Note 7 - Accounts Payable and Accrued Expenses - Summary of Accrued Liabilities (Details) link:calculationLink link:definitionLink link:presentationLink 048 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities - Changes in Product Warranty Costs (Details) link:calculationLink link:definitionLink link:presentationLink 049 - Disclosure - Note 8 - Warrants (Details Textual) link:calculationLink link:definitionLink link:presentationLink 050 - Disclosure - Note 9 - Stockholders' Equity (Details Textual) link:calculationLink link:definitionLink link:presentationLink 051 - Disclosure - Note 10 - Share-based Compensation (Details Textual) link:calculationLink link:definitionLink link:presentationLink 052 - Disclosure - Note 10 - Share-based Compensation - Summary of Stock Option Activity (Details) link:calculationLink link:definitionLink link:presentationLink 053 - Disclosure - Note 10 - Share-based Compensation - Summary of Stock Option Valuation Assumptions (Details) link:calculationLink link:definitionLink link:presentationLink 054 - Disclosure - Note 10 - Share-based Compensation - Summary of RSU Activity (Details) link:calculationLink link:definitionLink link:presentationLink 055 - Disclosure - Note 10 - Share-based Compensation - Allocation of Share-based Compensation Expense (Details) link:calculationLink link:definitionLink link:presentationLink 056 - Disclosure - Note 11 - Defined Contribution Plan (Details Textual) link:calculationLink link:definitionLink link:presentationLink 057 - Disclosure - Note 12 - Commitments and Contingencies (Details Textual) link:calculationLink link:definitionLink link:presentationLink 058 - Disclosure - Note 13 - Related Party Transactions (Details Textual) link:calculationLink link:definitionLink link:presentationLink 059 - Disclosure - Note 14 - Major Customers and Related Information (Details Textual) link:calculationLink link:definitionLink link:presentationLink 060 - Disclosure - Note 14 - Major Customers and Related Information - Disaggregation of Revenue by Geographic Region (Details) link:calculationLink link:definitionLink link:presentationLink 061 - Disclosure - Note 15 - Business Combination (Details Textual) link:calculationLink link:definitionLink link:presentationLink 062 - Disclosure - Note 15 - Business Combination - Schedule of Business Combination (Details) link:calculationLink link:definitionLink link:presentationLink 063 - Disclosure - Note 16 - Subsequent Events (Details Textual) link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 6 wrap-20230930_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 7 wrap-20230930_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Document And Entity Information us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill Intangible assets Note To Financial Statement Details Textual Significant Accounting Policies Note 2 - Revenue and Product Costs Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Note 3 - Financial Instruments Note 4 - Inventories Note 5 - Property and Equipment, Net Note 6 - Intangible Assets and Goodwill Long-term liabilities: Note 7 - Accounts Payable and Accrued Liabilities Note 10 - Share-based Compensation wrap_ConsultingFeesToRelatedPartyMonthlyAmount Consulting Fees to Related Party, Monthly Amount The amount of monthly consulting fees paid to a related party during the reporting period. us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables Accounts receivable Note 14 - Major Customers and Related Information Note 15 - Business Combination Net unrealized gain (loss) on short-term investments us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax Note 2 - Revenue and Product Costs - Contract Liabilities (Details) us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Cash and cash equivalents Note 3 - Financial Instruments - Instruments by Significant Investment Category (Details) Expected stock price volatility Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory Inventory us-gaap_LiabilitiesCurrent Total current liabilities Note 3 - Financial Instruments - (Details) Note 3 - Financial Instruments - Fair Value Assumptions (Details) Note 4 - Inventories - Summary of Inventories (Details) Note 5 - Property and Equipment, Net - Summary of Property and Equipment (Details) Expected life of options (Year) Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details) us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable Equity Note 6 - Intangible Assets and Goodwill - Future Amortization Expense (Details) Consultant [Member] Represents information related to the Company's consultant. Note 6 - Intangible Assets and Goodwill - Schedule of Goodwill (Details) us-gaap_BusinessCombinationConsiderationTransferred1 Total Note 7 - Accounts Payable and Accrued Expenses - Summary of Accrued Liabilities (Details) Note 7 - Accounts Payable and Accrued Liabilities - Changes in Product Warranty Costs (Details) Note 10 - Share-based Compensation - Summary of Stock Option Activity (Details) Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Note 10 - Share-based Compensation - Summary of Stock Option Valuation Assumptions (Details) Note 10 - Share-based Compensation - Summary of RSU Activity (Details) Liabilities assumed Note 10 - Share-based Compensation - Allocation of Share-based Compensation Expense (Details) Note 14 - Major Customers and Related Information - Disaggregation of Revenue by Geographic Region (Details) Note 15 - Business Combination - Schedule of Business Combination (Details) Share-Based Payment Arrangement, Option, Activity [Table Text Block] Notes To Financial Statements Notes To Financial Statements [Abstract] Awards other than options, granted, weighted average grant date fair value (in dollars per share) us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired Awards other than options, vested, weighted average grant date fair value (in dollars per share) Awards other than options, forfeited and cancelled, weighted average grant date fair value (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Awards other than options, unvested, weighted average grant date fair value, beginning balance (in dollars per share) Awards other than options, unvested, weighted average grant date fair value, beginning balance (in dollars per share) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod Awards other than options, Forfeited and cancelled (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Awards other than options, unvested, beginning balance (in shares) Awards other than options, unvested, beginning balance (in shares) Awards other than options, Granted (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Awards other than options, Vested (in shares) Schedule of Nonvested Restricted Stock Units Activity [Table Text Block] Outstanding, aggregate intrinsic value Exercisable, weighted average exercise price (in dollars per share) us-gaap_PaymentsToAcquireInvestments Purchase of short-term investments Exercisable, remaining contractual term (Year) Exercisable, aggregate intrinsic value Options on Common Shares, Exercisable (in shares) Outstanding, remaining contractual term (Year) Weighted-average fair value of options granted (in dollars per share) Proceeds from maturities of short-term investments us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Outstanding, weighted average exercise price (in dollars per share) Outstanding, weighted average exercise price (in dollars per share) Deferred revenue- short term Current portion Forfeited, cancelled, expired, weighted average exercise price (in dollars per share) Goodwill and Intangible Assets Disclosure [Text Block] Granted, weighted average exercise price (in dollars per share) Schedule of Goodwill [Table Text Block] Exercised, weighted average exercise price (in dollars per share) Accrued liabilities Total Accrued compensation Accounts payable us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Options on Common Shares, Outstanding (in shares) Options on Common Shares, Outstanding (in shares) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Options on Common Shares, Forfeited, cancelled, expired (in shares) Trademarks [Member] Taxes and other us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum us-gaap_PolicyTextBlockAbstract Accounting Policies Trademarks and Trade Names [Member] Warranty costs us-gaap_StockIssued1 Issuance of common stock for acquisition us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-Based Payment Arrangement, Accelerated Cost us-gaap_PaymentsToAcquireIntangibleAssets Investment in patents and trademarks us-gaap_PaymentsToAcquirePropertyPlantAndEquipment Capital expenditures for property and equipment us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized Supplemental Disclosure of Non-Cash Investing and Financing Activities: us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Weighted average vesting period (Year) us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1 Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Share-Based Payment Arrangement, Tranche Three [Member] Current liabilities: Vesting [Axis] Operating lease liability Vesting [Domain] Share-Based Payment Arrangement, Tranche One [Member] us-gaap_Assets Total assets Share-Based Payment Arrangement, Tranche Two [Member] Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block] Patents [Member] Plan Name [Axis] Technology-Based Intangible Assets [Member] Plan Name [Domain] us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic Net loss attributable to common stockholders us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Customer Relationships [Member] Computer Software, Intangible Asset [Member] Finite-Lived Intangible Assets by Major Class [Axis] Share-Based Payment Arrangement [Text Block] Finite-Lived Intangible Assets, Major Class Name [Domain] Commissions Payable [Member] Represents commissions payable. us-gaap_PaymentsForOtherDeposits Cash outlay for deposits Award Type [Domain] us-gaap_PreferredStockDividendsIncomeStatementImpact Less: Convertible preferred stock dividends Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block] Net loss for the period Net loss Net loss Award Type [Axis] us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization Accumulated amortization us-gaap_FiniteLivedIntangibleAssetsNet Total amortizable Intangible assets, net Total intangible assets, net Restricted Stock Units (RSUs) [Member] Amortizable intangible assets, gross Service-based Options [Member] Represents service-based options. Performance Shares [Member] Share-Based Payment Arrangement, Option [Member] us-gaap_PreferredStockConvertibleSharesIssuable Preferred Stock, Convertible, Shares Issuable Acquired goodwill us-gaap_PreferredStockConvertibleConversionPrice Preferred Stock, Convertible, Conversion Price Indefinite life assets (non-amortizable) us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated depreciation Commitments and Contingencies Disclosure [Text Block] Business Combination Disclosure [Text Block] Property and equipment, net Property and equipment, net Schedule of Business Acquisitions, by Acquisition [Table Text Block] Goodwill, net Goodwill Balance Balance Property and equipment, gross us-gaap_Dividends Dividends on convertible preferred stock Cash Flows From Investing Activities: us-gaap_RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction Related Party Transactions Disclosure [Text Block] us-gaap_IncreaseDecreaseInAccountsPayable Accounts payable Right-of-use asset and liability recorded during period Amount of right-of-use asset and liability recorded. us-gaap_OperatingExpenses Total operating expenses Former CEO Payable [Member] Represents former CEO payable. Additions, net Amount of addition to contract with customer liability. Customer Deposits [Member] Represents customer deposits. Deferred Revenue [Member] Represents deferred revenue. Cash and cash equivalents us-gaap_AllocatedShareBasedCompensationExpense Share-Based Payment Arrangement, Expense us-gaap_DefinedBenefitPlanContributionsByEmployer Defined Benefit Plan, Plan Assets, Contributions by Employer Customer deposits Represents the amount of customer deposits included in current liabilities as of the specified date. us-gaap_RoyaltyExpense Royalty Expense Amendment Flag Comprehensive loss: us-gaap_ComprehensiveIncomeNetOfTax Comprehensive loss dei_CityAreaCode City Area Code Use of Estimates, Policy [Policy Text Block] Market Value Patents and Trademarks [Member] Represents information regarding patents and trademarks. New Accounting Pronouncements, Policy [Policy Text Block] Intangibles Other than Patents and Trademarks [Member] Represents information regarding intangibles other than patents and trademarks. us-gaap_SharesOutstanding Balance (in shares) Balance (in shares) Common Stock, Shares, Outstanding (in shares) Preferred Stock, Shares Outstanding (in shares) Current Fiscal Year End Date Common shares issued upon vesting of restricted stock units Represents the value of restricted stock units vested during the period. Document Fiscal Period Focus us-gaap_IncreaseDecreaseInDepositOtherAssets Customer deposits Document Fiscal Year Focus Consolidation, Policy [Policy Text Block] dei_DocumentPeriodEndDate Document Period End Date Common shares issued upon vesting of restricted stock units (in shares) Represents the number of common shares issued upon vesting of restricted stock units. dei_EntityFileNumber Entity File Number Entity Emerging Growth Company dei_DocumentType Document Type Entity Small Business dei_EntityShellCompany Entity Shell Company Document Information [Line Items] Document Information [Table] us-gaap_AreaOfRealEstateProperty Area of Real Estate Property Entity Filer Category dei_EntityCurrentReportingStatus Entity Current Reporting Status Non-cash lease expense Represents the amount of noncash lease expense recognized during the period. Share-based compensation expense Share-based compensation expense us-gaap_IncreaseDecreaseInAccountsReceivable Accounts receivable us-gaap_ConcentrationRiskPercentage1 Concentration Risk, Percentage Entity Tax Identification Number Entity Central Index Key dei_EntityRegistrantName Entity Registrant Name Entity [Domain] Customer Concentration Risk [Member] Legal Entity [Axis] dei_EntityAddressAddressLine1 Entity Address, Address Line One us-gaap_AmortizationOfIntangibleAssets Amortization of Intangible Assets dei_EntityAddressCityOrTown Entity Address, City or Town dei_EntityAddressPostalZipCode Entity Address, Postal Zip Code dei_EntityAddressStateOrProvince Entity Address, State or Province Concentration Risk Type [Axis] Warranty settlement Represents the increase (decrease) in warranty settlement during the period. Concentration Risk Type [Domain] dei_EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding (in shares) Change in unrealized gain on short-term investments Represents the amount of change in unrealized gain on short-term investments. Revenue Benchmark [Member] Accounts Receivable [Member] us-gaap_IncreaseDecreaseInInventories Inventories Trading Symbol Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Issuance of common stock for acquisition (in shares) dei_LocalPhoneNumber Local Phone Number Issuance of common stock for acquisition Common shares issued upon exercise of stock options (in shares) Options on Common Shares, Exercised (in shares) us-gaap_TableTextBlock Notes Tables Virtual Reality Training [Member] Represents information regarding virtual reality training. Extended Product Warranties [Member] Represents information regarding extended product warranties. wrap_NumberOfWhollyOwnedSubsidiaries Number of Wholly-owned Subsidiaries Represents the reporting entity's number of wholly-owned subsidiaries. Common shares issued upon exercise of stock options Organization and Business Description [Policy Text Block] Accounting policy for business description and organization. Related Party, Type [Axis] Related Party, Type [Domain] Selling, general and administrative US Treasury Securities in Short-term Investments [Member] Represents information regarding US Treasury securities in short-term investments. Provision for doubtful accounts Adjusted Cost Represents the adjusted cost of financial instruments owned. Options on Common Shares, Granted (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Warrants, measurement input us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period us-gaap_WarrantsAndRightsOutstandingTerm Warrants and Rights Outstanding, Term Production and Lab Equipment [Member] Represents information regarding production and lab equipment. Tooling [Member] Represents information regarding tooling. Convertible preferred stock issued, net of offering costs (in shares) Stock Issued During Period, Shares, New Issues Raw materials Unrealized Gains Represents the unrealized gains on assets held on a recurring basis. Unrealized Losses Represents the amount of unrealized loss on assets still held on recurring basis. us-gaap_LiabilitiesAndStockholdersEquity Total liabilities and stockholders' equity Finished goods Work in process Convertible preferred stock issued, net of offering costs Related Party Transaction [Axis] Related Party Transaction [Domain] Chief Executive Officer and President [Member] Represents the CEO and president. Accumulated deficit Research and development Accumulated other comprehensive loss Syzygy Licensing LLC [Member] Represents information regarding Syzygy Licensing LLC. wrap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestingSustainedMarketCapitalization Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization Represents vesting based on sustained market capitalization. Measurement Input, Price Volatility [Member] Warranty provision The amount of product warranty expense (income). Changes in assets and liabilities: Measurement Input, Risk Free Interest Rate [Member] us-gaap_DisclosureTextBlockAbstract Notes to Financial Statements Operating lease liability - long term Measurement Input, Expected Dividend Rate [Member] Inventory Disclosure [Text Block] Patent and legal costs Represents the amount of accrued patent and legal costs as of the specified date. Subsequent Event [Member] Measurement Input, Expected Term [Member] Schedule of Inventory, Current [Table Text Block] Thereafter Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach). Operating lease liability - short term Measurement Input, Exercise Price [Member] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Events [Text Block] Operating lease right-of-use asset, net Measurement Input Type [Axis] Measurement Input Type [Domain] 2023 (9 months) 2025 2026 2027 us-gaap_OfficersCompensation Salary and Wage, Officer, Excluding Cost of Good and Service Sold Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] 2024 Change in fair value of warrant liabilities Change in fair value of warrant liabilities Other assets Share-based compensation us-gaap_ShareBasedCompensation Business Combinations Policy [Policy Text Block] Earnings Per Share, Policy [Policy Text Block] Revenues us-gaap_Revenues Total revenues Operating expenses: The 2017 Stock Incentive Plan [Member] Represents information regarding the 2017 Stock Incentive Plan. Schedule of Finite-Lived Intangible Assets [Table Text Block] Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis] us-gaap_LesseeOperatingLeaseTermOfContract Lessee, Operating Lease, Term of Contract (Month) Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation [Domain] us-gaap_Depreciation Depreciation Depreciation and amortization us-gaap_FinancialLiabilitiesFairValueDisclosure Fair value Fair value us-gaap_AssetsCurrent Total current assets Equity [Text Block] Common stock - 150,000,000 authorized; par value $0.0001 per share; 43,289,236 and 41,175,993 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Adjustments to reconcile net loss to net cash used in operating activities: Common stock, shares authorized (in shares) Common Stock, Shares Authorized Americas [Member] Common stock, shares issued (in shares) Certificates of Deposit [Member] Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Stockholders' Equity, Policy [Policy Text Block] wrap_RoyaltyPaymentsPercentageOfProductRevenue Royalty Payments, Percentage of Product Revenue Represents the percentage of product revenue to be paid by the reporting entity. Asia Pacific [Member] wrap_MaximumRoyaltiesToBePaidUnderAgreement Maximum Royalties to Be Paid Under Agreement Represents the maximum amount of royalties to be paid under the specified agreement. Related Party Technology License Agreement [Member] Represents information regarding a related party technology license agreement. Statistical Measurement [Domain] wrap_ReimbursementOfExpensesToRelatedPartyMonthlyAmount Reimbursement of Expenses to Related Party, Monthly Amount Represents the amount paid per month to reimburse a related party for expenses. Maximum [Member] Minimum [Member] wrap_NumberOfMajorCustomers Number of Major Customers Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc. Mr. Elwood Norris [Member] Represents information regarding Mr. Elwood Norris, a former officer and current stockholder of the reporting entity. Product and Service [Axis] Product and Service [Domain] Statistical Measurement [Axis] Distributors [Member] Represents information regarding distributors. Preferred stock Preferred Stock, Shares Issued (in shares) Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block] Distributor One [Member] Represents information regarding a first distributor. Distributor Two [Member] Represents information regarding a second distributor. Property, Plant and Equipment Disclosure [Text Block] Geographical [Axis] Geographical [Domain] Property, Plant and Equipment [Table Text Block] Preferred Stock, Shares Authorized (in shares) Preferred Stock, Shares Authorized Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Inventories, net Inventories - net Training [Member] Relating to training. Professional Services and Technology Acquisition Agreement [Member] Relating to the Professional Services and Technology Acquisition Agreement. Europe, Middle East and Africa [Member] Represents information regarding Europe, Middle East and Africa. Preferred Stock, Par or Stated Value Per Share (in dollars per share) Preferred Stock, Par or Stated Value Per Share Product sales Fair Value, Inputs, Level 3 [Member] Fair Value Hierarchy and NAV [Domain] Customer [Axis] Fair Value, Inputs, Level 1 [Member] Customer [Domain] Fair Value Hierarchy and NAV [Axis] us-gaap_ProductWarrantyAccrualPayments Warranty settlements us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease Warranty provision Deferred revenue us-gaap_PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage Cash Flows From Operating Activities: Warrants – short term Statement [Line Items] Accounts receivable and contract assets, net Furniture and Fixtures [Member] Additional paid-in capital Revenues: Short-term investments AOCI Attributable to Parent [Member] Stockholders' equity: Schedule of Product Warranty Liability [Table Text Block] Warrant liabilities Represents the amount of warrant liabilities issued. Proceeds from issuance of warrants and convertible preferred stock, net of offering costs The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt) and preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock. Other us-gaap_NonoperatingIncomeExpense Total other income (expense) Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Domain] wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAndEquity Total liabilities and equity Amount of equity and liabilities assumed at the acquisition date. wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill Total assets Amount of assets including goodwill acquired at the acquisition date. wrap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Granted Intrinsic value of granted awards under share-based payment arrangement. Excludes share and unit options. Current assets: Warrants [Text Block] Represents the entire disclosure regarding warrants. Fair Value Disclosures [Text Block] wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquity Equity Amount of equity assumed at the acquisition date. Executive Chairman [Member] Relating to the executive chairman. us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Interest income wrap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value Represents the weighted average grant date fair value of share-based payment options. us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Net decrease in cash and cash equivalents us-gaap_Liabilities Total liabilities us-gaap_NetCashProvidedByUsedInFinancingActivities Net cash provided by financing activities Commitments and Contingencies Sale of Stock [Axis] Sale of Stock [Domain] Other revenue us-gaap_OperatingIncomeLoss Loss from operations Other income (expense): us-gaap_NetCashProvidedByUsedInOperatingActivities Net cash used in operating activities us-gaap_ContractWithCustomerLiabilityRevenueRecognized Transfer to revenue Prepaid expense and other current assets us-gaap_NetCashProvidedByUsedInInvestingActivities Net cash provided by investing activities Accrued liabilities and other The increase (decrease) during the reporting period in accrued liabilities and other liabilities. Cost of revenues us-gaap_GrossProfit Gross profit wrap_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets Prepaid expense and other current assets Amount of increase (decrease) in prepaid expenses, and current assets classified as other. us-gaap_ContractWithCustomerLiability Contract with Customer, Liability Balance Balance us-gaap_AccountsPayableCurrentAndNoncurrent Accounts Payable us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent Employee-related Liabilities Intrensic, LLC [Member] Relating to Intrensic, LLC. us-gaap_ProductWarrantyAccrual Balance Balance us-gaap_ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity us-gaap_ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock Retained Earnings [Member] Proceeds from exercise of stock options Title of Individual [Domain] Title of Individual [Axis] Additional Paid-in Capital [Member] Common Stock [Member] Preferred Stock [Member] Equity Components [Axis] Equity Component [Domain] us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights us-gaap_RoyaltyGuaranteesCommitmentsAmount Royalty Guarantees, Commitments, Amount Disaggregation of Revenue [Table Text Block] Revenue from Contract with Customer [Text Block] Defined Contribution Plan [Text Block] Computer Equipment [Member] dei_DocumentQuarterlyReport Document Quarterly Report Entity Incorporation, State or Country Code Accounting Policies [Abstract] dei_DocumentTransitionReport Document Transition Report Basis of Accounting, Policy [Policy Text Block] Concentration Risk Disclosure [Text Block] Selling, General and Administrative Expenses [Member] dei_EntityInteractiveDataCurrent Entity Interactive Data Current Security Exchange Name Title of 12(b) Security Research and Development Expense [Member] Income Statement Location [Axis] Income Statement Location [Domain] us-gaap_ContractualObligation Contractual Obligation us-gaap_SharePrice Share Price us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Asset Class [Axis] Asset Class [Domain] Statement [Table] Statement of Financial Position [Abstract] Weighted average common shares used to compute net loss per basic and diluted common share (in shares) Accounts Payable and Accrued Liabilities Disclosure [Text Block] Net loss per basic and diluted common share (in dollars per share) Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block] Statement of Cash Flows [Abstract] Statement of Stockholders' Equity [Abstract] Lease Contractual Term [Domain] Lease Contractual Term [Axis] Income Statement [Abstract] wrap_PreferredStockStatedValuePerShare Preferred Stock, Stated Value Per Share Stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. Schedule of Accrued Liabilities [Table Text Block] us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs Registered Direct Offering [Member] Represents the registered direct offering. us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares Warrants Issued in Registered Direct Offering [Member] Represents warrants issued in registered direct offering. Settlement – US Treasury bills us-gaap_LiabilitiesNoncurrent Total long-term liabilities Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Cash Flows From Financing Activities: us-gaap_DividendsPayableAmountPerShare Dividends Payable, Amount Per Share (in dollars per share) Office Space in Miami, Florida [Member] Related to lease. Series A Preferred Stock [Member] Net assets acquired from acquisition The amount of net assets acquired from acquisition. Convertible Preferred Stock [Member] Deferred revenue- long term Long-term portion us-gaap_StockholdersEquity Total stockholders' equity Balance Balance us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities Liabilities us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired Net cash paid for acquisition of Intrensic Class of Stock [Axis] Class of Stock [Domain] us-gaap_PaymentsToAcquireBusinessesGross Payments to Acquire Businesses, Gross us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment Net property, plant and equipment EX-101.PRE 8 wrap-20230930_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE EX-101.CAL 9 wrap-20230930_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE GRAPHIC 10 wrap20230930_10qimg001.jpg begin 644 wrap20230930_10qimg001.jpg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end XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Document And Entity Information - shares
9 Months Ended
Sep. 30, 2023
Nov. 13, 2023
Document Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Sep. 30, 2023  
Document Transition Report false  
Entity File Number 000-55838  
Entity Registrant Name Wrap Technologies, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 98-0551945  
Entity Address, Address Line One 1817 W 4th Street  
Entity Address, City or Town Tempe  
Entity Address, State or Province AZ  
Entity Address, Postal Zip Code 85281  
City Area Code 800  
Local Phone Number 583-2652  
Title of 12(b) Security Common Stock, par value $0.0001 per share  
Trading Symbol WRAP  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   44,214,169
Entity Central Index Key 0001702924  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q3  
Amendment Flag false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Sep. 30, 2023
Dec. 31, 2022
Current assets:    
Cash and cash equivalents $ 4,934,000 $ 5,330,000
Short-term investments 10,000,000 13,949,000
Accounts receivable and contract assets, net 4,321,000 2,830,000
Inventories, net 5,816,000 3,975,000
Prepaid expense and other current assets 762,000 775,000
Total current assets 25,833,000 26,859,000
Property and equipment, net 533,000 758,000
Operating lease right-of-use asset, net 205,000 285,000
Intangible assets, net 3,319,000 2,569,000
Goodwill, net 1,611,000 0
Other assets 166,000 100,000
Total assets 31,667,000 30,571,000
Current liabilities:    
Accounts payable 1,546,000 1,419,000
Accrued liabilities 1,128,000 1,463,000
Customer deposits 2,000 0
Deferred revenue- short term 189,000 166,000
Operating lease liability - short term 116,000 108,000
Warrants – short term 7,834,000 0
Total current liabilities 10,815,000 3,156,000
Long-term liabilities:    
Deferred revenue- long term 176,000 167,000
Operating lease liability - long term 105,000 193,000
Total long-term liabilities 281,000 360,000
Total liabilities 11,096,000 3,516,000
Commitments and Contingencies  
Stockholders' equity:    
Preferred stock 0 0
Common stock - 150,000,000 authorized; par value $0.0001 per share; 43,289,236 and 41,175,993 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively 4,000 4,000
Additional paid-in capital 97,919,000 94,333,000
Accumulated deficit (79,388,000) (67,376,000)
Accumulated other comprehensive loss 0 94,000
Total stockholders' equity 20,571,000 27,055,000
Total liabilities and stockholders' equity 31,667,000 30,571,000
Convertible Preferred Stock [Member]    
Stockholders' equity:    
Preferred stock $ 2,036,000 $ 0
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares
Sep. 30, 2023
Dec. 31, 2022
Preferred Stock, Shares Authorized (in shares) 5,000,000 5,000,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share) $ 0.0001 $ 0.0001
Common stock, shares authorized (in shares) 150,000,000 150,000,000
Common stock, par value (in dollars per share) $ 0.0001 $ 0.0001
Common Stock, Shares, Outstanding (in shares) 43,289,236 41,175,993
Common stock, shares issued (in shares) 43,289,236 41,175,993
Convertible Preferred Stock [Member]    
Preferred Stock, Shares Authorized (in shares) 10,000 10,000
Preferred Stock, Par or Stated Value Per Share (in dollars per share) $ 0.0001 $ 0.0001
Preferred Stock, Shares Issued (in shares) 10,000 0
Preferred Stock, Shares Outstanding (in shares) 10,000 0
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues:        
Product sales $ 3,248 $ 1,612 $ 4,897 $ 4,042
Other revenue 383 89 647 422
Total revenues 3,631 1,701 5,544 4,464
Cost of revenues 1,454 790 2,347 2,430
Gross profit 2,177 911 3,197 2,034
Operating expenses:        
Selling, general and administrative 4,317 3,586 12,604 11,952
Research and development 610 1,236 2,683 4,210
Total operating expenses 4,927 4,822 15,287 16,162
Loss from operations (2,750) (3,911) (12,090) (14,128)
Other income (expense):        
Interest income 90 34 413 36
Change in fair value of warrant liabilities 117 (0) 117 0
Other (6) 12 (25) 10
Total other income (expense) (33) 46 271 46
Net loss (2,783) (3,865) (11,819) (14,082)
Less: Convertible preferred stock dividends (193) 0 (193) 0
Net loss attributable to common stockholders $ (2,976) $ (3,865) $ (12,012) $ (14,082)
Net loss per basic and diluted common share (in dollars per share) $ (0.07) $ (0.09) $ (0.29) $ (0.34)
Weighted average common shares used to compute net loss per basic and diluted common share (in shares) 42,652,481 41,086,285 41,914,512 40,955,234
Comprehensive loss:        
Net loss $ (2,783) $ (3,865) $ (11,819) $ (14,082)
Net unrealized gain (loss) on short-term investments 0 73 (0) 62
Comprehensive loss $ (2,783) $ (3,792) $ (11,819) $ (14,020)
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Preferred Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2021 40,851,945          
Balance at Dec. 31, 2021 $ 4   $ 91,025 $ (49,759) $ (6) $ 41,264
Share-based compensation expense $ 0   (2,628) 0 0 (2,628)
Dividends on convertible preferred stock           0
Common shares issued upon vesting of restricted stock units (in shares) 218,133          
Net loss $ 0   0 (14,082) 0 (14,082)
Common shares issued upon exercise of stock options (in shares) 55,500          
Common shares issued upon exercise of stock options $ 0   83 0 0 83
Share-based compensation expense 0   2,628 0 0 2,628
Net unrealized gain (loss) on short-term investments 0   0 0 62 62
Net loss for the period $ 0   0 (14,082) 0 (14,082)
Balance (in shares) at Sep. 30, 2022 41,125,578          
Balance at Sep. 30, 2022 $ 4   93,736 (63,841) 56 29,955
Balance (in shares) at Jun. 30, 2022 40,992,161          
Balance at Jun. 30, 2022 $ 4   92,856 (59,976) (17) 32,867
Share-based compensation expense $ 0   (872) 0 0 (872)
Common shares issued upon vesting of restricted stock units (in shares) 127,917          
Common shares issued upon vesting of restricted stock units $ 0   0 0 0 0
Net loss $ 0   0 (3,865) 0 (3,865)
Common shares issued upon exercise of stock options (in shares) 5,500          
Common shares issued upon exercise of stock options $ 0   8 0 0 8
Share-based compensation expense 0   872 0 0 872
Net unrealized gain (loss) on short-term investments 0   0 0 73 73
Net loss for the period $ 0   0 (3,865) 0 (3,865)
Balance (in shares) at Sep. 30, 2022 41,125,578          
Balance at Sep. 30, 2022 $ 4   93,736 (63,841) 56 29,955
Balance (in shares) at Dec. 31, 2022 41,175,993 0        
Balance at Dec. 31, 2022 $ 4 $ 0 94,333 (67,376) 94 27,055
Share-based compensation expense 0 0 (1,648) 0 0 (1,648)
Dividends on convertible preferred stock $ 0 $ 0 0 (193)   (193)
Convertible preferred stock issued, net of offering costs (in shares) 0 10,000        
Convertible preferred stock issued, net of offering costs $ 0 $ 2,036 0 0 0 2,036
Common shares issued upon vesting of restricted stock units (in shares) 862,993 0        
Common shares issued upon vesting of restricted stock units $ 0 $ 0 0 0 0 0
Issuance of common stock for acquisition (in shares) 1,250,000 0        
Issuance of common stock for acquisition $ 0 $ 0 1,938 0 0 1,938
Net loss $ 0 $ 0 0 (11,819) 0 $ (11,819)
Common shares issued upon exercise of stock options (in shares) 250 0       250
Common shares issued upon exercise of stock options $ 0 $ 0 0 0 0 $ 0
Share-based compensation expense 0 0 1,648 0 0 1,648
Settlement – US Treasury bills 0 0 0 0 (94) (94)
Net unrealized gain (loss) on short-term investments           (0)
Net loss for the period $ 0 $ 0 0 (11,819) 0 (11,819)
Balance (in shares) at Sep. 30, 2023 43,289,236 10,000        
Balance at Sep. 30, 2023 $ 4 $ 2,036 97,919 (79,388) 0 20,571
Balance (in shares) at Jun. 30, 2023 41,910,687          
Balance at Jun. 30, 2023 $ 4 0 96,182 (76,411) 0 19,775
Share-based compensation expense 0 0 (201) (1) 0 (202)
Dividends on convertible preferred stock $ 0 $ 0 0 (193) 0 (193)
Convertible preferred stock issued, net of offering costs (in shares) 0 2,036        
Convertible preferred stock issued, net of offering costs   $ 10,000 0 0 0 2,036
Common shares issued upon vesting of restricted stock units (in shares) 128,549 0        
Common shares issued upon vesting of restricted stock units $ 0 $ 0 0 0 0 0
Issuance of common stock for acquisition (in shares) 1,250,000 0        
Issuance of common stock for acquisition $ 0 $ 0 1,938 0 0 1,938
Net loss 0 0 0 (2,783) 0 (2,783)
Share-based compensation expense (0) (0) 201 1 (0) 202
Net unrealized gain (loss) on short-term investments           0
Net loss for the period $ 0 $ 0 0 (2,783) 0 (2,783)
Balance (in shares) at Sep. 30, 2023 43,289,236 10,000        
Balance at Sep. 30, 2023 $ 4 $ 2,036 $ 97,919 $ (79,388) $ 0 $ 20,571
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Cash Flows From Operating Activities:          
Net loss $ (2,783) $ (3,865) $ (11,819) $ (14,082)  
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization     675 574  
Share-based compensation     1,648 2,628  
Warranty provision     (8) 55  
Change in fair value of warrant liabilities 117 (0) 117 0  
Non-cash lease expense     80 75  
Provision for doubtful accounts     (48) 61  
Accounts receivable     (1,353) 1,576  
Inventories     (1,780) (1,396)  
Prepaid expense and other current assets     13 268  
Accounts payable     (67) (834)  
Operating lease liability     (80) (65)  
Customer deposits     2 (43)  
Accrued liabilities and other     (322) 175  
Warranty settlement     (8) (63)  
Deferred revenue     32 35  
Net cash used in operating activities     (12,918) (11,036)  
Changes in assets and liabilities:          
Provision for doubtful accounts     (48) 61  
Cash Flows From Investing Activities:          
Purchase of short-term investments     (6,145) (23,119)  
Proceeds from maturities of short-term investments     10,000 33,300  
Capital expenditures for property and equipment     (133) (201)  
Net cash paid for acquisition of Intrensic     (551) 0  
Cash outlay for deposits     (66) (3)  
Net cash provided by investing activities     2,768 9,844  
Cash Flows From Financing Activities:          
Proceeds from exercise of stock options     0 83  
Proceeds from issuance of warrants and convertible preferred stock, net of offering costs     9,754 0  
Net cash provided by financing activities     9,754 83  
Net decrease in cash and cash equivalents     (396) (1,109)  
Cash and cash equivalents, beginning of period     5,330 4,937 $ 4,937
Change in unrealized gain on short-term investments     (94) 62  
Net assets acquired from acquisition     147 0  
Warrant liabilities     (7,834) 0  
Dividends on convertible preferred stock (193)   (193) 0  
Right-of-use asset and liability recorded during period     0 260  
Cash and cash equivalents, end of period 4,934 3,828 4,934 3,828 5,330
Supplemental Disclosure of Non-Cash Investing and Financing Activities:          
us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations $ 4,934 $ 3,828 4,934 3,828 $ 5,330
Convertible Preferred Stock [Member]          
Cash Flows From Financing Activities:          
Issuance of common stock for acquisition     (2,036) 0  
Intrensic, LLC [Member]          
Cash Flows From Financing Activities:          
Issuance of common stock for acquisition     (1,938) 0  
Patents and Trademarks [Member]          
Cash Flows From Investing Activities:          
Investment in patents and trademarks     (277) (133)  
Intangibles Other than Patents and Trademarks [Member]          
Cash Flows From Investing Activities:          
Investment in patents and trademarks     $ (60) $ 0  
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Note 1 - Organization, Summary of Significant Accounting Policies and Recent Developments
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]

1.                ORGANIZATION, SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT DEVELOPMENTS

 

Organization and Business Description

 

Wrap Technologies, Inc., a Delaware corporation (the “Company”, “we”, “us”, and “our”), is a publicly traded company with our Common Stock, par value $0.0001 per share (“Common Stock”), listed on the Nasdaq Capital Market (“Nasdaq”) under the trading symbol “WRAP”. The Company is a developer and supplier of public safety products and training services for law enforcement and security personnel. The Company’s primary product is the BolaWrap® remote restraint device. The principal markets for the Company’s proprietary products and services are in North and South America, Europe, Middle East and Asia.

 

Basis of Presentation

 

The Company’s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. In management’s opinion, the accompanying financial statements reflect adjustments necessary to present fairly the financial position, results of operations, and cash flows for those periods indicated, and contain adequate disclosure to make the information presented not misleading. Adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the footnotes. The condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2022, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “Annual Report”), as filed with the SEC on March 2, 2023. The accompanying condensed consolidated balance sheet at December 31, 2022 has been derived from the audited consolidated balance sheet at December 31, 2022, contained in the Annual Report. Results of operations for interim periods are not necessarily indicative of the results of operations for a full year.

 

Where necessary, the prior year’s information has been reclassified to conform to the current year presentation.

 

Principles of Consolidation

 

The Company has two wholly owned subsidiaries, Wrap Reality, Inc. formed in December 2020 that sells a virtual reality (“VR”) training system primarily targeting law enforcement agencies and Intrensic, LLC which the Company acquired in August 2023 which specializes in Body Worn Camera and Digital Evidence Management solutions. The consolidated financial statements include the accounts of these subsidiaries after elimination of intercompany transactions and accounts.

 

Business Combinations

 

The Company accounts for its business combinations under the provisions of Accounting Standards Codification ("ASC") Topic 805-10, Business Combinations ("ASC 805-10"), which requires that the purchase method of accounting be used for all business combinations. Assets acquired and liabilities assumed, including non-controlling interests, are recorded at the date of acquisition at their respective fair values. The estimated fair value of net assets acquired, including the allocation of the fair value to identifiable assets and liabilities, was determined using established valuation techniques. ASC 805-10 also specifies criteria that intangible assets acquired in a business combination must meet to be recognized and reported apart from goodwill. Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from the business combinations and are expensed as incurred.

 

The estimated fair value of the acquired intangible assets was determined using a method which reflects the present value of the operating cash flows generated by this asset after taking into account the cost to realize the revenue, and an appropriate discount rate to reflect the time value and risk associated with the invested capital.

 

Certain adjustments to the assessed fair values of the assets and liabilities made subsequent to the acquisition date, but within the measurement period, which is up to one year, are recorded as adjustments to goodwill. Any adjustments subsequent to the measurement period are recorded in income.

 

Goodwill

 

Goodwill represents the difference, if any, between the aggregate consideration paid for an acquisition and the fair values of the underlying net assets and liabilities assumed from an acquired business. Goodwill is not amortized, but instead is tested for impairment. The Company tests goodwill for impairment on an annual basis during the fourth quarter, or more frequently if conditions indicate that such impairment could exist. The Company evaluates qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying value and whether it is necessary to perform goodwill impairment process.

 

Definite-lived Intangible Assets 

 

Definite-lived intangible assets represent certain trade names, patents, licenses, software, acquired technology and customer relationships. Definite-lived intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses, if any. Definite-lived intangible assets acquired through the business combination are measured at fair value at the acquisition date. The Company amortizes these acquired definite-lived intangibles assets with a finite life on a straight-line basis, over 6 years for technology; 7 years for customer relationships; and 8 years for trademarks and trade names.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions (e.g., stock-based compensation valuation, allowance for doubtful accounts, valuation of inventory and intangible assets, warranty reserve, accrued expense and recognition and measurement of contingencies) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenue and expense during the reporting period. Actual results could materially differ from those estimates.

 

 

Warrants

 

The Company accounts for warrants as liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

For issued warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company accounts for the warrants issued in accordance with the guidance contained in ASC 815-40-15-7C, under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statement of operations.

 

Convertible Preferred Stocks

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 480 and ASC 815 to determine if those instruments or embedded components of those instruments qualify as derivatives and are subject to bifurcation accounting. The Company determines that the economic characteristics and risks of the embedded derivative instrument are clearly and closely related to the economic characteristics and risks of the host contract. The convertible instruments are accounted for as a single hybrid instrument. Additionally, the convertible instruments do not have any redemption features that would preclude permanent equity classification in accordance with the guidance contained in ASC 480-10-S99.

 

The Company issued the Warrants, which are classified as liabilities and measured at fair value on a recurring basis, and Convertible Preferred Stocks in one transaction. The issuance proceeds were allocated by using the with-and-without method. Under this method, The Company first allocated the issuance proceeds to the Warrants based on their initial fair value measurement, and then allocated the remaining proceeds to the Convertible Preferred Stocks.

 

Loss per Share

 

Basic loss per share (EPS) is computed by dividing net loss, less any dividends, accretion or decretion, redemption or induced conversion, if any, on our Series A Convertible Preferred Stock, by the weighted average number of shares outstanding during the reported period.

 

In computing diluted EPS, we adjust the numerator used in the basic EPS computation, subject to anti-dilution requirements, to add back the dividends (declared or cumulative undeclared) applicable to the Series A Convertible Preferred Stock. Such add-back would also include any adjustments to equity in the period to accrete the Series A Convertible Preferred Stock to its redemption price, or recorded upon a redemption or induced conversion, if any. We adjust the denominator used in the basic EPS computation, subject to anti-dilution requirements, to include the dilution from potential shares resulting from the issuance of the Series A Convertible Preferred Stock, restricted stock units, and stock options. Stock options and restricted stock units exercisable or issuable for a total of 2,668,750 and 6,396,277 shares of Common Stock were outstanding at September 30, 2023, and 2022, respectively. These securities are not included in the computation of diluted net loss per common share for the periods presented as their inclusion would be antidilutive due to losses incurred by the Company.

 

Recent Issued Accounting Guidance

 

The Company has reviewed recently issued, but not yet effective, accounting pronouncements and does not believe the future adoptions of any such pronouncements will be expected to cause a material impact on its financial condition or the results of operations.

 

In July 2023, the SEC adopted the final rule under SEC Release No. 33-11216, Cybersecurity Risk Management, Strategy, Governance, and Incident Disclosure, requiring disclosure of material cybersecurity incidents on Form 8-K and periodic disclosure of a registrant’s cybersecurity risk management, strategy and governance in annual reports. Regulation S-K Item 6 disclosure requirements under this rule will be effective for us in the fourth quarter of 2023. Incident disclosure requirements in Form 8-K will be effective for us on June 15, 2024. We are still evaluating for any impact on our financial statement disclosures from the adoption of this final rule.

 

Recent Developments

 

On August 9, 2023, the Company entered into a Membership Interest Purchase Agreement (the “Purchase Agreement”) with Intrensic, LLC, a Delaware limited liability company (“Intrensic”), and certain members of Intrensic, including Kevin Mullins, the Company’s Chief Executive Officer (collectively, “Sellers”). Under the terms of the Purchase Agreement, the Company agreed to purchase, and Sellers agreed to sell, 100% of the membership interests (the “Membership Interests”) of Intrensic for the following consideration upon the consummation of the sale of the Membership Interests (the “Intrensic Closing”): (i) $553,588 in cash, subject to adjustment based upon the outstanding indebtedness of Intrensic and Intrensic’s working capital as of the Intrensic Closing; and (ii) 1,250,000 shares of Common Stock of the Company (collectively, the “Purchase Price”) (the “Intrensic Acquisition”).

 

Kevin Mullins, a director of the Company and the Company’s Chief Executive Officer, owns approximately 9.53% of the Membership Interests, and as such, has a financial interest in the Intrensic Acquisition.

 

  

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.3
Note 2 - Revenue and Product Costs
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Revenue from Contract with Customer [Text Block]

2.          REVENUE AND PRODUCT COSTS

 

Revenue consists of product revenue and other revenue. Product sales include BolaWrap products and accessories. Other revenue includes VR revenue, service, training and shipping revenue.

 

Periodically, certain customers request bill and hold transactions for future delivery as scheduled and designated by them. In such cases, revenue is not recognized until after control, title and risk of ownership has transferred which is generally when the customer has requested such transaction under normal billing and payment terms and has been notified that the product (i) has been completed according to customer specifications, (ii) has passed quality control inspections, and (iii) has been tagged and packed for shipment, separated from other inventory and ready for physical transfer to the customer. The value associated with custodial storage services is deemed immaterial in the context of such contracts and in total, and accordingly, none of the transaction price is allocated to such service.

 

The timing of revenue recognition may differ from the timing of invoicing to customers. The Company generally has an unconditional right to consideration when customers are invoiced, and a receivable is recorded. A contract asset is recognized when revenue is recognized prior to invoicing, or a contract liability (deferred revenue) when revenue will be recognized subsequent to invoicing. The Company recognizes an asset if there are incremental costs of obtaining a contract with a customer such as commissions. These costs are ascribed to or allocated to the underlying performance obligations in the contract. The Company may receive consideration, per terms of a contract, from customers prior to transferring goods to the customer. The Company records customer deposits as a contract liability. Additionally, the Company may receive payments, most typically for service and warranty contracts, at the onset of the contract and before the services have been performed. In such instances, a deferred revenue liability is recorded. The Company recognizes these contract liabilities as revenue after all revenue recognition criteria are met. The table below details the activity in our contract liabilities during the nine months ended September 30, 2023.

 

   

Customer

   

Deferred

 
   

Deposits

   

Revenue

 

Balance at January 1, 2023

  $ -     $ 333  

Additions, net

    2       229  

Transfer to revenue

    -       (197

)

Balance at September 30, 2023

  $ 2     $ 365  

Current portion

  $ 2     $ 189  

Long-term portion

  $ -     $ 176  

 

At September 30, 2023, the Company’s deferred revenue of $365 consisted of $199 related to VR, $6 related to training and $160 related to BolaWrap extended warranties and services. At December 31, 2022, the Company’s deferred revenue of $333 consisted of $198 related to VR, $11 related to training and $124 related to BolaWrap extended warranties and services.

 

Estimated costs for the Company’s standard warranty, generally one-year, are charged to cost of products sold when revenue is recorded for the related product. Royalties are also charged to the cost of products sold.

  

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.3
Note 3 - Financial Instruments
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Fair Value Disclosures [Text Block]

3.          FINANCIAL INSTRUMENTS

 

Assets and liabilities recorded at fair value on a recurring basis in the Condensed Consolidated Balance Sheets and assets and liabilities measured at fair value on a non-recurring basis or disclosed at fair value, are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The accounting guidance also establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows:

 

 

Level 1—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;

 

Level 2—Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and

 

Level 3—Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.

 

The Company’s short-term investments consisting of U.S. Treasury bill securities and Certificate of Deposits are classified as Level 1 because they are valued using quoted market prices.

 

The following table shows the Company’s short-term investments by significant investment category as of September 30, 2023, and December 31, 2022.

 

   

As of September 30, 2023

 
   

Adjusted

   

Unrealized

   

Unrealized

   

Market

 
   

Cost

   

Gains

   

Losses

   

Value

 

Level 1:

                               

Certificate of Deposits

    10,000       -       -       10,000  

Total Financial Assets

  $ 10,000     $ -     $ -     $ 10,000  

 

   

As of December 31, 2022

 
   

Adjusted

   

Unrealized

   

Unrealized

   

Market

 
   

Cost

   

Gains

   

Losses

   

Value

 

Level 1:

                               

U.S. Treasury securities in short-term investments

    9,849       100       -       9,949  

Certificate of Deposits

    4,000       -       -       4,000  

Total Financial Assets

  $ 13,849     $ 100     $ -     $ 13,949  

 

Unrealized gains or losses resulting from our short-term investments are recorded in accumulated other comprehensive gain or loss as they are classified as available for sale. During the three and nine months ended September 30, 2023, no gain (loss) was recorded to other comprehensive gain (loss). During the three and nine months ended September 30, 2022, a $73 gain and $62 gain was recorded to other comprehensive gain (loss), respectively.

 

The warrant liabilities are measured at fair value on a recurring basis. The subsequent measurement of the warrant liabilities as of September 30, 2023, is classified as Level 3 due to the use of an observable market quote in a non-active market and the management’s assumption of the expected stock price volatility.

 

The following table presents the fair value in the beginning of the period, the changes in the fair value, and the fair value at the end of the period of warrant liabilities (in thousands):

 

Level 3:  

September 30,

2023

   

December 31,

2022

 

Fair value at inception or the beginning of the period

  $ 7,717       -  

Change in fair value of warrant liabilities

    117       -  

Fair value as of September 30, 2023

  $ 7,834       -  

 

 

The Company uses the modified Black-Scholes option pricing model to determine the fair value of warrant liabilities. The following table summarizes the assumptions used to compute the fair value of Warrants:

 

   

As of

September 30,

2023

   

As of

December 31,

2022

 

Expected stock price volatility

    100

%

    -

%

Risk-free interest rate

    4.49

%

    -

%

Dividends yield

    0

%

    -

%

Expected life of warrants

    4.75       -  

Exercise price

  $ 1.45     $ -  

 

Our other financial instruments also include accounts receivable, accounts payable, accrued liabilities and business acquisition liabilities. Due to the short-term nature of these instruments, their fair values approximate their carrying values on the balance sheet.

  

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.3
Note 4 - Inventories
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Inventory Disclosure [Text Block]

4.          INVENTORIES

 

Inventory is recorded at the lower of cost or net realizable value. The cost of substantially all the Company’s inventory is determined by the FIFO cost method. Inventories consisted of the following:

 

   

September 30,

2023

   

December 31,

2022

 

Finished goods

  $ 2,921     $ 2,293  

Work in process

    -       -  

Raw materials

    2,895       1,682  

Inventories - net

  $ 5,816     $ 3,975  

  

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.3
Note 5 - Property and Equipment, Net
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Property, Plant and Equipment Disclosure [Text Block]

5.          PROPERTY AND EQUIPMENT, NET

 

Property and equipment consisted of the following:

 

   

September 30,

2023

   

December 31,

2022

 

Production and lab equipment

  $ 536     $ 513  

Tooling

    505       448  

Computer equipment

    587       531  

Furniture, fixtures and improvements

    190       181  
      1,818       1,673  

Accumulated depreciation

    (1,285 )     (915

)

Property and equipment, net

  $ 533     $ 758  

 

Depreciation expense was $122 and $358 for the three and nine months ended September 30, 2023, respectively, and $121 and $359 for the three and nine months ended September 30, 2022, respectively.

 

  

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.3
Note 6 - Intangible Assets and Goodwill
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Goodwill and Intangible Assets Disclosure [Text Block]

6.          INTANGIBLE ASSETS AND GOODWILL

 

Intangible Assets, net

 

Intangible assets, net consisted of the following:

 

   

September 30,

2023

   

December 31,

2022

 

Amortizable intangible assets:

               

Patents

  $ 841     $ 575  

Trademarks

    241       150  

Purchased software and technology

    2,452       1,962  
Customer Relationships     160       -  
      3,694       2,687  

Accumulated amortization

    (778 )     (462

)

Total amortizable

    2,916       2,225  

Indefinite life assets (non-amortizable)

    403       344  

Total intangible assets, net

  $ 3,319     $ 2,569  

 

Amortization expense was $150 and $317 for the three and nine months ended September 30, 2023, respectively, and $72 and $215 for the three and nine months ended September 30, 2022, respectively.

 

At September 30, 2023, future amortization expense is as follows:

 

2023 (3 months)

  $ 164  

2024

    655  

2025

    650  

2026

    427  

2027

    180  

Thereafter

    840  

Total estimated amortization expense

  $ 2,916  

 

 

Goodwill

 

The table below summarizes the changes in the carrying amount of goodwill:

 

Balance at January 1, 2023   $ -  
Acquired goodwill     1,611  
Balance at September 30, 2023   $ 1,611  

  

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.3
Note 7 - Accounts Payable and Accrued Liabilities
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]

7.          ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

Accounts payable includes $122 and $127 due to related party Syzygy Licensing, LLC (“Syzygy”) as of September 30, 2023, and December 31, 2022, respectively. See Note 11 for additional information on this related party.

 

Accrued liabilities consist of the following:

 

   

September 30,

2023

   

December 31,

2022

 

Patent and legal costs

  $ 61     $ 135  

Accrued compensation

    786       1,100  

Warranty costs

    109       125  

Taxes and other

    172       103  

Total

  $ 1,128     $ 1,463  

 

Accrued compensation includes $139 and $1,022 in employee bonuses and commissions payable at September 30, 2023 and December 31, 2022, respectively.

 

Changes in our estimated product warranty costs were as follows:

 

   

Nine Months Ended

September 30,

 
   

2023

   

2022

 

Balance, beginning of period

  $ 125     $ 96  

Warranty settlements

    (8 )     (63

)

Release of warranty provision

    (8 )     55  

Balance, end of period

  $ 109     $ 88  

 

  

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.3
Note 8 - Warrants
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Warrants [Text Block]

8.          WARRANTS

 

On June 29, 2023, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain directors of the Company and certain accredited and institutional investors (collectively, the “Investors”), pursuant to which it agreed to sell to the Investors in a private placement (the “Offering”): (i) warrants to acquire up to an aggregate of 6,896,553 shares of Common Stock (the “Warrants”) and (ii) Series A Convertible Preferred Stock (Note 9). The warrants are exercisable six months after issuance at an exercise price of $1.45 per share, subject to adjustment, and expire five years from the date of issuance. The closing of the Offering occurred on July 3, 2023. The aggregate gross proceeds from the Offering were $10,000. $7,717 of $10,000 was allocated to the Warrants.

  

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.3
Note 9 - Stockholders' Equity
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Equity [Text Block]

9.          STOCKHOLDERS' EQUITY

 

The Company’s authorized capital consists of 150,000,000 shares of Common Stock and 5,000,000 shares of preferred stock, par value $0.0001 per share (“Preferred Stock”).

 

On July 3, 2023, the Company filed a Certificate of Designations (the “Series A COD”) with the State of Delaware, designating 10,000 shares of its Preferred Stock as Series A Convertible Preferred Stock, $0.0001 per share (the “Series A Preferred”). Shares of Series A Preferred are convertible into Common Stock (the “Conversion Shares”) at an initial conversion price of $1.45 (the “Conversion Price”), subject to customary adjustments and price-based as defined in the Series A COD. Holders of Series A Preferred Shares are entitled to dividends of 8% per annum, payable quarterly, subject to adjustment upon the occurrence of certain events in accordance with the terms of the Series A COD. The holders of Series A Preferred have no voting rights on account of the Preferred Shares, other than with respect to certain matters affecting the rights of the Preferred Shares.

 

On June 29, 2023, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain directors of the Company and certain accredited and institutional investors (collectively, the “Investors”), pursuant to which it agreed to sell to the Investors in a private placement (the “Offering”): (i) the Warrants Note 8 and (ii) an aggregate of 10,000 shares of the Company’s newly designated Series A Convertible Preferred Stock, with par value $0.0001 per share and a stated value of $1,000 per share, initially convertible into up to 6,896,553 shares of the Company’s common stock, par value $0.0001 per share at a conversion price of $1.45 per share, subject to customary adjustments and price-based as defined in the Series A Certificate of Designations (the “Convertible Preferred Stocks”). The customary adjustments include: (i) additional amounts related to declared and unpaid Dividends and any other unpaid amounts due and payable and (ii) make-whole amounts related to the accrual of any additional dividends that would have accrued up to the date of conversion including the one-year anniversary from the date of conversion. Each preferred stock has a stated value of $1,000 per share, and holders thereof are entitled to cumulative dividends of 8% per annum on the stated value, payable quarterly in arrears, subject to adjustment upon the occurrence of certain events in accordance with the terms of the Convertible Preferred Stocks. The holders of Convertible Preferred Stocks have no voting rights on account of the Convertible Preferred Stocks, other than with respect to certain matters affecting the rights of the Convertible Preferred Stocks. $2,036 of the aggregate gross proceeds was allocated to the Convertible Preferred Stocks. In September 2023, the Company authorized and declared $193 dividend which was an accrued in accounts payable as of September 30, 2023.

  

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.3
Note 10 - Share-based Compensation
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

10.          SHARE-BASED COMPENSATION

 

On March 31, 2017, the Company adopted, and the stockholders approved, the 2017 Stock Incentive Plan (the “Plan”) authorizing 2,000,000 shares of Common Stock for issuance as awards to employees, directors or consultants. In May 2019, the stockholders ratified an increase in the Plan authorizing an additional 2,100,000 shares of Common Stock; in June 2020 ratified an additional 1,900,000 shares of Common Stock; in June 2021 ratified an additional 1,500,000 shares of Common Stock; and in June 2022 ratified an additional 1,500,000 shares of Common Stock; for a total of 9,000,000 shares subject to the Plan. At September 30, 2023, there were 4,438,539 shares of Common Stock remaining available for grant under the Plan.

 

The Company generally recognizes share-based compensation expense on the grant date and over the period of vesting or period that services will be provided. In April 2023 the Company recognized severance acceleration of $178 of share-based compensation expense resulting from the resignation of the Company’s Chief Executive Officer and Chief Operating Officer due to a reduction in force that resulted in changes in the composition of the executives of the Company. In January 2022 the Company recognized severance acceleration of $242 of share-based compensation expense resulting from the resignation of the Company’s Chief Executive Officer as part of a management transition plan.

 

 

Stock Options

 

The following table summarizes stock option activity for the nine months ended September 30, 2023:

 

           

Weighted Average

         
   

Options on

Common

Shares

   

Exercise

Price

   

Remaining

Contractual

Term

   

Aggregate

Intrinsic

Value

 

Outstanding January 1, 2023

    5,491,399     $ 3.72       5.96     $ 92  

Granted

    60,000     $ 1.34                  

Exercised

    (250

)

  $ 1.50                  

Forfeited, cancelled, expired

    (3,329,476

)

  $ 5.54                  

Outstanding September 30, 2023

    2,221,673     $ 3.56       7.65     $ 10  

Exercisable September 30, 2023

    1,033,504     $ 4.37       7.02     $ -  

 

At September 30, 2023, there were 1,529,275 service-based stock options outstanding, and 692,398 performance-based stock options outstanding, which performance-based stock options were granted in April 2022 to the Company’s former Chief Executive Officer and President, subject to future market capitalization targets. 1,207,698 of the 2,221,673 stock options granted included in the table above were granted in April 2022 outside the Plan as an employment inducement grant but are subject to the terms and conditions of the Plan.

 

The Company uses the Black-Scholes option pricing model to determine the fair value of service-based options granted. The following table summarizes the assumptions used to compute the fair value of options granted to employees and non-employees:

 

   

For the Nine Months

 
   

Ended September 30,

 
   

2023

   

2022

 

Expected stock price volatility

    49

%

    49

%

Risk-free interest rate

    3.64

%

    1.17

%

Expected dividend yield     0 %     0 %

Expected life of options

    6.66       3.46  

Weighted-average fair value of options granted

  $ 0.55     $ 1.25  

 

Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of awards. The Company’s estimated volatility was based on an average of the historical volatility of peer entities whose stock prices were publicly available. The Company’s calculation of estimated volatility is based on historical stock prices of these peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price. The Company records forfeitures as they are incurred.

 

The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the options. The dividend yield of zero is based on the fact that the Company has never paid cash dividends and has no present intention to pay cash dividends. The Company calculates the expected life of the options using the Simplified Method for the employee stock options as the Company does not have sufficient historical exercise data.

 

The Company used the Monte Carlo Simulation Model to value at the grant date the aggregate of 1,614,230 market condition performance options granted in April 2022 to the Company’s former Chief Executive Officer and President. The assumptions used in the Monte Carlo Simulation were stock price on date of grant of $2.89, contract term of 10 years, expected volatility of 49% and risk-free interest rate of 2.9%. Vesting is based on sustained market capitalization of $250 million, $500 million and $1 billion and resulted in implied service periods ranging from approximately 4 to 7 years. At September 30, 2023, 921,832 of the 1,614,230 market condition performance options granted in April 2022 were cancelled.

 

Stock option expense was $(169) and $399 for the three and nine months ended September 30, 2023, respectively, and $308 and $1,448 for the three and nine months ended September 30, 2022, respectively.

 

 

Restricted Stock Units

 

The Plan provides for the grant of restricted stock units (“RSUs”). RSUs are settled in shares of the Company’s Common Stock as the RSUs become vested. The following table summarizes RSU activity for the nine months ended September 30, 2023:

 

   

Service-Based

RSU's

   

Weighted

Average

Grant Date

Fair Value

   

Weighted

Average

Vesting

Period

(Years)

 

Unvested at January 1, 2023

    922,057     $ 2.88       2.11  

Granted - service based

    686,394     $ 1.33          

Vested

    (862,993

)

  $ 2.87          

Forfeited and cancelled

    (298,381

)

  $ 2.47          

Unvested at September 30, 2023

    447,077     $ 2.00       1.74  

 

RSU expense was $(33) and $1,249 for the three and nine months ended September 30, 2023, respectively, and $564 and $1,180 for the three and nine months ended September 30, 2022, respectively.

 

Share-Based Compensation Expense

 

The Company recorded share-based compensation for options and RSUs in its statements of operations for the relevant periods as follows:

 

   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
   

2023

   

2022

   

2023

   

2022

 

Selling, general and administrative

  $ (149 )   $ 700     $ 1,404     $ 2,180  

Research and development

    (53 )     172       244       448  

Total share-based expense

  $ (202 )   $ 872     $ 1,648     $ 2,628  

 

As of September 30, 2023, total estimated compensation cost of stock options granted and outstanding but not yet vested was $1,168 which is expected to be recognized over the weighted average period of 2.73 years.

 

As of September 30, 2023, total estimated compensation cost of RSUs granted and outstanding but not yet vested was $757 which is expected to be recognized over the weighted average period of 1.61 years.

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.3
Note 11 - Defined Contribution Plan
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Defined Contribution Plan [Text Block]

11.          DEFINED CONTRIBUTION PLAN

 

The Company has a defined contribution savings plan for all eligible U.S. employees established under the provisions of Section 401(k) of the Internal Revenue Code. This plan was formed on January 1, 2022. Eligible employees may contribute a percentage of their salary subject to certain limitations. The Company’s contributions for each of the three and nine months ended September 30, 2023, and year ended December 31, 2022, was $0.

  

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.3
Note 12 - Commitments and Contingencies
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Commitments and Contingencies Disclosure [Text Block]

12.          COMMITMENTS AND CONTINGENCIES

 

Related Party Technology License Agreement

 

The Company is obligated to pay royalties and development and patent costs pursuant to an exclusive Amended and Restated Intellectual Property License Agreement dated as of September 30, 2016, with Syzygy, a company owned and controlled by stockholder/consultant Mr. Elwood Norris and stockholder/consultant Mr. James Barnes. The agreement provides for royalty payments of 4% of revenue from products employing the licensed ensnarement device technology up to an aggregate of $1,000 in royalties or until September 30, 2026, whichever occurs earlier. The Company recorded $122 and $185 for royalties during the three and nine months ended September 30, 2023, respectively, and $61 and $147 for royalties during the three and nine months ended September 30, 2022, respectively. The maximum payout still available under this arrangement is $95 as of September 30, 2023.

 

Service Provider Agreement

 

Pursuant to the Professional Services and Technology Acquisition Agreement (the “Agreement”) entered into with Lumeto, Inc. and Spatial Industries Group, Inc. (collectively, “Service Provider”) on November 22, 2022, as amended on April 2, 2023, the Service Provider provided to the Company certain technology, services, and perpetual licenses for use within the Company’s Wrap Reality virtual simulation training platform (the “Technology, Services, and License”) in consideration for a cash payment of $700 to the Service Provider, which was completed as of June 30, 2023. The Company has no ongoing or future commitments, responsibilities, or obligations related to this matter.

 

 

Purchase Commitments

 

At September 30, 2023, the Company was committed for approximately $1,690 for future component deliveries that are generally subject to modification or rescheduling in the normal course of business.

 

Indemnifications and Guarantees

 

Our officers and directors are indemnified as to personal liability as provided by the Delaware law and the Company’s articles and bylaws. The Company may also undertake indemnification obligations in the ordinary course of business related to its operations. The Company is unable to estimate with any reasonable accuracy the liability that may be incurred pursuant to any such indemnification obligations now or in the future. Because of the uncertainty surrounding these circumstances, the Company’s current or future indemnification obligations could range from immaterial to having a material adverse impact on its financial position and its ability to continue in the ordinary course of business. The Company has no liabilities recorded for such indemnities.

 

Regulatory Agencies

 

The Company is subject to oversight from regulatory agencies regarding firearms that arise in the ordinary course of its business.

 

Litigation

 

The Company is subject to litigation and other claims in the ordinary course of business. The Company records a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed and adjusted to include the impacts of negotiations, estimated settlements, legal rulings, advice of legal counsel, and other information and events pertaining to a particular matter. At September 30, 2023, we had no provision for liability under existing litigation.

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.3
Note 13 - Related Party Transactions
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Related Party Transactions Disclosure [Text Block]

13.          RELATED PARTY TRANSACTIONS

 

Commencing in October 2017 the Company began reimbursing Mr. Elwood Norris, a former officer, current 10% stockholder and consultant of the Company, $1.5 per month on a month-to-month basis for laboratory facility expense, for an aggregate of $4.5 and $13.5 during the three and nine months ended September 30, 2023, and 2022, respectively. Mr. Norris retired as the Company’s Chief Technology Officer effective September 30, 2021, and commencing July 1, 2021, was engaged as a month-to-month consultant. Mr. Norris was paid a monthly fee of $7.5 per month for aggregate consulting payments of $22.5 and $67.5 during each of the three and nine months ended September 30, 2023, and 2022.

 

On June 29, 2023, we entered into the Purchase Agreement with certain investors, including Mr. Scot Cohen, the Executive Chairman of the Company, and V4, an entity over which Mr. Cohen exercises control and whose securities are beneficially owned by Mr. Cohen (the “Affiliated Offering”), pursuant to which the Company issued to Mr. Cohen and V4 an aggregate of 3,000 Series A Preferred and warrants to purchase up to an aggregate of 2,068,966 shares of Common Stock for aggregate gross proceeds of $3,000,000 (excluding the proceeds the Company may receive from the exercise of the warrants issued in the Affiliated Offering) (the “Affiliated Proceeds”). The Certificate of Designation for the Series A Preferred provides that Series A Preferred held by a holder who serves as a director, officer or is an employee of the Company shall only be convertible into shares of Common Stock following receipt of approval of a majority of the Company’s stockholders (“Stockholder Approval”). Similarly, any warrant issued to one of our directors may not be exercised prior to date that is the later of (x) the date on which the Company received Stockholder Approval and (y) the date that is six months from the date of issuance). Stockholder Approval was attained at a special meeting of stockholders held on September 19, 2023. 

 

On August 9, 2023, the Company entered into the Purchase Agreement with Intrensic and the Sellers, including Kevin Mullins, a director of the Company and its Chief Executive Officer. Under the terms of the Purchase Agreement, the Company agreed to purchase, and Sellers, including Mr. Mullins, agreed to sell, 100% of the Membership Interests of Intrensic for the following consideration: (i) $554 in cash, subject to adjustment based upon the outstanding indebtedness of Intrensic and Intrensic’s working capital; and (ii) 1,250,000 shares of Common Stock of the Company. Kevin Mullins owns approximately 9.53% of the Membership Interests, and as such, has a financial interest in the sale of Intrensic to the Company.

 

See Notes 1, 7 and 12 for additional information on related party transactions and obligations.

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.3
Note 14 - Major Customers and Related Information
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Concentration Risk Disclosure [Text Block]

14.          MAJOR CUSTOMERS AND RELATED INFORMATION

 

For the three months ended September 30, 2023, revenue from two distributors accounted for approximately 62% and 12% of revenue with no other single customer accounting for more than 10% of total revenue. For the three months ended September 30, 2022, revenue from one distributor accounted for approximately 59% of revenue with no other single customer accounting for more than 10% of total revenue.

 

 

For the nine months ended September 30, 2023, revenue from one distributor accounted for approximately 41% of revenue with no other single customer accounting for more than 10% of total revenue. For the nine months ended September 30, 2022, revenue from one distributor accounted for approximately 39% of revenue with no other single customer accounting for more than 10% of total revenue.

 

At September 30, 2023, accounts receivable from one distributor accounted for 51% of net accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance. At December 31, 2022, accounts receivable from one distributor accounted for 70% of net accounts receivable.

 

The following table summarizes revenue by geographic region. Revenue is attributed to countries based on customer’s delivery location:

 

   

For the Three Months

   

For the Nine Months

 
   

Ended September 30,

   

Ended September 30,

 
   

2023

   

2022

   

2023

   

2022

 

Americas

  $ 1,347     $ 1,478     $ 3,225     $ 3,484  

Europe, Middle East and Africa

    2,284       220       2,320       435  

Asia Pacific

    -       3       (1 )     545  
Total revenues   $ 3,631     $ 1,701     $ 5,544     $ 4,464  

  

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.3
Note 15 - Business Combination
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Business Combination Disclosure [Text Block]

15.          BUSINESS COMBINATION

 

The Company entered into the Purchase Agreement with Intrensic and the Sellers with an effective date of August 9, 2023 (the (“Closing”).  The Closing was consummated on August 16, 2023.  Under the terms of the Purchase Agreement, the Company agreed to purchase, and Sellers agreed to sell the  Membership Interests for the following consideration at Closing: (i) $554 in cash, subject to adjustment based upon the outstanding indebtedness of Intrensic and Intrensic’s working capital as of the Closing; and (ii) 1,250,000 shares of Common Stock of the Company valued at approximately $1,938.

 

The Company assessed the historical financial information of Intrensic to determine if it would materially impact Wrap's historical financial statements for the purposes of disclosing proforma financial information. The Company determined that in the current or prior reporting periods the acquired business contributed immaterially to the Company’s financial statements . Therefore, a pro forma disclosure of the Company as if the business combination had occurred is not warranted under ASC 805.

 

The preliminary purchase price is not finalized. The Company is still evaluating the impact of the income tax provision related to the acquisition and assessing the assumed contracts related to deferred revenue.

 

The table below sets forth the preliminary allocation of the fair value of Intrensic’s net assets acquired and the corresponding line item in the Company’s consolidated balance sheet at the date of acquisition.

  

Cash and cash equivalents

  $ 3  

Accounts receivable

    90  

Inventory

    61  

Net property, plant and equipment

    -  

Technology

    490  

Customer relationships (included in Intangibles)

    160  

Trademarks and trade names (included in Intangibles)

    80  

Goodwill

    1,611  

Total assets

  $ 2,495  
         

Liabilities

    3  

Equity

    2,492  

Total liabilities and equity

  $ 2,495  
         

Purchase Price:

       

Cash

    554  

Equity

    1,938  

Liabilities assumed

    3  

Total

  $ 2,495  

 

Legal fees incurred in connection with the transaction totaled approximately $38 and have been expensed as incurred.

 

  

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.23.3
Note 16 - Subsequent Events
9 Months Ended
Sep. 30, 2023
Notes to Financial Statements  
Subsequent Events [Text Block]

16.          SUBSEQUENT EVENTS

 

Appointment of Executive Chairman

 

On October 12, 2023, the Board of Directors (the “Board”) appointed Scot Cohen, the Company’s current Chairman of the Board, to the position of Executive Chairman, effective October 12, 2023 (the “Effective Date”). Mr. Cohen cofounded the Company in March 2016, and has previously served as the Executive Chairman of the Company from July 2017 until June 2021.

 

In connection with Mr. Cohen’s appointment as Executive Chairman, the Company and Mr. Cohen entered into an agreement on October 12, 2023 (the “Agreement”). Pursuant to the Agreement, unless earlier terminated pursuant to the terms therein, Mr. Cohen will serve as the Company’s Executive Chairman for an initial term of two years from the effective date of his appointment. As compensation for Mr. Cohen’s services to the Company, the Agreement entitles Mr. Cohen to an annualized base salary of $200,000 (the “Base Salary”) and eligibility to participate in customary benefits offered to other executives of the Company.

 

The Agreement further provides for:

 

A grant of that number of restricted shares (“RSAs”) of the Company’s Common Stock equal to $675,000 divided by $1.40, representing the closing price of Common Stock as reported on the Nasdaq Capital Market on October 12, 2023 (the “Closing Price”) for the date of grant (the “Grant Date”), which RSAs are subject to certain vesting conditions based on the achievement of certain targets based on total market capitalization of the Company.

 

A nonqualified option to purchase up to that number of shares of Common Stock with a Grant Date fair value equal to $675,000 divided by the Closing Price (the “Option”), an exercise price equal to the Closing Price, and a term of 10 years, which Option vests based on Mr. Cohen’s continued employment with the Company and the achievement of certain budgeted revenue targets established by the Board; and

 

A nonqualified option to purchase up to 2.25% of the number of shares of the Company’s Common Stock that are issued and outstanding (determined on a fully-diluted basis, including, without limitation, any shares issuable upon the conversion or exercise of any outstanding warrants or preferred stock) as of the Effective Date (the “Performance Option”), at an exercise price equal to the Closing Price, and a term of 10 years, which Performance Option vests, subject to Mr. Cohen’s continued employment with the Company through each vesting date, in accordance with the same vesting conditions as provided for in the RSAs.

 

The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by the full text of the Agreement, a copy of which is filed as Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on October 16, 2023.

 

Resignations of Michael Parris and Wayne Walker

 

Effective October 11, 2023 (the “Mr. Parris Resignation Date”), and October 12, 2023 (the “Mr. Walker Resignation Date”), Michael Parris and Wayne Walker, respectively, resigned from their positions as members of the Board. Neither director’s decision to resign was the result of any dispute or disagreements with the Company on any matter relating to the Company’s operations, policies or practices.

 

Appointment of Rajiv Srinivasan and Timothy Szymanski

 

On October 12, 2023, Rajiv Srinivasan and Timothy Szymanski were appointed to serve as members of the Board to fill the vacancies created as a result of the resignations of Messrs. Parris and Walker, until the Company’s next annual meeting of stockholders or until their respective successors are duly elected and qualified.

 

Miami Office Lease

 

The Company has entered into an 89-month lease for 4,487 square feet of office space in Miami, Florida, starting from November 1, 2023. This leasing arrangement aims to enhance the Company's footprint on the East Coast and in international markets.

 

In accordance with the Subsequent Events Topic of the FASB ASC 855, we have evaluated subsequent events through the filing date and determined that no additional subsequent events occurred that were reasonably expected to impact the consolidated condensed financial statements presented herein.

 

 

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.23.3
Significant Accounting Policies (Policies)
9 Months Ended
Sep. 30, 2023
Accounting Policies [Abstract]  
Organization and Business Description [Policy Text Block]

Organization and Business Description

 

Wrap Technologies, Inc., a Delaware corporation (the “Company”, “we”, “us”, and “our”), is a publicly traded company with our Common Stock, par value $0.0001 per share (“Common Stock”), listed on the Nasdaq Capital Market (“Nasdaq”) under the trading symbol “WRAP”. The Company is a developer and supplier of public safety products and training services for law enforcement and security personnel. The Company’s primary product is the BolaWrap® remote restraint device. The principal markets for the Company’s proprietary products and services are in North and South America, Europe, Middle East and Asia.

Basis of Accounting, Policy [Policy Text Block]

Basis of Presentation

 

The Company’s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) have been condensed or omitted pursuant to such rules and regulations. In management’s opinion, the accompanying financial statements reflect adjustments necessary to present fairly the financial position, results of operations, and cash flows for those periods indicated, and contain adequate disclosure to make the information presented not misleading. Adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the footnotes. The condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2022, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “Annual Report”), as filed with the SEC on March 2, 2023. The accompanying condensed consolidated balance sheet at December 31, 2022 has been derived from the audited consolidated balance sheet at December 31, 2022, contained in the Annual Report. Results of operations for interim periods are not necessarily indicative of the results of operations for a full year.

 

Where necessary, the prior year’s information has been reclassified to conform to the current year presentation.

Consolidation, Policy [Policy Text Block]

Principles of Consolidation

 

The Company has two wholly owned subsidiaries, Wrap Reality, Inc. formed in December 2020 that sells a virtual reality (“VR”) training system primarily targeting law enforcement agencies and Intrensic, LLC which the Company acquired in August 2023 which specializes in Body Worn Camera and Digital Evidence Management solutions. The consolidated financial statements include the accounts of these subsidiaries after elimination of intercompany transactions and accounts.

Business Combinations Policy [Policy Text Block]

Business Combinations

 

The Company accounts for its business combinations under the provisions of Accounting Standards Codification ("ASC") Topic 805-10, Business Combinations ("ASC 805-10"), which requires that the purchase method of accounting be used for all business combinations. Assets acquired and liabilities assumed, including non-controlling interests, are recorded at the date of acquisition at their respective fair values. The estimated fair value of net assets acquired, including the allocation of the fair value to identifiable assets and liabilities, was determined using established valuation techniques. ASC 805-10 also specifies criteria that intangible assets acquired in a business combination must meet to be recognized and reported apart from goodwill. Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from the business combinations and are expensed as incurred.

 

The estimated fair value of the acquired intangible assets was determined using a method which reflects the present value of the operating cash flows generated by this asset after taking into account the cost to realize the revenue, and an appropriate discount rate to reflect the time value and risk associated with the invested capital.

 

Certain adjustments to the assessed fair values of the assets and liabilities made subsequent to the acquisition date, but within the measurement period, which is up to one year, are recorded as adjustments to goodwill. Any adjustments subsequent to the measurement period are recorded in income.

Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]

Goodwill

 

Goodwill represents the difference, if any, between the aggregate consideration paid for an acquisition and the fair values of the underlying net assets and liabilities assumed from an acquired business. Goodwill is not amortized, but instead is tested for impairment. The Company tests goodwill for impairment on an annual basis during the fourth quarter, or more frequently if conditions indicate that such impairment could exist. The Company evaluates qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying value and whether it is necessary to perform goodwill impairment process.

Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]

Definite-lived Intangible Assets 

 

Definite-lived intangible assets represent certain trade names, patents, licenses, software, acquired technology and customer relationships. Definite-lived intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses, if any. Definite-lived intangible assets acquired through the business combination are measured at fair value at the acquisition date. The Company amortizes these acquired definite-lived intangibles assets with a finite life on a straight-line basis, over 6 years for technology; 7 years for customer relationships; and 8 years for trademarks and trade names.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions (e.g., stock-based compensation valuation, allowance for doubtful accounts, valuation of inventory and intangible assets, warranty reserve, accrued expense and recognition and measurement of contingencies) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenue and expense during the reporting period. Actual results could materially differ from those estimates.

Stockholders' Equity, Policy [Policy Text Block]

Warrants

 

The Company accounts for warrants as liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.

 

For issued warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company accounts for the warrants issued in accordance with the guidance contained in ASC 815-40-15-7C, under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statement of operations.

 

Convertible Preferred Stocks

 

The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 480 and ASC 815 to determine if those instruments or embedded components of those instruments qualify as derivatives and are subject to bifurcation accounting. The Company determines that the economic characteristics and risks of the embedded derivative instrument are clearly and closely related to the economic characteristics and risks of the host contract. The convertible instruments are accounted for as a single hybrid instrument. Additionally, the convertible instruments do not have any redemption features that would preclude permanent equity classification in accordance with the guidance contained in ASC 480-10-S99.

 

The Company issued the Warrants, which are classified as liabilities and measured at fair value on a recurring basis, and Convertible Preferred Stocks in one transaction. The issuance proceeds were allocated by using the with-and-without method. Under this method, The Company first allocated the issuance proceeds to the Warrants based on their initial fair value measurement, and then allocated the remaining proceeds to the Convertible Preferred Stocks.

Earnings Per Share, Policy [Policy Text Block]

Loss per Share

 

Basic loss per share (EPS) is computed by dividing net loss, less any dividends, accretion or decretion, redemption or induced conversion, if any, on our Series A Convertible Preferred Stock, by the weighted average number of shares outstanding during the reported period.

 

In computing diluted EPS, we adjust the numerator used in the basic EPS computation, subject to anti-dilution requirements, to add back the dividends (declared or cumulative undeclared) applicable to the Series A Convertible Preferred Stock. Such add-back would also include any adjustments to equity in the period to accrete the Series A Convertible Preferred Stock to its redemption price, or recorded upon a redemption or induced conversion, if any. We adjust the denominator used in the basic EPS computation, subject to anti-dilution requirements, to include the dilution from potential shares resulting from the issuance of the Series A Convertible Preferred Stock, restricted stock units, and stock options. Stock options and restricted stock units exercisable or issuable for a total of 2,668,750 and 6,396,277 shares of Common Stock were outstanding at September 30, 2023, and 2022, respectively. These securities are not included in the computation of diluted net loss per common share for the periods presented as their inclusion would be antidilutive due to losses incurred by the Company.

New Accounting Pronouncements, Policy [Policy Text Block]

Recent Issued Accounting Guidance

 

The Company has reviewed recently issued, but not yet effective, accounting pronouncements and does not believe the future adoptions of any such pronouncements will be expected to cause a material impact on its financial condition or the results of operations.

 

In July 2023, the SEC adopted the final rule under SEC Release No. 33-11216, Cybersecurity Risk Management, Strategy, Governance, and Incident Disclosure, requiring disclosure of material cybersecurity incidents on Form 8-K and periodic disclosure of a registrant’s cybersecurity risk management, strategy and governance in annual reports. Regulation S-K Item 6 disclosure requirements under this rule will be effective for us in the fourth quarter of 2023. Incident disclosure requirements in Form 8-K will be effective for us on June 15, 2024. We are still evaluating for any impact on our financial statement disclosures from the adoption of this final rule.

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.3
Note 2 - Revenue and Product Costs (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]
   

Customer

   

Deferred

 
   

Deposits

   

Revenue

 

Balance at January 1, 2023

  $ -     $ 333  

Additions, net

    2       229  

Transfer to revenue

    -       (197

)

Balance at September 30, 2023

  $ 2     $ 365  

Current portion

  $ 2     $ 189  

Long-term portion

  $ -     $ 176  
XML 35 R25.htm IDEA: XBRL DOCUMENT v3.23.3
Note 3 - Financial Instruments (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]
   

As of September 30, 2023

 
   

Adjusted

   

Unrealized

   

Unrealized

   

Market

 
   

Cost

   

Gains

   

Losses

   

Value

 

Level 1:

                               

Certificate of Deposits

    10,000       -       -       10,000  

Total Financial Assets

  $ 10,000     $ -     $ -     $ 10,000  
   

As of December 31, 2022

 
   

Adjusted

   

Unrealized

   

Unrealized

   

Market

 
   

Cost

   

Gains

   

Losses

   

Value

 

Level 1:

                               

U.S. Treasury securities in short-term investments

    9,849       100       -       9,949  

Certificate of Deposits

    4,000       -       -       4,000  

Total Financial Assets

  $ 13,849     $ 100     $ -     $ 13,949  
Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]
Level 3:  

September 30,

2023

   

December 31,

2022

 

Fair value at inception or the beginning of the period

  $ 7,717       -  

Change in fair value of warrant liabilities

    117       -  

Fair value as of September 30, 2023

  $ 7,834       -  
Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]
   

As of

September 30,

2023

   

As of

December 31,

2022

 

Expected stock price volatility

    100

%

    -

%

Risk-free interest rate

    4.49

%

    -

%

Dividends yield

    0

%

    -

%

Expected life of warrants

    4.75       -  

Exercise price

  $ 1.45     $ -  
XML 36 R26.htm IDEA: XBRL DOCUMENT v3.23.3
Note 4 - Inventories (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Schedule of Inventory, Current [Table Text Block]
   

September 30,

2023

   

December 31,

2022

 

Finished goods

  $ 2,921     $ 2,293  

Work in process

    -       -  

Raw materials

    2,895       1,682  

Inventories - net

  $ 5,816     $ 3,975  
XML 37 R27.htm IDEA: XBRL DOCUMENT v3.23.3
Note 5 - Property and Equipment, Net (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Property, Plant and Equipment [Table Text Block]
   

September 30,

2023

   

December 31,

2022

 

Production and lab equipment

  $ 536     $ 513  

Tooling

    505       448  

Computer equipment

    587       531  

Furniture, fixtures and improvements

    190       181  
      1,818       1,673  

Accumulated depreciation

    (1,285 )     (915

)

Property and equipment, net

  $ 533     $ 758  
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.23.3
Note 6 - Intangible Assets and Goodwill (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Schedule of Finite-Lived Intangible Assets [Table Text Block]
   

September 30,

2023

   

December 31,

2022

 

Amortizable intangible assets:

               

Patents

  $ 841     $ 575  

Trademarks

    241       150  

Purchased software and technology

    2,452       1,962  
Customer Relationships     160       -  
      3,694       2,687  

Accumulated amortization

    (778 )     (462

)

Total amortizable

    2,916       2,225  

Indefinite life assets (non-amortizable)

    403       344  

Total intangible assets, net

  $ 3,319     $ 2,569  
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]

2023 (3 months)

  $ 164  

2024

    655  

2025

    650  

2026

    427  

2027

    180  

Thereafter

    840  

Total estimated amortization expense

  $ 2,916  
Schedule of Goodwill [Table Text Block]
Balance at January 1, 2023   $ -  
Acquired goodwill     1,611  
Balance at September 30, 2023   $ 1,611  
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.23.3
Note 7 - Accounts Payable and Accrued Liabilities (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Schedule of Accrued Liabilities [Table Text Block]
   

September 30,

2023

   

December 31,

2022

 

Patent and legal costs

  $ 61     $ 135  

Accrued compensation

    786       1,100  

Warranty costs

    109       125  

Taxes and other

    172       103  

Total

  $ 1,128     $ 1,463  
Schedule of Product Warranty Liability [Table Text Block]
   

Nine Months Ended

September 30,

 
   

2023

   

2022

 

Balance, beginning of period

  $ 125     $ 96  

Warranty settlements

    (8 )     (63

)

Release of warranty provision

    (8 )     55  

Balance, end of period

  $ 109     $ 88  
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.23.3
Note 10 - Share-based Compensation (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
           

Weighted Average

         
   

Options on

Common

Shares

   

Exercise

Price

   

Remaining

Contractual

Term

   

Aggregate

Intrinsic

Value

 

Outstanding January 1, 2023

    5,491,399     $ 3.72       5.96     $ 92  

Granted

    60,000     $ 1.34                  

Exercised

    (250

)

  $ 1.50                  

Forfeited, cancelled, expired

    (3,329,476

)

  $ 5.54                  

Outstanding September 30, 2023

    2,221,673     $ 3.56       7.65     $ 10  

Exercisable September 30, 2023

    1,033,504     $ 4.37       7.02     $ -  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   

For the Nine Months

 
   

Ended September 30,

 
   

2023

   

2022

 

Expected stock price volatility

    49

%

    49

%

Risk-free interest rate

    3.64

%

    1.17

%

Expected dividend yield     0 %     0 %

Expected life of options

    6.66       3.46  

Weighted-average fair value of options granted

  $ 0.55     $ 1.25  
Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]
   

Service-Based

RSU's

   

Weighted

Average

Grant Date

Fair Value

   

Weighted

Average

Vesting

Period

(Years)

 

Unvested at January 1, 2023

    922,057     $ 2.88       2.11  

Granted - service based

    686,394     $ 1.33          

Vested

    (862,993

)

  $ 2.87          

Forfeited and cancelled

    (298,381

)

  $ 2.47          

Unvested at September 30, 2023

    447,077     $ 2.00       1.74  
Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]
   

Three Months Ended

September 30,

   

Nine Months Ended

September 30,

 
   

2023

   

2022

   

2023

   

2022

 

Selling, general and administrative

  $ (149 )   $ 700     $ 1,404     $ 2,180  

Research and development

    (53 )     172       244       448  

Total share-based expense

  $ (202 )   $ 872     $ 1,648     $ 2,628  
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.23.3
Note 14 - Major Customers and Related Information (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Disaggregation of Revenue [Table Text Block]
   

For the Three Months

   

For the Nine Months

 
   

Ended September 30,

   

Ended September 30,

 
   

2023

   

2022

   

2023

   

2022

 

Americas

  $ 1,347     $ 1,478     $ 3,225     $ 3,484  

Europe, Middle East and Africa

    2,284       220       2,320       435  

Asia Pacific

    -       3       (1 )     545  
Total revenues   $ 3,631     $ 1,701     $ 5,544     $ 4,464  
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.23.3
Note 15 - Business Combination (Tables)
9 Months Ended
Sep. 30, 2023
Notes Tables  
Schedule of Business Acquisitions, by Acquisition [Table Text Block]

Cash and cash equivalents

  $ 3  

Accounts receivable

    90  

Inventory

    61  

Net property, plant and equipment

    -  

Technology

    490  

Customer relationships (included in Intangibles)

    160  

Trademarks and trade names (included in Intangibles)

    80  

Goodwill

    1,611  

Total assets

  $ 2,495  
         

Liabilities

    3  

Equity

    2,492  

Total liabilities and equity

  $ 2,495  
         

Purchase Price:

       

Cash

    554  

Equity

    1,938  

Liabilities assumed

    3  

Total

  $ 2,495  
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.23.3
Note 1 - Organization, Summary of Significant Accounting Policies and Recent Developments (Details Textual)
9 Months Ended
Aug. 09, 2023
USD ($)
shares
Sep. 30, 2023
$ / shares
shares
Sep. 30, 2022
shares
Jul. 29, 2023
$ / shares
Dec. 31, 2022
$ / shares
Common Stock, Par or Stated Value Per Share | $ / shares   $ 0.0001   $ 0.0001 $ 0.0001
Number of Wholly-owned Subsidiaries   1      
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount   2,668,750 6,396,277    
Intrensic, LLC [Member]          
Business Acquisition, Percentage of Voting Interests Acquired 100.00%        
Payments to Acquire Businesses, Gross | $ $ 553,588        
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares 1,250,000        
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.23.3
Note 2 - Revenue and Product Costs (Details Textual) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Contract with Customer, Liability $ 365 $ 333
Virtual Reality Training [Member]    
Contract with Customer, Liability 199 198
Training [Member]    
Contract with Customer, Liability 6 11
Extended Product Warranties [Member]    
Contract with Customer, Liability $ 160 $ 124
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.23.3
Note 2 - Revenue and Product Costs - Contract Liabilities (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Balance $ 333  
Balance 365  
Current portion 189 $ 166
Long-term portion 176 $ 167
Customer Deposits [Member]    
Balance 0  
Additions, net 2  
Transfer to revenue 0  
Balance 2  
Current portion 2  
Long-term portion 0  
Deferred Revenue [Member]    
Balance 333  
Additions, net 229  
Transfer to revenue (197)  
Balance 365  
Current portion 189  
Long-term portion $ 176  
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.23.3
Note 3 - Financial Instruments (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax $ 0 $ 73 $ (0) $ 62
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.23.3
Note 3 - Financial Instruments - Instruments by Significant Investment Category (Details) - Fair Value, Inputs, Level 1 [Member] - USD ($)
$ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Adjusted Cost $ 10,000 $ 13,849
Unrealized Gains 0 100
Unrealized Losses 0 0
Market Value 10,000 13,949
US Treasury Securities in Short-term Investments [Member]    
Adjusted Cost   9,849
Unrealized Gains   100
Unrealized Losses   0
Market Value   9,949
Certificates of Deposit [Member]    
Adjusted Cost 10,000 4,000
Unrealized Gains 0 0
Unrealized Losses 0 0
Market Value $ 10,000 $ 4,000
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.23.3
Note 3 - Financial Instruments - (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Change in fair value of warrant liabilities $ 117 $ (0) $ 117 $ 0  
Fair Value, Inputs, Level 3 [Member]          
Fair value 7,717   0 $ 0 $ 0
Change in fair value of warrant liabilities 117       0
Fair value $ 7,834   $ 7,834   $ 0
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.23.3
Note 3 - Financial Instruments - Fair Value Assumptions (Details)
Sep. 30, 2023
Dec. 31, 2022
Measurement Input, Price Volatility [Member]    
Warrants, measurement input 1 0
Measurement Input, Risk Free Interest Rate [Member]    
Warrants, measurement input 0.0449 0
Measurement Input, Expected Dividend Rate [Member]    
Warrants, measurement input 0 0
Measurement Input, Expected Term [Member]    
Warrants, measurement input 4.75 0
Measurement Input, Exercise Price [Member]    
Warrants, measurement input 1.45 0
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.23.3
Note 4 - Inventories - Summary of Inventories (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Finished goods $ 2,921 $ 2,293
Work in process 0 0
Raw materials 2,895 1,682
Inventories - net $ 5,816 $ 3,975
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.23.3
Note 5 - Property and Equipment, Net (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Depreciation $ 122 $ 121 $ 358 $ 359
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.23.3
Note 5 - Property and Equipment, Net - Summary of Property and Equipment (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Property and equipment, gross $ 1,818 $ 1,673
Accumulated depreciation (1,285) (915)
Property and equipment, net 533 758
Production and Lab Equipment [Member]    
Property and equipment, gross 536 513
Tooling [Member]    
Property and equipment, gross 505 448
Computer Equipment [Member]    
Property and equipment, gross 587 531
Furniture and Fixtures [Member]    
Property and equipment, gross $ 190 $ 181
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.23.3
Note 6 - Intangible Assets and Goodwill (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Amortization of Intangible Assets $ 150 $ 72 $ 317 $ 215
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Amortizable intangible assets, gross $ 3,694 $ 2,687
Accumulated amortization (778) (462)
Total amortizable 2,916 2,225
Indefinite life assets (non-amortizable) 403 344
Total intangible assets, net 3,319 2,569
Patents [Member]    
Amortizable intangible assets, gross 841 575
Trademarks [Member]    
Amortizable intangible assets, gross 241 150
Computer Software, Intangible Asset [Member]    
Amortizable intangible assets, gross $ 2,452 $ 1,962
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.23.3
Note 6 - Intangible Assets and Goodwill - Future Amortization Expense (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
2023 (9 months) $ 164  
2024 655  
2025 650  
2026 427  
2027 180  
Thereafter 840  
Total amortizable $ 2,916 $ 2,225
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.23.3
Note 6 - Intangible Assets and Goodwill - Schedule of Goodwill (Details)
$ in Thousands
9 Months Ended
Sep. 30, 2023
USD ($)
Balance $ 0
Acquired goodwill 1,611
Balance $ 1,611
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.23.3
Note 7 - Accounts Payable and Accrued Liabilities (Details Textual) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Former CEO Payable [Member]    
Employee-related Liabilities $ 139  
Commissions Payable [Member]    
Employee-related Liabilities   $ 1,022
Syzygy Licensing LLC [Member]    
Accounts Payable $ 122 $ 127
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.23.3
Note 7 - Accounts Payable and Accrued Expenses - Summary of Accrued Liabilities (Details) - USD ($)
$ in Thousands
Sep. 30, 2023
Dec. 31, 2022
Patent and legal costs $ 61 $ 135
Accrued compensation 786 1,100
Warranty costs 109 125
Taxes and other 172 103
Total $ 1,128 $ 1,463
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.23.3
Note 7 - Accounts Payable and Accrued Liabilities - Changes in Product Warranty Costs (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Balance $ 125 $ 96
Warranty settlements (8) (63)
Warranty provision (8) 55
Balance $ 109 $ 88
XML 60 R50.htm IDEA: XBRL DOCUMENT v3.23.3
Note 8 - Warrants (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
Jul. 03, 2023
Jun. 29, 2023
Registered Direct Offering [Member]    
Proceeds from Issuance or Sale of Equity $ 10,000  
Proceeds from Issuance of Warrants $ 7,717  
Warrants Issued in Registered Direct Offering [Member]    
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   6,896,553
Class of Warrant or Right, Exercise Price of Warrants or Rights   $ 1.45
Warrants and Rights Outstanding, Term   5 years
XML 61 R51.htm IDEA: XBRL DOCUMENT v3.23.3
Note 9 - Stockholders' Equity (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
Jul. 29, 2023
Jul. 03, 2023
Sep. 30, 2023
Dec. 31, 2022
Common Stock, Shares Authorized     150,000,000 150,000,000
Preferred Stock, Shares Authorized     5,000,000 5,000,000
Preferred Stock, Par or Stated Value Per Share     $ 0.0001 $ 0.0001
Common Stock, Par or Stated Value Per Share $ 0.0001   0.0001 $ 0.0001
Proceeds from Issuance of Convertible Preferred Stock $ 2,036      
Dividends Payable, Amount Per Share (in dollars per share)     $ 193  
Series A Preferred Stock [Member] | Registered Direct Offering [Member]        
Preferred Stock, Par or Stated Value Per Share $ 0.0001 $ 0.0001    
Stock Issued During Period, Shares, New Issues 10,000 10,000    
Preferred Stock, Convertible, Conversion Price $ 1.45 $ 1.45    
Preferred Stock, Dividend Rate, Percentage 8.00% 8.00%    
Preferred Stock, Stated Value Per Share $ 1,000      
Preferred Stock, Convertible, Shares Issuable 6,896,553      
XML 62 R52.htm IDEA: XBRL DOCUMENT v3.23.3
Note 10 - Share-based Compensation (Details Textual) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Jun. 30, 2022
Apr. 30, 2022
Jan. 31, 2022
Jun. 30, 2021
Jun. 30, 2020
May 31, 2019
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Mar. 31, 2017
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number             2,221,673   2,221,673   5,491,399  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross                 60,000      
Share-Based Payment Arrangement, Expense             $ (202) $ 872 $ 1,648 $ 2,628    
Performance Shares [Member] | Chief Executive Officer and President [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross   1,207,698                    
Share-Based Payment Arrangement, Option [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate                 0.00%      
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term                 6 years 7 months 28 days 3 years 5 months 15 days    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate                 49.00% 49.00%    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate                 3.64% 1.17%    
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount             1,168   $ 1,168      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition                 2 years 8 months 23 days      
Restricted Stock Units (RSUs) [Member]                        
Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount             $ 757   $ 757      
Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition                 1 year 7 months 9 days      
The 2017 Stock Incentive Plan [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized 9,000,000                     2,000,000
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized 1,500,000     1,500,000 1,900,000 2,100,000            
Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant             4,438,539   4,438,539      
Share-Based Payment Arrangement, Accelerated Cost   $ 178 $ 242                  
The 2017 Stock Incentive Plan [Member] | Service-based Options [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number             1,529,275   1,529,275      
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number             692,398   692,398      
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross   1,614,230         1,614,230          
Share Price   $ 2.89                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term   10 years                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate   49.00%                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate   2.90%                    
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period   921,832                    
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Minimum [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period   4 years                    
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Maximum [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period   7 years                    
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Share-Based Payment Arrangement, Tranche One [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization   $ 250,000                    
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Share-Based Payment Arrangement, Tranche Two [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization   500,000                    
The 2017 Stock Incentive Plan [Member] | Performance Shares [Member] | Chief Executive Officer and President [Member] | Share-Based Payment Arrangement, Tranche Three [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization   $ 1,000,000                    
The 2017 Stock Incentive Plan [Member] | Share-Based Payment Arrangement, Option [Member]                        
Share-Based Payment Arrangement, Expense             $ 169 308 $ 399 $ 1,448    
The 2017 Stock Incentive Plan [Member] | Restricted Stock Units (RSUs) [Member]                        
Share-Based Payment Arrangement, Expense             $ (33) $ 564 $ 1,249 $ 1,180    
XML 63 R53.htm IDEA: XBRL DOCUMENT v3.23.3
Note 10 - Share-based Compensation - Summary of Stock Option Activity (Details)
$ / shares in Units, $ in Thousands
9 Months Ended 12 Months Ended
Sep. 30, 2023
USD ($)
$ / shares
shares
Dec. 31, 2022
USD ($)
$ / shares
shares
Options on Common Shares, Outstanding (in shares) | shares 5,491,399  
Outstanding, weighted average exercise price (in dollars per share) | $ / shares $ 3.72  
Outstanding, remaining contractual term (Year) 7 years 7 months 24 days 5 years 11 months 15 days
Outstanding, aggregate intrinsic value | $ $ 10 $ 92
Options on Common Shares, Granted (in shares) | shares 60,000  
Granted, weighted average exercise price (in dollars per share) | $ / shares $ 1.34  
Options on Common Shares, Exercised (in shares) | shares (250)  
Exercised, weighted average exercise price (in dollars per share) | $ / shares $ 1.50  
Options on Common Shares, Forfeited, cancelled, expired (in shares) | shares (3,329,476)  
Forfeited, cancelled, expired, weighted average exercise price (in dollars per share) | $ / shares $ 5.54  
Options on Common Shares, Outstanding (in shares) | shares 2,221,673 5,491,399
Outstanding, weighted average exercise price (in dollars per share) | $ / shares $ 3.56 $ 3.72
Options on Common Shares, Exercisable (in shares) | shares 1,033,504  
Exercisable, weighted average exercise price (in dollars per share) | $ / shares $ 4.37  
Exercisable, remaining contractual term (Year) 7 years 7 days  
Exercisable, aggregate intrinsic value | $ $ 0  
XML 64 R54.htm IDEA: XBRL DOCUMENT v3.23.3
Note 10 - Share-based Compensation - Summary of Stock Option Valuation Assumptions (Details) - Share-Based Payment Arrangement, Option [Member] - $ / shares
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Expected stock price volatility 49.00% 49.00%
Risk-free interest rate 3.64% 1.17%
Expected life of options (Year) 6 years 7 months 28 days 3 years 5 months 15 days
Weighted-average fair value of options granted (in dollars per share) $ 0.55 $ 1.25
XML 65 R55.htm IDEA: XBRL DOCUMENT v3.23.3
Note 10 - Share-based Compensation - Summary of RSU Activity (Details) - Restricted Stock Units (RSUs) [Member] - $ / shares
9 Months Ended 12 Months Ended
Sep. 30, 2023
Dec. 31, 2022
Awards other than options, unvested, beginning balance (in shares) 922,057  
Awards other than options, unvested, weighted average grant date fair value, beginning balance (in dollars per share) $ 2.88  
Weighted average vesting period (Year) 1 year 8 months 26 days 2 years 1 month 9 days
Awards other than options, Granted (in shares) 686,394  
Awards other than options, granted, weighted average grant date fair value (in dollars per share) $ 1.33  
Awards other than options, Vested (in shares) (862,993)  
Awards other than options, vested, weighted average grant date fair value (in dollars per share) $ 2.87  
Awards other than options, Forfeited and cancelled (in shares) (298,381)  
Awards other than options, forfeited and cancelled, weighted average grant date fair value (in dollars per share) $ 2.47  
Awards other than options, unvested, beginning balance (in shares) 447,077 922,057
Awards other than options, unvested, weighted average grant date fair value, beginning balance (in dollars per share) $ 2.00 $ 2.88
XML 66 R56.htm IDEA: XBRL DOCUMENT v3.23.3
Note 10 - Share-based Compensation - Allocation of Share-based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Share-Based Payment Arrangement, Expense $ (202) $ 872 $ 1,648 $ 2,628
Selling, General and Administrative Expenses [Member]        
Share-Based Payment Arrangement, Expense (149) 700 1,404 2,180
Research and Development Expense [Member]        
Share-Based Payment Arrangement, Expense $ (53) $ 172 $ 244 $ 448
XML 67 R57.htm IDEA: XBRL DOCUMENT v3.23.3
Note 11 - Defined Contribution Plan (Details Textual) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2023
Dec. 31, 2022
Defined Benefit Plan, Plan Assets, Contributions by Employer $ 0 $ 0 $ 0
XML 68 R58.htm IDEA: XBRL DOCUMENT v3.23.3
Note 12 - Commitments and Contingencies (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Nov. 22, 2022
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2016
Contractual Obligation   $ 1,690,000   $ 1,690,000    
Professional Services and Technology Acquisition Agreement [Member]            
Payments to Acquire Businesses, Gross $ 700,000          
Related Party Technology License Agreement [Member] | Syzygy Licensing LLC [Member]            
Royalty Payments, Percentage of Product Revenue           4.00%
Maximum Royalties to Be Paid Under Agreement           $ 1,000
Royalty Expense   122,000 $ 61,000 185,000 $ 147,000  
Royalty Guarantees, Commitments, Amount   $ 95,000   $ 95,000    
XML 69 R59.htm IDEA: XBRL DOCUMENT v3.23.3
Note 13 - Related Party Transactions (Details Textual) - USD ($)
3 Months Ended 9 Months Ended
Aug. 09, 2023
Jun. 29, 2023
Sep. 30, 2023
Sep. 30, 2023
Sep. 30, 2022
Related Party Transaction, Amounts of Transaction     $ 4,500 $ 13,500  
Intrensic, LLC [Member]          
Business Acquisition, Percentage of Voting Interests Acquired 100.00%        
Payments to Acquire Businesses, Gross $ 553,588        
Business Acquisition, Equity Interest Issued or Issuable, Number of Shares 1,250,000        
Mr. Elwood Norris [Member]          
Reimbursement of Expenses to Related Party, Monthly Amount       1,500  
Consulting Fees to Related Party, Monthly Amount       7,500  
Mr. Elwood Norris [Member] | Consultant [Member]          
Related Party Transaction, Amounts of Transaction     $ 22,500 $ 67,500 $ 67,500
Executive Chairman [Member]          
Class of Warrant or Right, Number of Securities Called by Warrants or Rights   2,068,966      
Proceeds from Issuance or Sale of Equity   $ 3,000,000      
Executive Chairman [Member] | Series A Preferred Stock [Member]          
Stock Issued During Period, Shares, New Issues   3,000      
XML 70 R60.htm IDEA: XBRL DOCUMENT v3.23.3
Note 14 - Major Customers and Related Information (Details Textual) - Customer Concentration Risk [Member]
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Revenue Benchmark [Member] | Distributors [Member]          
Number of Major Customers 2 3 3 1  
Revenue Benchmark [Member] | Distributor One [Member]          
Concentration Risk, Percentage 62.00% 59.00% 41.00% 39.00%  
Revenue Benchmark [Member] | Distributor Two [Member]          
Concentration Risk, Percentage 12.00%        
Accounts Receivable [Member] | Distributors [Member]          
Number of Major Customers     3   1
Accounts Receivable [Member] | Distributor One [Member]          
Concentration Risk, Percentage     51.00%   70.00%
XML 71 R61.htm IDEA: XBRL DOCUMENT v3.23.3
Note 14 - Major Customers and Related Information - Disaggregation of Revenue by Geographic Region (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Revenues $ 3,631 $ 1,701 $ 5,544 $ 4,464
Americas [Member]        
Revenues 1,347 1,478 3,225 3,484
Europe, Middle East and Africa [Member]        
Revenues 2,284 220 2,320 435
Asia Pacific [Member]        
Revenues $ 0 $ 3 $ (1) $ 545
XML 72 R62.htm IDEA: XBRL DOCUMENT v3.23.3
Note 15 - Business Combination (Details Textual)
Aug. 09, 2023
USD ($)
Intrensic, LLC [Member]  
Business Acquisition, Transaction Costs $ 38
XML 73 R63.htm IDEA: XBRL DOCUMENT v3.23.3
Note 15 - Business Combination - Schedule of Business Combination (Details) - USD ($)
Aug. 09, 2023
Sep. 30, 2023
Dec. 31, 2022
Goodwill   $ 1,611,000 $ 0
Intrensic, LLC [Member]      
Cash and cash equivalents $ 3,000    
Accounts receivable 90,000    
Inventory 61,000    
Net property, plant and equipment 0    
Goodwill 1,611,000    
Total assets 2,495,000    
Liabilities 3,000    
Equity 2,492,000    
Total liabilities and equity 2,495,000    
Payments to Acquire Businesses, Gross 553,588    
Equity 1,938,000    
Liabilities assumed 3,000    
Total 2,495,000    
Intrensic, LLC [Member] | Technology-Based Intangible Assets [Member]      
Intangible assets 490,000    
Intrensic, LLC [Member] | Customer Relationships [Member]      
Intangible assets 160,000    
Intrensic, LLC [Member] | Trademarks and Trade Names [Member]      
Intangible assets $ 80,000    
XML 74 R64.htm IDEA: XBRL DOCUMENT v3.23.3
Note 16 - Subsequent Events (Details Textual) - Subsequent Event [Member]
Oct. 12, 2023
USD ($)
Nov. 01, 2023
ft²
Office Space in Miami, Florida [Member]    
Lessee, Operating Lease, Term of Contract (Month)   89 months
Area of Real Estate Property | ft²   4,487
Executive Chairman [Member]    
Salary and Wage, Officer, Excluding Cost of Good and Service Sold $ 200,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value $ 675,000  
Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period 10 years  
Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum 2.25%  
Executive Chairman [Member] | Restricted Stock Units (RSUs) [Member]    
Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Granted $ 675,000  
XML 75 wrap20230930_10q_htm.xml IDEA: XBRL DOCUMENT 0001702924 2023-01-01 2023-09-30 0001702924 wrap:OfficeSpaceInMiamiFloridaMember us-gaap:SubsequentEventMember 2023-11-01 0001702924 wrap:ExecutiveChairmanMember us-gaap:SubsequentEventMember 2023-10-12 2023-10-12 0001702924 wrap:ExecutiveChairmanMember us-gaap:SubsequentEventMember 2023-10-12 0001702924 wrap:ExecutiveChairmanMember us-gaap:RestrictedStockUnitsRSUMember us-gaap:SubsequentEventMember 2023-10-12 2023-10-12 0001702924 wrap:IntrensicLLCMember 2023-08-09 0001702924 wrap:IntrensicLLCMember 2023-08-09 2023-08-09 0001702924 wrap:IntrensicLLCMember us-gaap:TrademarksAndTradeNamesMember 2023-08-09 0001702924 wrap:IntrensicLLCMember us-gaap:CustomerRelationshipsMember 2023-08-09 0001702924 wrap:IntrensicLLCMember us-gaap:TechnologyBasedIntangibleAssetsMember 2023-08-09 0001702924 2022-01-01 2022-09-30 0001702924 2022-07-01 2022-09-30 0001702924 2023-07-01 2023-09-30 0001702924 srt:AsiaPacificMember 2022-01-01 2022-09-30 0001702924 srt:AsiaPacificMember 2023-01-01 2023-09-30 0001702924 srt:AsiaPacificMember 2022-07-01 2022-09-30 0001702924 srt:AsiaPacificMember 2023-07-01 2023-09-30 0001702924 wrap:EuropeMiddleEastAndAfricaMember 2022-01-01 2022-09-30 0001702924 wrap:EuropeMiddleEastAndAfricaMember 2023-01-01 2023-09-30 0001702924 wrap:EuropeMiddleEastAndAfricaMember 2022-07-01 2022-09-30 0001702924 wrap:EuropeMiddleEastAndAfricaMember 2023-07-01 2023-09-30 0001702924 srt:AmericasMember 2022-01-01 2022-09-30 0001702924 srt:AmericasMember 2023-01-01 2023-09-30 0001702924 srt:AmericasMember 2022-07-01 2022-09-30 0001702924 srt:AmericasMember 2023-07-01 2023-09-30 0001702924 wrap:DistributorOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001702924 wrap:DistributorsMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-12-31 0001702924 wrap:DistributorOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001702924 wrap:DistributorsMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001702924 wrap:DistributorOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001702924 wrap:DistributorsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-01-01 2022-09-30 0001702924 wrap:DistributorOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001702924 wrap:DistributorsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-09-30 0001702924 wrap:DistributorOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001702924 wrap:DistributorsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2022-07-01 2022-09-30 0001702924 wrap:DistributorTwoMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001702924 wrap:DistributorOneMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001702924 wrap:DistributorsMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-07-01 2023-09-30 0001702924 wrap:ExecutiveChairmanMember 2023-06-29 2023-06-29 0001702924 wrap:ExecutiveChairmanMember 2023-06-29 0001702924 wrap:ExecutiveChairmanMember us-gaap:SeriesAPreferredStockMember 2023-06-29 2023-06-29 0001702924 wrap:ConsultantMember wrap:MrElwoodNorrisMember 2022-01-01 2022-09-30 0001702924 wrap:ConsultantMember wrap:MrElwoodNorrisMember 2023-01-01 2023-09-30 0001702924 wrap:ConsultantMember wrap:MrElwoodNorrisMember 2023-07-01 2023-09-30 0001702924 wrap:MrElwoodNorrisMember 2023-01-01 2023-09-30 0001702924 2023-09-30 0001702924 wrap:ProfessionalServicesAndTechnologyAcquisitionAgreementMember 2022-11-22 2022-11-22 0001702924 wrap:RelatedPartyTechnologyLicenseAgreementMember wrap:SyzygyLicensingLLCMember 2023-09-30 0001702924 wrap:RelatedPartyTechnologyLicenseAgreementMember wrap:SyzygyLicensingLLCMember 2022-01-01 2022-09-30 0001702924 wrap:RelatedPartyTechnologyLicenseAgreementMember wrap:SyzygyLicensingLLCMember 2022-07-01 2022-09-30 0001702924 wrap:RelatedPartyTechnologyLicenseAgreementMember wrap:SyzygyLicensingLLCMember 2023-01-01 2023-09-30 0001702924 wrap:RelatedPartyTechnologyLicenseAgreementMember wrap:SyzygyLicensingLLCMember 2023-07-01 2023-09-30 0001702924 wrap:RelatedPartyTechnologyLicenseAgreementMember wrap:SyzygyLicensingLLCMember 2016-09-30 0001702924 2022-01-01 2022-12-31 0001702924 us-gaap:RestrictedStockUnitsRSUMember 2023-01-01 2023-09-30 0001702924 us-gaap:RestrictedStockUnitsRSUMember 2023-09-30 0001702924 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-09-30 0001702924 us-gaap:EmployeeStockOptionMember 2023-09-30 0001702924 us-gaap:ResearchAndDevelopmentExpenseMember 2022-01-01 2022-09-30 0001702924 us-gaap:ResearchAndDevelopmentExpenseMember 2023-01-01 2023-09-30 0001702924 us-gaap:ResearchAndDevelopmentExpenseMember 2022-07-01 2022-09-30 0001702924 us-gaap:ResearchAndDevelopmentExpenseMember 2023-07-01 2023-09-30 0001702924 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-01-01 2022-09-30 0001702924 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-01-01 2023-09-30 0001702924 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2022-07-01 2022-09-30 0001702924 us-gaap:SellingGeneralAndAdministrativeExpensesMember 2023-07-01 2023-09-30 0001702924 us-gaap:RestrictedStockUnitsRSUMember wrap:The2017StockIncentivePlanMember 2022-01-01 2022-09-30 0001702924 us-gaap:RestrictedStockUnitsRSUMember wrap:The2017StockIncentivePlanMember 2022-07-01 2022-09-30 0001702924 us-gaap:RestrictedStockUnitsRSUMember wrap:The2017StockIncentivePlanMember 2023-01-01 2023-09-30 0001702924 us-gaap:RestrictedStockUnitsRSUMember wrap:The2017StockIncentivePlanMember 2023-07-01 2023-09-30 0001702924 us-gaap:RestrictedStockUnitsRSUMember 2022-01-01 2022-12-31 0001702924 us-gaap:RestrictedStockUnitsRSUMember 2022-12-31 0001702924 us-gaap:EmployeeStockOptionMember wrap:The2017StockIncentivePlanMember 2022-01-01 2022-09-30 0001702924 us-gaap:EmployeeStockOptionMember wrap:The2017StockIncentivePlanMember 2022-07-01 2022-09-30 0001702924 us-gaap:EmployeeStockOptionMember wrap:The2017StockIncentivePlanMember 2023-01-01 2023-09-30 0001702924 us-gaap:EmployeeStockOptionMember wrap:The2017StockIncentivePlanMember 2023-07-01 2023-09-30 0001702924 wrap:ChiefExecutiveOfficerAndPresidentMember us-gaap:PerformanceSharesMember wrap:The2017StockIncentivePlanMember 2023-07-01 2023-09-30 0001702924 wrap:ChiefExecutiveOfficerAndPresidentMember us-gaap:PerformanceSharesMember wrap:The2017StockIncentivePlanMember 2022-04-01 2022-04-30 0001702924 srt:MaximumMember wrap:ChiefExecutiveOfficerAndPresidentMember us-gaap:PerformanceSharesMember wrap:The2017StockIncentivePlanMember 2022-04-01 2022-04-30 0001702924 srt:MinimumMember wrap:ChiefExecutiveOfficerAndPresidentMember us-gaap:PerformanceSharesMember wrap:The2017StockIncentivePlanMember 2022-04-01 2022-04-30 0001702924 wrap:ChiefExecutiveOfficerAndPresidentMember us-gaap:PerformanceSharesMember wrap:The2017StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2022-04-01 2022-04-30 0001702924 wrap:ChiefExecutiveOfficerAndPresidentMember us-gaap:PerformanceSharesMember wrap:The2017StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2022-04-01 2022-04-30 0001702924 wrap:ChiefExecutiveOfficerAndPresidentMember us-gaap:PerformanceSharesMember wrap:The2017StockIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2022-04-01 2022-04-30 0001702924 wrap:ChiefExecutiveOfficerAndPresidentMember us-gaap:PerformanceSharesMember wrap:The2017StockIncentivePlanMember 2022-04-30 0001702924 us-gaap:EmployeeStockOptionMember 2022-01-01 2022-09-30 0001702924 wrap:ChiefExecutiveOfficerAndPresidentMember us-gaap:PerformanceSharesMember 2022-04-01 2022-04-30 0001702924 us-gaap:PerformanceSharesMember wrap:The2017StockIncentivePlanMember 2023-09-30 0001702924 wrap:ServicebasedOptionsMember wrap:The2017StockIncentivePlanMember 2023-09-30 0001702924 2022-12-31 0001702924 wrap:The2017StockIncentivePlanMember 2022-01-01 2022-01-31 0001702924 wrap:The2017StockIncentivePlanMember 2022-04-01 2022-04-30 0001702924 wrap:The2017StockIncentivePlanMember 2023-09-30 0001702924 wrap:The2017StockIncentivePlanMember 2022-06-30 0001702924 wrap:The2017StockIncentivePlanMember 2022-06-01 2022-06-30 0001702924 wrap:The2017StockIncentivePlanMember 2021-06-01 2021-06-30 0001702924 wrap:The2017StockIncentivePlanMember 2020-06-01 2020-06-30 0001702924 wrap:The2017StockIncentivePlanMember 2019-05-01 2019-05-31 0001702924 wrap:The2017StockIncentivePlanMember 2017-03-31 0001702924 2023-07-29 2023-07-29 0001702924 us-gaap:SeriesAPreferredStockMember wrap:RegisteredDirectOfferingMember 2023-07-29 2023-07-29 0001702924 us-gaap:SeriesAPreferredStockMember wrap:RegisteredDirectOfferingMember 2023-07-29 0001702924 2023-07-29 0001702924 us-gaap:SeriesAPreferredStockMember wrap:RegisteredDirectOfferingMember 2023-07-03 2023-07-03 0001702924 us-gaap:SeriesAPreferredStockMember wrap:RegisteredDirectOfferingMember 2023-07-03 0001702924 wrap:RegisteredDirectOfferingMember 2023-07-03 2023-07-03 0001702924 wrap:WarrantsIssuedInRegisteredDirectOfferingMember 2023-06-29 0001702924 2022-09-30 0001702924 2021-12-31 0001702924 wrap:CommissionsPayableMember 2022-12-31 0001702924 wrap:FormerCeoPayableMember 2023-09-30 0001702924 wrap:SyzygyLicensingLLCMember 2022-12-31 0001702924 wrap:SyzygyLicensingLLCMember 2023-09-30 0001702924 us-gaap:ComputerSoftwareIntangibleAssetMember 2022-12-31 0001702924 us-gaap:ComputerSoftwareIntangibleAssetMember 2023-09-30 0001702924 us-gaap:TrademarksMember 2022-12-31 0001702924 us-gaap:TrademarksMember 2023-09-30 0001702924 us-gaap:PatentsMember 2022-12-31 0001702924 us-gaap:PatentsMember 2023-09-30 0001702924 us-gaap:FurnitureAndFixturesMember 2022-12-31 0001702924 us-gaap:FurnitureAndFixturesMember 2023-09-30 0001702924 us-gaap:ComputerEquipmentMember 2022-12-31 0001702924 us-gaap:ComputerEquipmentMember 2023-09-30 0001702924 wrap:ToolingMember 2022-12-31 0001702924 wrap:ToolingMember 2023-09-30 0001702924 wrap:ProductionAndLabEquipmentMember 2022-12-31 0001702924 wrap:ProductionAndLabEquipmentMember 2023-09-30 0001702924 us-gaap:MeasurementInputExercisePriceMember 2022-12-31 0001702924 us-gaap:MeasurementInputExercisePriceMember 2023-09-30 0001702924 us-gaap:MeasurementInputExpectedTermMember 2022-12-31 0001702924 us-gaap:MeasurementInputExpectedTermMember 2023-09-30 0001702924 us-gaap:MeasurementInputExpectedDividendRateMember 2022-12-31 0001702924 us-gaap:MeasurementInputExpectedDividendRateMember 2023-09-30 0001702924 us-gaap:MeasurementInputRiskFreeInterestRateMember 2022-12-31 0001702924 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-09-30 0001702924 us-gaap:MeasurementInputPriceVolatilityMember 2022-12-31 0001702924 us-gaap:MeasurementInputPriceVolatilityMember 2023-09-30 0001702924 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001702924 us-gaap:FairValueInputsLevel3Member 2023-09-30 0001702924 us-gaap:FairValueInputsLevel3Member 2022-01-01 2022-12-31 0001702924 us-gaap:FairValueInputsLevel3Member 2023-07-01 2023-09-30 0001702924 us-gaap:FairValueInputsLevel3Member 2021-12-31 0001702924 us-gaap:FairValueInputsLevel3Member 2023-06-30 0001702924 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001702924 us-gaap:FairValueInputsLevel1Member 2022-01-01 2022-12-31 0001702924 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001702924 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel1Member 2022-01-01 2022-12-31 0001702924 wrap:USTreasurySecuritiesInShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member 2022-12-31 0001702924 wrap:USTreasurySecuritiesInShortTermInvestmentsMember us-gaap:FairValueInputsLevel1Member 2022-01-01 2022-12-31 0001702924 us-gaap:FairValueInputsLevel1Member 2023-09-30 0001702924 us-gaap:FairValueInputsLevel1Member 2023-01-01 2023-09-30 0001702924 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel1Member 2023-09-30 0001702924 us-gaap:CertificatesOfDepositMember us-gaap:FairValueInputsLevel1Member 2023-01-01 2023-09-30 0001702924 wrap:ExtendedProductWarrantiesMember 2022-12-31 0001702924 wrap:TrainingMember 2022-12-31 0001702924 wrap:VirtualRealityTrainingMember 2022-12-31 0001702924 wrap:ExtendedProductWarrantiesMember 2023-09-30 0001702924 wrap:TrainingMember 2023-09-30 0001702924 wrap:VirtualRealityTrainingMember 2023-09-30 0001702924 wrap:DeferredRevenueMember 2023-09-30 0001702924 wrap:CustomerDepositsMember 2023-09-30 0001702924 wrap:DeferredRevenueMember 2023-01-01 2023-09-30 0001702924 wrap:CustomerDepositsMember 2023-01-01 2023-09-30 0001702924 wrap:DeferredRevenueMember 2022-12-31 0001702924 wrap:CustomerDepositsMember 2022-12-31 0001702924 us-gaap:ConvertiblePreferredStockMember 2022-01-01 2022-09-30 0001702924 us-gaap:ConvertiblePreferredStockMember 2023-01-01 2023-09-30 0001702924 wrap:IntrensicLLCMember 2022-01-01 2022-09-30 0001702924 wrap:IntrensicLLCMember 2023-01-01 2023-09-30 0001702924 wrap:IntangiblesOtherThanPatentsAndTrademarksMember 2022-01-01 2022-09-30 0001702924 wrap:IntangiblesOtherThanPatentsAndTrademarksMember 2023-01-01 2023-09-30 0001702924 wrap:PatentsAndTrademarksMember 2022-01-01 2022-09-30 0001702924 wrap:PatentsAndTrademarksMember 2023-01-01 2023-09-30 0001702924 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-09-30 0001702924 us-gaap:RetainedEarningsMember 2022-09-30 0001702924 us-gaap:AdditionalPaidInCapitalMember 2022-09-30 0001702924 us-gaap:CommonStockMember 2022-09-30 0001702924 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-09-30 0001702924 us-gaap:RetainedEarningsMember 2022-01-01 2022-09-30 0001702924 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-09-30 0001702924 us-gaap:CommonStockMember 2022-01-01 2022-09-30 0001702924 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001702924 us-gaap:RetainedEarningsMember 2021-12-31 0001702924 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001702924 us-gaap:CommonStockMember 2021-12-31 0001702924 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-07-01 2022-09-30 0001702924 us-gaap:RetainedEarningsMember 2022-07-01 2022-09-30 0001702924 us-gaap:AdditionalPaidInCapitalMember 2022-07-01 2022-09-30 0001702924 us-gaap:CommonStockMember 2022-07-01 2022-09-30 0001702924 2022-06-30 0001702924 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-06-30 0001702924 us-gaap:RetainedEarningsMember 2022-06-30 0001702924 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001702924 us-gaap:CommonStockMember 2022-06-30 0001702924 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-09-30 0001702924 us-gaap:RetainedEarningsMember 2023-09-30 0001702924 us-gaap:AdditionalPaidInCapitalMember 2023-09-30 0001702924 us-gaap:PreferredStockMember 2023-09-30 0001702924 us-gaap:CommonStockMember 2023-09-30 0001702924 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-09-30 0001702924 us-gaap:RetainedEarningsMember 2023-01-01 2023-09-30 0001702924 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-09-30 0001702924 us-gaap:PreferredStockMember 2023-01-01 2023-09-30 0001702924 us-gaap:CommonStockMember 2023-01-01 2023-09-30 0001702924 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0001702924 us-gaap:RetainedEarningsMember 2022-12-31 0001702924 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001702924 us-gaap:PreferredStockMember 2022-12-31 0001702924 us-gaap:CommonStockMember 2022-12-31 0001702924 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-07-01 2023-09-30 0001702924 us-gaap:RetainedEarningsMember 2023-07-01 2023-09-30 0001702924 us-gaap:AdditionalPaidInCapitalMember 2023-07-01 2023-09-30 0001702924 us-gaap:PreferredStockMember 2023-07-01 2023-09-30 0001702924 us-gaap:CommonStockMember 2023-07-01 2023-09-30 0001702924 2023-06-30 0001702924 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-06-30 0001702924 us-gaap:RetainedEarningsMember 2023-06-30 0001702924 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001702924 us-gaap:PreferredStockMember 2023-06-30 0001702924 us-gaap:CommonStockMember 2023-06-30 0001702924 us-gaap:ConvertiblePreferredStockMember 2022-12-31 0001702924 us-gaap:ConvertiblePreferredStockMember 2023-09-30 0001702924 2023-11-13 thunderdome:item utr:sqft utr:M utr:Y pure iso4217:USD shares iso4217:USD shares Q3 2023 --12-31 false 0001702924 1 3 1 3 3 2 -33000 0 P5Y -0 0 1 10-Q true 2023-09-30 false 000-55838 Wrap Technologies, Inc. DE 98-0551945 1817 W 4th Street Tempe AZ 85281 800 583-2652 Common Stock, par value $0.0001 per share WRAP NASDAQ Yes Yes Non-accelerated Filer true false false 44214169 4934000 5330000 10000000 13949000 4321000 2830000 5816000 3975000 762000 775000 25833000 26859000 533000 758000 205000 285000 3319000 2569000 1611000 0 166000 100000 31667000 30571000 1546000 1419000 1128000 1463000 2000 0 189000 166000 116000 108000 7834000 0 10815000 3156000 176000 167000 105000 193000 281000 360000 11096000 3516000 5000000 5000000 0.0001 0.0001 0 0 10000 10000 0.0001 0.0001 10000 10000 0 0 2036000 0 150000000 150000000 0.0001 0.0001 43289236 43289236 41175993 41175993 4000 4000 97919000 94333000 -79388000 -67376000 0 94000 20571000 27055000 31667000 30571000 3248000 1612000 4897000 4042000 383000 89000 647000 422000 3631000 1701000 5544000 4464000 1454000 790000 2347000 2430000 2177000 911000 3197000 2034000 4317000 3586000 12604000 11952000 610000 1236000 2683000 4210000 4927000 4822000 15287000 16162000 -2750000 -3911000 -12090000 -14128000 90000 34000 413000 36000 117000 -0 117000 -6000 12000 -25000 10000 -33000 46000 271000 46000 -2783000 -3865000 -11819000 -14082000 193000 -0 193000 -0 -2976000 -3865000 -12012000 -14082000 -0.07 -0.09 -0.29 -0.34 42652481 41086285 41914512 40955234 -2783000 -3865000 -11819000 -14082000 0 73000 0 62000 -2783000 -3792000 -11819000 -14020000 41910687 4000 0 96182000 -76411000 0 19775000 -0 -0 201000 1000 -0 202000 -0 -0 -0 193000 -0 193000 0 10000000 2036 0 0 0 2036000 128549 0 0 0 0 0 0 0 1250000 0 0 0 1938000 0 0 1938000 0 0 0 -2783000 0 -2783000 43289236 4000 10000 2036000 97919000 -79388000 0 20571000 41175993 4000 0 0 94333000 -67376000 94000 27055000 250 0 0 0 0 0 0 0 0 0 1648000 0 0 1648000 -0 -0 -0 193000 193000 0 0 10000 2036000 0 0 0 2036000 862993 0 0 0 0 0 0 0 1250000 0 0 0 1938000 0 0 1938000 0 0 0 0 -94000 -94000 0 0 0 -11819000 0 -11819000 43289236 4000 10000 2036000 97919000 -79388000 0 20571000 40992161 4000 92856000 -59976000 -17000 32867000 5500 0 8000 0 0 8000 0 872000 0 0 872000 127917 0 0 0 0 0 0 0 0 73000 73000 0 0 -3865000 0 -3865000 41125578 4000 93736000 -63841000 56000 29955000 40851945 4000 91025000 -49759000 -6000 41264000 55500 0 83000 0 0 83000 0 2628000 0 0 2628000 218133 0 0 0 62000 62000 0 0 -14082000 0 -14082000 41125578 4000 93736000 -63841000 56000 29955000 -11819000 -14082000 675000 574000 1648000 2628000 -8000 55000 117000 0 80000 75000 -48000 61000 1353000 -1576000 1780000 1396000 -13000 -268000 -67000 -834000 -80000 -65000 -2000 43000 -322000 175000 -8000 -63000 32000 35000 -12918000 -11036000 6145000 23119000 10000000 33300000 133000 201000 277000 133000 60000 -0 551000 -0 66000 3000 2768000 9844000 0 83000 9754000 0 9754000 83000 -396000 -1109000 5330000 4937000 4934000 3828000 -94000 62000 1938000 -0 147000 0 2036000 -0 -7834000 0 193000 -0 0 260000 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"><b>1.</b>                <b>ORGANIZATION, SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND RECENT DEVELOPMENTS</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Organization and Business Description</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Wrap Technologies, Inc., a Delaware corporation (the “<i>Company</i>”, “<i>we</i>”, “<i>us</i>”, and “<i>our</i>”), is a publicly traded company with our Common Stock, par value $0.0001 per share (“<i>Common Stock</i>”), listed on the Nasdaq Capital Market (“<i>Nasdaq</i>”) under the trading symbol “WRAP”. The Company is a developer and supplier of public safety products and training services for law enforcement and security personnel. The Company’s primary product is the BolaWrap® remote restraint device. The principal markets for the Company’s proprietary products and services are in North and South America, Europe, Middle East and Asia.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Basis of Presentation</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company’s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (“<i>SEC</i>”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“<i>U.S. GAAP</i>”) have been condensed or omitted pursuant to such rules and regulations. In management’s opinion, the accompanying financial statements reflect adjustments necessary to present fairly the financial position, results of operations, and cash flows for those periods indicated, and contain adequate disclosure to make the information presented not misleading. Adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the footnotes. The condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2022, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “<i>Annual Report</i>”), as filed with the SEC on March 2, 2023. The accompanying condensed consolidated balance sheet at December 31, 2022 has been derived from the audited consolidated balance sheet at December 31, 2022, contained in the Annual Report. Results of operations for interim periods are not necessarily indicative of the results of operations for a full year.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Where necessary, the prior year’s information has been reclassified to conform to the current year presentation.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Principles of Consolidation</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company has <span style="-sec-ix-hidden:c535">two</span> wholly owned subsidiaries, Wrap Reality, Inc. formed in December 2020 that sells a virtual reality (“<i>VR</i>”) training system primarily targeting law enforcement agencies and Intrensic, LLC which the Company acquired in August 2023 which specializes in Body Worn Camera and Digital Evidence Management solutions. The consolidated financial statements include the accounts of these subsidiaries after elimination of intercompany transactions and accounts.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="text-decoration: underline; ">Business Combinations</span></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company accounts for its business combinations under the provisions of Accounting Standards Codification ("ASC") Topic 805-10, Business Combinations ("ASC 805-10"), which requires that the purchase method of accounting be used for all business combinations. Assets acquired and liabilities assumed, including non-controlling interests, are recorded at the date of acquisition at their respective fair values. The estimated fair value of net assets acquired, including the allocation of the fair value to identifiable assets and liabilities, was determined using established valuation techniques. ASC 805-10 also specifies criteria that intangible assets acquired in a business combination must meet to be recognized and reported apart from goodwill. Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from the business combinations and are expensed as incurred.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The estimated fair value of the acquired intangible assets was determined using a method which reflects the present value of the operating cash flows generated by this asset after taking into account the cost to realize the revenue, and an appropriate discount rate to reflect the time value and risk associated with the invested capital.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Certain adjustments to the assessed fair values of the assets and liabilities made subsequent to the acquisition date, but within the measurement period, which is up to one year, are recorded as adjustments to goodwill. Any adjustments subsequent to the measurement period are recorded in income.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="text-decoration: underline; ">Goodwill</span></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Goodwill represents the difference, if any, between the aggregate consideration paid for an acquisition and the fair values of the underlying net assets and liabilities assumed from an acquired business. Goodwill is not amortized, but instead is tested for impairment. The Company tests goodwill for impairment on an annual basis during the fourth quarter, or more frequently if conditions indicate that such impairment could exist. The Company evaluates qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying value and whether it is necessary to perform goodwill impairment process.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="text-decoration: underline; ">Definite-lived Intangible Assets</span><span style="text-decoration: underline; "> </span></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Definite-lived intangible assets represent certain trade names, patents, licenses, software, acquired technology and customer relationships. Definite-lived intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses, if any. Definite-lived intangible assets acquired through the business combination are measured at fair value at the acquisition date. The Company amortizes these acquired definite-lived intangibles assets with a finite life on a straight-line basis, over 6 years for technology; 7 years for customer relationships; and 8 years for trademarks and trade names.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Use of Estimates</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions (e.g., stock-based compensation valuation, allowance for doubtful accounts, valuation of inventory and intangible assets, warranty reserve, accrued expense and recognition and measurement of contingencies) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenue and expense during the reporting period. Actual results could materially differ from those estimates.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Warrants</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for warrants as liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">For issued warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company accounts for the warrants issued in accordance with the guidance contained in ASC 815-40-15-7C, under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statement of operations.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Convertible Preferred Stocks</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 480 and ASC 815 to determine if those instruments or embedded components of those instruments qualify as derivatives and are subject to bifurcation accounting. The Company determines that the economic characteristics and risks of the embedded derivative instrument are clearly and closely related to the economic characteristics and risks of the host contract. The convertible instruments are accounted for as a single hybrid instrument. Additionally, the convertible instruments do not have any redemption features that would preclude permanent equity classification in accordance with the guidance contained in ASC 480-10-S99.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company issued the Warrants, which are classified as liabilities and measured at fair value on a recurring basis, and Convertible Preferred Stocks in one transaction. The issuance proceeds were allocated by using the with-and-without method. Under this method, The Company first allocated the issuance proceeds to the Warrants based on their initial fair value measurement, and then allocated the remaining proceeds to the Convertible Preferred Stocks.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Loss per Share</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Basic loss per share (EPS) is computed by dividing net loss, less any dividends, accretion or decretion, redemption or induced conversion, if any, on our Series A Convertible Preferred Stock, by the weighted average number of shares outstanding during the reported period.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In computing diluted EPS, we adjust the numerator used in the basic EPS computation, subject to anti-dilution requirements, to add back the dividends (declared or cumulative undeclared) applicable to the Series A Convertible Preferred Stock. Such add-back would also include any adjustments to equity in the period to accrete the Series A Convertible Preferred Stock to its redemption price, or recorded upon a redemption or induced conversion, if any. We adjust the denominator used in the basic EPS computation, subject to anti-dilution requirements, to include the dilution from potential shares resulting from the issuance of the Series A Convertible Preferred Stock, restricted stock units, and stock options. Stock options and restricted stock units exercisable or issuable for a total of 2,668,750 and 6,396,277 shares of Common Stock were outstanding at September 30, 2023, and 2022, respectively. These securities are not included in the computation of diluted net loss per common share for the periods presented as their inclusion would be antidilutive due to losses incurred by the Company.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Recent Issued Accounting Guidance</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has reviewed recently issued, but not yet effective, accounting pronouncements and does not believe the future adoptions of any such pronouncements will be expected to cause a material impact on its financial condition or the results of operations.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In July 2023, the SEC adopted the final rule under SEC Release No. 33-11216, Cybersecurity Risk Management, Strategy, Governance, and Incident Disclosure, requiring disclosure of material cybersecurity incidents on Form 8-K and periodic disclosure of a registrant’s cybersecurity risk management, strategy and governance in annual reports. Regulation S-K Item 6 disclosure requirements under this rule will be effective for us in the fourth quarter of 2023. Incident disclosure requirements in Form 8-K will be effective for us on June 15, 2024. We are still evaluating for any impact on our financial statement disclosures from the adoption of this final rule.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Recent Developments</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On August 9, 2023, the Company entered into a Membership Interest Purchase Agreement (the “<i>Purchase Agreement</i>”) with Intrensic, LLC, a Delaware limited liability company (“<i>Intrensic</i>”), and certain members of Intrensic, including Kevin Mullins, the Company’s Chief Executive Officer (collectively, “<i>Sellers</i>”). Under the terms of the Purchase Agreement, the Company agreed to purchase, and Sellers agreed to sell, 100% of the membership interests (the “<i>Membership Interests</i>”) of Intrensic for the following consideration upon the consummation of the sale of the Membership Interests (the “<i>Intrensic Closing</i>”): (i) $553,588 in cash, subject to adjustment based upon the outstanding indebtedness of Intrensic and Intrensic’s working capital as of the Intrensic Closing; and (ii) 1,250,000 shares of Common Stock of the Company (collectively, the “<i>Purchase Price</i>”) (the “<i>Intrensic Acquisition</i>”).</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Kevin Mullins, a director of the Company and the Company’s Chief Executive Officer, owns approximately 9.53% of the Membership Interests, and as such, has a financial interest in the Intrensic Acquisition.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">  </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Organization and Business Description</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Wrap Technologies, Inc., a Delaware corporation (the “<i>Company</i>”, “<i>we</i>”, “<i>us</i>”, and “<i>our</i>”), is a publicly traded company with our Common Stock, par value $0.0001 per share (“<i>Common Stock</i>”), listed on the Nasdaq Capital Market (“<i>Nasdaq</i>”) under the trading symbol “WRAP”. The Company is a developer and supplier of public safety products and training services for law enforcement and security personnel. The Company’s primary product is the BolaWrap® remote restraint device. The principal markets for the Company’s proprietary products and services are in North and South America, Europe, Middle East and Asia.</p> 0.0001 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Basis of Presentation</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company’s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to Form 10-Q and Article 8 of Regulation S-X and the rules and regulations of the Securities and Exchange Commission (“<i>SEC</i>”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles (“<i>U.S. GAAP</i>”) have been condensed or omitted pursuant to such rules and regulations. In management’s opinion, the accompanying financial statements reflect adjustments necessary to present fairly the financial position, results of operations, and cash flows for those periods indicated, and contain adequate disclosure to make the information presented not misleading. Adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the footnotes. The condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended December 31, 2022, included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022 (the “<i>Annual Report</i>”), as filed with the SEC on March 2, 2023. The accompanying condensed consolidated balance sheet at December 31, 2022 has been derived from the audited consolidated balance sheet at December 31, 2022, contained in the Annual Report. Results of operations for interim periods are not necessarily indicative of the results of operations for a full year.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Where necessary, the prior year’s information has been reclassified to conform to the current year presentation.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Principles of Consolidation</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company has <span style="-sec-ix-hidden:c535">two</span> wholly owned subsidiaries, Wrap Reality, Inc. formed in December 2020 that sells a virtual reality (“<i>VR</i>”) training system primarily targeting law enforcement agencies and Intrensic, LLC which the Company acquired in August 2023 which specializes in Body Worn Camera and Digital Evidence Management solutions. The consolidated financial statements include the accounts of these subsidiaries after elimination of intercompany transactions and accounts.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="text-decoration: underline; ">Business Combinations</span></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company accounts for its business combinations under the provisions of Accounting Standards Codification ("ASC") Topic 805-10, Business Combinations ("ASC 805-10"), which requires that the purchase method of accounting be used for all business combinations. Assets acquired and liabilities assumed, including non-controlling interests, are recorded at the date of acquisition at their respective fair values. The estimated fair value of net assets acquired, including the allocation of the fair value to identifiable assets and liabilities, was determined using established valuation techniques. ASC 805-10 also specifies criteria that intangible assets acquired in a business combination must meet to be recognized and reported apart from goodwill. Goodwill represents the excess purchase price over the fair value of the tangible net assets and intangible assets acquired in a business combination. Acquisition-related expenses are recognized separately from the business combinations and are expensed as incurred.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The estimated fair value of the acquired intangible assets was determined using a method which reflects the present value of the operating cash flows generated by this asset after taking into account the cost to realize the revenue, and an appropriate discount rate to reflect the time value and risk associated with the invested capital.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Certain adjustments to the assessed fair values of the assets and liabilities made subsequent to the acquisition date, but within the measurement period, which is up to one year, are recorded as adjustments to goodwill. Any adjustments subsequent to the measurement period are recorded in income.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="text-decoration: underline; ">Goodwill</span></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Goodwill represents the difference, if any, between the aggregate consideration paid for an acquisition and the fair values of the underlying net assets and liabilities assumed from an acquired business. Goodwill is not amortized, but instead is tested for impairment. The Company tests goodwill for impairment on an annual basis during the fourth quarter, or more frequently if conditions indicate that such impairment could exist. The Company evaluates qualitative factors to determine if it is more likely than not that the fair value of a reporting unit is less than its carrying value and whether it is necessary to perform goodwill impairment process.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><span style="text-decoration: underline; ">Definite-lived Intangible Assets</span><span style="text-decoration: underline; "> </span></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Definite-lived intangible assets represent certain trade names, patents, licenses, software, acquired technology and customer relationships. Definite-lived intangible assets are recorded at cost less any accumulated amortization and accumulated impairment losses, if any. Definite-lived intangible assets acquired through the business combination are measured at fair value at the acquisition date. The Company amortizes these acquired definite-lived intangibles assets with a finite life on a straight-line basis, over 6 years for technology; 7 years for customer relationships; and 8 years for trademarks and trade names.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Use of Estimates</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions (e.g., stock-based compensation valuation, allowance for doubtful accounts, valuation of inventory and intangible assets, warranty reserve, accrued expense and recognition and measurement of contingencies) that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities at the date of the financial statements and affect the reported amounts of revenue and expense during the reporting period. Actual results could materially differ from those estimates.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Warrants</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company accounts for warrants as liability-classified instruments based on an assessment of the warrant’s specific terms and applicable authoritative guidance in Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 480, Distinguishing Liabilities from Equity (“ASC 480”) and ASC 815, Derivatives and Hedging (“ASC 815”). The assessment considers whether the warrants are freestanding financial instruments pursuant to ASC 480, meet the definition of a liability pursuant to ASC 480, and whether the warrants meet all of the requirements for equity classification under ASC 815, including whether the warrants are indexed to the Company’s own common shares and whether the warrant holders could potentially require “net cash settlement” in a circumstance outside of the Company’s control, among other conditions for equity classification. This assessment, which requires the use of professional judgment, is conducted at the time of warrant issuance and as of each subsequent quarterly period end date while the warrants are outstanding.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">For issued warrants that do not meet all the criteria for equity classification, the warrants are required to be recorded at their initial fair value on the date of issuance, and each balance sheet date thereafter. The Company accounts for the warrants issued in accordance with the guidance contained in ASC 815-40-15-7C, under which the warrants do not meet the criteria for equity treatment and must be recorded as liabilities. Accordingly, the Company classifies the warrants as liabilities at their fair value and adjusts the warrants to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s condensed consolidated statement of operations.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Convertible Preferred Stocks</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company evaluates and accounts for conversion options embedded in its convertible instruments in accordance with ASC 480 and ASC 815 to determine if those instruments or embedded components of those instruments qualify as derivatives and are subject to bifurcation accounting. The Company determines that the economic characteristics and risks of the embedded derivative instrument are clearly and closely related to the economic characteristics and risks of the host contract. The convertible instruments are accounted for as a single hybrid instrument. Additionally, the convertible instruments do not have any redemption features that would preclude permanent equity classification in accordance with the guidance contained in ASC 480-10-S99.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company issued the Warrants, which are classified as liabilities and measured at fair value on a recurring basis, and Convertible Preferred Stocks in one transaction. The issuance proceeds were allocated by using the with-and-without method. Under this method, The Company first allocated the issuance proceeds to the Warrants based on their initial fair value measurement, and then allocated the remaining proceeds to the Convertible Preferred Stocks.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Loss per Share</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Basic loss per share (EPS) is computed by dividing net loss, less any dividends, accretion or decretion, redemption or induced conversion, if any, on our Series A Convertible Preferred Stock, by the weighted average number of shares outstanding during the reported period.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">In computing diluted EPS, we adjust the numerator used in the basic EPS computation, subject to anti-dilution requirements, to add back the dividends (declared or cumulative undeclared) applicable to the Series A Convertible Preferred Stock. Such add-back would also include any adjustments to equity in the period to accrete the Series A Convertible Preferred Stock to its redemption price, or recorded upon a redemption or induced conversion, if any. We adjust the denominator used in the basic EPS computation, subject to anti-dilution requirements, to include the dilution from potential shares resulting from the issuance of the Series A Convertible Preferred Stock, restricted stock units, and stock options. Stock options and restricted stock units exercisable or issuable for a total of 2,668,750 and 6,396,277 shares of Common Stock were outstanding at September 30, 2023, and 2022, respectively. These securities are not included in the computation of diluted net loss per common share for the periods presented as their inclusion would be antidilutive due to losses incurred by the Company.</p> 2668750 6396277 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Recent Issued Accounting Guidance</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has reviewed recently issued, but not yet effective, accounting pronouncements and does not believe the future adoptions of any such pronouncements will be expected to cause a material impact on its financial condition or the results of operations.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">In July 2023, the SEC adopted the final rule under SEC Release No. 33-11216, Cybersecurity Risk Management, Strategy, Governance, and Incident Disclosure, requiring disclosure of material cybersecurity incidents on Form 8-K and periodic disclosure of a registrant’s cybersecurity risk management, strategy and governance in annual reports. Regulation S-K Item 6 disclosure requirements under this rule will be effective for us in the fourth quarter of 2023. Incident disclosure requirements in Form 8-K will be effective for us on June 15, 2024. We are still evaluating for any impact on our financial statement disclosures from the adoption of this final rule.</p> 1 553588 1250000 <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>2.</b>          <b>REVENUE AND PRODUCT COSTS</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Revenue consists of product revenue and other revenue. Product sales include BolaWrap products and accessories. Other revenue includes VR revenue, service, training and shipping revenue.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Periodically, certain customers request bill and hold transactions for future delivery as scheduled and designated by them. In such cases, revenue is not recognized until after control, title and risk of ownership has transferred which is generally when the customer has requested such transaction under normal billing and payment terms and has been notified that the product (i) has been completed according to customer specifications, (ii) has passed quality control inspections, and (iii) has been tagged and packed for shipment, separated from other inventory and ready for physical transfer to the customer. The value associated with custodial storage services is deemed immaterial in the context of such contracts and in total, and accordingly, none of the transaction price is allocated to such service.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The timing of revenue recognition may differ from the timing of invoicing to customers. The Company generally has an unconditional right to consideration when customers are invoiced, and a receivable is recorded. A contract asset is recognized when revenue is recognized prior to invoicing, or a contract liability (deferred revenue) when revenue will be recognized subsequent to invoicing. The Company recognizes an asset if there are incremental costs of obtaining a contract with a customer such as commissions. These costs are ascribed to or allocated to the underlying performance obligations in the contract. The Company may receive consideration, per terms of a contract, from customers prior to transferring goods to the customer. The Company records customer deposits as a contract liability. Additionally, the Company may receive payments, most typically for service and warranty contracts, at the onset of the contract and before the services have been performed. In such instances, a deferred revenue liability is recorded. The Company recognizes these contract liabilities as revenue after all revenue recognition criteria are met. The table below details the activity in our contract liabilities during the nine months ended September 30, 2023.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Customer</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Deferred</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Deposits</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Revenue</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Balance at January 1, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">333</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Additions, net</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">229</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Transfer to revenue</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(197</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Balance at September 30, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">365</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Current portion</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">189</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Long-term portion</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">176</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At September 30, 2023, the Company’s deferred revenue of $365 consisted of $199 related to VR, $6 related to training and $160 related to BolaWrap extended warranties and services. At December 31, 2022, the Company’s deferred revenue of $333 consisted of $198 related to VR, $11 related to training and $124 related to BolaWrap extended warranties and services.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Estimated costs for the Company’s standard warranty, generally one-year, are charged to cost of products sold when revenue is recorded for the related product. Royalties are also charged to the cost of products sold.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Customer</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Deferred</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Deposits</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Revenue</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Balance at January 1, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">333</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Additions, net</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">229</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Transfer to revenue</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(197</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Balance at September 30, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">365</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Current portion</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">189</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Long-term portion</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">176</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> 0 333000 2000 229000 -0 197000 2000 365000 2000 189000 0 176000 365000 199000 6000 160000 333000 198000 11000 124000 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><b>3.</b>          <b>FINANCIAL INSTRUMENTS</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Assets and liabilities recorded at fair value on a recurring basis in the Condensed Consolidated Balance Sheets and assets and liabilities measured at fair value on a non-recurring basis or disclosed at fair value, are categorized based upon the level of judgment associated with inputs used to measure their fair values. The accounting guidance for fair value provides a framework for measuring fair value and requires certain disclosures about how fair value is determined. Fair value is defined as the price that would be received upon the sale of an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the measurement date. The accounting guidance also establishes a three-level valuation hierarchy that prioritizes the inputs to valuation techniques used to measure fair value based upon whether such inputs are observable or unobservable. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect market assumptions made by the reporting entity. The three-level hierarchy for the inputs to valuation techniques is briefly summarized as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Level 1</i>—Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date;</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Level 2</i>—Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><i>Level 3</i>—Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are supported by little or no market data.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company’s short-term investments consisting of U.S. Treasury bill securities and Certificate of Deposits are classified as Level 1 because they are valued using quoted market prices.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table shows the Company’s short-term investments by significant investment category as of September 30, 2023, and December 31, 2022.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="14" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>As of September 30, 2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Adjusted</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Unrealized</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Unrealized</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Market</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Cost</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Gains</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Losses</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Value</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Level 1:</p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certificate of Deposits</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">10,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">10,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total Financial Assets</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">10,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">10,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="14" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>As of December 31, 2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Adjusted</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Unrealized</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Unrealized</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Market</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Cost</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Gains</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Losses</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Value</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Level 1:</p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">U.S. Treasury securities in short-term investments</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">9,849</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">100</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">9,949</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certificate of Deposits</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total Financial Assets</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">13,849</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">100</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">13,949</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Unrealized gains or losses resulting from our short-term investments are recorded in accumulated other comprehensive gain or loss as they are classified as available for sale. During the three and nine months ended September 30, 2023, <span style="-sec-ix-hidden:c611"><span style="-sec-ix-hidden:c612">no</span></span> gain (loss) was recorded to other comprehensive gain (loss). During the three and nine months ended September 30, 2022, a $73 gain and $62 gain was recorded to other comprehensive gain (loss), respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The warrant liabilities are measured at fair value on a recurring basis. The subsequent measurement of the warrant liabilities as of September 30, 2023, is classified as Level 3 due to the use of an observable market quote in a non-active market and the management’s assumption of the expected stock price volatility.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table presents the fair value in the beginning of the period, the changes in the fair value, and the fair value at the end of the period of warrant liabilities (in thousands):</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Level 3:</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fair value at inception or the beginning of the period</p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7,717</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Change in fair value of warrant liabilities</p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">117</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fair value as of September 30, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">7,834</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company uses the modified Black-Scholes option pricing model to determine the fair value of warrant liabilities. The following table summarizes the assumptions used to compute the fair value of Warrants:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>As of </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>As of </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected stock price volatility</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">100</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Risk-free interest rate</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4.49</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dividends yield</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected life of warrants</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4.75</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exercise price</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1.45</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our other financial instruments also include accounts receivable, accounts payable, accrued liabilities and business acquisition liabilities. Due to the short-term nature of these instruments, their fair values approximate their carrying values on the balance sheet.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="14" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>As of September 30, 2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Adjusted</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Unrealized</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Unrealized</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Market</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Cost</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Gains</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Losses</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Value</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Level 1:</p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certificate of Deposits</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">10,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">10,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total Financial Assets</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">10,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">10,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="14" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>As of December 31, 2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Adjusted</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Unrealized</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Unrealized</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Market</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Cost</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Gains</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Losses</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Value</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Level 1:</p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">U.S. Treasury securities in short-term investments</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">9,849</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">100</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">9,949</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Certificate of Deposits</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">4,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total Financial Assets</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">13,849</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">100</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">13,949</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> 10000000 0 0 10000000 10000000 0 0 10000000 9849000 100000 0 9949000 4000000 0 0 4000000 13849000 100000 0 13949000 73000 62000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;">Level 3:</td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fair value at inception or the beginning of the period</p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">7,717</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Change in fair value of warrant liabilities</p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">117</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Fair value as of September 30, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">7,834</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> 7717000 0 117000 0 7834000 0 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>As of </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>As of </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected stock price volatility</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">100</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Risk-free interest rate</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4.49</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Dividends yield</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected life of warrants</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">4.75</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exercise price</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1.45</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> </tbody></table> 1 0 0.0449 0 0 0 4.75 0 1.45 0 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"><b>4.</b>          <b>INVENTORIES</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Inventory is recorded at the lower of cost or net realizable value. The cost of substantially all the Company’s inventory is determined by the FIFO cost method. Inventories consisted of the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Finished goods</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,921</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,293</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Work in process</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Raw materials</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,895</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,682</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Inventories - net</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">5,816</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,975</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Finished goods</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,921</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,293</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Work in process</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Raw materials</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,895</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,682</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Inventories - net</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">5,816</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,975</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> 2921000 2293000 0 0 2895000 1682000 5816000 3975000 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"><b>5.</b>          <b>PROPERTY AND EQUIPMENT, NET</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Property and equipment consisted of the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Production and lab equipment</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">536</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">513</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tooling</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">505</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">448</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Computer equipment</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">587</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">531</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Furniture, fixtures and improvements</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">190</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">181</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,818</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,673</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accumulated depreciation</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,285</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(915</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Property and equipment, net</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">533</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">758</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Depreciation expense was $122 and $358 for the three and nine months ended September 30, 2023, respectively, and $121 and $359 for the three and nine months ended September 30, 2022, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Production and lab equipment</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">536</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">513</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Tooling</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">505</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">448</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Computer equipment</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">587</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">531</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Furniture, fixtures and improvements</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">190</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">181</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,818</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,673</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accumulated depreciation</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1,285</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(915</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Property and equipment, net</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">533</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">758</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> 536000 513000 505000 448000 587000 531000 190000 181000 1818000 1673000 1285000 915000 533000 758000 122000 358000 121000 359000 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"><b>6.</b>          <b>INTANGIBLE ASSETS AND GOODWILL</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>Intangible Assets, net</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Intangible assets, net consisted of the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b><b><b><b>September 30,</b></b></b></b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Amortizable intangible assets:</p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Patents</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">841</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">575</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Trademarks</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">241</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">150</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Purchased software and technology</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,452</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,962</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt; text-indent: 9pt;">Customer Relationships</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">160</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-indent: 9pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,694</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,687</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Accumulated amortization</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(778</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(462</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total amortizable</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,916</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,225</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indefinite life assets (non-amortizable)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">403</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">344</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total intangible assets, net</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,319</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,569</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Amortization expense was $150 and $317 for the three and nine months ended September 30, 2023, respectively, and $72 and $215 for the three and nine months ended September 30, 2022, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At September 30, 2023, future amortization expense is as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 85%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2023 (3 months)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">164</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2024</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">655</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2025</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">650</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2026</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">427</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2027</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">180</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Thereafter</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">840</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total estimated amortization expense</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,916</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>Goodwill</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">The table below summarizes the changes in the carrying amount of goodwill:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"> <tbody><tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 85%;">Balance at January 1, 2023</td> <td style="width: 1%;"> </td> <td style="width: 1%;">$</td> <td style="width: 12%; text-align: right;">-</td> <td style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-indent: 9pt;">Acquired goodwill</td> <td style="width: 1%; padding-bottom: 1px;"> </td> <td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">1,611</td> <td style="width: 1%; margin-left: 0pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>Balance at September 30, 2023</td> <td style="width: 1%; padding-bottom: 3px;"> </td> <td style="width: 1%; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">1,611</td> <td style="width: 1%; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b><b><b><b>September 30,</b></b></b></b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Amortizable intangible assets:</p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Patents</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">841</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">575</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Trademarks</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">241</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">150</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Purchased software and technology</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,452</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,962</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt; text-indent: 9pt;">Customer Relationships</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">160</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; text-indent: 9pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,694</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,687</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Accumulated amortization</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(778</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(462</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total amortizable</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,916</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,225</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Indefinite life assets (non-amortizable)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">403</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">344</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Total intangible assets, net</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,319</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,569</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> 841000 575000 241000 150000 2452000 1962000 3694000 2687000 778000 462000 2916000 2225000 403000 344000 3319000 2569000 150000 317000 72000 215000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 85%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2023 (3 months)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">164</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2024</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">655</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2025</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">650</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2026</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">427</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">2027</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">180</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Thereafter</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">840</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total estimated amortization expense</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,916</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> 164000 655000 650000 427000 180000 840000 2916000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, serif; text-indent: 0px;"> <tbody><tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="width: 85%;">Balance at January 1, 2023</td> <td style="width: 1%;"> </td> <td style="width: 1%;">$</td> <td style="width: 12%; text-align: right;">-</td> <td style="width: 1%; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="text-indent: 9pt;">Acquired goodwill</td> <td style="width: 1%; padding-bottom: 1px;"> </td> <td style="width: 1%; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; border-bottom: 1px solid rgb(0, 0, 0);">1,611</td> <td style="width: 1%; margin-left: 0pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td>Balance at September 30, 2023</td> <td style="width: 1%; padding-bottom: 3px;"> </td> <td style="width: 1%; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; border-bottom: 3px double rgb(0, 0, 0);">1,611</td> <td style="width: 1%; margin-left: 0pt; padding-bottom: 3px;"> </td> </tr> </tbody></table> 0 1611000 1611000 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"><b>7.</b>          <b>ACCOUNTS PAYABLE AND ACCRUED LIABILITIES</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Accounts payable includes $122 and $127 due to related party Syzygy Licensing, LLC (“<i>Syzygy</i>”) as of September 30, 2023, and December 31, 2022, respectively. See Note 11 for additional information on this related party.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Accrued liabilities consist of the following:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Patent and legal costs</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">61</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">135</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accrued compensation</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">786</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,100</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Warranty costs</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">109</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">125</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Taxes and other</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">172</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">103</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,128</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,463</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Accrued compensation includes $139 and $1,022 in employee bonuses and commissions payable at September 30, 2023 and December 31, 2022, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Changes in our estimated product warranty costs were as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Nine Months Ended</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Balance, beginning of period</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">125</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">96</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Warranty settlements</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(8</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(63</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Release of warranty provision</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(8</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">55</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Balance, end of period</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">109</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">88</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">  </p> 122000 127000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>December 31,</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Patent and legal costs</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">61</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">135</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Accrued compensation</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">786</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,100</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Warranty costs</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">109</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">125</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Taxes and other</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">172</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">103</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,128</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,463</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> 61000 135000 786000 1100000 109000 125000 172000 103000 1128000 1463000 139000 1022000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Nine Months Ended</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Balance, beginning of period</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">125</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">96</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Warranty settlements</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(8</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(63</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Release of warranty provision</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(8</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">55</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Balance, end of period</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">109</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">88</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> 125000 96000 8000 63000 -8000 55000 109000 88000 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"><b>8.</b>          <b>WARRANTS</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">On June 29, 2023, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain directors of the Company and certain accredited and institutional investors (collectively, the “Investors”), pursuant to which it agreed to sell to the Investors in a private placement (the “Offering”): (i) warrants to acquire up to an aggregate of 6,896,553 shares of Common Stock (the “Warrants”) and (ii) Series A Convertible Preferred Stock (Note 9). The warrants are exercisable six months after issuance at an exercise price of $1.45 per share, subject to adjustment, and expire <span style="-sec-ix-hidden:c849">five</span> years from the date of issuance. The closing of the Offering occurred on July 3, 2023. The aggregate gross proceeds from the Offering were $10,000. $7,717 of $10,000 was allocated to the Warrants.</p> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;">  </p> 6896553 1.45 10000000 7717000 10000000 <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"><b>9.</b>          <b>STOCKHOLDERS' EQUITY</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company’s authorized capital consists of 150,000,000 shares of Common Stock and 5,000,000 shares of preferred stock, par value $0.0001 per share (“<i>Preferred Stock</i>”).</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On July 3, 2023, the Company filed a Certificate of Designations (the “<i>Series A COD</i>”) with the State of Delaware, designating 10,000 shares of its Preferred Stock as Series A Convertible Preferred Stock, $0.0001 per share (the “<i>Series A Preferred</i>”). Shares of Series A Preferred are convertible into Common Stock (the “<i>Conversion Shares</i>”) at an initial conversion price of $1.45 (the “<i>Conversion Price</i>”), subject to customary adjustments and price-based as defined in the Series A COD. Holders of Series A Preferred Shares are entitled to dividends of 8% per annum, payable quarterly, subject to adjustment upon the occurrence of certain events in accordance with the terms of the Series A COD. The holders of Series A Preferred have no voting rights on account of the Preferred Shares, other than with respect to certain matters affecting the rights of the Preferred Shares.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On June 29, 2023, the Company entered into a securities purchase agreement (the “Purchase Agreement”) with certain directors of the Company and certain accredited and institutional investors (collectively, the “Investors”), pursuant to which it agreed to sell to the Investors in a private placement (the “Offering”): (i) the Warrants Note 8 and (ii) an aggregate of 10,000 shares of the Company’s newly designated Series A Convertible Preferred Stock, with par value $0.0001 per share and a stated value of $1,000 per share, initially convertible into up to 6,896,553 shares of the Company’s common stock, par value $0.0001 per share at a conversion price of $1.45 per share, subject to customary adjustments and price-based as defined in the Series A Certificate of Designations (the “Convertible Preferred Stocks”). The customary adjustments include: (i) additional amounts related to declared and unpaid Dividends and any other unpaid amounts due and payable and (ii) make-whole amounts related to the accrual of any additional dividends that would have accrued up to the date of conversion including the one-year anniversary from the date of conversion. Each preferred stock has a stated value of $1,000 per share, and holders thereof are entitled to cumulative dividends of 8% per annum on the stated value, payable quarterly in arrears, subject to adjustment upon the occurrence of certain events in accordance with the terms of the Convertible Preferred Stocks. The holders of Convertible Preferred Stocks have no voting rights on account of the Convertible Preferred Stocks, other than with respect to certain matters affecting the rights of the Convertible Preferred Stocks. $2,036 of the aggregate gross proceeds was allocated to the Convertible Preferred Stocks. In September 2023, the Company authorized and declared $193 dividend which was an accrued in accounts payable as of September 30, 2023.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> 150000000 5000000 0.0001 10000 0.0001 1.45 0.08 10000 0.0001 1000 6896553 0.0001 1.45 1000 0.08 2036000 193 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"><b>10.</b>          <b>SHARE-BASED COMPENSATION </b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On March 31, 2017<i>,</i> the Company adopted, and the stockholders approved, the 2017 Stock Incentive Plan (the “<i>Plan</i>”) authorizing 2,000,000 shares of Common Stock for issuance as awards to employees, directors or consultants. In May 2019<i>,</i> the stockholders ratified an increase in the Plan authorizing an additional 2,100,000 shares of Common Stock; in June 2020 ratified an additional 1,900,000 shares of Common Stock; in June 2021 ratified an additional 1,500,000 shares of Common Stock; and in June 2022 ratified an additional 1,500,000 shares of Common Stock; for a total of 9,000,000 shares subject to the Plan. At September 30, 2023, there were 4,438,539 shares of Common Stock remaining available for grant under the Plan.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company generally recognizes share-based compensation expense on the grant date and over the period of vesting or period that services will be provided. In April 2023 the Company recognized severance acceleration of $178 of share-based compensation expense resulting from the resignation of the Company’s Chief Executive Officer and Chief Operating Officer due to a reduction in force that resulted in changes in the composition of the executives of the Company. In January 2022 the Company recognized severance acceleration of $242 of share-based compensation expense resulting from the resignation of the Company’s Chief Executive Officer as part of a management transition plan.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Stock Options</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table summarizes stock option activity for the nine months ended September 30, 2023:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted Average</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Options on </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Common</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Exercise </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Price</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Remaining </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Contractual </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Term</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Aggregate </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Intrinsic </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Value</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding January 1, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">5,491,399</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3.72</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">5.96</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">92</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Granted</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">60,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.34</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Exercised</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(250</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.50</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Forfeited, cancelled, expired</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,329,476</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">5.54</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding September 30, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,221,673</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3.56</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">7.65</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">10</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exercisable September 30, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,033,504</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4.37</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">7.02</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At September 30, 2023, there were 1,529,275 service-based stock options outstanding, and 692,398 performance-based stock options outstanding, which performance-based stock options were granted in April 2022 to the Company’s former Chief Executive Officer and President, subject to future market capitalization targets. 1,207,698 of the 2,221,673 stock options granted included in the table above were granted in April 2022 outside the Plan as an employment inducement grant but are subject to the terms and conditions of the Plan.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company uses the Black-Scholes option pricing model to determine the fair value of service-based options granted. The following table summarizes the assumptions used to compute the fair value of options granted to employees and non-employees:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>For the Nine Months</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Ended September 30,</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b><b><b><b>2023</b></b></b></b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b><b><b><b>2022</b></b></b></b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected stock price volatility</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">49</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">49</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Risk-free interest rate</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3.64</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.17</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">Expected dividend yield</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected life of options</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6.66</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3.46</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Weighted-average fair value of options granted</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.55</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1.25</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Estimated volatility is a measure of the amount by which the Company’s stock price is expected to fluctuate each year during the expected life of awards. The Company’s estimated volatility was based on an average of the historical volatility of peer entities whose stock prices were publicly available. The Company’s calculation of estimated volatility is based on historical stock prices of these peer entities over a period equal to the expected life of the awards. The Company uses the historical volatility of peer entities due to the lack of sufficient historical data of its stock price. The Company records forfeitures as they are incurred.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The risk-free interest rate assumption is based upon observed interest rates on zero coupon U.S. Treasury bonds whose maturity period is appropriate for the term of the options. The dividend yield of <span style="-sec-ix-hidden:c929">zero</span> is based on the fact that the Company has never paid cash dividends and has no present intention to pay cash dividends. The Company calculates the expected life of the options using the Simplified Method for the employee stock options as the Company does not have sufficient historical exercise data.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company used the Monte Carlo Simulation Model to value at the grant date the aggregate of 1,614,230 market condition performance options granted in April 2022 to the Company’s former Chief Executive Officer and President. The assumptions used in the Monte Carlo Simulation were stock price on date of grant of $2.89, contract term of 10 years, expected volatility of 49% and risk-free interest rate of 2.9%. Vesting is based on sustained market capitalization of $250 million, $500 million and $1 billion and resulted in implied service periods ranging from approximately 4 to 7 years. At September 30, 2023, 921,832 of the 1,614,230 market condition performance options granted in April 2022 were cancelled.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Stock option expense was $(169) and $399 for the three and nine months ended September 30, 2023, respectively, and $308 and $1,448 for the three and nine months ended September 30, 2022, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Restricted Stock Units</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Plan provides for the grant of restricted stock units (“<i>RSUs</i>”). RSUs are settled in shares of the Company’s Common Stock as the RSUs become vested. The following table summarizes RSU activity for the nine months ended September 30, 2023:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Service-Based </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>RSU's</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Average</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Grant Date </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Fair Value</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Average </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Vesting</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Period </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(Years)</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unvested at January 1, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">922,057</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.88</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.11</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Granted - service based</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">686,394</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.33</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Vested</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(862,993</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.87</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Forfeited and cancelled</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(298,381</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2.47</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unvested at September 30, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">447,077</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2.00</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.74</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">RSU expense was $<span style="-sec-ix-hidden:c975">(33)</span> and $1,249 for the three and nine months ended September 30, 2023, respectively, and $564 and $1,180 for the three and nine months ended September 30, 2022, respectively.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Share-Based Compensation Expense</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company recorded share-based compensation for options and RSUs in its statements of operations for the relevant periods as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Three Months Ended </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Nine Months Ended </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Selling, general and administrative</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(149</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">700</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,404</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,180</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Research and development</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(53</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">172</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">244</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">448</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total share-based expense</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(202</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">872</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,648</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,628</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of September 30, 2023, total estimated compensation cost of stock options granted and outstanding but not yet vested was $1,168 which is expected to be recognized over the weighted average period of 2.73 years.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">As of September 30, 2023, total estimated compensation cost of RSUs granted and outstanding but not yet vested was $757 which is expected to be recognized over the weighted average period of 1.61 years.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> 2000000 2100000 1900000 1500000 1500000 9000000 4438539 178000 242000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted Average</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Options on </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Common</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Shares</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Exercise </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Price</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Remaining </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Contractual </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Term</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Aggregate </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Intrinsic </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Value</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding January 1, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">5,491,399</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3.72</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">5.96</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">92</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Granted</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">60,000</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.34</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Exercised</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(250</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.50</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Forfeited, cancelled, expired</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(3,329,476</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">5.54</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Outstanding September 30, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,221,673</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3.56</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">7.65</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">10</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Exercisable September 30, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,033,504</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4.37</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">7.02</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> 5491399 3.72 P5Y11M15D 92000 60000 1.34 250 1.50 3329476 5.54 2221673 3.56 P7Y7M24D 10000 1033504 4.37 P7Y7D 0 1529275 692398 1207698 2221673 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>For the Nine Months</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Ended September 30,</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b><b><b><b>2023</b></b></b></b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b><b><b><b>2022</b></b></b></b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 70%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected stock price volatility</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">49</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">49</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Risk-free interest rate</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3.64</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.17</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td> </tr> <tr style="background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">Expected dividend yield</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">%</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">0</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">%</td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Expected life of options</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">6.66</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3.46</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Weighted-average fair value of options granted</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">0.55</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1.25</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> </tbody></table> 0.49 0.49 0.0364 0.0117 P6Y7M28D P3Y5M15D 0.55 1.25 1614230 2.89 P10Y 0.49 0.029 250000000 500000000 1000000000 P4Y P7Y 921832 1614230 169000 399000 308000 1448000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Service-Based </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>RSU's</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Average</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Grant Date </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Fair Value</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Weighted </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Average </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Vesting</b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Period </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>(Years)</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 55%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unvested at January 1, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">922,057</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.88</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.11</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Granted - service based</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">686,394</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1.33</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Vested</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(862,993</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2.87</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 9pt;">Forfeited and cancelled</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(298,381</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2.47</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Unvested at September 30, 2023</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">447,077</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2.00</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 3px double rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1.74</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> 922057 2.88 P2Y1M9D 686394 1.33 862993 2.87 298381 2.47 447077 2.00 P1Y8M26D 1249000 564000 1180000 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Three Months Ended </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Nine Months Ended </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>September 30,</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Selling, general and administrative</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">(149</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">700</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,404</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,180</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Research and development</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(53</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">172</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">244</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">448</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Total share-based expense</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">(202</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 3px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">872</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,648</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,628</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> -149000 700000 1404000 2180000 -53000 172000 244000 448000 -202000 872000 1648000 2628000 1168000 P2Y8M23D 757000 P1Y7M9D <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><b>11.</b>          <b>DEFINED CONTRIBUTION PLAN</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company has a defined contribution savings plan for all eligible U.S. employees established under the provisions of Section 401(k) of the Internal Revenue Code. This plan was formed on January 1, 2022. Eligible employees may contribute a percentage of their salary subject to certain limitations. The Company’s contributions for each of the three and nine months ended September 30, 2023, and year ended December 31, 2022, was $0.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> 0 0 0 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"><b>12.</b>          <b>COMMITMENTS AND CONTINGENCIES</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Related Party Technology License Agreement</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The Company is obligated to pay royalties and development and patent costs pursuant to an exclusive Amended and Restated Intellectual Property License Agreement dated as of September 30, 2016, with Syzygy, a company owned and controlled by stockholder/consultant Mr. Elwood Norris and stockholder/consultant Mr. James Barnes. The agreement provides for royalty payments of 4% of revenue from products employing the licensed ensnarement device technology up to an aggregate of $1,000 in royalties or until September 30, 2026<i>,</i> whichever occurs earlier. The Company recorded $122 and $185 for royalties during the three and nine months ended September 30, 2023, respectively, and $61 and $147 for royalties during the three and nine months ended September 30, 2022, respectively. The maximum payout still available under this arrangement is $95 as of September 30, 2023.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Service Provider Agreement</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Pursuant to the Professional Services and Technology Acquisition Agreement (the “<i>Agreement</i>”) entered into with Lumeto, Inc. and Spatial Industries Group, Inc. (collectively, “<i>Service Provider</i>”) on November 22, 2022, as amended on April 2, 2023, the Service Provider provided to the Company certain technology, services, and perpetual licenses for use within the Company’s Wrap Reality virtual simulation training platform (the “<i>Technology, Services, and License</i>”) in consideration for a cash payment of $700 to the Service Provider, which was completed as of June 30, 2023. The Company has no ongoing or future commitments, responsibilities, or obligations related to this matter.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Purchase Commitments</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At September 30, 2023, the Company was committed for approximately $1,690 for future component deliveries that are generally subject to modification or rescheduling in the normal course of business.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;"><span style="text-decoration: underline; ">Indemnifications and Guarantees</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Our officers and directors are indemnified as to personal liability as provided by the Delaware law and the Company’s articles and bylaws. The Company may also undertake indemnification obligations in the ordinary course of business related to its operations. The Company is unable to estimate with any reasonable accuracy the liability that may be incurred pursuant to any such indemnification obligations now or in the future. Because of the uncertainty surrounding these circumstances, the Company’s current or future indemnification obligations could range from immaterial to having a material adverse impact on its financial position and its ability to continue in the ordinary course of business. The Company has no liabilities recorded for such indemnities.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Regulatory Agencies</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">The Company is subject to oversight from regulatory agencies regarding firearms that arise in the ordinary course of its business.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;"><span style="text-decoration: underline; ">Litigation</span></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company is subject to litigation and other claims in the ordinary course of business. The Company records a provision for a liability relating to legal matters when it is both probable that a liability has been incurred and the amount of the loss can be reasonably estimated. These provisions are reviewed and adjusted to include the impacts of negotiations, estimated settlements, legal rulings, advice of legal counsel, and other information and events pertaining to a particular matter. At September 30, 2023, we had no provision for liability under existing litigation.</p> 0.04 1000 122000 185000 61000 147000 95000 700000 1690000 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"><b>13.</b>          <b>RELATED PARTY TRANSACTIONS</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">Commencing in October 2017 the Company began reimbursing Mr. Elwood Norris, a former officer, current 10% stockholder and consultant of the Company, $1.5 per month on a month-to-month basis for laboratory facility expense, for an aggregate of $4.5 and $13.5 during the three and nine months ended September 30, 2023, and 2022, respectively. Mr. Norris retired as the Company’s Chief Technology Officer effective September 30, 2021, and commencing July 1, 2021, was engaged as a month-to-month consultant. Mr. Norris was paid a monthly fee of $7.5 per month for aggregate consulting payments of $22.5 and $67.5 during each of the three and nine months ended September 30, 2023, and 2022.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On June 29, 2023, we entered into the Purchase Agreement with certain investors, including Mr. Scot Cohen, the Executive Chairman of the Company, and V4, an entity over which Mr. Cohen exercises control and whose securities are beneficially owned by Mr. Cohen (the “<i>Affiliated Offering</i>”), pursuant to which the Company issued to Mr. Cohen and V4 an aggregate of 3,000 Series A Preferred and warrants to purchase up to an aggregate of 2,068,966 shares of Common Stock for aggregate gross proceeds of $3,000,000 (excluding the proceeds the Company may receive from the exercise of the warrants issued in the Affiliated Offering) (the “<i>Affiliated Proceeds</i>”). The Certificate of Designation for the Series A Preferred provides that Series A Preferred held by a holder who serves as a director, officer or is an employee of the Company shall only be convertible into shares of Common Stock following receipt of approval of a majority of the Company’s stockholders (“<i>Stockholder Approval</i>”). Similarly, any warrant issued to one of our directors may not be exercised prior to date that is the later of (x) the date on which the Company received Stockholder Approval and (y) the date that is six months from the date of issuance). Stockholder Approval was attained at a special meeting of stockholders held on September 19, 2023. </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">On August 9, 2023, the Company entered into the Purchase Agreement with Intrensic and the Sellers, including Kevin Mullins, a director of the Company and its Chief Executive Officer. Under the terms of the Purchase Agreement, the Company agreed to purchase, and Sellers, including Mr. Mullins, agreed to sell, 100% of the Membership Interests of Intrensic for the following consideration: (i) $554 in cash, subject to adjustment based upon the outstanding indebtedness of Intrensic and Intrensic’s working capital; and (ii) 1,250,000 shares of Common Stock of the Company. Kevin Mullins owns approximately 9.53% of the Membership Interests, and as such, has a financial interest in the sale of Intrensic to the Company.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">See Notes 1, 7 and 12 for additional information on related party transactions and obligations.</p> 1500 4500 13500 7500 22500 67500 67500 3000 2068966 3000000 1 554000 1250000 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"><b>14.</b>          <b>MAJOR CUSTOMERS AND RELATED INFORMATION</b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the three months ended September 30, 2023, revenue from <span style="-sec-ix-hidden:c1098">two</span> distributors accounted for approximately 62% and 12% of revenue with no other single customer accounting for more than 10% of total revenue. For the three months ended September 30, 2022, revenue from <span style="-sec-ix-hidden:c1101">one</span> distributor accounted for approximately 59% of revenue with no other single customer accounting for more than 10% of total revenue.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">For the nine months ended September 30, 2023, revenue from <span style="-sec-ix-hidden:c1103">one</span> distributor accounted for approximately 41% of revenue with no other single customer accounting for more than 10% of total revenue. For the nine months ended September 30, 2022, revenue from <span style="-sec-ix-hidden:c1105">one</span> distributor accounted for approximately 39% of revenue with no other single customer accounting for more than 10% of total revenue.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">At September 30, 2023, accounts receivable from <span style="-sec-ix-hidden:c1107">one</span> distributor accounted for 51% of net accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance. At December 31, 2022, accounts receivable from <span style="-sec-ix-hidden:c1109">one</span> distributor accounted for 70% of net accounts receivable.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:justify;margin:0pt;">The following table summarizes revenue by geographic region. Revenue is attributed to countries based on customer’s delivery location:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>For the Three Months</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>For the Nine Months</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Ended September 30,</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Ended September 30,</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023 </b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Americas</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,347</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,478</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,225</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,484</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Europe, Middle East and Africa</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,284</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">220</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,320</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">435</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Asia Pacific</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">545</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt; text-indent: 0pt; padding-left: 9pt;">Total revenues</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,631</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,701</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">5,544</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,464</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> 0.62 0.12 0.59 0.41 0.39 0.51 0.70 <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>For the Three Months</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>For the Nine Months</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Ended September 30,</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="6" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>Ended September 30,</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> </tr> <tr class="finHeading" style="vertical-align: bottom;"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023 </b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2023</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td colspan="2" style="text-align: center; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:center;margin:0pt;"><b><b>2022</b></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; width: 52%;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Americas</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,347</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,478</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,225</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3,484</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Europe, Middle East and Africa</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,284</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">220</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">2,320</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">435</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">Asia Pacific</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">(1</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;">)</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">545</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 9pt; text-indent: 0pt; padding-left: 9pt;">Total revenues</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">3,631</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">1,701</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">5,544</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">$</td> <td style="width: 9%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">4,464</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> 1347000 1478000 3225000 3484000 2284000 220000 2320000 435000 0 3000 -1000 545000 3631000 1701000 5544000 4464000 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"><b>15.</b>         <b> BUSINESS COMBINATION</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt;">The Company entered into the Purchase Agreement with Intrensic and the Sellers with an effective date of August 9, 2023 (the (“Closing”).  The Closing was consummated on August 16, 2023.  Under the terms of the Purchase Agreement, the Company agreed to purchase, and Sellers agreed to sell the  Membership Interests for the following consideration at Closing: (i) $554 in cash, subject to adjustment based upon the outstanding indebtedness of Intrensic and Intrensic’s working capital as of the Closing; and (ii) 1,250,000 shares of Common Stock of the Company valued at approximately $1,938.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The Company assessed the historical financial information of Intrensic to determine if it would materially impact Wrap's historical financial statements for the purposes of disclosing proforma financial information. The Company determined that in the current or prior reporting periods the acquired business contributed immaterially to the Company’s financial statements . Therefore, a pro forma disclosure of the Company as if the business combination had occurred is not warranted under ASC 805.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The preliminary purchase price is not finalized. The Company is still evaluating the impact of the income tax provision related to the acquisition and assessing the assumed contracts related to deferred revenue.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The table below sets forth the preliminary allocation of the fair value of Intrensic’s net assets acquired and the corresponding line item in the Company’s consolidated balance sheet at the date of acquisition.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cash and cash equivalents</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts receivable</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">90</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">61</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net property, plant and equipment</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Technology</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">490</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Customer relationships (included in Intangibles)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">160</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Trademarks and trade names (included in Intangibles)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">80</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Goodwill</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,611</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total assets</b></p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,495</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Liabilities</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Equity</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,492</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total liabilities and equity</b></p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,495</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><span style="text-decoration: underline; ">Purchase Price:</span></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cash</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">554</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Equity</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,938</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Liabilities assumed</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total</b></p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,495</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Legal fees incurred in connection with the transaction totaled approximately $38 and have been expensed as incurred.</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"> </p> <p style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; margin: 0pt; text-align: left">  </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="width: 100%; font-size: 10pt; font-family: &quot;Times New Roman&quot;; text-indent: 0px;"> <tbody><tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; width: 85%;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cash and cash equivalents</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">$</td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Accounts receivable</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">90</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Inventory</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">61</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Net property, plant and equipment</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">-</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Technology</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">490</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Customer relationships (included in Intangibles)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">160</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Trademarks and trade names (included in Intangibles)</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">80</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Goodwill</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">1,611</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total assets</b></p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,495</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Liabilities</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">3</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Equity</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">2,492</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total liabilities and equity</b></p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,495</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td> </td> <td> </td> <td> </td> <td> </td> <td> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b><span style="text-decoration: underline; ">Purchase Price:</span></b></p> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"><b> </b></td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Cash</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">554</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Equity</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;">1,938</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;">Liabilities assumed</p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">3</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 1px; margin-left: 0pt;"> </td> </tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"> <td style="font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt;"><b>Total</b></p> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt;"> </td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);"><b>$</b></td> <td style="width: 12%; text-align: right; font-family: &quot;Times New Roman&quot;; font-size: 10pt; margin-left: 0pt; border-bottom: 3px double rgb(0, 0, 0);">2,495</td> <td style="width: 1%; font-family: &quot;Times New Roman&quot;; font-size: 10pt; padding-bottom: 3px; margin-left: 0pt;"> </td> </tr> </tbody></table> 3000 90000 61000 0 490000 160000 80000 1611000 2495000 3000 2492000 2495000 554000 1938000 3000 2495000 38 <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"><b>16.</b>          <b>SUBSEQUENT EVENTS</b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 1pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;"><i>Appointment of Executive Chairman</i></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">On October 12, 2023, the Board of Directors (the “<i>Board</i>”) appointed Scot Cohen, the Company’s current Chairman of the Board, to the position of Executive Chairman, effective October 12, 2023 (the “<i>Effective Date</i>”). Mr. Cohen cofounded the Company in March 2016, and has previously served as the Executive Chairman of the Company from July 2017 until June 2021.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In connection with Mr. Cohen’s appointment as Executive Chairman, the Company and Mr. Cohen entered into an agreement on October 12, 2023 (the “<i>Agreement</i>”). Pursuant to the Agreement, unless earlier terminated pursuant to the terms therein, Mr. Cohen will serve as the Company’s Executive Chairman for an initial term of two years from the effective date of his appointment. As compensation for Mr. Cohen’s services to the Company, the Agreement entitles Mr. Cohen to an annualized base salary of $200,000 (the “<i>Base Salary</i>”) and eligibility to participate in customary benefits offered to other executives of the Company.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt 0pt 0pt 36pt;">The Agreement further provides for:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody><tr style="vertical-align: top;"> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">●</p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">A grant of that number of restricted shares (“<i>RSAs</i>”) of the Company’s Common Stock equal to $675,000 divided by $1.40, representing the closing price of Common Stock as reported on the Nasdaq Capital Market on October 12, 2023 (the “<i>Closing Price</i>”) for the date of grant (the “<i>Grant Date</i>”), which RSAs are subject to certain vesting conditions based on the achievement of certain targets based on total market capitalization of the Company.</p> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody><tr style="vertical-align: top;"> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">●</p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">A nonqualified option to purchase up to that number of shares of Common Stock with a Grant Date fair value equal to $675,000 divided by the Closing Price (the “<i>Option</i>”), an exercise price equal to the Closing Price, and a term of 10 years, which Option vests based on Mr. Cohen’s continued employment with the Company and the achievement of certain budgeted revenue targets established by the Board; and</p> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" style="width: 100%; text-indent: 0px;"> <tbody><tr style="vertical-align: top;"> <td style="width: 36pt;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;margin:0pt;">●</p> </td> <td style="width: auto;"> <p style="font-family: 'Times New Roman', Times, serif;font-size: 10pt;font-variant:normal;text-align:justify;margin:0pt;">A nonqualified option to purchase up to 2.25% of the number of shares of the Company’s Common Stock that are issued and outstanding (determined on a fully-diluted basis, including, without limitation, any shares issuable upon the conversion or exercise of any outstanding warrants or preferred stock) as of the Effective Date (the “<i>Performance Option</i>”), at an exercise price equal to the Closing Price, and a term of 10 years, which Performance Option vests, subject to Mr. Cohen’s continued employment with the Company through each vesting date, in accordance with the same vesting conditions as provided for in the RSAs.</p> </td> </tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">The foregoing description of the Agreement does not purport to be complete and is qualified in its entirety by the full text of the Agreement, a copy of which is filed as Exhibit 10.1 to the Current Report on Form 8-K filed with the Securities and Exchange Commission on October 16, 2023.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Resignations of Michael Parris and Wayne Walker</i></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">Effective October 11, 2023 (the “<i>Mr</i>. <i>Parris Resignation Date</i>”), and October 12, 2023 (the “<i>Mr.</i> <i>Walker Resignation Date</i>”), Michael Parris and Wayne Walker, respectively, resigned from their positions as members of the Board. Neither director’s decision to resign was the result of any dispute or disagreements with the Company on any matter relating to the Company’s operations, policies or practices.</p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Appointment of Rajiv Srinivasan and Timothy Szymanski</i></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">On October 12, 2023, Rajiv Srinivasan and Timothy Szymanski were appointed to serve as members of the Board to fill the vacancies created as a result of the resignations of Messrs. Parris and Walker, until the Company’s next annual meeting of stockholders or until their respective successors are duly elected and qualified.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"><i>Miami Office Lease</i></p> <p style="font-family: &quot;Times New Roman&quot;; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;">The Company has entered into an 89-month lease for 4,487 square feet of office space in Miami, Florida, starting from November 1, 2023. This leasing arrangement aims to enhance the Company's footprint on the East Coast and in international markets.</p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin: 0pt; text-align: justify;"> </p> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; text-align: justify; margin: 0pt;">In accordance with the Subsequent Events Topic of the FASB ASC 855, we have evaluated subsequent events through the filing date and determined that no additional subsequent events occurred that were reasonably expected to impact the consolidated condensed financial statements presented herein.</p> <p style="margin: 0pt; font-size: 10pt; font-family: &quot;Times New Roman&quot;;"> </p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> 200000 675000 675000 P10Y 0.0225 P10Y P89M 4487 EXCEL 76 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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

";E=_+R ' MZP0 "(K / " 01( 0!X;"]W;W)K8F]O:RYX;6Q02P$" M% ,4 " !W@FY7TDF\;1$" 7)@ &@ @ $<30$ >&PO M7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " !W@FY7P(AM=.D! M !^)0 $P @ %E3P$ 6T-O;G1E;G1?5'EP97-=+GAM;%!+ 4!08 2 !( *\3 !_40$ ! end XML 77 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 78 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 79 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 222 296 1 false 69 0 false 8 false false R1.htm 000 - Document - Document And Entity Information Sheet http://wrap.com/20230930/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) Sheet http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited Condensed Consolidated Balance Sheets (Current Period Unaudited) Statements 2 false false R3.htm 002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Sheet http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Sheet http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) Statements 4 false false R5.htm 004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Sheet http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited Condensed Consolidated Statements of Stockholders' Equity (Unaudited) Statements 5 false false R6.htm 005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited) Sheet http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited Condensed Consolidated Statements of Cash Flows (Unaudited) Statements 6 false false R7.htm 006 - Disclosure - Note 1 - Organization, Summary of Significant Accounting Policies and Recent Developments Sheet http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments Note 1 - Organization, Summary of Significant Accounting Policies and Recent Developments Notes 7 false false R8.htm 007 - Disclosure - Note 2 - Revenue and Product Costs Sheet http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs Note 2 - Revenue and Product Costs Notes 8 false false R9.htm 008 - Disclosure - Note 3 - Financial Instruments Sheet http://wrap.com/20230930/role/statement-note-3-financial-instruments Note 3 - Financial Instruments Notes 9 false false R10.htm 009 - Disclosure - Note 4 - Inventories Sheet http://wrap.com/20230930/role/statement-note-4-inventories Note 4 - Inventories Notes 10 false false R11.htm 010 - Disclosure - Note 5 - Property and Equipment, Net Sheet http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net Note 5 - Property and Equipment, Net Notes 11 false false R12.htm 011 - Disclosure - Note 6 - Intangible Assets and Goodwill Sheet http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill Note 6 - Intangible Assets and Goodwill Notes 12 false false R13.htm 012 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities Sheet http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities Note 7 - Accounts Payable and Accrued Liabilities Notes 13 false false R14.htm 013 - Disclosure - Note 8 - Warrants Sheet http://wrap.com/20230930/role/statement-note-8-warrants Note 8 - Warrants Notes 14 false false R15.htm 014 - Disclosure - Note 9 - Stockholders' Equity Sheet http://wrap.com/20230930/role/statement-note-9-stockholders-equity Note 9 - Stockholders' Equity Notes 15 false false R16.htm 015 - Disclosure - Note 10 - Share-based Compensation Sheet http://wrap.com/20230930/role/statement-note-10-sharebased-compensation Note 10 - Share-based Compensation Notes 16 false false R17.htm 016 - Disclosure - Note 11 - Defined Contribution Plan Sheet http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan Note 11 - Defined Contribution Plan Notes 17 false false R18.htm 017 - Disclosure - Note 12 - Commitments and Contingencies Sheet http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies Note 12 - Commitments and Contingencies Notes 18 false false R19.htm 018 - Disclosure - Note 13 - Related Party Transactions Sheet http://wrap.com/20230930/role/statement-note-13-related-party-transactions Note 13 - Related Party Transactions Notes 19 false false R20.htm 019 - Disclosure - Note 14 - Major Customers and Related Information Sheet http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information Note 14 - Major Customers and Related Information Notes 20 false false R21.htm 020 - Disclosure - Note 15 - Business Combination Sheet http://wrap.com/20230930/role/statement-note-15-business-combination Note 15 - Business Combination Notes 21 false false R22.htm 021 - Disclosure - Note 16 - Subsequent Events Sheet http://wrap.com/20230930/role/statement-note-16-subsequent-events Note 16 - Subsequent Events Notes 22 false false R23.htm 022 - Disclosure - Significant Accounting Policies (Policies) Sheet http://wrap.com/20230930/role/statement-significant-accounting-policies-policies Significant Accounting Policies (Policies) Policies http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments 23 false false R24.htm 023 - Disclosure - Note 2 - Revenue and Product Costs (Tables) Sheet http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-tables Note 2 - Revenue and Product Costs (Tables) Tables http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs 24 false false R25.htm 024 - Disclosure - Note 3 - Financial Instruments (Tables) Sheet http://wrap.com/20230930/role/statement-note-3-financial-instruments-tables Note 3 - Financial Instruments (Tables) Tables http://wrap.com/20230930/role/statement-note-3-financial-instruments 25 false false R26.htm 025 - Disclosure - Note 4 - Inventories (Tables) Sheet http://wrap.com/20230930/role/statement-note-4-inventories-tables Note 4 - Inventories (Tables) Tables http://wrap.com/20230930/role/statement-note-4-inventories 26 false false R27.htm 026 - Disclosure - Note 5 - Property and Equipment, Net (Tables) Sheet http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-tables Note 5 - Property and Equipment, Net (Tables) Tables http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net 27 false false R28.htm 027 - Disclosure - Note 6 - Intangible Assets and Goodwill (Tables) Sheet http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-tables Note 6 - Intangible Assets and Goodwill (Tables) Tables http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill 28 false false R29.htm 028 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities (Tables) Sheet http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-tables Note 7 - Accounts Payable and Accrued Liabilities (Tables) Tables http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities 29 false false R30.htm 029 - Disclosure - Note 10 - Share-based Compensation (Tables) Sheet http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-tables Note 10 - Share-based Compensation (Tables) Tables http://wrap.com/20230930/role/statement-note-10-sharebased-compensation 30 false false R31.htm 030 - Disclosure - Note 14 - Major Customers and Related Information (Tables) Sheet http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-tables Note 14 - Major Customers and Related Information (Tables) Tables http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information 31 false false R32.htm 031 - Disclosure - Note 15 - Business Combination (Tables) Sheet http://wrap.com/20230930/role/statement-note-15-business-combination-tables Note 15 - Business Combination (Tables) Tables http://wrap.com/20230930/role/statement-note-15-business-combination 32 false false R33.htm 032 - Disclosure - Note 1 - Organization, Summary of Significant Accounting Policies and Recent Developments (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual Note 1 - Organization, Summary of Significant Accounting Policies and Recent Developments (Details Textual) Details 33 false false R34.htm 033 - Disclosure - Note 2 - Revenue and Product Costs (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-details-textual Note 2 - Revenue and Product Costs (Details Textual) Details http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-tables 34 false false R35.htm 034 - Disclosure - Note 2 - Revenue and Product Costs - Contract Liabilities (Details) Sheet http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details Note 2 - Revenue and Product Costs - Contract Liabilities (Details) Details 35 false false R36.htm 035 - Disclosure - Note 3 - Financial Instruments (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-3-financial-instruments-details-textual Note 3 - Financial Instruments (Details Textual) Details http://wrap.com/20230930/role/statement-note-3-financial-instruments-tables 36 false false R37.htm 036 - Disclosure - Note 3 - Financial Instruments - Instruments by Significant Investment Category (Details) Sheet http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details Note 3 - Financial Instruments - Instruments by Significant Investment Category (Details) Details 37 false false R38.htm 037 - Disclosure - Note 3 - Financial Instruments - (Details) Sheet http://wrap.com/20230930/role/statement-note-3-financial-instruments-details Note 3 - Financial Instruments - (Details) Details http://wrap.com/20230930/role/statement-note-3-financial-instruments-tables 38 false false R39.htm 038 - Disclosure - Note 3 - Financial Instruments - Fair Value Assumptions (Details) Sheet http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details Note 3 - Financial Instruments - Fair Value Assumptions (Details) Details 39 false false R40.htm 039 - Disclosure - Note 4 - Inventories - Summary of Inventories (Details) Sheet http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details Note 4 - Inventories - Summary of Inventories (Details) Details 40 false false R41.htm 040 - Disclosure - Note 5 - Property and Equipment, Net (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-details-textual Note 5 - Property and Equipment, Net (Details Textual) Details http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-tables 41 false false R42.htm 041 - Disclosure - Note 5 - Property and Equipment, Net - Summary of Property and Equipment (Details) Sheet http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details Note 5 - Property and Equipment, Net - Summary of Property and Equipment (Details) Details 42 false false R43.htm 042 - Disclosure - Note 6 - Intangible Assets and Goodwill (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-details-textual Note 6 - Intangible Assets and Goodwill (Details Textual) Details http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-tables 43 false false R44.htm 043 - Disclosure - Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details) Sheet http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details) Details 44 false false R45.htm 044 - Disclosure - Note 6 - Intangible Assets and Goodwill - Future Amortization Expense (Details) Sheet http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details Note 6 - Intangible Assets and Goodwill - Future Amortization Expense (Details) Details 45 false false R46.htm 045 - Disclosure - Note 6 - Intangible Assets and Goodwill - Schedule of Goodwill (Details) Sheet http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-schedule-of-goodwill-details Note 6 - Intangible Assets and Goodwill - Schedule of Goodwill (Details) Details 46 false false R47.htm 046 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual Note 7 - Accounts Payable and Accrued Liabilities (Details Textual) Details http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-tables 47 false false R48.htm 047 - Disclosure - Note 7 - Accounts Payable and Accrued Expenses - Summary of Accrued Liabilities (Details) Sheet http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details Note 7 - Accounts Payable and Accrued Expenses - Summary of Accrued Liabilities (Details) Details 48 false false R49.htm 048 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities - Changes in Product Warranty Costs (Details) Sheet http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-changes-in-product-warranty-costs-details Note 7 - Accounts Payable and Accrued Liabilities - Changes in Product Warranty Costs (Details) Details 49 false false R50.htm 049 - Disclosure - Note 8 - Warrants (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-8-warrants-details-textual Note 8 - Warrants (Details Textual) Details http://wrap.com/20230930/role/statement-note-8-warrants 50 false false R51.htm 050 - Disclosure - Note 9 - Stockholders' Equity (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual Note 9 - Stockholders' Equity (Details Textual) Details http://wrap.com/20230930/role/statement-note-9-stockholders-equity 51 false false R52.htm 051 - Disclosure - Note 10 - Share-based Compensation (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual Note 10 - Share-based Compensation (Details Textual) Details http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-tables 52 false false R53.htm 052 - Disclosure - Note 10 - Share-based Compensation - Summary of Stock Option Activity (Details) Sheet http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details Note 10 - Share-based Compensation - Summary of Stock Option Activity (Details) Details 53 false false R54.htm 053 - Disclosure - Note 10 - Share-based Compensation - Summary of Stock Option Valuation Assumptions (Details) Sheet http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details Note 10 - Share-based Compensation - Summary of Stock Option Valuation Assumptions (Details) Details 54 false false R55.htm 054 - Disclosure - Note 10 - Share-based Compensation - Summary of RSU Activity (Details) Sheet http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details Note 10 - Share-based Compensation - Summary of RSU Activity (Details) Details 55 false false R56.htm 055 - Disclosure - Note 10 - Share-based Compensation - Allocation of Share-based Compensation Expense (Details) Sheet http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-allocation-of-sharebased-compensation-expense-details Note 10 - Share-based Compensation - Allocation of Share-based Compensation Expense (Details) Details 56 false false R57.htm 056 - Disclosure - Note 11 - Defined Contribution Plan (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan-details-textual Note 11 - Defined Contribution Plan (Details Textual) Details http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan 57 false false R58.htm 057 - Disclosure - Note 12 - Commitments and Contingencies (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual Note 12 - Commitments and Contingencies (Details Textual) Details http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies 58 false false R59.htm 058 - Disclosure - Note 13 - Related Party Transactions (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual Note 13 - Related Party Transactions (Details Textual) Details http://wrap.com/20230930/role/statement-note-13-related-party-transactions 59 false false R60.htm 059 - Disclosure - Note 14 - Major Customers and Related Information (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual Note 14 - Major Customers and Related Information (Details Textual) Details http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-tables 60 false false R61.htm 060 - Disclosure - Note 14 - Major Customers and Related Information - Disaggregation of Revenue by Geographic Region (Details) Sheet http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details Note 14 - Major Customers and Related Information - Disaggregation of Revenue by Geographic Region (Details) Details 61 false false R62.htm 061 - Disclosure - Note 15 - Business Combination (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-15-business-combination-details-textual Note 15 - Business Combination (Details Textual) Details http://wrap.com/20230930/role/statement-note-15-business-combination-tables 62 false false R63.htm 062 - Disclosure - Note 15 - Business Combination - Schedule of Business Combination (Details) Sheet http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details Note 15 - Business Combination - Schedule of Business Combination (Details) Details 63 false false R64.htm 063 - Disclosure - Note 16 - Subsequent Events (Details Textual) Sheet http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual Note 16 - Subsequent Events (Details Textual) Details http://wrap.com/20230930/role/statement-note-16-subsequent-events 64 false false All Reports Book All Reports wrap-20230930.xsd wrap-20230930_cal.xml wrap-20230930_def.xml wrap-20230930_lab.xml wrap-20230930_pre.xml wrap20230930_10q.htm wrap20230930_10qimg001.jpg http://fasb.org/us-gaap/2023 http://xbrl.sec.gov/dei/2023 true true JSON 82 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "wrap20230930_10q.htm": { "nsprefix": "wrap", "nsuri": "http://wrap.com/20230930", "dts": { "schema": { "local": [ "wrap-20230930.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "calculationLink": { "local": [ "wrap-20230930_cal.xml" ] }, "definitionLink": { "local": [ "wrap-20230930_def.xml" ] }, "labelLink": { "local": [ "wrap-20230930_lab.xml" ] }, "presentationLink": { "local": [ "wrap-20230930_pre.xml" ] }, "inline": { "local": [ "wrap20230930_10q.htm" ] } }, "keyStandard": 262, "keyCustom": 34, "axisStandard": 26, "axisCustom": 0, "memberStandard": 39, "memberCustom": 29, "hidden": { "total": 17, "http://xbrl.sec.gov/dei/2023": 5, "http://fasb.org/us-gaap/2023": 5, "http://wrap.com/20230930": 7 }, "contextCount": 222, "entityCount": 1, "segmentCount": 69, "elementCount": 473, "unitCount": 8, "baseTaxonomies": { "http://fasb.org/us-gaap/2023": 733, "http://xbrl.sec.gov/dei/2023": 29 }, "report": { "R1": { "role": "http://wrap.com/20230930/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "b", "p", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R2": { "role": "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "longName": "001 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited)", "shortName": "Condensed Consolidated Balance Sheets (Current Period Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R3": { "role": "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "longName": "002 - Statement - Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals)", "shortName": "Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:PreferredStockSharesAuthorized", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R4": { "role": "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited", "longName": "003 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "shortName": "Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R5": { "role": "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited", "longName": "004 - Statement - Condensed Consolidated Statements of Stockholders' Equity (Unaudited)", "shortName": "Condensed Consolidated Statements of Stockholders' Equity (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "i_2021-12-31_StatementEquityComponentsAxis-CommonStockMember", "name": "us-gaap:SharesOutstanding", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2021-12-31_StatementEquityComponentsAxis-CommonStockMember", "name": "us-gaap:SharesOutstanding", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R6": { "role": "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "longName": "005 - Statement - Condensed Consolidated Statements of Cash Flows (Unaudited)", "shortName": "Condensed Consolidated Statements of Cash Flows (Unaudited)", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:NetIncomeLoss", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:DepreciationDepletionAndAmortization", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R7": { "role": "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments", "longName": "006 - Disclosure - Note 1 - Organization, Summary of Significant Accounting Policies and Recent Developments", "shortName": "Note 1 - Organization, Summary of Significant Accounting Policies and Recent Developments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "7", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R8": { "role": "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs", "longName": "007 - Disclosure - Note 2 - Revenue and Product Costs", "shortName": "Note 2 - Revenue and Product Costs", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "8", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R9": { "role": "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "longName": "008 - Disclosure - Note 3 - Financial Instruments", "shortName": "Note 3 - Financial Instruments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R10": { "role": "http://wrap.com/20230930/role/statement-note-4-inventories", "longName": "009 - Disclosure - Note 4 - Inventories", "shortName": "Note 4 - Inventories", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:InventoryDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R11": { "role": "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net", "longName": "010 - Disclosure - Note 5 - Property and Equipment, Net", "shortName": "Note 5 - Property and Equipment, Net", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R12": { "role": "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill", "longName": "011 - Disclosure - Note 6 - Intangible Assets and Goodwill", "shortName": "Note 6 - Intangible Assets and Goodwill", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R13": { "role": "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities", "longName": "012 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities", "shortName": "Note 7 - Accounts Payable and Accrued Liabilities", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R14": { "role": "http://wrap.com/20230930/role/statement-note-8-warrants", "longName": "013 - Disclosure - Note 8 - Warrants", "shortName": "Note 8 - Warrants", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "wrap:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "wrap:WarrantsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R15": { "role": "http://wrap.com/20230930/role/statement-note-9-stockholders-equity", "longName": "014 - Disclosure - Note 9 - Stockholders' Equity", "shortName": "Note 9 - Stockholders' Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R16": { "role": "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "longName": "015 - Disclosure - Note 10 - Share-based Compensation", "shortName": "Note 10 - Share-based Compensation", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R17": { "role": "http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan", "longName": "016 - Disclosure - Note 11 - Defined Contribution Plan", "shortName": "Note 11 - Defined Contribution Plan", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:DefinedContributionPlanTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:DefinedContributionPlanTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R18": { "role": "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "longName": "017 - Disclosure - Note 12 - Commitments and Contingencies", "shortName": "Note 12 - Commitments and Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R19": { "role": "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "longName": "018 - Disclosure - Note 13 - Related Party Transactions", "shortName": "Note 13 - Related Party Transactions", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R20": { "role": "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "longName": "019 - Disclosure - Note 14 - Major Customers and Related Information", "shortName": "Note 14 - Major Customers and Related Information", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ConcentrationRiskDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R21": { "role": "http://wrap.com/20230930/role/statement-note-15-business-combination", "longName": "020 - Disclosure - Note 15 - Business Combination", "shortName": "Note 15 - Business Combination", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R22": { "role": "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "longName": "021 - Disclosure - Note 16 - Subsequent Events", "shortName": "Note 16 - Subsequent Events", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "22", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R23": { "role": "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies", "longName": "022 - Disclosure - Significant Accounting Policies (Policies)", "shortName": "Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "23", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "wrap:OrganizationAndBusinessDescriptionPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "wrap:OrganizationAndBusinessDescriptionPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R24": { "role": "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-tables", "longName": "023 - Disclosure - Note 2 - Revenue and Product Costs (Tables)", "shortName": "Note 2 - Revenue and Product Costs (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R25": { "role": "http://wrap.com/20230930/role/statement-note-3-financial-instruments-tables", "longName": "024 - Disclosure - Note 3 - Financial Instruments (Tables)", "shortName": "Note 3 - Financial Instruments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R26": { "role": "http://wrap.com/20230930/role/statement-note-4-inventories-tables", "longName": "025 - Disclosure - Note 4 - Inventories (Tables)", "shortName": "Note 4 - Inventories (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R27": { "role": "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-tables", "longName": "026 - Disclosure - Note 5 - Property and Equipment, Net (Tables)", "shortName": "Note 5 - Property and Equipment, Net (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R28": { "role": "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-tables", "longName": "027 - Disclosure - Note 6 - Intangible Assets and Goodwill (Tables)", "shortName": "Note 6 - Intangible Assets and Goodwill (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R29": { "role": "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-tables", "longName": "028 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities (Tables)", "shortName": "Note 7 - Accounts Payable and Accrued Liabilities (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "29", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R30": { "role": "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-tables", "longName": "029 - Disclosure - Note 10 - Share-based Compensation (Tables)", "shortName": "Note 10 - Share-based Compensation (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "30", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R31": { "role": "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-tables", "longName": "030 - Disclosure - Note 14 - Major Customers and Related Information (Tables)", "shortName": "Note 14 - Major Customers and Related Information (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "31", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R32": { "role": "http://wrap.com/20230930/role/statement-note-15-business-combination-tables", "longName": "031 - Disclosure - Note 15 - Business Combination (Tables)", "shortName": "Note 15 - Business Combination (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "32", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R33": { "role": "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual", "longName": "032 - Disclosure - Note 1 - Organization, Summary of Significant Accounting Policies and Recent Developments (Details Textual)", "shortName": "Note 1 - Organization, Summary of Significant Accounting Policies and Recent Developments (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:CommonStockParOrStatedValuePerShare", "unitRef": "USDPerShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:EarningsPerSharePolicyTextBlock", "us-gaap:OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R34": { "role": "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-details-textual", "longName": "033 - Disclosure - Note 2 - Revenue and Product Costs (Details Textual)", "shortName": "Note 2 - Revenue and Product Costs (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2023-09-30_ProductOrServiceAxis-VirtualRealityTrainingMember", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R35": { "role": "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details", "longName": "034 - Disclosure - Note 2 - Revenue and Product Costs - Contract Liabilities (Details)", "shortName": "Note 2 - Revenue and Product Costs - Contract Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "i_2022-12-31", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2022-12-31_ProductOrServiceAxis-CustomerDepositsMember", "name": "us-gaap:ContractWithCustomerLiability", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "us-gaap:RevenueFromContractWithCustomerTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R36": { "role": "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details-textual", "longName": "035 - Disclosure - Note 3 - Financial Instruments (Details Textual)", "shortName": "Note 3 - Financial Instruments (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "d_2022-07-01_2022-09-30", "name": "us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": null }, "R37": { "role": "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details", "longName": "036 - Disclosure - Note 3 - Financial Instruments - Instruments by Significant Investment Category (Details)", "shortName": "Note 3 - Financial Instruments - Instruments by Significant Investment Category (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member", "name": "wrap:FinancialInstrumentsOwnedAdjustedCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-7", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-09-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel1Member", "name": "wrap:FinancialInstrumentsOwnedAdjustedCost", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-7", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R38": { "role": "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details", "longName": "037 - Disclosure - Note 3 - Financial Instruments - (Details)", "shortName": "Note 3 - Financial Instruments - (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:FairValueAdjustmentOfWarrants", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2023-06-30_FairValueByFairValueHierarchyLevelAxis-FairValueInputsLevel3Member", "name": "us-gaap:FinancialLiabilitiesFairValueDisclosure", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R39": { "role": "http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details", "longName": "038 - Disclosure - Note 3 - Financial Instruments - Fair Value Assumptions (Details)", "shortName": "Note 3 - Financial Instruments - Fair Value Assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "i_2023-09-30_MeasurementInputTypeAxis-MeasurementInputPriceVolatilityMember", "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-09-30_MeasurementInputTypeAxis-MeasurementInputPriceVolatilityMember", "name": "us-gaap:WarrantsAndRightsOutstandingMeasurementInput", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R40": { "role": "http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details", "longName": "039 - Disclosure - Note 4 - Inventories - Summary of Inventories (Details)", "shortName": "Note 4 - Inventories - Summary of Inventories (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:InventoryFinishedGoodsNetOfReserves", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfInventoryCurrentTableTextBlock", "us-gaap:InventoryDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R41": { "role": "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-details-textual", "longName": "040 - Disclosure - Note 5 - Property and Equipment, Net (Details Textual)", "shortName": "Note 5 - Property and Equipment, Net (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:Depreciation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R42": { "role": "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details", "longName": "041 - Disclosure - Note 5 - Property and Equipment, Net - Summary of Property and Equipment (Details)", "shortName": "Note 5 - Property and Equipment, Net - Summary of Property and Equipment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:PropertyPlantAndEquipmentGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R43": { "role": "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-details-textual", "longName": "042 - Disclosure - Note 6 - Intangible Assets and Goodwill (Details Textual)", "shortName": "Note 6 - Intangible Assets and Goodwill (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:AmortizationOfIntangibleAssets", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R44": { "role": "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details", "longName": "043 - Disclosure - Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details)", "shortName": "Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R45": { "role": "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details", "longName": "044 - Disclosure - Note 6 - Intangible Assets and Goodwill - Future Amortization Expense (Details)", "shortName": "Note 6 - Intangible Assets and Goodwill - Future Amortization Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R46": { "role": "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-schedule-of-goodwill-details", "longName": "045 - Disclosure - Note 6 - Intangible Assets and Goodwill - Schedule of Goodwill (Details)", "shortName": "Note 6 - Intangible Assets and Goodwill - Schedule of Goodwill (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "i_2022-12-31", "name": "us-gaap:Goodwill", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:GoodwillAcquiredDuringPeriod", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfGoodwillTextBlock", "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R47": { "role": "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual", "longName": "046 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities (Details Textual)", "shortName": "Note 7 - Accounts Payable and Accrued Liabilities (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "i_2023-09-30_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis-FormerCeoPayableMember", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-09-30_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis-FormerCeoPayableMember", "name": "us-gaap:EmployeeRelatedLiabilitiesCurrentAndNoncurrent", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R48": { "role": "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details", "longName": "047 - Disclosure - Note 7 - Accounts Payable and Accrued Expenses - Summary of Accrued Liabilities (Details)", "shortName": "Note 7 - Accounts Payable and Accrued Expenses - Summary of Accrued Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "i_2023-09-30", "name": "wrap:AccruedPatentAndLegalCosts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-09-30", "name": "wrap:AccruedPatentAndLegalCosts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R49": { "role": "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-changes-in-product-warranty-costs-details", "longName": "048 - Disclosure - Note 7 - Accounts Payable and Accrued Liabilities - Changes in Product Warranty Costs (Details)", "shortName": "Note 7 - Accounts Payable and Accrued Liabilities - Changes in Product Warranty Costs (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "i_2022-12-31", "name": "us-gaap:ProductWarrantyAccrual", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2022-12-31", "name": "us-gaap:ProductWarrantyAccrual", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R50": { "role": "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual", "longName": "049 - Disclosure - Note 8 - Warrants (Details Textual)", "shortName": "Note 8 - Warrants (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "d_2023-07-03_2023-07-03_SubsidiarySaleOfStockAxis-RegisteredDirectOfferingMember", "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-7", "ancestors": [ "p", "wrap:WarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-07-03_2023-07-03_SubsidiarySaleOfStockAxis-RegisteredDirectOfferingMember", "name": "us-gaap:ProceedsFromIssuanceOrSaleOfEquity", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-7", "ancestors": [ "p", "wrap:WarrantsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R51": { "role": "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual", "longName": "050 - Disclosure - Note 9 - Stockholders' Equity (Details Textual)", "shortName": "Note 9 - Stockholders' Equity (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-07-29_2023-07-29", "name": "us-gaap:ProceedsFromIssuanceOfConvertiblePreferredStock", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R52": { "role": "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "longName": "051 - Disclosure - Note 10 - Share-based Compensation (Details Textual)", "shortName": "Note 10 - Share-based Compensation (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "52", "firstAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2022-04-01_2022-04-30_AwardTypeAxis-PerformanceSharesMember_TitleOfIndividualAxis-ChiefExecutiveOfficerAndPresidentMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R53": { "role": "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details", "longName": "052 - Disclosure - Note 10 - Share-based Compensation - Summary of Stock Option Activity (Details)", "shortName": "Note 10 - Share-based Compensation - Summary of Stock Option Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "53", "firstAnchor": { "contextRef": "i_2022-12-31", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30", "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R54": { "role": "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details", "longName": "053 - Disclosure - Note 10 - Share-based Compensation - Summary of Stock Option Valuation Assumptions (Details)", "shortName": "Note 10 - Share-based Compensation - Summary of Stock Option Valuation Assumptions (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "54", "firstAnchor": { "contextRef": "d_2023-01-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30_AwardTypeAxis-EmployeeStockOptionMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "unitRef": "USDPerShare", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R55": { "role": "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details", "longName": "054 - Disclosure - Note 10 - Share-based Compensation - Summary of RSU Activity (Details)", "shortName": "Note 10 - Share-based Compensation - Summary of RSU Activity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "55", "firstAnchor": { "contextRef": "i_2022-12-31_AwardTypeAxis-RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "unitRef": "Share", "xsiNil": "false", "lang": null, "decimals": "INF", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-01-01_2023-09-30_AwardTypeAxis-RestrictedStockUnitsRSUMember", "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R56": { "role": "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-allocation-of-sharebased-compensation-expense-details", "longName": "055 - Disclosure - Note 10 - Share-based Compensation - Allocation of Share-based Compensation Expense (Details)", "shortName": "Note 10 - Share-based Compensation - Allocation of Share-based Compensation Expense (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "56", "firstAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-07-01_2023-09-30_IncomeStatementLocationAxis-SellingGeneralAndAdministrativeExpensesMember", "name": "us-gaap:AllocatedShareBasedCompensationExpense", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R57": { "role": "http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan-details-textual", "longName": "056 - Disclosure - Note 11 - Defined Contribution Plan (Details Textual)", "shortName": "Note 11 - Defined Contribution Plan (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "57", "firstAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "us-gaap:DefinedBenefitPlanContributionsByEmployer", "us-gaap:DefinedBenefitPlanContributionsByEmployer", "p", "us-gaap:DefinedContributionPlanTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:DefinedBenefitPlanContributionsByEmployer", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "us-gaap:DefinedBenefitPlanContributionsByEmployer", "us-gaap:DefinedBenefitPlanContributionsByEmployer", "p", "us-gaap:DefinedContributionPlanTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R58": { "role": "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual", "longName": "057 - Disclosure - Note 12 - Commitments and Contingencies (Details Textual)", "shortName": "Note 12 - Commitments and Contingencies (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "58", "firstAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:ContractualObligation", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-4", "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2022-11-22_2022-11-22_BusinessAcquisitionAxis-ProfessionalServicesAndTechnologyAcquisitionAgreementMember", "name": "us-gaap:PaymentsToAcquireBusinessesGross", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-5", "ancestors": [ "p", "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R59": { "role": "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "longName": "058 - Disclosure - Note 13 - Related Party Transactions (Details Textual)", "shortName": "Note 13 - Related Party Transactions (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "59", "firstAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-2", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:RelatedPartyTransactionAmountsOfTransaction", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-2", "ancestors": [ "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R60": { "role": "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual", "longName": "059 - Disclosure - Note 14 - Major Customers and Related Information (Details Textual)", "shortName": "Note 14 - Major Customers and Related Information (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "60", "firstAnchor": { "contextRef": "d_2023-07-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember_MajorCustomersAxis-DistributorOneMember", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d_2023-07-01_2023-09-30_ConcentrationRiskByBenchmarkAxis-SalesRevenueNetMember_ConcentrationRiskByTypeAxis-CustomerConcentrationRiskMember_MajorCustomersAxis-DistributorOneMember", "name": "us-gaap:ConcentrationRiskPercentage1", "unitRef": "Pure", "xsiNil": "false", "lang": null, "decimals": "2", "ancestors": [ "p", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R61": { "role": "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details", "longName": "060 - Disclosure - Note 14 - Major Customers and Related Information - Disaggregation of Revenue by Geographic Region (Details)", "shortName": "Note 14 - Major Customers and Related Information - Disaggregation of Revenue by Geographic Region (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "61", "firstAnchor": { "contextRef": "d_2023-07-01_2023-09-30", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "d_2023-07-01_2023-09-30_StatementGeographicalAxis-AmericasMember", "name": "us-gaap:Revenues", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "us-gaap:ConcentrationRiskDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R62": { "role": "http://wrap.com/20230930/role/statement-note-15-business-combination-details-textual", "longName": "061 - Disclosure - Note 15 - Business Combination (Details Textual)", "shortName": "Note 15 - Business Combination (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "62", "firstAnchor": { "contextRef": "i_2023-08-09_BusinessAcquisitionAxis-IntrensicLLCMember", "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-08-09_BusinessAcquisitionAxis-IntrensicLLCMember", "name": "us-gaap:BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "0", "ancestors": [ "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } }, "R63": { "role": "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details", "longName": "062 - Disclosure - Note 15 - Business Combination - Schedule of Business Combination (Details)", "shortName": "Note 15 - Business Combination - Schedule of Business Combination (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "63", "firstAnchor": { "contextRef": "i_2023-09-30", "name": "us-gaap:Goodwill", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true }, "uniqueAnchor": { "contextRef": "i_2023-08-09_BusinessAcquisitionAxis-IntrensicLLCMember", "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "unitRef": "USD", "xsiNil": "false", "lang": null, "decimals": "-3", "ancestors": [ "td", "tr", "tbody", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "unique": true } }, "R64": { "role": "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual", "longName": "063 - Disclosure - Note 16 - Subsequent Events (Details Textual)", "shortName": "Note 16 - Subsequent Events (Details Textual)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "64", "firstAnchor": { "contextRef": "i_2023-11-01_LeaseContractualTermAxis-OfficeSpaceInMiamiFloridaMember_SubsequentEventTypeAxis-SubsequentEventMember", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "i_2023-11-01_LeaseContractualTermAxis-OfficeSpaceInMiamiFloridaMember_SubsequentEventTypeAxis-SubsequentEventMember", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "wrap20230930_10q.htm", "first": true, "unique": true } } }, "tag": { "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_IncreaseDecreaseInAccountsReceivable", "negatedLabel": "Accounts receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r8" ] }, "wrap_MrElwoodNorrisMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "MrElwoodNorrisMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual" ], "lang": { "en-us": { "role": { "label": "Mr. Elwood Norris [Member]", "documentation": "Represents information regarding Mr. Elwood Norris, a former officer and current stockholder of the reporting entity." } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "presentation": [ "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "terseLabel": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "documentation": "Exercise price per share or per unit of warrants or rights outstanding." } } }, "auth_ref": [ "r285" ] }, "us-gaap_DefinedContributionPlanTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedContributionPlanTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan" ], "lang": { "en-us": { "role": { "label": "Defined Contribution Plan [Text Block]", "documentation": "The entire disclosure for defined contribution plan." } } }, "auth_ref": [ "r312", "r313" ] }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment Disclosure [Text Block]", "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections." } } }, "auth_ref": [ "r123", "r143", "r146", "r147" ] }, "wrap_FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details" ], "lang": { "en-us": { "role": { "label": "Thereafter", "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [] }, "wrap_MaximumRoyaltiesToBePaidUnderAgreement": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "MaximumRoyaltiesToBePaidUnderAgreement", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "wrap_MaximumRoyaltiesToBePaidUnderAgreement", "terseLabel": "Maximum Royalties to Be Paid Under Agreement", "documentation": "Represents the maximum amount of royalties to be paid under the specified agreement." } } }, "auth_ref": [] }, "wrap_DeferredRevenueMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "DeferredRevenueMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details" ], "lang": { "en-us": { "role": { "label": "Deferred Revenue [Member]", "documentation": "Represents deferred revenue." } } }, "auth_ref": [] }, "us-gaap_OtherOperatingIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherOperatingIncome", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "Other revenue", "documentation": "The total amount of other operating income, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operation." } } }, "auth_ref": [ "r101" ] }, "wrap_IncreaseDecreaseInWarrantySettlement": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "IncreaseDecreaseInWarrantySettlement", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Warranty settlement", "documentation": "Represents the increase (decrease) in warranty settlement during the period." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r45", "r47", "r78", "r79", "r229", "r554" ] }, "wrap_EuropeMiddleEastAndAfricaMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "EuropeMiddleEastAndAfricaMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details" ], "lang": { "en-us": { "role": { "label": "Europe, Middle East and Africa [Member]", "documentation": "Represents information regarding Europe, Middle East and Africa." } } }, "auth_ref": [] }, "wrap_FairValueAssetRecurringBasisStillHeldUnrealizedGain": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "FairValueAssetRecurringBasisStillHeldUnrealizedGain", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details" ], "lang": { "en-us": { "role": { "label": "Unrealized Gains", "documentation": "Represents the unrealized gains on assets held on a recurring basis." } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Domain]", "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "auth_ref": [ "r124" ] }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "xbrltype": "decimalItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingMeasurementInput", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details" ], "lang": { "en-us": { "role": { "label": "Warrants, measurement input", "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur." } } }, "auth_ref": [ "r377" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementLineItems", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-allocation-of-sharebased-compensation-expense-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-tables", "http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan", "http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan-details-textual", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-tables", "http://wrap.com/20230930/role/statement-note-15-business-combination", "http://wrap.com/20230930/role/statement-note-15-business-combination-details-textual", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details", "http://wrap.com/20230930/role/statement-note-15-business-combination-tables", "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-details-textual", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-tables", "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details-textual", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-tables", "http://wrap.com/20230930/role/statement-note-4-inventories", "http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details", "http://wrap.com/20230930/role/statement-note-4-inventories-tables", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-details-textual", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-tables", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-details-textual", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-schedule-of-goodwill-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-tables", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-changes-in-product-warranty-costs-details", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-tables", "http://wrap.com/20230930/role/statement-note-8-warrants", "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual", "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r186", "r187", "r188", "r210", "r403", "r450", "r470", "r476", "r477", "r478", "r479", "r480", "r481", "r484", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r497", "r498", "r499", "r500", "r501", "r503", "r506", "r507", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r525", "r604" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_MeasurementInputExercisePriceMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExercisePriceMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Exercise Price [Member]", "documentation": "Measurement input using agreed upon price for exchange of underlying asset." } } }, "auth_ref": [ "r696" ] }, "wrap_DistributorOneMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "DistributorOneMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "Distributor One [Member]", "documentation": "Represents information regarding a first distributor." } } }, "auth_ref": [] }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExpectedDividendRateMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Expected Dividend Rate [Member]", "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year." } } }, "auth_ref": [ "r696" ] }, "us-gaap_MeasurementInputExpectedTermMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputExpectedTermMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Expected Term [Member]", "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date." } } }, "auth_ref": [ "r696" ] }, "wrap_DistributorTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "DistributorTwoMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "Distributor Two [Member]", "documentation": "Represents information regarding a second distributor." } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Changes in assets and liabilities:" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInAccountsPayable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInAccountsPayable", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_IncreaseDecreaseInAccountsPayable", "terseLabel": "Accounts payable", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r8" ] }, "us-gaap_Revenues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Revenues", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details" ], "lang": { "en-us": { "role": { "verboseLabel": "Revenues", "label": "us-gaap_Revenues", "totalLabel": "Total revenues", "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss)." } } }, "auth_ref": [ "r177", "r185", "r214", "r215", "r218", "r221", "r222", "r226", "r227", "r229", "r233", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r378", "r422", "r662" ] }, "us-gaap_IncreaseDecreaseInDepositOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDepositOtherAssets", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 12.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_IncreaseDecreaseInDepositOtherAssets", "negatedLabel": "Customer deposits", "documentation": "The increase (decrease) during the reporting period in moneys or securities given as security including, but not limited to, contract, escrow, or earnest money deposits, retainage (if applicable), deposits with clearing organizations and others, collateral, or margin deposits." } } }, "auth_ref": [ "r8" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_OperatingIncomeLoss", "totalLabel": "Loss from operations", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r213", "r219", "r223", "r225", "r579" ] }, "wrap_DistributorsMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "DistributorsMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "Distributors [Member]", "documentation": "Represents information regarding distributors." } } }, "auth_ref": [] }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SaleOfStockNameOfTransactionDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-8-warrants", "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Domain]", "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement." } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details" ], "lang": { "en-us": { "role": { "label": "Asset Class [Domain]", "documentation": "Class of asset." } } }, "auth_ref": [ "r19" ] }, "us-gaap_MeasurementInputPriceVolatilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputPriceVolatilityMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Price Volatility [Member]", "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns." } } }, "auth_ref": [ "r696" ] }, "us-gaap_RelatedPartyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Domain]", "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r310", "r392", "r393", "r477", "r478", "r479", "r480", "r481", "r501", "r503", "r533" ] }, "us-gaap_CommonStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockParOrStatedValuePerShare", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "Common stock, par value (in dollars per share)", "terseLabel": "Common Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of common stock." } } }, "auth_ref": [ "r90" ] }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-tables" ], "lang": { "en-us": { "role": { "label": "Contract with Customer, Contract Asset, Contract Liability, and Receivable [Table Text Block]", "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability." } } }, "auth_ref": [ "r666" ] }, "wrap_ExecutiveChairmanMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "ExecutiveChairmanMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Executive Chairman [Member]", "documentation": "Relating to the executive chairman." } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsIntangibleAssetsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsIntangibleAssetsPolicy", "presentation": [ "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets, Intangible Assets, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for intangible assets. This accounting policy may address both intangible assets subject to amortization and those that are not. The following also may be disclosed: (1) a description of intangible assets (2) the estimated useful lives of those assets (3) the amortization method used (4) how the entity assesses and measures impairment of such assets (5) how future cash flows are estimated (6) how the fair values of such asset are determined." } } }, "auth_ref": [ "r13" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Operating lease liability - short term", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r387" ] }, "wrap_FinancialInstrumentsOwnedAdjustedCost": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "FinancialInstrumentsOwnedAdjustedCost", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details" ], "lang": { "en-us": { "role": { "label": "Adjusted Cost", "documentation": "Represents the adjusted cost of financial instruments owned." } } }, "auth_ref": [] }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputRiskFreeInterestRateMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details" ], "lang": { "en-us": { "role": { "label": "Measurement Input, Risk Free Interest Rate [Member]", "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss." } } }, "auth_ref": [ "r696" ] }, "us-gaap_MeasurementInputTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Domain]", "documentation": "Measurement input used to determine value of asset and liability." } } }, "auth_ref": [] }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "presentation": [ "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined." } } }, "auth_ref": [ "r238", "r241", "r581" ] }, "us-gaap_VestingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Vesting [Axis]", "documentation": "Information by vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693" ] }, "us-gaap_ResearchAndDevelopmentExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpense", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "Research and development", "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use." } } }, "auth_ref": [ "r84", "r353", "r710" ] }, "us-gaap_RevenuesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenuesAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "Revenues:" } } }, "auth_ref": [] }, "wrap_ExtendedProductWarrantiesMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "ExtendedProductWarrantiesMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-details-textual" ], "lang": { "en-us": { "role": { "label": "Extended Product Warranties [Member]", "documentation": "Represents information regarding extended product warranties." } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "Accounts Receivable [Member]", "documentation": "Due from customers or clients for goods or services that have been delivered or sold." } } }, "auth_ref": [ "r554" ] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_Liabilities", "totalLabel": "Total liabilities", "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future." } } }, "auth_ref": [ "r29", "r185", "r233", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r361", "r362", "r363", "r378", "r482", "r578", "r611", "r662", "r702", "r703" ] }, "wrap_FormerCeoPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "FormerCeoPayableMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual" ], "lang": { "en-us": { "role": { "label": "Former CEO Payable [Member]", "documentation": "Represents former CEO payable." } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization", "negatedLabel": "Accumulated amortization", "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r158", "r244" ] }, "us-gaap_ContractualObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractualObligation", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ContractualObligation", "terseLabel": "Contractual Obligation", "documentation": "Amount of contractual obligation, including, but not limited to, long-term debt, lease obligation, purchase obligation, and other commitments." } } }, "auth_ref": [ "r636" ] }, "us-gaap_VestingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "VestingDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Vesting [Domain]", "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "auth_ref": [ "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693" ] }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-note-15-business-combination", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets by Major Class [Axis]", "documentation": "Information by major type or class of finite-lived intangible assets." } } }, "auth_ref": [ "r242", "r243", "r244", "r245", "r404", "r405" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "Selling, general and administrative", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r105" ] }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "negatedLabel": "Accumulated depreciation", "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services." } } }, "auth_ref": [ "r58", "r156", "r431" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Operating lease liability - long term", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r387" ] }, "wrap_IntrensicLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "IntrensicLLCMember", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-15-business-combination", "http://wrap.com/20230930/role/statement-note-15-business-combination-details-textual", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "Intrensic, LLC [Member]", "documentation": "Relating to Intrensic, LLC." } } }, "auth_ref": [] }, "wrap_FairValueAssetRecurringBasisStillHeldUnrealizedLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "FairValueAssetRecurringBasisStillHeldUnrealizedLoss", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details" ], "lang": { "en-us": { "role": { "label": "Unrealized Losses", "documentation": "Represents the amount of unrealized loss on assets still held on recurring basis." } } }, "auth_ref": [] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Accumulated other comprehensive loss", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r34", "r35", "r99", "r164", "r428", "r447", "r448" ] }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-note-15-business-combination", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]", "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "auth_ref": [ "r53", "r55" ] }, "wrap_IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherLiabilities", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Accrued liabilities and other", "documentation": "The increase (decrease) during the reporting period in accrued liabilities and other liabilities." } } }, "auth_ref": [] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "auth_ref": [ "r641", "r700" ] }, "wrap_IntangiblesOtherThanPatentsAndTrademarksMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "IntangiblesOtherThanPatentsAndTrademarksMember", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Intangibles Other than Patents and Trademarks [Member]", "documentation": "Represents information regarding intangibles other than patents and trademarks." } } }, "auth_ref": [] }, "wrap_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 9.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "wrap_IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets", "negatedLabel": "Prepaid expense and other current assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and current assets classified as other." } } }, "auth_ref": [] }, "wrap_NetAssetsAcquiredFromAcquisition": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "NetAssetsAcquiredFromAcquisition", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Net assets acquired from acquisition", "documentation": "The amount of net assets acquired from acquisition." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual" ], "lang": { "en-us": { "role": { "label": "Related Party, Type [Axis]", "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "auth_ref": [ "r310", "r392", "r393", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r477", "r478", "r479", "r480", "r481", "r501", "r503", "r533", "r701" ] }, "wrap_ProductWarrantyExpenseIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "ProductWarrantyExpenseIncome", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Warranty provision", "documentation": "The amount of product warranty expense (income)." } } }, "auth_ref": [] }, "us-gaap_ComputerEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerEquipmentMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Computer Equipment [Member]", "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems." } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment", "negatedLabel": "Capital expenditures for property and equipment", "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets." } } }, "auth_ref": [ "r110" ] }, "wrap_OfficeSpaceInMiamiFloridaMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "OfficeSpaceInMiamiFloridaMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Office Space in Miami, Florida [Member]", "documentation": "Related to lease." } } }, "auth_ref": [] }, "us-gaap_ComputerSoftwareIntangibleAssetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComputerSoftwareIntangibleAssetMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "Computer Software, Intangible Asset [Member]", "documentation": "Collection of computer programs and related data that provide instructions to a computer, for example, but not limited to, application program, control module or operating system, that perform one or more particular functions or tasks." } } }, "auth_ref": [ "r570", "r654", "r655" ] }, "us-gaap_IncomeStatementLocationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-allocation-of-sharebased-compensation-expense-details" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Domain]", "documentation": "Location in the income statement." } } }, "auth_ref": [ "r247", "r510" ] }, "us-gaap_SharePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharePrice", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_SharePrice", "terseLabel": "Share Price", "documentation": "Price of a single share of a number of saleable stocks of a company." } } }, "auth_ref": [] }, "wrap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "wrap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueGranted", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Granted", "documentation": "Intrinsic value of granted awards under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Axis]", "documentation": "Information by type of related party transaction." } } }, "auth_ref": [ "r392", "r393", "r701" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r45", "r47", "r78", "r79", "r229", "r554", "r620" ] }, "wrap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "wrap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Grant Date Fair Value", "documentation": "Represents the weighted average grant date fair value of share-based payment options." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRequisiteServicePeriod1", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period", "documentation": "Estimated period over which an employee is required to provide service in exchange for the equity-based payment award, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r595" ] }, "wrap_StockIssuedDuringPeriodSharesRestrictedStockUnitsVested": { "xbrltype": "sharesItemType", "nsuri": "http://wrap.com/20230930", "localname": "StockIssuedDuringPeriodSharesRestrictedStockUnitsVested", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Common shares issued upon vesting of restricted stock units (in shares)", "documentation": "Represents the number of common shares issued upon vesting of restricted stock units." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost", "terseLabel": "Share-Based Payment Arrangement, Accelerated Cost", "documentation": "Amount of additional cost recognized for award under share-based payment arrangement from occurrence of event accelerating recognition of cost." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ConcentrationRiskPercentage1", "terseLabel": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r45", "r47", "r78", "r79", "r229" ] }, "wrap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestingSustainedMarketCapitalization": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestingSustainedMarketCapitalization", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "wrap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestingSustainedMarketCapitalization", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vesting, Sustained Market Capitalization", "documentation": "Represents vesting based on sustained market capitalization." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details" ], "lang": { "en-us": { "role": { "label": "Weighted average vesting period (Year)", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r595" ] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_EntityCurrentReportingStatus", "terseLabel": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskDisclosureTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Disclosure [Text Block]", "documentation": "The entire disclosure for any concentrations existing at the date of the financial statements that make an entity vulnerable to a reasonably possible, near-term, severe impact. This disclosure informs financial statement users about the general nature of the risk associated with the concentration, and may indicate the percentage of concentration risk as of the balance sheet date." } } }, "auth_ref": [ "r116" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_EntityShellCompany", "terseLabel": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r613" ] }, "wrap_NoteToFinancialStatementDetailsTextual": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "NoteToFinancialStatementDetailsTextual", "lang": { "en-us": { "role": { "label": "Note To Financial Statement Details Textual" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "totalLabel": "Net cash provided by financing activities", "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit." } } }, "auth_ref": [ "r182" ] }, "wrap_NoncashLeaseExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "NoncashLeaseExpense", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Non-cash lease expense", "documentation": "Represents the amount of noncash lease expense recognized during the period." } } }, "auth_ref": [] }, "us-gaap_CustomerRelationshipsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerRelationshipsMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "Customer Relationships [Member]", "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships." } } }, "auth_ref": [ "r73" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Additional Shares Authorized", "documentation": "Number of additional shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1", "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition", "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r347" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Cash Flows From Financing Activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "totalLabel": "Net cash provided by investing activities", "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets." } } }, "auth_ref": [ "r182" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Cash Flows From Investing Activities:" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "totalLabel": "Net cash used in operating activities", "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities." } } }, "auth_ref": [ "r111", "r112", "r113" ] }, "wrap_NotesToFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "NotesToFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Notes To Financial Statements [Abstract]" } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r613" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Percentage of Outstanding Stock Maximum", "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock." } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Cash Flows From Operating Activities:" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Outstanding, aggregate intrinsic value", "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur." } } }, "auth_ref": [ "r337" ] }, "wrap_NumberOfWhollyOwnedSubsidiaries": { "xbrltype": "integerItemType", "nsuri": "http://wrap.com/20230930", "localname": "NumberOfWhollyOwnedSubsidiaries", "presentation": [ "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual" ], "lang": { "en-us": { "role": { "label": "wrap_NumberOfWhollyOwnedSubsidiaries", "terseLabel": "Number of Wholly-owned Subsidiaries", "documentation": "Represents the reporting entity's number of wholly-owned subsidiaries." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r613" ] }, "wrap_NumberOfMajorCustomers": { "xbrltype": "integerItemType", "nsuri": "http://wrap.com/20230930", "localname": "NumberOfMajorCustomers", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "wrap_NumberOfMajorCustomers", "terseLabel": "Number of Major Customers", "documentation": "Represents the number of major customers accounting for 10% or more of the specified concentration risk benchmark, which includes, but not limited to, sales revenue, accounts receivable, etc." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferred1", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_BusinessCombinationConsiderationTransferred1", "totalLabel": "Total", "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer." } } }, "auth_ref": [ "r1", "r2", "r15" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductOrServiceAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-details-textual" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "auth_ref": [ "r226", "r403", "r436", "r437", "r438", "r439", "r440", "r441", "r568", "r585", "r599", "r623", "r658", "r659", "r667", "r712" ] }, "wrap_OrganizationAndBusinessDescriptionPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://wrap.com/20230930", "localname": "OrganizationAndBusinessDescriptionPolicyTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Organization and Business Description [Policy Text Block]", "documentation": "Accounting policy for business description and organization." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r613" ] }, "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_BusinessAcquisitionCostOfAcquiredEntityTransactionCosts", "terseLabel": "Business Acquisition, Transaction Costs", "documentation": "Amount of direct costs of the business combination including legal, accounting, and other costs incurred to consummate the business acquisition." } } }, "auth_ref": [] }, "us-gaap_PreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockMember", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Preferred Stock [Member]", "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company." } } }, "auth_ref": [ "r601", "r602", "r605", "r606", "r607", "r608", "r714", "r716" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "auth_ref": [ "r250", "r251", "r252", "r253", "r303", "r314", "r340", "r341", "r342", "r401", "r402", "r442", "r474", "r475", "r534", "r537", "r541", "r542", "r544", "r565", "r566", "r580", "r584", "r594", "r600", "r603", "r656", "r664", "r705", "r706", "r707", "r708", "r709" ] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfStockDomain", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Domain]", "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "auth_ref": [ "r149", "r161", "r162", "r163", "r185", "r201", "r202", "r205", "r207", "r211", "r212", "r233", "r260", "r262", "r263", "r264", "r267", "r268", "r271", "r272", "r275", "r278", "r284", "r378", "r451", "r452", "r453", "r454", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r484", "r505", "r525", "r547", "r548", "r549", "r550", "r551", "r618", "r634", "r640" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "ProductsAndServicesDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-details-textual" ], "lang": { "en-us": { "role": { "label": "Product and Service [Domain]" } } }, "auth_ref": [ "r226", "r403", "r436", "r437", "r438", "r439", "r440", "r441", "r568", "r585", "r599", "r623", "r658", "r659", "r667", "r712" ] }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationDisclosureTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination" ], "lang": { "en-us": { "role": { "label": "Business Combination Disclosure [Text Block]", "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable)." } } }, "auth_ref": [ "r131", "r357" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementClassOfStockAxis", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]", "documentation": "Information by the different classes of stock of the entity." } } }, "auth_ref": [ "r149", "r161", "r162", "r163", "r185", "r201", "r202", "r205", "r207", "r211", "r212", "r233", "r260", "r262", "r263", "r264", "r267", "r268", "r271", "r272", "r275", "r278", "r284", "r378", "r451", "r452", "r453", "r454", "r459", "r460", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r484", "r505", "r525", "r547", "r548", "r549", "r550", "r551", "r618", "r634", "r640" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MaximumMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "auth_ref": [ "r250", "r251", "r252", "r253", "r314", "r402", "r442", "r474", "r475", "r534", "r537", "r541", "r542", "r544", "r565", "r566", "r580", "r584", "r594", "r600", "r664", "r704", "r705", "r706", "r707", "r708", "r709" ] }, "wrap_PreferredStockStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://wrap.com/20230930", "localname": "PreferredStockStatedValuePerShare", "presentation": [ "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "wrap_PreferredStockStatedValuePerShare", "terseLabel": "Preferred Stock, Stated Value Per Share", "documentation": "Stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "RangeMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "auth_ref": [ "r250", "r251", "r252", "r253", "r303", "r314", "r340", "r341", "r342", "r401", "r402", "r442", "r474", "r475", "r534", "r537", "r541", "r542", "r544", "r565", "r566", "r580", "r584", "r594", "r600", "r603", "r656", "r664", "r705", "r706", "r707", "r708", "r709" ] }, "wrap_PatentsAndTrademarksMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "PatentsAndTrademarksMember", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Patents and Trademarks [Member]", "documentation": "Represents information regarding patents and trademarks." } } }, "auth_ref": [] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MinimumMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "auth_ref": [ "r250", "r251", "r252", "r253", "r314", "r402", "r442", "r474", "r475", "r534", "r537", "r541", "r542", "r544", "r565", "r566", "r580", "r584", "r594", "r600", "r664", "r704", "r705", "r706", "r707", "r708", "r709" ] }, "us-gaap_AllocatedShareBasedCompensationExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AllocatedShareBasedCompensationExpense", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-allocation-of-sharebased-compensation-expense-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_AllocatedShareBasedCompensationExpense", "terseLabel": "Share-Based Payment Arrangement, Expense", "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized." } } }, "auth_ref": [ "r344", "r352" ] }, "us-gaap_ProceedsFromStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromStockOptionsExercised", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Proceeds from exercise of stock options", "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement." } } }, "auth_ref": [ "r5", "r22" ] }, "wrap_ProfessionalServicesAndTechnologyAcquisitionAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "ProfessionalServicesAndTechnologyAcquisitionAgreementMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Professional Services and Technology Acquisition Agreement [Member]", "documentation": "Relating to the Professional Services and Technology Acquisition Agreement." } } }, "auth_ref": [] }, "wrap_ProceedsFromIssuanceOfWarrantsAndConvertiblePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "ProceedsFromIssuanceOfWarrantsAndConvertiblePreferredStock", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Proceeds from issuance of warrants and convertible preferred stock, net of offering costs", "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt) and preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "presentation": [ "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "terseLabel": "Business Acquisition, Equity Interest Issued or Issuable, Number of Shares", "documentation": "Number of shares of equity interests issued or issuable to acquire entity." } } }, "auth_ref": [ "r133" ] }, "wrap_ProductionAndLabEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "ProductionAndLabEquipmentMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Production and Lab Equipment [Member]", "documentation": "Represents information regarding production and lab equipment." } } }, "auth_ref": [] }, "wrap_ServicebasedOptionsMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "ServicebasedOptionsMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Service-based Options [Member]", "documentation": "Represents service-based options." } } }, "auth_ref": [] }, "us-gaap_InventoryNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryNet", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 }, "http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details" ], "lang": { "en-us": { "role": { "label": "Inventories, net", "totalLabel": "Inventories - net", "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer." } } }, "auth_ref": [ "r165", "r572", "r598" ] }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "presentation": [ "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired", "terseLabel": "Business Acquisition, Percentage of Voting Interests Acquired", "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination." } } }, "auth_ref": [ "r68" ] }, "us-gaap_TechnologyBasedIntangibleAssetsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TechnologyBasedIntangibleAssetsMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "Technology-Based Intangible Assets [Member]", "documentation": "Technology-based intangible assets, including, but not limited to, patented technology, unpatented technology, and developed technology rights." } } }, "auth_ref": [ "r24" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period", "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r596" ] }, "wrap_ReimbursementOfExpensesToRelatedPartyMonthlyAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "ReimbursementOfExpensesToRelatedPartyMonthlyAmount", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual" ], "lang": { "en-us": { "role": { "label": "wrap_ReimbursementOfExpensesToRelatedPartyMonthlyAmount", "terseLabel": "Reimbursement of Expenses to Related Party, Monthly Amount", "documentation": "Represents the amount paid per month to reimburse a related party for expenses." } } }, "auth_ref": [] }, "wrap_RoyaltyPaymentsPercentageOfProductRevenue": { "xbrltype": "percentItemType", "nsuri": "http://wrap.com/20230930", "localname": "RoyaltyPaymentsPercentageOfProductRevenue", "presentation": [ "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "wrap_RoyaltyPaymentsPercentageOfProductRevenue", "terseLabel": "Royalty Payments, Percentage of Product Revenue", "documentation": "Represents the percentage of product revenue to be paid by the reporting entity." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Share-based compensation", "label": "us-gaap_ShareBasedCompensation", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r8" ] }, "us-gaap_BusinessAcquisitionAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAxis", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-15-business-combination", "http://wrap.com/20230930/role/statement-note-15-business-combination-details-textual", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "Business Acquisition [Axis]", "documentation": "Information by business combination or series of individually immaterial business combinations." } } }, "auth_ref": [ "r67", "r69", "r356", "r592", "r593" ] }, "wrap_RegisteredDirectOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "RegisteredDirectOfferingMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-8-warrants", "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "Registered Direct Offering [Member]", "documentation": "Represents the registered direct offering." } } }, "auth_ref": [] }, "wrap_RightofuseAssetAndLiabilityRecorded": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "RightofuseAssetAndLiabilityRecorded", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Right-of-use asset and liability recorded during period", "documentation": "Amount of right-of-use asset and liability recorded." } } }, "auth_ref": [] }, "wrap_RelatedPartyTechnologyLicenseAgreementMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "RelatedPartyTechnologyLicenseAgreementMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "Related Party Technology License Agreement [Member]", "documentation": "Represents information regarding a related party technology license agreement." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual" ], "lang": { "en-us": { "role": { "label": "Related Party Transaction [Domain]", "documentation": "Transaction between related party." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r612" ] }, "us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualPreexistingIncreaseDecrease", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-changes-in-product-warranty-costs-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ProductWarrantyAccrualPreexistingIncreaseDecrease", "terseLabel": "Warranty provision", "documentation": "Amount of increase (decrease) in the standard and extended product warranty accrual from changes in estimates attributable to preexisting product warranties." } } }, "auth_ref": [ "r258" ] }, "us-gaap_TableTextBlock": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TableTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-tables", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-tables", "http://wrap.com/20230930/role/statement-note-15-business-combination-tables", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-tables", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-tables", "http://wrap.com/20230930/role/statement-note-4-inventories-tables", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-tables", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-tables", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-tables" ], "lang": { "en-us": { "role": { "label": "us-gaap_TableTextBlock", "terseLabel": "Notes Tables" } } }, "auth_ref": [] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [] }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessAcquisitionAcquireeDomain", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-15-business-combination", "http://wrap.com/20230930/role/statement-note-15-business-combination-details-textual", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "Business Acquisition, Acquiree [Domain]", "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "auth_ref": [ "r356", "r592", "r593" ] }, "us-gaap_ProductWarrantyAccrual": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrual", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-changes-in-product-warranty-costs-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ProductWarrantyAccrual", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers." } } }, "auth_ref": [ "r82", "r254", "r256", "r259" ] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Long-Lived Tangible Asset [Axis]", "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale." } } }, "auth_ref": [ "r10" ] }, "us-gaap_DisclosureTextBlockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureTextBlockAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-15-business-combination", "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs", "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-4-inventories", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities", "http://wrap.com/20230930/role/statement-note-8-warrants", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "us-gaap_DisclosureTextBlockAbstract", "terseLabel": "Notes to Financial Statements" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireIntangibleAssets", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 5.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_PaymentsToAcquireIntangibleAssets", "negatedLabel": "Investment in patents and trademarks", "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill." } } }, "auth_ref": [ "r110" ] }, "us-gaap_AccountsPayableCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_AccountsPayableCurrentAndNoncurrent", "terseLabel": "Accounts Payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business." } } }, "auth_ref": [ "r82", "r711" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "Cost of revenues", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r103", "r185", "r233", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r378", "r662" ] }, "us-gaap_PlanNameAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Plan Name [Axis]", "documentation": "Information by plan name for share-based payment arrangement." } } }, "auth_ref": [ "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireInvestments", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_PaymentsToAcquireInvestments", "negatedLabel": "Purchase of short-term investments", "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period." } } }, "auth_ref": [ "r109" ] }, "us-gaap_ScheduleOfGoodwillTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfGoodwillTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Goodwill [Table Text Block]", "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule." } } }, "auth_ref": [ "r581", "r643", "r644", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r614" ] }, "us-gaap_ProductWarrantyAccrualPayments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualPayments", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-changes-in-product-warranty-costs-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ProductWarrantyAccrualPayments", "negatedLabel": "Warranty settlements", "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty." } } }, "auth_ref": [ "r257" ] }, "us-gaap_InventoryFinishedGoodsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryFinishedGoodsNetOfReserves", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details" ], "lang": { "en-us": { "role": { "label": "Finished goods", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale." } } }, "auth_ref": [ "r118", "r573" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_AmortizationOfIntangibleAssets", "terseLabel": "Amortization of Intangible Assets", "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method." } } }, "auth_ref": [ "r9", "r52", "r56" ] }, "us-gaap_InventoryWorkInProcessNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryWorkInProcessNetOfReserves", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details" ], "lang": { "en-us": { "role": { "label": "Work in process", "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing." } } }, "auth_ref": [ "r118", "r574" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SalesRevenueNetMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r229", "r619" ] }, "us-gaap_PolicyTextBlockAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PolicyTextBlockAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "us-gaap_PolicyTextBlockAbstract", "terseLabel": "Accounting Policies" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTableTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments-tables" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]", "documentation": "Tabular disclosure of financial instruments measured at fair value, including those classified in shareholders' equity measured on a recurring or nonrecurring basis. Disclosures include, but are not limited to, fair value measurements recorded and the reasons for the measurements, level within the fair value hierarchy in which the fair value measurements are categorized and transfers between levels 1 and 2. Nonrecurring fair value measurements are those that are required or permitted in the statement of financial position in particular circumstances." } } }, "auth_ref": [ "r23", "r76", "r77", "r135" ] }, "us-gaap_InventoryRawMaterialsNetOfReserves": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryRawMaterialsNetOfReserves", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details": { "parentTag": "us-gaap_InventoryNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details" ], "lang": { "en-us": { "role": { "label": "Raw materials", "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process." } } }, "auth_ref": [ "r118", "r575" ] }, "us-gaap_IncreaseDecreaseInDeferredRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInDeferredRevenue", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Deferred revenue", "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r567" ] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementTable", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-allocation-of-sharebased-compensation-expense-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-tables", "http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan", "http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan-details-textual", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-tables", "http://wrap.com/20230930/role/statement-note-15-business-combination", "http://wrap.com/20230930/role/statement-note-15-business-combination-details-textual", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details", "http://wrap.com/20230930/role/statement-note-15-business-combination-tables", "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-details-textual", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-tables", "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details-textual", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-tables", "http://wrap.com/20230930/role/statement-note-4-inventories", "http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details", "http://wrap.com/20230930/role/statement-note-4-inventories-tables", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-details-textual", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-tables", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-details-textual", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-schedule-of-goodwill-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-tables", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-changes-in-product-warranty-costs-details", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-tables", "http://wrap.com/20230930/role/statement-note-8-warrants", "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual", "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Statement [Table]", "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed." } } }, "auth_ref": [ "r186", "r187", "r188", "r210", "r403", "r450", "r470", "r476", "r477", "r478", "r479", "r480", "r481", "r484", "r487", "r488", "r489", "r490", "r491", "r492", "r493", "r494", "r495", "r497", "r498", "r499", "r500", "r501", "r503", "r506", "r507", "r511", "r512", "r513", "r514", "r515", "r516", "r517", "r518", "r519", "r520", "r521", "r522", "r525", "r604" ] }, "us-gaap_WarrantsAndRightsOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstanding", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Warrants \u2013 short term", "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price." } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details" ], "lang": { "en-us": { "role": { "label": "Deferred revenue- short term", "terseLabel": "Current portion", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r287", "r288", "r299" ] }, "us-gaap_OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OrganizationConsolidationBasisOfPresentationBusinessDescriptionAndAccountingPoliciesTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments" ], "lang": { "en-us": { "role": { "label": "Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]", "documentation": "The entire disclosure for the general note to the financial statements for the reporting entity which may include, descriptions of the basis of presentation, business description, significant accounting policies, consolidations, reclassifications, new pronouncements not yet adopted and changes in accounting principles." } } }, "auth_ref": [ "r114", "r115", "r116", "r134" ] }, "us-gaap_BusinessCombinationsPolicy": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationsPolicy", "presentation": [ "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Business Combinations Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy." } } }, "auth_ref": [ "r66" ] }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_LiabilitiesNoncurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details" ], "lang": { "en-us": { "role": { "label": "Deferred revenue- long term", "terseLabel": "Long-term portion", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r287", "r288", "r299" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "totalLabel": "Net decrease in cash and cash equivalents", "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r3", "r111" ] }, "us-gaap_ContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiability", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ContractWithCustomerLiability", "terseLabel": "Contract with Customer, Liability", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r287", "r288", "r299" ] }, "us-gaap_InventoryDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InventoryDisclosureTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-4-inventories" ], "lang": { "en-us": { "role": { "label": "Inventory Disclosure [Text Block]", "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory." } } }, "auth_ref": [ "r237" ] }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill" ], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Text Block]", "documentation": "The entire disclosure for goodwill and intangible assets." } } }, "auth_ref": [ "r119" ] }, "us-gaap_PlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PlanNameDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Plan Name [Domain]", "documentation": "Plan name for share-based payment arrangement." } } }, "auth_ref": [ "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r677", "r678", "r679", "r680", "r681", "r682", "r683", "r684", "r685", "r686", "r687", "r688", "r689", "r690", "r691", "r692", "r693" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "periodStartLabel": "Cash and cash equivalents, beginning of period", "periodEndLabel": "Cash and cash equivalents, end of period", "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r39", "r111", "r183" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_EntityCommonStockSharesOutstanding", "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "auth_ref": [ "r229", "r587", "r667", "r712", "r713" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AwardTypeAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details", "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Other assets", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r159" ] }, "us-gaap_StockholdersEquityPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityPolicyTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Stockholders' Equity, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for its capital stock transactions, including dividends and accumulated other comprehensive income." } } }, "auth_ref": [ "r11", "r529" ] }, "us-gaap_DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-tables" ], "lang": { "en-us": { "role": { "label": "Disclosure of Share-Based Compensation Arrangements by Share-Based Payment Award [Table Text Block]", "documentation": "Tabular disclosure of share-based payment arrangement." } } }, "auth_ref": [ "r12", "r61" ] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockMember", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Common Stock [Member]", "documentation": "Stock that is subordinate to all other stock of the issuer." } } }, "auth_ref": [ "r601", "r602", "r603", "r605", "r606", "r607", "r608", "r637", "r638", "r695", "r714", "r716" ] }, "us-gaap_PropertyPlantAndEquipmentGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentGross", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details": { "parentTag": "us-gaap_PropertyPlantAndEquipmentNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Property and equipment, gross", "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r124", "r155", "r432" ] }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Business Acquisitions, by Acquisition [Table Text Block]", "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts." } } }, "auth_ref": [ "r67", "r69" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "Other", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r108" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_StockholdersEquity", "totalLabel": "Total stockholders' equity", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r90", "r93", "r94", "r117", "r486", "r502", "r526", "r527", "r598", "r611", "r635", "r642", "r698", "r716" ] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events" ], "lang": { "en-us": { "role": { "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r395", "r397" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 }, "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Property and equipment, net", "totalLabel": "Property and equipment, net", "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures." } } }, "auth_ref": [ "r10", "r423", "r432", "r598" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrentAndNoncurrent", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_EmployeeRelatedLiabilitiesCurrentAndNoncurrent", "terseLabel": "Employee-related Liabilities", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r82", "r711" ] }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PropertyPlantAndEquipmentTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-tables" ], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Table Text Block]", "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation." } } }, "auth_ref": [ "r10" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingencies", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r32", "r83", "r425", "r483" ] }, "us-gaap_RoyaltyGuaranteesCommitmentsAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RoyaltyGuaranteesCommitmentsAmount", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_RoyaltyGuaranteesCommitmentsAmount", "terseLabel": "Royalty Guarantees, Commitments, Amount", "documentation": "The amount the entity has committed to make for future royalty guarantees." } } }, "auth_ref": [ "r406" ] }, "us-gaap_ProvisionForDoubtfulAccounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProvisionForDoubtfulAccounts", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Provision for doubtful accounts", "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable." } } }, "auth_ref": [ "r180", "r236" ] }, "us-gaap_OfficersCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OfficersCompensation", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_OfficersCompensation", "terseLabel": "Salary and Wage, Officer, Excluding Cost of Good and Service Sold", "documentation": "Amount of expense for salary and wage arising from service rendered by officer. Excludes allocated cost, labor-related nonsalary expense, and direct and overhead labor cost included in cost of good and service sold." } } }, "auth_ref": [ "r631" ] }, "us-gaap_IncomeStatementLocationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncomeStatementLocationAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-allocation-of-sharebased-compensation-expense-details" ], "lang": { "en-us": { "role": { "label": "Income Statement Location [Axis]", "documentation": "Information by location in the income statement." } } }, "auth_ref": [ "r246", "r247", "r510" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r385", "r396" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Accumulated deficit", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r92", "r127", "r429", "r446", "r448", "r455", "r485", "r598" ] }, "us-gaap_DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredBonusAndProfitSharingArrangementIndividualContractTypeOfDeferredCompensationDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual" ], "lang": { "en-us": { "role": { "label": "Deferred Bonus and Profit Sharing Arrangement, Individual Contract, Type of Deferred Compensation [Domain]", "documentation": "Deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans." } } }, "auth_ref": [ "r59", "r128" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "Weighted average common shares used to compute net loss per basic and diluted common share (in shares)", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r199", "r207" ] }, "us-gaap_OtherAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details" ], "lang": { "en-us": { "role": { "label": "Taxes and other", "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r30" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Operating lease right-of-use asset, net", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r386" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_EntityRegistrantName", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r613" ] }, "us-gaap_AccountsPayableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableCurrent", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Accounts payable", "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r27", "r598" ] }, "us-gaap_AdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapitalMember", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Additional Paid-in Capital [Member]", "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders." } } }, "auth_ref": [ "r349", "r350", "r351", "r459", "r637", "r638", "r639", "r695", "r716" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r269", "r304", "r305", "r306", "r307", "r308", "r309", "r398", "r399", "r400", "r582", "r583", "r588", "r589", "r590" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited", "http://wrap.com/20230930/role/statement-document-and-entity-information", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-allocation-of-sharebased-compensation-expense-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-tables", "http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan", "http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan-details-textual", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-tables", "http://wrap.com/20230930/role/statement-note-15-business-combination", "http://wrap.com/20230930/role/statement-note-15-business-combination-details-textual", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details", "http://wrap.com/20230930/role/statement-note-15-business-combination-tables", "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-details-textual", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-tables", "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details-textual", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-tables", "http://wrap.com/20230930/role/statement-note-4-inventories", "http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details", "http://wrap.com/20230930/role/statement-note-4-inventories-tables", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-details-textual", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-tables", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-details-textual", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-schedule-of-goodwill-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-tables", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-changes-in-product-warranty-costs-details", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-tables", "http://wrap.com/20230930/role/statement-note-8-warrants", "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual", "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact." } } }, "auth_ref": [] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited", "http://wrap.com/20230930/role/statement-document-and-entity-information", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments", "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-allocation-of-sharebased-compensation-expense-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-tables", "http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan", "http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan-details-textual", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-tables", "http://wrap.com/20230930/role/statement-note-15-business-combination", "http://wrap.com/20230930/role/statement-note-15-business-combination-details-textual", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details", "http://wrap.com/20230930/role/statement-note-15-business-combination-tables", "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-details-textual", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-tables", "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details-textual", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-tables", "http://wrap.com/20230930/role/statement-note-4-inventories", "http://wrap.com/20230930/role/statement-note-4-inventories-summary-of-inventories-details", "http://wrap.com/20230930/role/statement-note-4-inventories-tables", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-details-textual", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-tables", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-details-textual", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-schedule-of-goodwill-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-tables", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-changes-in-product-warranty-costs-details", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-tables", "http://wrap.com/20230930/role/statement-note-8-warrants", "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual", "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "us-gaap_FairValueAdjustmentOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAdjustmentOfWarrants", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0, "order": 1.0 }, "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details" ], "lang": { "en-us": { "role": { "verboseLabel": "Change in fair value of warrant liabilities", "label": "Change in fair value of warrant liabilities", "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability." } } }, "auth_ref": [ "r0", "r9" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Stockholders' equity:" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "presentation": [ "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "terseLabel": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares." } } }, "auth_ref": [ "r285" ] }, "us-gaap_InvestmentIncomeInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "InvestmentIncomeInterest", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "Interest income", "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities." } } }, "auth_ref": [ "r106", "r216" ] }, "us-gaap_ProductWarrantyAccrualClassifiedCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProductWarrantyAccrualClassifiedCurrent", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details" ], "lang": { "en-us": { "role": { "label": "Warranty costs", "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r30", "r660", "r661" ] }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockholdersEquityNoteDisclosureTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-9-stockholders-equity" ], "lang": { "en-us": { "role": { "label": "Equity [Text Block]", "documentation": "The entire disclosure for equity." } } }, "auth_ref": [ "r126", "r184", "r270", "r272", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r286", "r370", "r528", "r531", "r552" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r613" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-tables" ], "lang": { "en-us": { "role": { "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r667" ] }, "us-gaap_PreferredStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesIssued", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Issued (in shares)", "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt." } } }, "auth_ref": [ "r89", "r271" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_EntityFileNumber", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r17", "r33", "r150", "r174", "r175", "r176", "r186", "r187", "r188", "r190", "r196", "r198", "r210", "r234", "r235", "r286", "r349", "r350", "r351", "r354", "r355", "r364", "r365", "r366", "r367", "r368", "r369", "r371", "r379", "r380", "r381", "r382", "r383", "r384", "r388", "r443", "r444", "r445", "r459", "r525" ] }, "us-gaap_RevenueFromContractWithCustomerIncludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerIncludingAssessedTax", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_Revenues", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "Product sales", "documentation": "Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise." } } }, "auth_ref": [ "r214", "r215", "r218", "r221", "r222", "r226", "r227", "r229", "r297", "r298", "r403" ] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r46", "r229" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RetainedEarningsMember", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r150", "r186", "r187", "r188", "r190", "r196", "r198", "r234", "r235", "r349", "r350", "r351", "r354", "r355", "r364", "r366", "r367", "r369", "r371", "r443", "r445", "r459", "r716" ] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ContractWithCustomerLiabilityRevenueRecognized", "negatedLabel": "Transfer to revenue", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r300" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r385", "r396" ] }, "us-gaap_PreferredStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesAuthorized", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Authorized (in shares)", "terseLabel": "Preferred Stock, Shares Authorized", "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r89", "r484" ] }, "us-gaap_PreferredStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockSharesOutstanding", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Shares Outstanding (in shares)", "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased." } } }, "auth_ref": [ "r89", "r484", "r502", "r716", "r717" ] }, "us-gaap_AccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 }, "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details" ], "lang": { "en-us": { "role": { "label": "Accrued liabilities", "totalLabel": "Total", "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r30" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Exercisable, aggregate intrinsic value", "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable." } } }, "auth_ref": [ "r61" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r613" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r385", "r396" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EquityComponentDomain", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r17", "r150", "r174", "r175", "r176", "r186", "r187", "r188", "r190", "r196", "r198", "r210", "r234", "r235", "r286", "r349", "r350", "r351", "r354", "r355", "r364", "r365", "r366", "r367", "r368", "r369", "r371", "r379", "r380", "r381", "r382", "r383", "r384", "r388", "r443", "r444", "r445", "r459", "r525" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r4", "r16", "r35", "r365", "r368", "r388", "r443", "r444", "r628", "r629", "r630", "r637", "r638", "r639" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockParOrStatedValuePerShare", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "Preferred Stock, Par or Stated Value Per Share (in dollars per share)", "terseLabel": "Preferred Stock, Par or Stated Value Per Share", "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer." } } }, "auth_ref": [ "r89", "r271" ] }, "us-gaap_SubsidiarySaleOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SubsidiarySaleOfStockAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-8-warrants", "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "Sale of Stock [Axis]", "documentation": "Information by type of sale of the entity's stock." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_TrademarksAndTradeNamesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksAndTradeNamesMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "Trademarks and Trade Names [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof." } } }, "auth_ref": [ "r72" ] }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueNewIssues", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Convertible preferred stock issued, net of offering costs", "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering." } } }, "auth_ref": [ "r17", "r89", "r90", "r127", "r459", "r525", "r548", "r610" ] }, "us-gaap_ConvertiblePreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConvertiblePreferredStockMember", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Convertible Preferred Stock [Member]", "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option." } } }, "auth_ref": [ "r271", "r272", "r275", "r605", "r606", "r607", "r608" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs" ], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r148", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r301" ] }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTypeOfDeferredCompensationAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual" ], "lang": { "en-us": { "role": { "label": "Deferred Bonus and Profit Sharing Arrangements, Individual Contracts, Type of Deferred Compensation [Axis]", "documentation": "Information by type of deferred compensation that is not equivalent to a defined benefit pension plan or a defined benefit other postretirement benefit plan. Includes, but is not limited to, employment contracts with one or more selected officers or key employees. Excludes equity-based compensation plans, defined benefit pension plans and defined benefit other postretirement benefit plans." } } }, "auth_ref": [ "r59", "r128" ] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_AssetsCurrent", "totalLabel": "Total current assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r152", "r166", "r185", "r233", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r360", "r362", "r378", "r598", "r662", "r663", "r702" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_GrossProfit", "totalLabel": "Gross profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r102", "r185", "r213", "r219", "r223", "r225", "r233", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r378", "r579", "r662" ] }, "us-gaap_AssetsCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AssetsCurrentAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Current assets:" } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired", "negatedLabel": "Net cash paid for acquisition of Intrensic", "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase." } } }, "auth_ref": [ "r38" ] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_LiabilitiesAndStockholdersEquity", "totalLabel": "Total liabilities and stockholders' equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r95", "r137", "r430", "r598", "r635", "r642", "r698" ] }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueAcquisitions", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock for acquisition", "documentation": "Value of stock issued pursuant to acquisitions during the period." } } }, "auth_ref": [ "r17", "r33", "r127" ] }, "us-gaap_OperatingExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpenses", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_OperatingExpenses", "totalLabel": "Total operating expenses", "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_AdditionalPaidInCapital": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdditionalPaidInCapital", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Additional paid-in capital", "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock." } } }, "auth_ref": [ "r91", "r598", "r715" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_EntityAddressCityOrTown", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Common shares issued upon exercise of stock options", "documentation": "Value of stock issued as a result of the exercise of stock options." } } }, "auth_ref": [ "r17", "r33", "r127" ] }, "us-gaap_FurnitureAndFixturesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FurnitureAndFixturesMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Furniture and Fixtures [Member]", "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases." } } }, "auth_ref": [] }, "us-gaap_OperatingExpensesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OperatingExpensesAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "Operating expenses:" } } }, "auth_ref": [] }, "us-gaap_FinancialLiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialLiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_FinancialLiabilitiesFairValueDisclosure", "periodStartLabel": "Fair value", "periodEndLabel": "Fair value", "documentation": "Fair value of financial obligations, including, but not limited to, debt instruments, derivative liabilities, federal funds purchased and sold under agreements to repurchase, securities loaned or sold under agreements to repurchase, financial instruments sold not yet purchased, guarantees, line of credit, loans and notes payable, servicing liability, and trading liabilities." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_EntityAddressStateOrProvince", "terseLabel": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "us-gaap_RoyaltyExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RoyaltyExpense", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_RoyaltyExpense", "terseLabel": "Royalty Expense", "documentation": "Amount of expense related to royalty payments under a contractual arrangement such as payment for mineral and drilling rights and use of technology or intellectual property." } } }, "auth_ref": [ "r104" ] }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesNewIssues", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "Convertible preferred stock issued, net of offering costs (in shares)", "terseLabel": "Stock Issued During Period, Shares, New Issues", "documentation": "Number of new stock issued during the period." } } }, "auth_ref": [ "r17", "r89", "r90", "r127", "r451", "r525", "r548" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeStockOptionMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_EntityAddressPostalZipCode", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r269", "r304", "r309", "r375", "r398", "r588", "r589", "r590" ] }, "us-gaap_FinancialInstrumentsOwnedAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FinancialInstrumentsOwnedAtFairValue", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details" ], "lang": { "en-us": { "role": { "label": "Market Value", "documentation": "The aggregate fair value as of the balance sheet date of financial instruments and other positions owned by the entity including: (1) mortgages, mortgage-backed and asset backed securities; (2) US government and agency obligations; (3) state and municipal government obligations; (4) other sovereign government debt; (5) corporate obligations; (6) corporate equities; (7) principal investments; (8) derivative contracts; and (9) physical commodities. Includes both pledged and unpledged holdings." } } }, "auth_ref": [ "r81" ] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerShareBasic", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "Net loss per basic and diluted common share (in dollars per share)", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r179", "r191", "r192", "r193", "r194", "r195", "r199", "r201", "r205", "r206", "r207", "r209", "r372", "r373", "r421", "r435", "r577" ] }, "us-gaap_PreferredStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockValue", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Preferred stock", "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r89", "r426", "r598" ] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details" ], "lang": { "en-us": { "role": { "label": "Accrued compensation", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r30" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details" ], "lang": { "en-us": { "role": { "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r269", "r304", "r305", "r306", "r307", "r308", "r309", "r375", "r400", "r582", "r583", "r588", "r589", "r590" ] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_LiabilitiesCurrent", "totalLabel": "Total current liabilities", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r31", "r153", "r185", "r233", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r361", "r362", "r363", "r378", "r598", "r662", "r702", "r703" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r208" ] }, "us-gaap_Dividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Dividends", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_Dividends", "negatedLabel": "Dividends on convertible preferred stock", "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind (PIK) dividends declared, for example, but not limited to, common and preferred stock." } } }, "auth_ref": [ "r7", "r127" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_CityAreaCode", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesAcquisitions", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Issuance of common stock for acquisition (in shares)", "documentation": "Number of shares of stock issued during the period pursuant to acquisitions." } } }, "auth_ref": [ "r89", "r90", "r127" ] }, "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "calculation": { "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "totalLabel": "Total assets", "documentation": "Amount of assets including goodwill acquired at the acquisition date." } } }, "auth_ref": [] }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "WarrantsAndRightsOutstandingTerm", "presentation": [ "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_WarrantsAndRightsOutstandingTerm", "terseLabel": "Warrants and Rights Outstanding, Term", "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r697" ] }, "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquity", "calculation": { "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAndEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedEquity", "terseLabel": "Equity", "documentation": "Amount of equity assumed at the acquisition date." } } }, "auth_ref": [] }, "us-gaap_TrademarksMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "TrademarksMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "Trademarks [Member]", "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style." } } }, "auth_ref": [ "r72" ] }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Common shares issued upon exercise of stock options (in shares)", "negatedLabel": "Options on Common Shares, Exercised (in shares)", "documentation": "Number of share options (or share units) exercised during the current period." } } }, "auth_ref": [ "r17", "r89", "r90", "r127", "r326" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_LocalPhoneNumber", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities" ], "lang": { "en-us": { "role": { "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]", "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period." } } }, "auth_ref": [ "r28" ] }, "wrap_CommissionsPayableMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "CommissionsPayableMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual" ], "lang": { "en-us": { "role": { "label": "Commissions Payable [Member]", "documentation": "Represents commissions payable." } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details-textual" ], "lang": { "en-us": { "role": { "verboseLabel": "Net unrealized gain (loss) on short-term investments", "label": "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax", "terseLabel": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax", "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale." } } }, "auth_ref": [ "r167", "r168", "r232" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents", "terseLabel": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions, acquired at the acquisition date. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "auth_ref": [ "r71" ] }, "wrap_ChangeInUnrealizedGainOnShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "ChangeInUnrealizedGainOnShortTermInvestments", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Change in unrealized gain on short-term investments", "documentation": "Represents the amount of change in unrealized gain on short-term investments." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesCurrentAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Current liabilities:" } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "terseLabel": "Intangible assets", "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date." } } }, "auth_ref": [ "r71" ] }, "us-gaap_ShortTermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShortTermInvestments", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Short-term investments", "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current." } } }, "auth_ref": [ "r138", "r139", "r626" ] }, "wrap_CurrentLiabilitiesCustomerDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "CurrentLiabilitiesCustomerDeposits", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Customer deposits", "documentation": "Represents the amount of customer deposits included in current liabilities as of the specified date." } } }, "auth_ref": [] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "terseLabel": "Accounts receivable", "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date." } } }, "auth_ref": [ "r71" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAndEquity", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities", "terseLabel": "Liabilities", "documentation": "Amount of liabilities assumed at the acquisition date." } } }, "auth_ref": [ "r71" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r45", "r47", "r78", "r79", "r229", "r554" ] }, "wrap_CustomerDepositsMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "CustomerDepositsMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details" ], "lang": { "en-us": { "role": { "label": "Customer Deposits [Member]", "documentation": "Represents customer deposits." } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpenseAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "Other income (expense):" } } }, "auth_ref": [] }, "wrap_ContractWithCustomerLiabilityAddition": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "ContractWithCustomerLiabilityAddition", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-contract-liabilities-details" ], "lang": { "en-us": { "role": { "label": "Additions, net", "documentation": "Amount of addition to contract with customer liability." } } }, "auth_ref": [] }, "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAndEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAndEquity", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesAndEquity", "totalLabel": "Total liabilities and equity", "documentation": "Amount of equity and liabilities assumed at the acquisition date." } } }, "auth_ref": [] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r45", "r47", "r78", "r79", "r229", "r449", "r554" ] }, "wrap_ChiefExecutiveOfficerAndPresidentMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "ChiefExecutiveOfficerAndPresidentMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer and President [Member]", "documentation": "Represents the CEO and president." } } }, "auth_ref": [] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Accounts receivable and contract assets, net", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r230", "r231" ] }, "wrap_ConsultingFeesToRelatedPartyMonthlyAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "ConsultingFeesToRelatedPartyMonthlyAmount", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual" ], "lang": { "en-us": { "role": { "label": "wrap_ConsultingFeesToRelatedPartyMonthlyAmount", "terseLabel": "Consulting Fees to Related Party, Monthly Amount", "documentation": "The amount of monthly consulting fees paid to a related party during the reporting period." } } }, "auth_ref": [] }, "us-gaap_NonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_NonoperatingIncomeExpense", "totalLabel": "Total other income (expense)", "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business)." } } }, "auth_ref": [ "r107" ] }, "wrap_ConsultantMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "ConsultantMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual" ], "lang": { "en-us": { "role": { "label": "Consultant [Member]", "documentation": "Represents information related to the Company's consultant." } } }, "auth_ref": [] }, "us-gaap_EarningsPerSharePolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EarningsPerSharePolicyTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Earnings Per Share, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements." } } }, "auth_ref": [ "r43", "r44" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details" ], "lang": { "en-us": { "role": { "label": "2025", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r121" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details" ], "lang": { "en-us": { "role": { "label": "Weighted-average fair value of options granted (in dollars per share)", "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology." } } }, "auth_ref": [ "r335" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "periodStartLabel": "Outstanding, weighted average exercise price (in dollars per share)", "periodEndLabel": "Outstanding, weighted average exercise price (in dollars per share)", "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan." } } }, "auth_ref": [ "r321", "r322" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Outstanding, remaining contractual term (Year)", "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r129" ] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "UseOfEstimates", "presentation": [ "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r48", "r49", "r50", "r141", "r142", "r144", "r145" ] }, "us-gaap_SeriesAPreferredStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SeriesAPreferredStockMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-13-related-party-transactions", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "Series A Preferred Stock [Member]", "documentation": "Series A preferred stock." } } }, "auth_ref": [ "r624", "r625", "r665" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details" ], "lang": { "en-us": { "role": { "label": "2024", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r121" ] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NoncashInvestingAndFinancingItemsAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Supplemental Disclosure of Non-Cash Investing and Financing Activities:" } } }, "auth_ref": [] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details" ], "lang": { "en-us": { "role": { "label": "2026", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r121" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodStartLabel": "Options on Common Shares, Outstanding (in shares)", "periodEndLabel": "Options on Common Shares, Outstanding (in shares)", "documentation": "Number of options outstanding, including both vested and non-vested options." } } }, "auth_ref": [ "r321", "r322" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details" ], "lang": { "en-us": { "role": { "label": "Awards other than options, forfeited and cancelled, weighted average grant date fair value (in dollars per share)", "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event." } } }, "auth_ref": [ "r334" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details" ], "lang": { "en-us": { "role": { "label": "2027", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r121" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory", "terseLabel": "Inventory", "documentation": "The amount of inventory recognized as of the acquisition date." } } }, "auth_ref": [ "r70", "r71" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Options on Common Shares, Exercisable (in shares)", "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan." } } }, "auth_ref": [ "r323" ] }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment", "terseLabel": "Net property, plant and equipment", "documentation": "The amount of property, plant, and equipment recognized as of the acquisition date." } } }, "auth_ref": [ "r70", "r71" ] }, "us-gaap_ConsolidationPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ConsolidationPolicyTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Consolidation, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary." } } }, "auth_ref": [ "r75", "r576" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Exercisable, weighted average exercise price (in dollars per share)", "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan." } } }, "auth_ref": [ "r323" ] }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IntangibleAssetsNetExcludingGoodwill", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 0.0 }, "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "Intangible assets, net", "totalLabel": "Total intangible assets, net", "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges." } } }, "auth_ref": [ "r51", "r54" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Cash and cash equivalents", "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation." } } }, "auth_ref": [ "r39", "r154", "r571" ] }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details" ], "lang": { "en-us": { "role": { "label": "2023 (9 months)", "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year." } } }, "auth_ref": [] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r315", "r317", "r345", "r346", "r348", "r595" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate", "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term." } } }, "auth_ref": [ "r341" ] }, "us-gaap_FairValueByAssetClassAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByAssetClassAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details" ], "lang": { "en-us": { "role": { "label": "Asset Class [Axis]", "documentation": "Information by class of asset." } } }, "auth_ref": [ "r76", "r77" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details" ], "lang": { "en-us": { "role": { "label": "Expected stock price volatility", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate", "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period." } } }, "auth_ref": [ "r340" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-details", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details" ], "lang": { "en-us": { "role": { "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r269", "r304", "r305", "r306", "r307", "r308", "r309", "r375", "r398", "r399", "r400", "r582", "r583", "r588", "r589", "r590" ] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details" ], "lang": { "en-us": { "role": { "label": "Risk-free interest rate", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares." } } }, "auth_ref": [ "r342" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_DocumentType", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details", "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r318", "r319", "r320", "r321", "r322", "r323", "r324", "r325", "r326", "r327", "r328", "r329", "r330", "r331", "r332", "r333", "r334", "r335", "r336", "r337", "r338", "r339", "r340", "r341", "r342", "r343" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Assets", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_Assets", "totalLabel": "Total assets", "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events." } } }, "auth_ref": [ "r136", "r160", "r185", "r213", "r220", "r224", "r233", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r360", "r362", "r378", "r424", "r496", "r598", "r611", "r662", "r663", "r702" ] }, "us-gaap_StockIssued1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StockIssued1", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_StockIssued1", "negatedLabel": "Issuance of common stock for acquisition", "documentation": "The fair value of stock issued in noncash financing activities." } } }, "auth_ref": [ "r40", "r41", "r42" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 0.0 }, "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_FiniteLivedIntangibleAssetsNet", "totalLabel": "Total amortizable", "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r120", "r404" ] }, "us-gaap_PreferredStockConvertibleConversionPrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockConvertibleConversionPrice", "presentation": [ "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_PreferredStockConvertibleConversionPrice", "terseLabel": "Preferred Stock, Convertible, Conversion Price", "documentation": "Per share conversion price of preferred stock." } } }, "auth_ref": [ "r273" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_DocumentQuarterlyReport", "terseLabel": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r615" ] }, "us-gaap_PreferredStockConvertibleSharesIssuable": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockConvertibleSharesIssuable", "presentation": [ "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_PreferredStockConvertibleSharesIssuable", "terseLabel": "Preferred Stock, Convertible, Shares Issuable", "documentation": "Number of common shares issuable upon conversion of preferred stock." } } }, "auth_ref": [ "r273" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 }, "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": "wrap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsIncludingGoodwill", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-schedule-of-goodwill-details" ], "lang": { "en-us": { "role": { "label": "Goodwill, net", "terseLabel": "Goodwill", "periodStartLabel": "Balance", "periodEndLabel": "Balance", "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized." } } }, "auth_ref": [ "r157", "r239", "r419", "r581", "r598", "r644", "r651" ] }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FiniteLivedIntangibleAssetsGross", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details": { "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "Amortizable intangible assets, gross", "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life." } } }, "auth_ref": [ "r120", "r405" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_DocumentTransitionReport", "terseLabel": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r616" ] }, "us-gaap_PreferredStockDividendsIncomeStatementImpact": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendsIncomeStatementImpact", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_PreferredStockDividendsIncomeStatementImpact", "negatedLabel": "Less: Convertible preferred stock dividends", "documentation": "The amount of preferred stock dividends that is an adjustment to net income apportioned to common stockholders." } } }, "auth_ref": [] }, "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details": { "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "Indefinite life assets (non-amortizable)", "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit." } } }, "auth_ref": [ "r122" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Prepaid expense and other current assets", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r627" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_EntityInteractiveDataCurrent", "terseLabel": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r617" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Product Warranty Liability [Table Text Block]", "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability." } } }, "auth_ref": [ "r255" ] }, "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Accrued Liabilities [Table Text Block]", "documentation": "Tabular disclosure of the components of accrued liabilities." } } }, "auth_ref": [] }, "wrap_AccruedPatentAndLegalCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "AccruedPatentAndLegalCosts", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details": { "parentTag": "us-gaap_AccruedLiabilitiesCurrent", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details" ], "lang": { "en-us": { "role": { "label": "Patent and legal costs", "documentation": "Represents the amount of accrued patent and legal costs as of the specified date." } } }, "auth_ref": [] }, "us-gaap_PaymentsForOtherDeposits": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsForOtherDeposits", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_PaymentsForOtherDeposits", "negatedLabel": "Cash outlay for deposits", "documentation": "Amount of cash outflow for deposits classified as other." } } }, "auth_ref": [ "r632" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details", "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_ComprehensiveIncomeNetOfTax", "totalLabel": "Comprehensive loss", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r36", "r171", "r173", "r178", "r420", "r434" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Exercisable, remaining contractual term (Year)", "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r61" ] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details" ], "lang": { "en-us": { "role": { "label": "Expected life of options (Year)", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r339" ] }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions", "terseLabel": "Share-Based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount", "documentation": "Amount of cost to be recognized for option under share-based payment arrangement." } } }, "auth_ref": [ "r694" ] }, "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfInventoryCurrentTableTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-4-inventories-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Inventory, Current [Table Text Block]", "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process." } } }, "auth_ref": [ "r26", "r96", "r97", "r98" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies" ], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r125", "r248", "r249", "r555", "r657" ] }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfWarrants", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ProceedsFromIssuanceOfWarrants", "terseLabel": "Proceeds from Issuance of Warrants", "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Proceeds from maturities of short-term investments", "documentation": "The cash inflow from maturities, prepayments, calls and collections of all investments, including securities and other assets, having ready marketability and intended by management to be liquidated, if necessary, within the current operating cycle. Includes cash flows from securities classified as trading securities that were acquired for reasons other than sale in the short-term." } } }, "auth_ref": [ "r37", "r109" ] }, "us-gaap_ClassOfWarrantOrRightAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-8-warrants", "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Axis]", "documentation": "Information by type of warrant or right issued." } } }, "auth_ref": [ "r60" ] }, "wrap_statement-statement-note-7-accounts-payable-and-accrued-liabilities-changes-in-product-warranty-costs-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-7-accounts-payable-and-accrued-liabilities-changes-in-product-warranty-costs-details", "lang": { "en-us": { "role": { "label": "Note 7 - Accounts Payable and Accrued Liabilities - Changes in Product Warranty Costs (Details)" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInInventories": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInInventories", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_IncreaseDecreaseInInventories", "negatedLabel": "Inventories", "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities." } } }, "auth_ref": [ "r8" ] }, "us-gaap_SellingGeneralAndAdministrativeExpensesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SellingGeneralAndAdministrativeExpensesMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-allocation-of-sharebased-compensation-expense-details" ], "lang": { "en-us": { "role": { "label": "Selling, General and Administrative Expenses [Member]", "documentation": "Primary financial statement caption encompassing selling, general and administrative expense." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionAmountsOfTransaction": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionAmountsOfTransaction", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_RelatedPartyTransactionAmountsOfTransaction", "terseLabel": "Related Party Transaction, Amounts of Transaction", "documentation": "Amount of transactions with related party during the financial reporting period." } } }, "auth_ref": [ "r80", "r392" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments-tables" ], "lang": { "en-us": { "role": { "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]", "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset." } } }, "auth_ref": [ "r76", "r135" ] }, "wrap_statement-statement-note-7-accounts-payable-and-accrued-liabilities-tables": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-7-accounts-payable-and-accrued-liabilities-tables", "lang": { "en-us": { "role": { "label": "Note 7 - Accounts Payable and Accrued Liabilities" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 0.0 }, "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited", "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "verboseLabel": "Net loss for the period", "label": "Net loss", "totalLabel": "Net loss", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r100", "r113", "r140", "r151", "r170", "r172", "r176", "r185", "r189", "r191", "r192", "r193", "r194", "r197", "r198", "r203", "r213", "r219", "r223", "r225", "r233", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r373", "r378", "r433", "r504", "r523", "r524", "r579", "r609", "r662" ] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "us-gaap_LiabilitiesNoncurrentAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrentAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Long-term liabilities:" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments" ], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r374" ] }, "wrap_statement-statement-significant-accounting-policies-policies": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-significant-accounting-policies-policies", "lang": { "en-us": { "role": { "label": "Significant Accounting Policies" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "NetIncomeLossAvailableToCommonStockholdersBasic", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic", "totalLabel": "Net loss attributable to common stockholders", "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders." } } }, "auth_ref": [ "r181", "r191", "r192", "r193", "r194", "r199", "r200", "r204", "r207", "r213", "r219", "r223", "r225", "r579" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "RelatedPartyTransactionsDisclosureTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-13-related-party-transactions" ], "lang": { "en-us": { "role": { "label": "Related Party Transactions Disclosure [Text Block]", "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates." } } }, "auth_ref": [ "r389", "r390", "r391", "r393", "r394", "r456", "r457", "r458", "r508", "r509", "r510", "r530", "r532" ] }, "us-gaap_PreferredStockDividendRatePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PreferredStockDividendRatePercentage", "presentation": [ "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_PreferredStockDividendRatePercentage", "terseLabel": "Preferred Stock, Dividend Rate, Percentage", "documentation": "The percentage rate used to calculate dividend payments on preferred stock." } } }, "auth_ref": [ "r272", "r535", "r538", "r540", "r545" ] }, "us-gaap_ComprehensiveIncomeNetOfTaxAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ComprehensiveIncomeNetOfTaxAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-operations-and-comprehensive-loss-unaudited" ], "lang": { "en-us": { "role": { "label": "Comprehensive loss:" } } }, "auth_ref": [] }, "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AccountingPoliciesAbstract", "presentation": [ "http://wrap.com/20230930/role/statement-significant-accounting-policies-policies" ], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment." } } }, "auth_ref": [ "r53", "r55" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Granted, weighted average exercise price (in dollars per share)", "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options." } } }, "auth_ref": [ "r325" ] }, "us-gaap_BusinessCombinationConsiderationTransferredLiabilitiesIncurred": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferredLiabilitiesIncurred", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "Liabilities assumed", "documentation": "Amount of liabilities incurred by the acquirer as part of consideration transferred in a business combination." } } }, "auth_ref": [ "r1", "r2", "r74", "r359" ] }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "terseLabel": "Equity", "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination." } } }, "auth_ref": [ "r1", "r2" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Exercised, weighted average exercise price (in dollars per share)", "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares." } } }, "auth_ref": [ "r326" ] }, "us-gaap_LiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_LiabilitiesNoncurrent", "totalLabel": "Total long-term liabilities", "documentation": "Amount of obligation due after one year or beyond the normal operating cycle, if longer." } } }, "auth_ref": [ "r25", "r85", "r86", "r87", "r88", "r185", "r233", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r361", "r362", "r363", "r378", "r662", "r702", "r703" ] }, "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOfConvertiblePreferredStock", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ProceedsFromIssuanceOfConvertiblePreferredStock", "terseLabel": "Proceeds from Issuance of Convertible Preferred Stock", "documentation": "The cash inflow from issuance of preferred stocks identified as being convertible into another form of financial instrument, typically the entity's common stock." } } }, "auth_ref": [ "r5" ] }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ProceedsFromIssuanceOrSaleOfEquity", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ProceedsFromIssuanceOrSaleOfEquity", "terseLabel": "Proceeds from Issuance or Sale of Equity", "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity." } } }, "auth_ref": [ "r5", "r451" ] }, "us-gaap_SharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "SharesOutstanding", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "us-gaap_SharesOutstanding", "periodStartLabel": "Balance (in shares)", "periodEndLabel": "Balance (in shares)", "documentation": "Number of shares issued which are neither cancelled nor held in the treasury." } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LeaseContractualTermDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseContractualTermDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Lease Contractual Term [Domain]", "documentation": "Contractual term of lease arrangement." } } }, "auth_ref": [ "r621" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_ClassOfWarrantOrRightDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ClassOfWarrantOrRightDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-8-warrants", "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Class of Warrant or Right [Domain]", "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "auth_ref": [] }, "us-gaap_Depreciation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "Depreciation", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_Depreciation", "terseLabel": "Depreciation", "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation." } } }, "auth_ref": [ "r9", "r57" ] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_DocumentPeriodEndDate", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesIssued", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "lang": { "en-us": { "role": { "label": "Common stock, shares issued (in shares)", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r90" ] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PerformanceSharesMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [] }, "us-gaap_LeaseContractualTermAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LeaseContractualTermAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events", "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "Lease Contractual Term [Axis]", "documentation": "Information by contractual term of lease arrangement." } } }, "auth_ref": [ "r621" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod", "negatedLabel": "Options on Common Shares, Forfeited, cancelled, expired (in shares)", "documentation": "For presentations that combine terminations, the number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan or that expired." } } }, "auth_ref": [ "r674" ] }, "us-gaap_CommonStockValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockValue", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited" ], "lang": { "en-us": { "role": { "label": "Common stock - 150,000,000 authorized; par value $0.0001 per share; 43,289,236 and 41,175,993 shares issued and outstanding at September 30, 2023 and December 31, 2022, respectively", "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity." } } }, "auth_ref": [ "r90", "r427", "r598" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Forfeited, cancelled, expired, weighted average exercise price (in dollars per share)", "documentation": "Weighted average price of options that were either forfeited or expired." } } }, "auth_ref": [ "r674" ] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals", "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "Common stock, shares authorized (in shares)", "terseLabel": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r90", "r484" ] }, "us-gaap_OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Settlement \u2013 US Treasury bills", "documentation": "Amount before tax of reclassification adjustment from accumulated other comprehensive income for unrealized gain (loss) realized upon the sale of available-for-sale securities." } } }, "auth_ref": [ "r6", "r99", "r169", "r232" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-balance-sheets-current-period-unaudited-parentheticals" ], "lang": { "en-us": { "role": { "label": "Common Stock, Shares, Outstanding (in shares)", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r17", "r90", "r484", "r502", "r716", "r717" ] }, "us-gaap_ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfNonvestedRestrictedStockUnitsActivityTableTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Nonvested Restricted Stock Units Activity [Table Text Block]", "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock units." } } }, "auth_ref": [ "r63" ] }, "us-gaap_DepreciationDepletionAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DepreciationDepletionAndAmortization", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Depreciation and amortization", "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets." } } }, "auth_ref": [ "r9", "r217" ] }, "us-gaap_AreaOfRealEstateProperty": { "xbrltype": "areaItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AreaOfRealEstateProperty", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_AreaOfRealEstateProperty", "terseLabel": "Area of Real Estate Property", "documentation": "Area of a real estate property." } } }, "auth_ref": [] }, "us-gaap_CertificatesOfDepositMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "CertificatesOfDepositMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details" ], "lang": { "en-us": { "role": { "label": "Certificates of Deposit [Member]", "documentation": "Short to medium-term investment available at banks and savings and loan institutions where a customer agrees to lend money to the institution for a certain amount of time and is paid a predetermined rate of interest. Certificates of deposit (CD) are typically Federal Deposit Insurance Corporation (FDIC) insured." } } }, "auth_ref": [ "r14", "r605", "r606", "r607", "r608" ] }, "srt_AmericasMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AmericasMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details" ], "lang": { "en-us": { "role": { "label": "Americas [Member]" } } }, "auth_ref": [ "r718", "r719", "r720", "r721" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Share-based compensation expense", "negatedLabel": "Share-based compensation expense", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r64", "r65", "r316" ] }, "us-gaap_DividendsPayableAmountPerShare": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DividendsPayableAmountPerShare", "presentation": [ "http://wrap.com/20230930/role/statement-note-9-stockholders-equity-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_DividendsPayableAmountPerShare", "terseLabel": "Dividends Payable, Amount Per Share (in dollars per share)", "documentation": "The per share amount of a dividend declared, but not paid, as of the financial reporting date." } } }, "auth_ref": [ "r40" ] }, "srt_AsiaPacificMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "AsiaPacificMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details" ], "lang": { "en-us": { "role": { "label": "Asia Pacific [Member]" } } }, "auth_ref": [ "r718", "r719", "r720", "r721" ] }, "wrap_StockIssuedDuringPeriodValueRestrictedStockUnitsVested": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "StockIssuedDuringPeriodValueRestrictedStockUnitsVested", "crdr": "credit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-stockholders-equity-unaudited" ], "lang": { "en-us": { "role": { "label": "Common shares issued upon vesting of restricted stock units", "documentation": "Represents the value of restricted stock units vested during the period." } } }, "auth_ref": [] }, "srt_StatementGeographicalAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "StatementGeographicalAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details" ], "lang": { "en-us": { "role": { "label": "Geographical [Axis]" } } }, "auth_ref": [ "r227", "r228", "r471", "r472", "r473", "r536", "r539", "r543", "r546", "r553", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r569", "r586", "r603", "r667", "r712" ] }, "wrap_ToolingMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "ToolingMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net", "http://wrap.com/20230930/role/statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details" ], "lang": { "en-us": { "role": { "label": "Tooling [Member]", "documentation": "Represents information regarding tooling." } } }, "auth_ref": [] }, "us-gaap_PaymentsToAcquireBusinessesGross": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PaymentsToAcquireBusinessesGross", "crdr": "credit", "calculation": { "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details": { "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0, "order": 0.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-note-1-organization-summary-of-significant-accounting-policies-and-recent-developments-details-textual", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual", "http://wrap.com/20230930/role/statement-note-13-related-party-transactions-details-textual", "http://wrap.com/20230930/role/statement-note-15-business-combination-schedule-of-business-combination-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_PaymentsToAcquireBusinessesGross", "terseLabel": "Payments to Acquire Businesses, Gross", "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price." } } }, "auth_ref": [ "r38", "r358" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable." } } }, "auth_ref": [ "r61" ] }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-tables" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value." } } }, "auth_ref": [ "r20", "r21", "r62" ] }, "wrap_VirtualRealityTrainingMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "VirtualRealityTrainingMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-details-textual" ], "lang": { "en-us": { "role": { "label": "Virtual Reality Training [Member]", "documentation": "Represents information regarding virtual reality training." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]", "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions." } } }, "auth_ref": [ "r130" ] }, "us-gaap_MeasurementInputTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "MeasurementInputTypeAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-fair-value-assumptions-details" ], "lang": { "en-us": { "role": { "label": "Measurement Input Type [Axis]", "documentation": "Information by type of measurement input used to determine value of asset and liability." } } }, "auth_ref": [ "r376" ] }, "wrap_statement-statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details", "lang": { "en-us": { "role": { "label": "Note 10 - Share-based Compensation - Summary of Stock Option Activity (Details)" } } }, "auth_ref": [] }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments-tables" ], "lang": { "en-us": { "role": { "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]", "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis." } } }, "auth_ref": [ "r18" ] }, "wrap_statement-statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-6-intangible-assets-and-goodwill-future-amortization-expense-details", "lang": { "en-us": { "role": { "label": "Note 6 - Intangible Assets and Goodwill - Future Amortization Expense (Details)" } } }, "auth_ref": [] }, "us-gaap_GoodwillAcquiredDuringPeriod": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "GoodwillAcquiredDuringPeriod", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-schedule-of-goodwill-details" ], "lang": { "en-us": { "role": { "label": "Acquired goodwill", "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination." } } }, "auth_ref": [ "r240", "r581" ] }, "wrap_statement-statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details", "lang": { "en-us": { "role": { "label": "Note 6 - Intangible Assets and Goodwill - Summary of Intangible Assets (Details)" } } }, "auth_ref": [] }, "wrap_statement-statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-7-accounts-payable-and-accrued-expenses-summary-of-accrued-liabilities-details", "lang": { "en-us": { "role": { "label": "Note 7 - Accounts Payable and Accrued Expenses - Summary of Accrued Liabilities (Details)" } } }, "auth_ref": [] }, "wrap_SyzygyLicensingLLCMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "SyzygyLicensingLLCMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies", "http://wrap.com/20230930/role/statement-note-12-commitments-and-contingencies-details-textual", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities", "http://wrap.com/20230930/role/statement-note-7-accounts-payable-and-accrued-liabilities-details-textual" ], "lang": { "en-us": { "role": { "label": "Syzygy Licensing LLC [Member]", "documentation": "Represents information regarding Syzygy Licensing LLC." } } }, "auth_ref": [] }, "wrap_statement-statement-note-6-intangible-assets-and-goodwill-tables": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-6-intangible-assets-and-goodwill-tables", "lang": { "en-us": { "role": { "label": "Note 6 - Intangible Assets and Goodwill" } } }, "auth_ref": [] }, "srt_SegmentGeographicalDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "SegmentGeographicalDomain", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details" ], "lang": { "en-us": { "role": { "label": "Geographical [Domain]" } } }, "auth_ref": [ "r227", "r228", "r471", "r472", "r473", "r536", "r539", "r543", "r546", "r556", "r557", "r558", "r559", "r560", "r561", "r562", "r563", "r564", "r569", "r586", "r603", "r667", "r712" ] }, "wrap_The2017StockIncentivePlanMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "The2017StockIncentivePlanMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "The 2017 Stock Incentive Plan [Member]", "documentation": "Represents information regarding the 2017 Stock Incentive Plan." } } }, "auth_ref": [] }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "LesseeOperatingLeaseTermOfContract", "presentation": [ "http://wrap.com/20230930/role/statement-note-16-subsequent-events-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_LesseeOperatingLeaseTermOfContract", "terseLabel": "Lessee, Operating Lease, Term of Contract (Month)", "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r699" ] }, "wrap_statement-statement-note-10-sharebased-compensation-tables": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-10-sharebased-compensation-tables", "lang": { "en-us": { "role": { "label": "Note 10 - Share-based Compensation" } } }, "auth_ref": [] }, "wrap_TrainingMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "TrainingMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs", "http://wrap.com/20230930/role/statement-note-2-revenue-and-product-costs-details-textual" ], "lang": { "en-us": { "role": { "label": "Training [Member]", "documentation": "Relating to training." } } }, "auth_ref": [] }, "wrap_statement-statement-note-6-intangible-assets-and-goodwill-schedule-of-goodwill-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-6-intangible-assets-and-goodwill-schedule-of-goodwill-details", "lang": { "en-us": { "role": { "label": "Note 6 - Intangible Assets and Goodwill - Schedule of Goodwill (Details)" } } }, "auth_ref": [] }, "wrap_statement-statement-note-5-property-and-equipment-net-tables": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-5-property-and-equipment-net-tables", "lang": { "en-us": { "role": { "label": "Note 5 - Property and Equipment, Net" } } }, "auth_ref": [] }, "wrap_USTreasurySecuritiesInShortTermInvestmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "USTreasurySecuritiesInShortTermInvestmentsMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-3-financial-instruments", "http://wrap.com/20230930/role/statement-note-3-financial-instruments-instruments-by-significant-investment-category-details" ], "lang": { "en-us": { "role": { "label": "US Treasury Securities in Short-term Investments [Member]", "documentation": "Represents information regarding US Treasury securities in short-term investments." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationAwardTrancheOneMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheOneMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Tranche One [Member]", "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod", "negatedLabel": "Awards other than options, Forfeited and cancelled (in shares)", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period." } } }, "auth_ref": [ "r334" ] }, "wrap_WarrantLiabilitiesIssued": { "xbrltype": "monetaryItemType", "nsuri": "http://wrap.com/20230930", "localname": "WarrantLiabilitiesIssued", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Warrant liabilities", "documentation": "Represents the amount of warrant liabilities issued." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details" ], "lang": { "en-us": { "role": { "label": "Awards other than options, Granted (in shares)", "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r332" ] }, "us-gaap_DefinedBenefitPlanContributionsByEmployer": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "DefinedBenefitPlanContributionsByEmployer", "crdr": "debit", "presentation": [ "http://wrap.com/20230930/role/statement-note-11-defined-contribution-plan-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_DefinedBenefitPlanContributionsByEmployer", "terseLabel": "Defined Benefit Plan, Plan Assets, Contributions by Employer", "documentation": "Amount of contribution received by defined benefit plan from employer which increases plan assets." } } }, "auth_ref": [ "r302", "r304", "r311", "r588", "r589", "r590", "r591" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details" ], "lang": { "en-us": { "role": { "label": "Awards other than options, granted, weighted average grant date fair value (in dollars per share)", "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)." } } }, "auth_ref": [ "r332" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber", "periodStartLabel": "Awards other than options, unvested, beginning balance (in shares)", "periodEndLabel": "Awards other than options, unvested, beginning balance (in shares)", "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date." } } }, "auth_ref": [ "r329", "r330" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue", "periodStartLabel": "Awards other than options, unvested, weighted average grant date fair value, beginning balance (in dollars per share)", "periodEndLabel": "Awards other than options, unvested, weighted average grant date fair value, beginning balance (in dollars per share)", "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options." } } }, "auth_ref": [ "r329", "r330" ] }, "us-gaap_PatentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "PatentsMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill", "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-summary-of-intangible-assets-details" ], "lang": { "en-us": { "role": { "label": "Patents [Member]", "documentation": "Exclusive legal right granted by the government to the owner of the patent to exploit an invention or a process for a period of time specified by law." } } }, "auth_ref": [ "r132" ] }, "us-gaap_ShareBasedCompensationAwardTrancheThreeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheThreeMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Tranche Three [Member]", "documentation": "Third portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "wrap_WarrantsIssuedInRegisteredDirectOfferingMember": { "xbrltype": "domainItemType", "nsuri": "http://wrap.com/20230930", "localname": "WarrantsIssuedInRegisteredDirectOfferingMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-8-warrants", "http://wrap.com/20230930/role/statement-note-8-warrants-details-textual" ], "lang": { "en-us": { "role": { "label": "Warrants Issued in Registered Direct Offering [Member]", "documentation": "Represents warrants issued in registered direct offering." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod", "negatedLabel": "Awards other than options, Vested (in shares)", "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period." } } }, "auth_ref": [ "r333" ] }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-6-intangible-assets-and-goodwill-tables" ], "lang": { "en-us": { "role": { "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]", "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets." } } }, "auth_ref": [ "r55" ] }, "wrap_statement-statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-10-sharebased-compensation-summary-of-stock-option-valuation-assumptions-details", "lang": { "en-us": { "role": { "label": "Note 10 - Share-based Compensation - Summary of Stock Option Valuation Assumptions (Details)" } } }, "auth_ref": [] }, "wrap_statement-statement-note-10-sharebased-compensation-allocation-of-sharebased-compensation-expense-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-10-sharebased-compensation-allocation-of-sharebased-compensation-expense-details", "lang": { "en-us": { "role": { "label": "Note 10 - Share-based Compensation - Allocation of Share-based Compensation Expense (Details)" } } }, "auth_ref": [] }, "wrap_WarrantsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://wrap.com/20230930", "localname": "WarrantsTextBlock", "presentation": [ "http://wrap.com/20230930/role/statement-note-8-warrants" ], "lang": { "en-us": { "role": { "label": "Warrants [Text Block]", "documentation": "Represents the entire disclosure regarding warrants." } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-rsu-activity-details" ], "lang": { "en-us": { "role": { "label": "Awards other than options, vested, weighted average grant date fair value (in dollars per share)", "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement." } } }, "auth_ref": [ "r333" ] }, "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "IncreaseDecreaseInOperatingLeaseLiability", "crdr": "debit", "calculation": { "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 11.0 } }, "presentation": [ "http://wrap.com/20230930/role/statement-condensed-consolidated-statements-of-cash-flows-unaudited" ], "lang": { "en-us": { "role": { "label": "Operating lease liability", "documentation": "Amount of increase (decrease) in obligation for operating lease." } } }, "auth_ref": [ "r622", "r633" ] }, "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationAwardTrancheTwoMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement, Tranche Two [Member]", "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period." } } }, "auth_ref": [] }, "wrap_statement-statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-14-major-customers-and-related-information-disaggregation-of-revenue-by-geographic-region-details", "lang": { "en-us": { "role": { "label": "Note 14 - Major Customers and Related Information - Disaggregation of Revenue by Geographic Region (Details)" } } }, "auth_ref": [] }, "wrap_statement-statement-note-15-business-combination-schedule-of-business-combination-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-15-business-combination-schedule-of-business-combination-details", "lang": { "en-us": { "role": { "label": "Note 15 - Business Combination - Schedule of Business Combination (Details)" } } }, "auth_ref": [] }, "wrap_statement-statement-note-10-sharebased-compensation-summary-of-rsu-activity-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-10-sharebased-compensation-summary-of-rsu-activity-details", "lang": { "en-us": { "role": { "label": "Note 10 - Share-based Compensation - Summary of RSU Activity (Details)" } } }, "auth_ref": [] }, "wrap_statement-statement-note-14-major-customers-and-related-information-tables": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-14-major-customers-and-related-information-tables", "lang": { "en-us": { "role": { "label": "Note 14 - Major Customers and Related Information" } } }, "auth_ref": [] }, "wrap_statement-statement-note-15-business-combination-tables": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-15-business-combination-tables", "lang": { "en-us": { "role": { "label": "Note 15 - Business Combination" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-summary-of-stock-option-activity-details" ], "lang": { "en-us": { "role": { "label": "Options on Common Shares, Granted (in shares)", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "documentation": "Gross number of share options (or share units) granted during the period." } } }, "auth_ref": [ "r325" ] }, "wrap_statement-statement-note-2-revenue-and-product-costs-contract-liabilities-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-2-revenue-and-product-costs-contract-liabilities-details", "lang": { "en-us": { "role": { "label": "Note 2 - Revenue and Product Costs - Contract Liabilities (Details)" } } }, "auth_ref": [] }, "wrap_statement-statement-note-2-revenue-and-product-costs-tables": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-2-revenue-and-product-costs-tables", "lang": { "en-us": { "role": { "label": "Note 2 - Revenue and Product Costs" } } }, "auth_ref": [] }, "wrap_statement-statement-note-3-financial-instruments-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-3-financial-instruments-details", "lang": { "en-us": { "role": { "label": "Note 3 - Financial Instruments - (Details)" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://wrap.com/20230930/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "dei_EntityAddressAddressLine1", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "us-gaap_ResearchAndDevelopmentExpenseMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ResearchAndDevelopmentExpenseMember", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation", "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-allocation-of-sharebased-compensation-expense-details" ], "lang": { "en-us": { "role": { "label": "Research and Development Expense [Member]", "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included." } } }, "auth_ref": [] }, "wrap_statement-statement-note-3-financial-instruments-fair-value-assumptions-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-3-financial-instruments-fair-value-assumptions-details", "lang": { "en-us": { "role": { "label": "Note 3 - Financial Instruments - Fair Value Assumptions (Details)" } } }, "auth_ref": [] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2023", "localname": "MajorCustomersAxis", "presentation": [ "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information", "http://wrap.com/20230930/role/statement-note-14-major-customers-and-related-information-details-textual" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "auth_ref": [ "r229", "r587", "r667", "r712", "r713" ] }, "wrap_statement-statement-note-3-financial-instruments-instruments-by-significant-investment-category-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-3-financial-instruments-instruments-by-significant-investment-category-details", "lang": { "en-us": { "role": { "label": "Note 3 - Financial Instruments - Instruments by Significant Investment Category (Details)" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "documentation": "Number of shares authorized for issuance under share-based payment arrangement." } } }, "auth_ref": [ "r597" ] }, "wrap_statement-statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-5-property-and-equipment-net-summary-of-property-and-equipment-details", "lang": { "en-us": { "role": { "label": "Note 5 - Property and Equipment, Net - Summary of Property and Equipment (Details)" } } }, "auth_ref": [] }, "wrap_statement-statement-note-4-inventories-tables": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-4-inventories-tables", "lang": { "en-us": { "role": { "label": "Note 4 - Inventories" } } }, "auth_ref": [] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2023", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "presentation": [ "http://wrap.com/20230930/role/statement-note-10-sharebased-compensation-details-textual" ], "lang": { "en-us": { "role": { "label": "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan." } } }, "auth_ref": [ "r327" ] }, "wrap_statement-statement-note-3-financial-instruments-tables": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-3-financial-instruments-tables", "lang": { "en-us": { "role": { "label": "Note 3 - Financial Instruments" } } }, "auth_ref": [] }, "wrap_statement-statement-note-4-inventories-summary-of-inventories-details": { "xbrltype": "stringItemType", "nsuri": "http://wrap.com/20230930", "localname": "statement-statement-note-4-inventories-summary-of-inventories-details", "lang": { "en-us": { "role": { "label": "Note 4 - Inventories - Summary of Inventories (Details)" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "13", "SubTopic": "10", "Topic": "480", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481766/480-10-25-13" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "7", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-7" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "8", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479637/805-30-30-8" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481877/830-230-45-1" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "14", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-14" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-15" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481071/942-405-45-2" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "360", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-1" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "30", "Topic": "350", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "405", "Topic": "942", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481047/942-405-50-1" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "30", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c),(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1A" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "SubTopic": "10", "Topic": "505", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "718", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2A" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2C", "SubTopic": "10", "Topic": "820", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2C" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-13" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(22))", "SubTopic": "10", "Topic": "210", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483489/210-10-50-1" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.19-26)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.20)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.21)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.25)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "210", "SubTopic": "10", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02.29-31)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-14A" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-5" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-12" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-4" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-3" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-4" }, "r42": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-5" }, "r43": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r44": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "260", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-2" }, "r45": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r46": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r47": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-20" }, "r48": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-4" }, "r49": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-8" }, "r50": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "275", "SubTopic": "10", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-9" }, "r51": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-1" }, "r52": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482686/350-30-45-2" }, "r53": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r54": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "((a)(1),(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r55": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r56": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "350", "SubTopic": "30", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r57": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r58": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "360", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r59": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "710", "SubTopic": "10", "Section": "25", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483070/710-10-25-11" }, "r60": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-1" }, "r61": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r62": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r63": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r64": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-12" }, "r65": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "20", "Section": "55", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481089/718-20-55-13" }, "r66": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "05", "Paragraph": "4", "Subparagraph": "(a)-(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479515/805-10-05-4" }, "r67": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r68": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-2" }, "r69": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479328/805-10-50-3" }, "r70": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "10", "Section": "55", "Paragraph": "37", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479303/805-10-55-37" }, "r71": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-1" }, "r72": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-14" }, "r73": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "20", "Section": "55", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-20" }, "r74": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "805", "SubTopic": "30", "Section": "25", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479668/805-30-25-5" }, "r75": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "810", "SubTopic": "10", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-1" }, "r76": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r77": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "820", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-3" }, "r78": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "20", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-20" }, "r79": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "825", "SubTopic": "10", "Section": "50", "Paragraph": "21", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-21" }, "r80": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "850", "SubTopic": "10", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r81": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "940", "SubTopic": "320", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481961/940-320-45-2" }, "r82": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.15(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r83": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "210", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03.17)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r84": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "985", "SubTopic": "20", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481283/985-20-50-1" }, "r85": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r86": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r87": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 201.5-02(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r88": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r89": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r90": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r91": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r92": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r93": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r94": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(31))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r95": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(32))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r96": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r97": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r98": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r99": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r100": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r101": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r102": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.1,2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r103": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r104": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r105": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r106": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r107": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.7)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r108": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03.9)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r109": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r110": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r111": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r112": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-25" }, "r113": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r114": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "235", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//235/tableOfContent" }, "r115": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "250", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//250/tableOfContent" }, "r116": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "275", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//275/tableOfContent" }, "r117": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480418/310-10-S99-2" }, "r118": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "330", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 5.BB)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480581/330-10-S99-2" }, "r119": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350/tableOfContent" }, "r120": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r121": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r122": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r123": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//360/tableOfContent" }, "r124": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-1" }, "r125": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "440", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//440/tableOfContent" }, "r126": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//505/tableOfContent" }, "r127": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r128": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "710", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "30", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483043/710-10-30-1" }, "r129": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(e)(1)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r130": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "718", "SubTopic": "10", "Subparagraph": "(f)(2)", "Name": "Accounting Standards Codification", "Paragraph": "2", "Section": "50", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r131": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//805/tableOfContent" }, "r132": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r133": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r134": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//810/tableOfContent" }, "r135": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r136": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(11))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r137": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r138": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r139": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r140": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r141": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r142": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-1" }, "r143": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-1" }, "r144": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-11" }, "r145": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-12" }, "r146": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-6" }, "r147": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "SubTopic": "360", "Topic": "958", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480321/958-360-50-7" }, "r148": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org//606/tableOfContent" }, "r149": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-K (SK)", "Number": "229", "Section": "1402", "Paragraph": "(a)", "Publisher": "SEC" }, "r150": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479343/105-10-65-6" }, "r151": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483499/205-20-50-7" }, "r152": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r153": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-5" }, "r154": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r155": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(13))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r156": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r157": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r158": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(16))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r159": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r160": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r161": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r162": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r163": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(29))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r164": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(30)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r165": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r166": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r167": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-10A" }, "r168": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-11" }, "r169": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-17A" }, "r170": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r171": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1A" }, "r172": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r173": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482790/220-10-45-1B" }, "r174": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r175": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r176": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r177": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r178": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(24))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r179": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r180": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r181": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "5", "Subparagraph": "(SAB Topic 6.B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-5" }, "r182": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-24" }, "r183": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482913/230-10-50-8" }, "r184": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(e)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r185": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r186": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r187": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r188": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r189": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r190": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-1" }, "r191": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r192": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-11" }, "r193": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-3" }, "r194": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-4" }, "r195": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r196": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-7" }, "r197": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-8" }, "r198": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483443/250-10-50-9" }, "r199": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-10" }, "r200": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-11" }, "r201": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-2" }, "r202": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-3" }, "r203": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r204": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r205": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "60B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-60B" }, "r206": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-7" }, "r207": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r208": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482662/260-10-50-1" }, "r209": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-15" }, "r210": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-1" }, "r211": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-1" }, "r212": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482987/272-10-50-3" }, "r213": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r214": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r215": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r216": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r217": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "22", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-22" }, "r218": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r219": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r220": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r221": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r222": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r223": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r224": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r225": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "32", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-32" }, "r226": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "40", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-40" }, "r227": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r228": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "41", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-41" }, "r229": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "42", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-42" }, "r230": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-2" }, "r231": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-9" }, "r232": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "320", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481800/320-10-50-9" }, "r233": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r234": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "4", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-4" }, "r235": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "5", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479654/326-10-65-5" }, "r236": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "326", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479319/326-20-50-13" }, "r237": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "330", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//330/tableOfContent" }, "r238": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//350-20/tableOfContent" }, "r239": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482598/350-20-45-1" }, "r240": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r241": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r242": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r243": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r244": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r245": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r246": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "360", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482099/360-10-50-3" }, "r247": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "420", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482017/420-10-50-1" }, "r248": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r249": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "440", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482648/440-10-50-4" }, "r250": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-4" }, "r251": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r252": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r253": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r254": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-4" }, "r255": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r256": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r257": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r258": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r259": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r260": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r261": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r262": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r263": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r264": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r265": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r266": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r267": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r268": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1B", "Subparagraph": "(SX 210.13-02(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1B" }, "r269": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1D", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1D" }, "r270": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r271": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r272": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r273": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r274": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r275": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r276": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r277": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r278": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r279": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "14", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-14" }, "r280": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "16", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-16" }, "r281": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r282": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r283": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-18" }, "r284": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r285": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-3" }, "r286": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.3-04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480008/505-10-S99-1" }, "r287": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-1" }, "r288": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479837/606-10-45-2" }, "r289": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r290": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r291": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r292": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r293": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r294": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "12", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-12" }, "r295": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-13" }, "r296": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-15" }, "r297": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-4" }, "r298": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r299": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r300": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-8" }, "r301": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-9" }, "r302": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r303": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r304": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r305": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r306": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(A)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r307": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(B)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r308": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(02)(C)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r309": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r310": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(n)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r311": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-6" }, "r312": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//715-70/tableOfContent" }, "r313": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "70", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480794/715-70-50-1" }, "r314": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-5" }, "r315": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//718/tableOfContent" }, "r316": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "35", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480483/718-10-35-2" }, "r317": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r318": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r319": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r320": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r321": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r322": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r323": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r324": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r325": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r326": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r327": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r328": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r329": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r330": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r331": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r332": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r333": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r334": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r335": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r336": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r337": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r338": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r339": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r340": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r341": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r342": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r343": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r344": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r345": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r346": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(h)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r347": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r348": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(l)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r349": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r350": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r351": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "15", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480336/718-10-65-15" }, "r352": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 14.F)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479830/718-10-S99-1" }, "r353": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "730", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482916/730-10-50-1" }, "r354": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r355": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "740", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "8", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482615/740-10-65-8" }, "r356": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r357": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479907/805-20-50-5" }, "r358": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r359": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "805", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479581/805-30-50-1" }, "r360": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r361": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481231/810-10-45-25" }, "r362": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r363": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481203/810-10-50-3" }, "r364": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r365": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r366": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r367": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r368": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(h)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r369": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "6", "Subparagraph": "(i)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480528/815-20-65-6" }, "r370": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480237/815-40-50-6" }, "r371": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r372": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r373": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r374": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r375": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r376": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r377": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r378": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r379": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-17" }, "r380": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r381": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r382": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r383": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481694/830-30-45-20" }, "r384": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-1" }, "r385": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "830", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481674/830-30-50-2" }, "r386": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r387": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479041/842-20-45-1" }, "r388": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "848", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(a)(3)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483550/848-10-65-2" }, "r389": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//850/tableOfContent" }, "r390": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r391": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r392": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r393": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-1" }, "r394": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-6" }, "r395": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//855/tableOfContent" }, "r396": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r397": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "855", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483399/855-10-50-2" }, "r398": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r399": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r400": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(bb)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r401": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r402": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "910", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482546/910-10-50-6" }, "r403": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "924", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 11.L)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479941/924-10-S99-1" }, "r404": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "926", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483154/926-20-50-5" }, "r405": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "340", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483147/928-340-50-1" }, "r406": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "928", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483119/928-440-50-1" }, "r407": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r408": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "15", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-15" }, "r409": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r410": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "20", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-20" }, "r411": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r412": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-28" }, "r413": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r414": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "33", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-33" }, "r415": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r416": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "35A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-35A" }, "r417": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r418": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "932", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482274/932-235-50-8" }, "r419": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-03(10)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479853/942-210-S99-1" }, "r420": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(26))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r421": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(27))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483589/942-220-S99-1" }, "r422": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-05(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479557/942-235-S99-1" }, "r423": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "942", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480842/942-360-50-1" }, "r424": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(12))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r425": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r426": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(21))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r427": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r428": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r429": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r430": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(25))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r431": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r432": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r433": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r434": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r435": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-04(23))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483586/944-220-S99-1" }, "r436": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column A))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r437": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r438": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r439": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r440": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r441": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-17(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480149/944-235-S99-2" }, "r442": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7A", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-7A" }, "r443": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r444": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r445": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(f)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r446": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r447": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(g)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r448": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "2", "Subparagraph": "(h)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480016/944-40-65-2" }, "r449": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "944", "SubTopic": "825", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r450": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r451": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r452": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r453": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r454": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-03(i)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479886/946-10-S99-3" }, "r455": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-11" }, "r456": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-2" }, "r457": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-5" }, "r458": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480990/946-20-50-6" }, "r459": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r460": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-2" }, "r461": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "27", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-27" }, "r462": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r463": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r464": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r465": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r466": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r467": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r468": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r469": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480737/946-205-50-7" }, "r470": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480555/946-210-45-4" }, "r471": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r472": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-2" }, "r473": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r474": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r475": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r476": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r477": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r478": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r479": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(12)(b)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r480": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r481": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(13)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r482": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(14))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r483": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r484": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(16)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r485": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(17))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r486": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(19))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r487": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r488": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(2)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r489": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r490": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r491": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(3)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r492": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r493": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r494": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r495": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(6)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r496": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r497": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r498": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r499": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r500": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(9)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r501": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r502": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.6-05(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-2" }, "r503": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-3" }, "r504": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483581/946-220-45-7" }, "r505": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483580/946-220-50-3" }, "r506": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r507": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r508": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r509": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(e))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r510": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(2)(g)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r511": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r512": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r513": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r514": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r515": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r516": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(a)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r517": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r518": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r519": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r520": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r521": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r522": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(7)(c)(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r523": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-07(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-1" }, "r524": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(1)(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r525": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r526": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(6))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r527": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r528": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r529": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r530": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r531": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r532": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "235", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481062/946-235-50-2" }, "r533": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r534": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r535": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r536": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r537": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r538": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r539": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r540": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r541": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r542": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r543": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r544": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r545": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r546": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r547": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-1" }, "r548": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r549": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r550": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r551": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-2" }, "r552": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "946", "SubTopic": "505", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481004/946-505-50-6" }, "r553": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "948", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479851/948-310-S99-1" }, "r554": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481027/954-310-50-2" }, "r555": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "954", "SubTopic": "440", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480327/954-440-50-1" }, "r556": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column B))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r557": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column C))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r558": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column D))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r559": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column E))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r560": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column F))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r561": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column G))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r562": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column H))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r563": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Column I))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r564": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "970", "SubTopic": "360", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479438/970-360-S99-1" }, "r565": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "976", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482856/976-310-50-1" }, "r566": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "978", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482707/978-310-50-1" }, "r567": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r568": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(a)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r569": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(b)", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r570": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "38", "Subparagraph": "(b)", "SubTopic": "20", "Topic": "805", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479876/805-20-55-38" }, "r571": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r572": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483467/210-10-45-1" }, "r573": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r574": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(3))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r575": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(6)(a)(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r576": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483426/235-10-50-4" }, "r577": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "52", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482635/260-10-55-52" }, "r578": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "30", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-30" }, "r579": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "280", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "31", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482810/280-10-50-31" }, "r580": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481933/310-10-55-12A" }, "r581": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482548/350-20-55-24" }, "r582": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69B", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69B" }, "r583": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "69C", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481568/470-20-55-69C" }, "r584": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-13" }, "r585": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r586": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r587": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "91", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479777/606-10-55-91" }, "r588": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r589": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480506/715-20-50-1" }, "r590": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "17", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-17" }, "r591": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "18", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480482/715-20-55-18" }, "r592": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "11", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-11" }, "r593": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480576/715-80-50-6" }, "r594": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "715", "SubTopic": "80", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480547/715-80-55-8" }, "r595": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r596": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r597": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r598": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481372/852-10-55-10" }, "r599": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479401/944-30-55-2" }, "r600": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "29F", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-29F" }, "r601": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-1" }, "r602": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480524/946-210-50-6" }, "r603": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480493/946-210-55-1" }, "r604": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "310", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480833/946-310-45-1" }, "r605": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r606": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r607": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r608": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" }, "r609": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-10" }, "r610": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-11" }, "r611": { "role": "http://www.xbrl.org/2003/role/exampleRef", "Topic": "946", "SubTopic": "830", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "12", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480167/946-830-55-12" }, "r612": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r613": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r614": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r615": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r616": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r617": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r618": { "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef", "Topic": "272", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483014/272-10-45-3" }, "r619": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "18", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482861/275-10-50-18" }, "r620": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "SubTopic": "825", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479383/944-825-50-1B" }, "r621": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r622": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(g)(1)", "SubTopic": "20", "Topic": "842", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-4" }, "r623": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4H", "SubTopic": "40", "Topic": "944", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480081/944-40-50-4H" }, "r624": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(27)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r625": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(28))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r626": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(8))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r627": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "210", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.5-02(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480566/210-10-S99-1" }, "r628": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-4" }, "r629": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-5" }, "r630": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482765/220-10-50-6" }, "r631": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483621/220-10-S99-2" }, "r632": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-13" }, "r633": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482740/230-10-45-28" }, "r634": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(d))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r635": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-1" }, "r636": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "235", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480678/235-10-S99-3" }, "r637": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "23", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-23" }, "r638": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-24" }, "r639": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "250", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "5", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483421/250-10-45-5" }, "r640": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "260", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "55", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482689/260-10-45-55" }, "r641": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481990/310-10-45-13" }, "r642": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "323", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481687/323-10-50-3" }, "r643": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r644": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r645": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r646": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r647": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r648": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r649": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r650": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(g)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r651": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(h)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1" }, "r652": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-1A" }, "r653": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482573/350-20-50-2" }, "r654": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-1" }, "r655": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "350", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482665/350-30-50-2" }, "r656": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "410", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481931/410-30-50-10" }, "r657": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org//450/tableOfContent" }, "r658": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483076/450-20-50-9" }, "r659": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "450", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480102/450-20-S99-1" }, "r660": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r661": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "460", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Subparagraph": "(c)(5)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482425/460-10-50-8" }, "r662": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r663": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1A", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480097/470-10-S99-1A" }, "r664": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "470", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1B", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481139/470-20-50-1B" }, "r665": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481112/505-10-50-2" }, "r666": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-10" }, "r667": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "606", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479806/606-10-50-5" }, "r668": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r669": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r670": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r671": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r672": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r673": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r674": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r675": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r676": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r677": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r678": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(1)(iv)(04)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r679": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r680": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r681": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r682": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(01)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r683": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(02)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r684": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(c)(2)(iii)(03)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r685": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r686": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r687": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r688": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(e)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r689": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r690": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(ii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r691": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iii)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r692": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(iv)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r693": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(f)(2)(v)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r694": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "718", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(i)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480429/718-10-50-2" }, "r695": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "815", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "1", "Subparagraph": "(e)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480175/815-40-65-1" }, "r696": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r697": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "820", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Subparagraph": "(bbb)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482106/820-10-50-2" }, "r698": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "825", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "28", "Subparagraph": "(f)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482907/825-10-50-28" }, "r699": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "842", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(a)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147478964/842-20-50-3" }, "r700": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-2" }, "r701": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "850", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483326/850-10-50-3" }, "r702": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r703": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "852", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481404/852-10-50-7" }, "r704": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r705": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r706": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Subparagraph": "(c)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-3" }, "r707": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r708": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r709": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "860", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4", "Subparagraph": "(b)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147481326/860-20-50-4" }, "r710": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "912", "SubTopic": "730", "Name": "Accounting Standards Codification", "Section": "25", "Paragraph": "1", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147482517/912-730-25-1" }, "r711": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.7-03(a)(15)(a))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479440/944-210-S99-1" }, "r712": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "30", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479432/944-30-50-2B" }, "r713": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "944", "SubTopic": "40", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "13H", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480046/944-40-55-13H" }, "r714": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "205", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "4", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480767/946-205-45-4" }, "r715": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "210", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.6-04(18))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147479617/946-210-S99-1" }, "r716": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(4)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r717": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.6-09(7))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147483575/946-220-S99-3" }, "r718": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-1" }, "r719": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-2" }, "r720": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-3" }, "r721": { "role": "http://www.xbrl.org/2009/role/commonPracticeRef", "Topic": "946", "SubTopic": "320", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "6", "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))", "Publisher": "FASB", "URI": "https://asc.fasb.org//1943274/2147480032/946-320-S99-6" } } } ZIP 83 0001437749-23-031987-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-23-031987-xbrl.zip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

/"^:S.)P.IYPL(5?P )-& M33.D^?QO&)XV_]M47<#BT+ &[*L'ZVAK-'Z,0%%R /+E-&"E+ ZMP [B<>4 M2)ZS-(1?J!H&R#9&G 7&DC>);_F>"EB=/?@A4D8LBUL-EIPZN^FV5U\H[<.1 M $@ ) 20"X":#93OM;/!\V#;-8K\]SHTG##T;ZPIAYZ2VYIL+";,Z3RH1QY M)^7#E\L&T*Y#8*!6VP,"[(M6FZ?[4*DAZR#K;,$Z/#E!*L,V>T*U@>WE+>OV MT'[<$S"%!R/PO$EU) $J4%2@>7 /*S"K7UG589P]H5L5(V%[0KJ56AHD7KF( MMUR>\1.:L-4#5>(MAP5@+SC[*UO4Q>P01)(7H^;'MF]Y2/']H7BXUP-)OC\D M/Z=#0S.0R_>(Y$$)/5)\?R@>U')+0/%2-6 @8;EP\_C'3+<=K#9C^%_5\E5G M2I1*=6*0H\-"S(Z)PT8C8L>$4E>:]98B:^>$1NVXK=2ZAX6V=)$!-^+G5/#6 MNUB4*IF@M!I-#1":A4(SJO5,,FA*T&] J36:*$:KA]7H5@"'C:CF,,G *D,K M@,-N[:C=+1:NV1G#E=SU+S$O1#6*22BX9=JFO]0I SD#.4. 11/5+R9DC'R, M9Z76[$AE0>\>O*G@*3%A!: ;I$<-?@HS\4%.$OI,'PR_>!/2_"(&AIXO\ /^T&PV9! ,"6#" M8\ZF$0?@.+45AC%!.!^680U.4;0Y-V4=;H#25 M-7D&9[CO77]0@<2 JO$$9!GO?TCH,_N=8B1&%!@S/'T797#>,KA50/BAK__I MNQY[FCNP8_Q SLZH,R:&Q7P7[@ZCCU(%/D"J MB?4LFT*R"ENFB^-"LM_FO/R+;;+N&I^!H[_8KGMCW5,-G%#/H&[?,5RXM.R3 M@ARX&0[49PRG(K(7R!:32$B?)D:42P+"2J-$4$V# B$H .V3"R5[^P$GBYJXRB(3$ M@\TP#!/5#;:*2J":P(A6*:UDF[/$1GI I 0ZAZD7F2U[1'P%$=\L. *$Z$?T MYX#^F.Z +2$[P=*$AA+A/EE#0.6PUC@NU'6(:8V?D4G^L1JM BO)9S%L)F8[ MFI@0%6HGI-6HU%DMZSS< M A[6;?_!I&60./&CC9$XG8A&OUFU"!5T]HM24YKM6OLHSQU1ZV*H555UNP/" M"NYEO3,K'&7""M4X8 ;Q7WW\'Z?&OP2GV+1J1ZT\#S] AJ@00\2Y8]W4'"'# M43F=5NWX4)'*>VMAZ \9+E8#'48=1)E_^];=M5$;-9%X=D "-4'DY\WEK5T MUDR6_\9CW4P&$X,]S1B3H6&IEF:H)HPXE-_N^TVS$+Q20!2BF:H+*+O]_.G7 M@W4,-1H_1G%3^ EG5/X1B)#59UT.[C:>K;[T@K7OCH9UQ_[^\D.-FB:Y_7S] M[>OKA[8O WF%!]9!P*,$')FK/]ZK.A,H)T-VB*U/Z2$8T6)LF8YLPVOWO!O\G*A >7CH@']87\I?SZ(5DU$B] MC(.;LR^&]=<"#!%+D"O'LE>MC"4W)CY]Z/WNJ!,RH-K( F(\&M2M$3")WL_C M]9426C#?L[E,.EN627,+TF6-F,Y4=T0N3?N[^]HZB!_C6\,BWLCV7=72W7^. /\OSGENC*4*CSJSY@U5,3SO]V)JLW_#M@:M,B ?35:?&^6B!NM M KY6!D,+%_.!<\J3?8%V]YRE(?Q"U3!KL3$-*##!M\FF%OQ4D-.P\-;/!YW7 MM8^VU8E)RRF:[,TG-4RV6VZHD_F5!'4UT*7QF??F!W]N!E(Y=< M $STU;QG(#DV9SW%T6DY$[UOJ&SFALK$-1SY@Q=TQN0'.HO,]G7_.,)[X+\"0_]2#JJ3"SV8,? M(N,O^_EP7.P$#R_-MM"LB^5F6T&KF(_:G&=2FGGL^H[)V!Y&]:QI+0IH6WD7 MT"JU8Z5;[,;M=XB]?+ GHOU\I8JWL4Z[B)59.L& I6H<"J#4#),2:]:> #YE MOVO,?O5=GJTA]MQX59>-US(9KOA4?"IV*7FU2\DYG8!,,(*C0%5+)^K8AC7Y MAW]0?GLUR0MR,1.BK81VU&G5VUJHRR2$WTW*?NE;>G^)DNF:#!WE68)1P2(E MV=$GXH#IS-#7/LIS2P.V#!=YJ#0JCJQ9-ZH9R[:*@U/OT_K)9:F85:EU#J4Z MDPP1)QIQR?J?Y(8X/ 6O# KB=]5QX+XIF3CVD^&B:L@A]-B.:J&25#?PP^IN M'5OW-6]&O(MGQJKAQHG=PI %6UGY0#A&MR^,;*&UM;U2. 2;OB$3CR+01 -ME\,SQ $- M=(%\Y]X:^R?<-^_MR:FBAP9^.B(SRG(J7MG,>TK ? MDG"W^$_120(, &6E)CHBDLFB@=?K%-KQ"/V'!"HC"#>Y+-ZDNB[U7%Z&M!1D MPL)#?&JIGUH:2U$YSH7OP]?,!#LK2J;&$]O2C_9AYO;A+LG!F9J^LC2'.7/G M-/AY93'?NJ8S7FJSZN MK"=J>;;#TY"H-C)6&R+RD2]Y=XF&J4+/2NVHZ.@SZHOL0"B0BHQH?MK@-Z+CCX1X%EV6B$Y0=_$3D53.&WW&KX*VZZ \5K9<6[0Z# M,M!9_G:*"BIS"2%B+_!+"3&G**_;^S*C9YHXW9*DP&A=96$H8H-PAC!X<%QX5+I9!7^[X=*7^=9%;0AV5N7C8IJ)7/5 MDD&APHR0]W,Z8GLF1%\D^C(H21"-O@YZ/WON_9S3(74<<'\<^D0MOP+5#8D/ ME)-"?"0>;;20.#E+4.7I5#/;M%[BS*<00 NX\G:YT MX"Z-)Y:U*7"=Y*P=U'N2BH88Z_I81 D&((,=(LI[8.A4_S3]!@A92H OSA'= ML?B\6>LJA7IZ,0?-EMC]VS.XBRCUR WN2JW1*G2_5@SH>=<;@I3 1P0\1 M+;]G(HD-%F]K4@8;I&>C7EL.#4;HG= ^DQ)Z+3 M@G#,-5LUI>CSTDMEI%?$2 674*-4=\F0V:> %=\)"N%0*Q55A72\2_'"4G=7 M3E?F=GR=4Y5O; \D1]_2SU33=&^&]XS,C,H[R9 C\/X;M48#&]17&IN[E#84 MALWV0:_5JK7DPB8Z0J$*.E,GAJ>:07L?W0 \P.-82_N)P_(UWI0795,P'A=H5TM=^W4*]#:EY:P(0@,,O9@1-5_S:PMZEE<6?D/;VV>*OV2BXVSTZ M2_FOS,((8<4$$]5C ./:R7-4G<*]?Z%[E+UX2%8 \,>E >*!?C&>6*K34ZU' MX\&DP8;!3].OZI^V M0Y5%;[)\?HG16[AI5BK56!$G;CF;9X?+_B8*1: M$DF:PX->!SL$5/98NVVP6':5!% M9*8B,JFC2 ' THOT_?18>&VN[7NF.N4JI#K-Z?9K@T172+E$* S+N@"BQ(MHS/ LIL1")YT+#>578T%.1]-?"[0KWD9&':5@9B%MJ2R%R M(B5.NR&BWB-FB^%\Q]-N6PQ[S=I1KF?F8%N)*@)=1&%)QD#OUHX/\SSAHZ@6 M$[C)M1(V0<0FUTO#4BT--[E6\^&XV+C)->WV(OI,')CJ8[P1=LO4K@;KNN#W<>%^_>@6VU0&PV@XNO#ZL$FSJSK*)?_ M-6)1CWW!'L+'S&34;!=3,&5SJW<^R&%9;%R%.+H9ACV/^7; !89N9Q#B\B6E MCWW4EM_'1M3+C?J=#XL0C_K=C+-*!I3*IE0CDRS#>4@%DRQE%1@ 5X;Z;-699RB$M)Y&!:Z3-1<_&LC53KD=ZI'KT8#JFVXV%!K6ZA%8VE M+EZ4'LPB:B+*!&:EIC2PT>'>!:MGA0I1:K-&'BC<:3$'VQZ2"0=D-73I7KD> MREIG$",08$JSWE(R%&!S475NN!/;5\SN[0CK=@JL$NK=MPL M)';M6W5N1$SW_K#3!4"7V)6 M#>Z"J/+#<;%SV051D=CC&0]@L\R=;SD4IOX/U3H3 M"R1[G:;D^S)D,$^OEO9%:/9XS$0^W_NVUK<0N2H72=],5KSQQZP17']!H5D7 MT:"UY)"3NB!P&?[W_B>.13_>;-8LK-#-AA50,N@P_.L+2C;O;/$B>ED_&'!!WY4 M+U\@,0:3G0"2 09EV!Y65C/^+'X7,]_Z3/78S&%"'MOBQ(%W#,;I'[H]IQKM5"*.,+D_$[-X?8%H%HVZ+5PMK,5 3T:S@5:B5WIS>S[*= M.X;#NCVL^VYXDBG?KS"SYZ?$H1HK]=6)[O-XSVS# I;NY,?!K5TVXW-+BY/9 M'@*1>5"U;^DSHVMZ%Q*XU$87XB]3_.VR?WY7_&W<,MHL^GC<2+7R!GX^V/J4 M#44%&[L''^C&4^_-FV@A_M/: '[:6HS/AC&)?4<*1;&$-HT"]9W5=]Y3T!B: M9H\GJC5EJL&R/7B%9P,,5%\W/,K[HH+5X :_\5V<*OO88$\SQK.>;ZH)(PX# M@>[[3;,0O%) %**QR.//![>?/_UZL Z71N/'J,TOX2>< _E'H*%7GW7][>O\ M8]]AQ-H[GUOQQ\)+!^3#^G1_.;^+G"Y;LY5W M+M:?SZ"*;''ZT/L=1!X94&UDP<(]&M2MD2M+>S_?&9'G6*YG3/EMSI1G)C%<]O0OUY[8]A*;5D1MNJHW7C/*J6\0_?@+8@#_SQ274-]V9X MZU"7[=3A'X5%4N?4U1R#=R$'S=H'F>RSO6R/M_!E#> W@#%\,GE/U5"A-P\( M?$>=,'YU?,KDEWCW@LS^4V8453@/!$N6W?_#BV[N/O>OK_Y??W!UF?G=U\NQY<77\FMS=?KLZN+NY)__J6Y66"\ M@0G="S[5/]:6KW^GL9=\=_426_RER[;O+%]_5R.&"Z.:^ \ /7-*/$?5N57( M!P F@L<.*G9 (_'J\?N@<_Y$==G]+G7NF*U[L)^8OY.^[ M59T;A^L\_3?VTL570L^DD= SN;J^/.@UWH.M]/)D]B7]]7:5$O-YKRV<:;A, M/=M,&5)RK;JZ^C^.'R(;#&DNS]P3/A$6#=3&#M MQGSM@E%YT6^SX6[J+;W1#<<;3HB1$:R4:]OQ@D8?][8/O_6YY%9KY,*'1] : M^6KHNDG)A>H&$^Z[AAHX.C. A-)>=@TS8YO0&EFS-:;1FD4Y5+K-]O'Q(?S2 M['0R5"UI]0B?#H/SLGE57;T1R5L+KWWFGL=X[U%>.WR'M5: JR/J4&")D?I$ MR0.E%DLP@ASGC^7Q D?G6X6XR&=L9UC ICZ7CMQ1N80Y@+-8_T_ *2PJ#ZQS MS*AS1Q]],U!E]_7_"X0,/,'Q31HPIC._@5.37;P/9(L1WC%KM<@UC>&Z7"TN M2<_[B[,5T?F>G%''8_M8#2L0_C-38VC;'@MY$'V^9=XE 0',Z6(]X)N1"[9I M6;Z]OW]/'JE%'?XLN R>#]RJSMEM)L;8Q)>'S[_YN=^_797_"VHL: I2SQX; M'GONQ'?8!BZ/+;_K:Z/H%7T/Q@4(34M]Y%-8(,>>@)RWK1I?[Y604.3,'3HT M*0AO56?@##ZS*(A3EPE:&,(D8$(R5 V'V0KPU,6#^"'?_&UPEV]ZG-#VO&=' M;=%O:4(-FBJH(4K8# ";/*UBJ1Y[GV^9S'BUV7GF MW]DI\W$]PN$ ^&G3))M^#",>G;,B]:I!X.U.&1VQNPO*F<$\24;!+ M^I-LGR&1"K*IJURQ(ED[H&GDD8_A9X($$3&E"9 R@ZR+K"[E5"<51W($:Y6Z M-E$B>1.H,O$,@_9GEPG>G05BR.F!$N.:$%0T/#D^A1R40GN0D>16FM_8J/7;O7:KW^RV6WB) J0D M;@+##&(0>CQ"Q"C%?57^I3B$R M8N8G".7;1R?NLR5HI#Q/+71]K&?47HYW[^B:#FO % =E/6ZQW=^=\X0'A>5< MR_E:$#BO!N(#BM%AAH%![)-NNZC];/[5B-_TQVW480IBUSE$WX\B\$2M!]'@ M R,7+!;)@L:G6ZG4^OU>]WNLNIJ5^*X2C@LLZCA1UU">^WJ4?*IXWRQ M(0<*?MY+,HY#9 SEXFC\F2.#U2"7@@=OIJ;:&FZ !F[!6*1OCP9W9TN]ORW\$)FO%\] MO#Q2@P;X(KZ"H^ KN 3X9JAU@0UT+/'PKQ5]%(OP=<%'Q) M!]==H\OQF[B8R-?_HJ4'FP?+<"QN#R9(R[&MHVNN\BT$LJGF@QY>0XIX3^\$DQ"X>\F-T@'_,5 BT* QYL"SM63>,8^6+^ T_QGU1 MGH/%XUFXC\]/8#$1$.9)\'J4^I2)E@L/;X6IK?5(0+" ,:HV,VC'V2<.X$)@$'7(M,XYYGYHP3=BX4^%OXN+^ M)LJ(*C62U%R4-'*$XN0)HL@-1,2),7B0_>%)-)>/F'2GNB.+7,F'<=4?0O=8 M4NOQB,MR2#8$II2(;9^8Z3&>,P)#JL[X\8#,&-&7\5;\BSS%17P.E!G2 MG1^X"&NLT[I">5!$JL(PGY_ME/P568E,PX:SAB) QBUUG C7^>G?9+T,-]2X M5PL&D?'$I\^DPKR@R:F 7G!IBT0"Y9&IF!@D'YOG1J1I!=;R9G@=R^1YJ$5# MYBPN/="I _0>0F_&%Q:_;_3JE)\&U<4*[6%+VS(PM4M?2W#G0KX5<;B[O5X' MW.U:O=WH-&OUXCK<\NE*'SMA)6D>!WC&$_ 9(?(%SPU<0W..0X[<9TRID3 _ M/-CL 34RAK_@K8DJB)FJ"X_6C/J3XC@I08OPS>)5KE%O)<'-%;A'9F#RI',1 M\IYTA_*IZB.X6NB4<$V#9V&4B8#GZ.X.&9]5\>N'@,=!5\%Y8"K]M<\6!^=T+9;)V[0O+41.14 M\)0H=+,Q'22P%]U96"/C_BU0!VX%=%*%FSYV+9NTH&_X\7XZ'>G30@S]!Z/# M'W@(I)0?L41="U6XJ_A<6.^!WZ#8A;A<]>V(V MY5Y]JH8>M*N+%OR,*N5GOMUOM;KW6A&NWECWHSZ%"/F<3 M';B)50TZB@D>6L2Z4E$O?T6Y/Z6"CZUD@=CQ ,%7_,I8>(%4/T9,ZV"9F,N' MZ@ G4L!741QKXF+Y6R50PJZLDYOS8U^X/?A+F#T0Y]M3?08:^M7%+*8G*%@@ ME2.20-ZCQ^-/H=R#DH'PFR&]8E@.+9H;L666X#_3U+:\AVEJ!$N+%;XC+3:D M/(4Z771YH^I;VB=')(+].VMI:W3\J X#&U7A'X.MF3 R20H596'7(4H&-TP5 MGB?HD-\LCNS]W?I%Z89>3]ZV7XB\O?#WD4&PPLNO19/\4F@/^;O#KB=#$68[ M,N_<[C>X2>U*Z%$)1WW/,$*+'N>G++#O"=A>V #,59+DB(> S?Z M63F1:J2DG*\@PV$N84E3&IH?JWWD+J!*\W%%2D8F*A_]\ZJT/"R^H$5FF_@7 M3_?GH[GG:!W20L7+*\L2V2/ZJ"1 R!L/?%@>W&,^4YQ5\HH*[E_C)@/KX<$H M#WYD_A++FWPNV*."(PW'7N@H\61[[747H^1^LX3VNH7O3B=5VWJ.OSAFX.J_ MWK>W:JM>)]KH5N3&O>7).+H^^ZJ;/Y)[_2(_B$( 38Q0T0Y_O(%?"+P56HDAN/-.OM"M_GT4(KN5TN22\>7@#S'.!DE MDXE]X?4"DGJA,^K4)];A&R^\E#"QD-9Z-OTQ'=B)Y*2M61%Z3;@?,POC;.Y_ MB,7[];28%J5S-_"D7"-4(*[]PH]MQ[H-P2]N!!X+>RYNFZ1$;(6B,J""+A0. MK*>%A9*1J=1"!A&'?)Q#$BH?J*:!>I=L:\*H!0#XX;^>]L"_H-/]L=LGJ#^@ M0SSXBB2,+B>><(\;WV(JUFT%)S^B_T%D:0643X>4)%>"%2W3J>L_Z68#<_KJ^'0 M4UXE8?_0AAH0PC%[K#NRA82>S1^ %UJ.[H3K3M(:&U)Z!OP(,UI/?XCU\ROX MI&&0>A\9FC?.OA,_-3A2"Y?6\NPH$8>:VBR1 L)J:$V6"% F(:!?V =*T"_" MI0E[;[$3.YY["%\(U8:\)R:;('SU:XD7/TMG@I.Y0@5 48<0M7)(0N_UB6<+ MCR@H4(SJ4']AH?I&8"/3>L30#CP==8RJ#<@[=OQ:'/^,UU]TL)+06FD]8X.I M:-#I_ #;LL@1XOE\X6PM?[\IGAN0HP,?\\NT$_>&,$[X0\MB3"QHQSHI^.1T M?F_KX8 $N]"XIX2N6D64-"5?6JA_:A!$&H(P,9X]5":,FM($,9^Y"XB]*E@G M#NH(6!L)D^RUKFRN@-&J]5KUKM\_1 47[:@G@X[DD &V]%(YD_DQYJ)=##*D MBXQN%>Y5Q5_ BQ65>\?*=U'JC&?Z]%(E(J\3W7;:IFI]=K=INM6J/7ZK>+ MT7/UU<+*8V U>J[#]0(0IF!,Q\5A&)'AS=U''K0^SCPAG!KB] TN MZ M*7Z,.@X^JX#2;'K5L@6$4^8A0*!P_)L&&=>[4'^ 67YIB'^G1=8,V%'88 M+ 03 1"1PD0]H+JP.UZH._R>& 0^+BXBPMV0'P5+T:MT7=S<< JJ0F]K&AT@ MB ([B1G_0<,659NC!H@:!O2/4 KY&Q_#*4RA29=ABF/E#DO)X+Y5NB]W,ZCG M0;:DJ0O5L7!UX7.(IQ;Y%5[$#2S,EKX[M7%0@8G/[]2W0/5P?GSKS81Y74XH MCI4_(UL%)+2H56[3FQ7NV?,_10E9/U,G!8J?(U(&5'8\Z*&AO5BGB16O:/TS4&L&-70Z*)8*$ Z"C,)+^2Q&"^?OV>&SIZX!9QX!*&C M:M+B6&2->:GZPD6HLON>]_6-1?9FK-(,!+_(ABHTQU1'CT8J.#GTSZ$4(?") ML">9SND62)Z?TQIP87_S8(NY'G8%=@[MBPB^D98&@4R)2Z .:B 3<"6NP<(1+Y@":D9',! M7HNJKXIPH;AK':X%\_=\'+F=+J[A^&A#O>KO='6NXT$%1J^#3N*#CA6NX?/^ MZ$6I ? Q] R.> :Z\(/_&)1"X]T;/.YQCJ, :+\KEPA-T0FO(7*F[ 7I%Z*U MS_52SLAD>4Z +17N"<'GX2!'/BG3;J2'J)-Z$PO9PF0*'F)C=P!WDS'+Z^)7 M1%:;7%3JS9F'!!!#S(32NPCT6@"7)#0 =VQU)\1N>RV-RZ^).N?PG@+J^U"- MTK4/M-*OA)23?ZQ"" 2:Z 96^)Q1K"[GR.@0NB@WLKE]\& SSH&+H&+QCT2! M92@3'@6'B<#U(JH*JLG@I%*"JH3A:OP++,*6X<&$:)%XY ^ 4A"Z7U ^\CO8 M9%/YYB'^@A,A1:"YSJ8ZFRC#%]!=),K7DPE$Q[;R86P9AO2I([C =PS>L)T% M#,7O ?XLE3R)D#-.K.B6J/@R&6<)*\ ?4=PD]#YB_%32HJ1>,DAP#SS4_TCT MC!!^ ,V?]4D&&Q0;.0OKC@51"1>" G%"Q3]]>0/"U6;Y"1_JKD?-54;2X9- MM:.3>BT>*OXD:?H8\*V/J1'CT@3FCFY9A&O\R&9B89&X@+D+=512@D2<,CG> MXV,$-,-1#3_'D'3?V.*"^YZ!;H>[15;V2?F@?TS%@TZ:=2:W^JV[GC 6[4:= MD](<66)#Y869\\6&(&[EH!AVM]UN5MJ]7CP@QOX U9E&,T1^7DR(6BSW,\)KNV+T6JZ8H2T-<3NMSB%-*5$AKU2J-=J]02)#0MH1&M M@5M4K6GFY0;3E%&139>C$"&BBCEW,R5K"" MA90.!P)YH=8+"'KZQ^WF3UGJKB)+!C$NK5!TK$;*4H6O(7SRQ$W-H;UW/*N+IXAYX4\?X)_?R9Z5&,35MK+0I2\788_ MWY\TWCQM!RYR._QC>/5]2(-Q;FZOS[^?C92SZ[L=C\39G;406\H=7(2T MB7 3'R])%Z\<@SGF'T%G-P#3E',IHM,C$,[=<2R;:F6OP]>17W24/VX#P"DQ M;:(2@)+RR5?Z;(9_R#4(HH]B MZ"(RPQK#7G6;J@V=\91IGB$0[X#BL(8 )HP]$M8]98[!Y4;-Y.\03SR'JGIY M13 '%//[%ES=-4)X7Y@9?C:%*X FG]8H3E9]_*@ \?]Y*C!L_'9WGD6GQR5 M7"SC#IY3I/HX68D#%%R,$9;_,GC M!99UHF7#@=B1,X["Y!_Q8-X873,!RQ[*>9"(!JJ(]UWAS?RF #KLTI^HE$$T M F YR;$R\+E!H!%&VP3HRB%]$WJ+0\I3Z8=X+JI448,+!GG##YHLW1#7^AB] MLDS4AX$Q([AS_CVBY/(_[\AV1Y<7@E.%*)%AS \&Z*Q,V%#KWI7&*UBL@ @) M5 F5 E$EFYC-XL@#>WXA*H3&P6[WG/TY+&T@#FX4JTN .?$JEWO@,E5B6?DR M&A1?R^=#AN([MP <5J$C?S^!&3Q'A7->P S^-OEJ'E>#D%).3/_$:(N-F3Y% M-$;S3AQ>\!W?Y:12[Z0'$68 -.XC85O.9]RJ.* % M\YM: PXVL8QA@I!=E.V3RC$T (CO G*^-*I8@8Z[PN/Q!3Z-=ND$8I/"A*[@ MCP72<$"VP&B4?XT-01PTGB!2L[#NG?/+LA%NS$!GN/D'JQ$*B; HFZ$SA M,:7;,.JGTYTDVZ2G(?(#NTSS\+)*F'2U*1\Q0L0\!__ M#^=[B['>KAU:PJ]\](^_"*J= ^&2(>J]Y0*!Z!*1F>3K'\UG#:??\%7'%A+> M_-^CQNMIE(T-5:>;[V[.,/PKF9@'M2*P_7\TT'W;%"[W[0W[=BY,QV[W#7[: M]+/4 UOD)V$0JIQN\+'9BT+-L8K]]LNVRG2),8)@"Y9[O M:\]%8C '6QY6/]FZ)N'H .G8J+7 Z6SVX'_M]L=-:J2$'14^61=@L;9XGD1FZ09&O_E76WQD_14Q)*86QZ M!"+4+%-SK+W&"?DIS4^A;/ M7+W=Y#S;KXFTW/FU1+N1)\$NN7337-I[ Y>N8'JVS:2-?I[8M# !T"[MSRAT MP&W+6+7H1FCI?$ NM,#2JTU1%BG%ZQLW:4LYJD+KW/JGPRN&50J6U,!ONXVO MDO(GAVCW#E0P/B1+1B^EA6#39G2S@I%I4NO]..3!#DUJ2J)Q>_FYCXO&J#!! MY!;.MM(RE_&R@ ,PX:]J@R9H YPW8K!%=;#O--+R*TW16_7DSL,=FO'S;T; M4<%/I2TMQ6'_XM#:MRU]BS34>[O,)._+I![@\>97"^B(O0^E43T(+9)4IK-; MHWIE<7C+=$V2AX*=TJ2^ V%(J@K:J4E]71:RK6JWDWN1$%;U'_"3-]'\3&T_ M!X_&-TB&)TX$FHEUPEF3-*2K3H8"ST.>1 (H(&1\^D.L+'A_Z#;.1;YEU%,^ M$H (^TD/U?MQ7S8\#NB/VTKJ@W=7??#]/FI. 6$+_V)AR\N M-4N*-\7\%YWM(R?>@MWN)$!ZA8C@8WTPL6[92BLG]\C.V&-E@(B;8Z$1>)5Z M8P,:H9]>VYJ'@M6E-$*WMFJ!;KXT0@)LWW(:H9MT5)3YX'M^U/J;54(WZ50@ M\Y'SI!*0!HW6AE3" 2)W#.&U1Z($AVZ0&*(Q%>>(<=0^]$ EA,AAF:PZ9ZI= MX:/1IG '@=:., 8!-I.#]23)T!DTPF7B0[7SW1%?.X;GG:N&/P>"YLZ$[@)? MX<1+O-U.MFWWJ&87JF[_@5@X 7*Z$^OC[W6W-X-AL?NNN0D@LXO+J\'5V>7@ MJW)Y=3>Z_?YM>'6P(&:$Q+FTF?XI0G,/CK# MV)]#+M',PA#VZCU.3YQ:SPLSA/W!IMJQJ>N<^(^0+L M^ ,N/%,Q;Z[/^)1G5P!4!X.6D9O2B4W:F#F8)]"=*5'9G=J,5?E.BX$!<->I M#N;"'D_G_-$)?@?83Z##R&V'IPN^XK+QU-013RW&#B':AS@,3 LAC0G\&KHB M36V_1RLN9U=Y9O#WL7(=O">^8;,)@OM*^L#SJP(:2>*9(>S(C!'V"!@9SR:0 M'#XQ/GSQE O"?GJ/8O[)HZHQ.3HHF(>-<\'0VEX)4IM;D-I=SP+13[Z2>-<#X._6+Y>! M^O),#B&/J'68\.4@'5:MV,I$SKA;=HM7=R7+*6?AJ6(,%X*D"WQ- M;@ODAZ)6;ZRBY0>=8-O6O65+(-70A\+VCI[/N\>X#T=4&G,QO@N$F Z8!<*< M#-425TY3!PZ9IYIAGOJ>8/C]K< ^&\)?Y:B-B](GJ!GVO?DKR1P17-:;B6&[ ML)/PILNWVK3">WF(B8M18I)B"K3@]0\(-2M'T8J4I@ ;_7Y\!WZ53<2?MOVH2:3 M1I'A,QPO$+;DV4E)*27O%C!R6%B"MV14.1>#3M+FB<:R]H5";?3S.CP]$,)J MI PJC].OS5L9D<,'KBS3#]!Q^+B3!.IXT3Z[&-8&M>KY1:]5;75[G6JO5VM6 M^X-6Y[3;&-:&G>%"LHB6KYO R /W?X_.>_7SVA"671\,X0*#P:#:[S9ZU5J[ M6^MTF_W!Q>"BQ(DL!CY7G5\JKE5N)V+K>9]*^%O^K[_*^DOR6N@2_GN\IHC>J+\* WVAFZHYUE7CTG1< MVZ.C[^MGDVGR? #3$*OWNW2/3NJU2JT6[X(KT5Q+<5I!G-K+8;GF4;(B!12W MD<*(.U9A:E2 MQI@EP%LI)UQ.EARLDR?WMFC!8RDV!R W<*RVZW][7?9;?;.]OPLMOMO>UXV>U6=KN55RVO6EZUO&IY MU;+;+6J HO"G(>13W4Q!Y"Q^]6$^RII3CZ*3A@3*"4OI]&G> MX1:.8 9:F=E+;RDK>;5$@$(K6(U9*UP%( M5_V]2%?>P\12N@Y0NAJ%\02W&W06QA_=N"W(V6$K/X4M/$B!LSJ6G:+%A*3:')S:=/3AG6S]I M!/=LMT>-VX 9"2-^'-HD]D '*@_8\*58MF)0(Y!B,\GH3XSN)&^$(]KA(W.Z M"#66ZA,=O@?NHH MS,1%)$U\_XR=/Y*L58>-J_I+=:IK&C,_C3OU.DAF]B<:1R>F]?EG_-")^,$? MY0,^R$?E674",KA6^J/SSZ__,(V*HBK_2M8C]6:R^>WZYE<,D\_2!]>X\K/P MPB]-> X6<,NOEH%RAFXG&L]K,ZB9&-BZ V_QA[MAMFYI5\R]GHS4E[5T2+<9 MTQ^(_VJ !M45=I#^28* UX B*@^T"*!^(U:O?\++LGQ'F ]=R M/G[:X7Y$<-66 8R,.9/28_P:/,\W(7?79C06&\&U3PU@P2/I!G>/% ;J<8:= MN39XG25PVAIAFE LG\J.ZAUW5$?4?J2S>O=K00G-07-WR7L[VN\(7M_^>2]O M<(&YKROV@07:VP46N(AX);HY9L(UM+.-2,/-E5* (:_-O]BY[HPA>@0/;KT(OM*M=_/4;U"\S/@R-]@CZW9J":Q; M?WOV>A>LFX<#GL.I2^IOLRY)D?_QNYQ1"(X1>#B7DQA0'XSYVESYY"[TQ1OK M)SM)U_,FY+/7@./M@;*<&L:PM/D3A:&R] MT&)[PI$'HUM.(-Q8')ERYE&6"^=)OZQ:DM))JA?>FS CH=C+V/ T=O)9TY_DR=_-E]/?DP\>XWPH7B$6 MIY?PU#-RK8O1;>811^@&"]^=3JJV]1Q_$<],E9LO5]^_O7YVDGI*NNA"')WT M/_\,]\'-"/_XQ^>I[RS=#+X,JZ>WP\'OU<'%:'C[25&-9W7N2''\A,4-+/)( MORA3QFG30!81OM0_:_1/DILEWCI2?EXDY*_GR83$W5B;C*/KLZ^Z^2-@C 02 M\!_$HY)=TAA4B7%HA5.ZHCC V9-4W2;8:?&Y]EAP@=53JCG'LA9>9/%H:;S\ MY=2 7:O>C:>6 6]9_ @"ZU#PY $^Q0PLB=$8%AMB1=Q"/45REH?7["Q6>3C> M(RP,GH4O(:B&<7!=5#2%Y5*>FW07&<@4LP2#=^T-3"V[%@,^<&69=J0T []/ M):\C-IZ:^E\>GKC8S\W+(_CPL37M2\U,I%]N6BRSDV_S+15)2LK;W0IP="D1AJGRV39E;W?E1 MG6!+I([^$7--_ MUZ5Y+:YT=).J7%GEU@8%KMYVG?K22;&PI8WN7L2R4WYS+6"[,_)MZ-G/3,[*K$OQKSQ9XH!-_ MD(L>0#PKL(<6(@!A.P*B]H++XQ*:*-,)>;(2O#A3Y_XKMD>Q;0CSTM24>\_1 M38: ON._/-W1B>LCM?GG 8[6_^(0EP!M5 YX8;\68NQ- R] 6)_ 5MG]$^D,V4.>/,XE- MU[+G0<-7K#R_FX"HN$5DCKHL86P=8^5BF#*K_A\N$Z?O[B\N.:7?&3NU-*.%;E.%'?@5$=W M"-V;0X3Y'3>%ZI*Y&T^9YAGL>N)OPIEGV_!;.N:\F!9V@&[274?B9#43A^TYR M^[[@[M&LBUN&(PS8>@AIC4J_4<_3 4+)@-MDP'Y&;>6^&+#1CX^>*?0)UH'4 M5_QIV3\0]7-F6V/F'("ER/G9=#^C3U^KNL M#2B1F ^1JS-J]_;"U?5*IQ>?%YDWKB[CF84S0#Q;J^(9WP%8M7>,F]S/**1; M4AV "EA+\-N57KV3>PC7DIT+Q"(Q+OO@ )HNP9F.SY MC0$K&YC:\"]/GV'M5D9!4G]/!4GM310DW=Q>WPQO1_]6!E?GRO#_OE_>?!M> MC2K*U7!TH 5*8N'<*D"G86;MHQ BXW:E_C62N"6@V;/+.BR_+-GJ]7+$WL6*C3:IG4Y MXQ/)[$,*@O(NR5G@8'MBMTRV/;_(8XPS&8^_1,U0L8=38S(9MHW'W M95R34T?N0XJXKXU<$N* \Q #P.\&$\>_@T<+9.-O>CU5.ZRI&!J]O1X,I50J M?2SYOAA\WUP;,&6O?-^OYY'KMV=F/I;SY](+_A(:"RIE_^.^*ZO>V##6;:X- M%Y.J:M;NAVSNTODNNR'? 7.O#5"S<>;NMG>9R"AX;^2.N^;"CI7"7F;,=)CR MK#K*OU)JKA=J#V3[6G>Q?2V+P\(W72\H:<11(SCYT$:G+;V5O/18Y]U6E]Y, M$ ;\-O4FNE,<)8_/8.HF4QYAM5-'829"K4=:HQ1<;T6QF8-SM/0G9LPK2M:S MMQ.>O1%L6V-'VQ8_ ,A<=2=YU?6=KKK9CH]B7V_'&M$=V\FPAZ !E;W0_(P3 M;+"6W94W7TY_3V[NC!LD\0K9.GH).TLCU[H8W68VDH5NL/#=Z:1J6\_Q%[$O M5;GY.M(^7F1DK^>)U,2 MMV-M.HZNS[[JYH^ ,Q)(P'\0OTM^2>-0)<:B%4[JBN* J9RD>CF"GQ:?:W_H M C$^JP;!C@[EZ:KF@\ZF/Z!XS#72<<'Z#:;^\$'Z&QF8,EH#I#P4C M(9B3@@C++OL*5C8FT(DC4[J=3@F:4((F%+1QW?\W!3TA_%^)I% R9(FD4"(I MY %)01[>H9G5%SV33]O9K1WJA/*J[_JJA2E@ZF_S_-0/7_E=;E3W0'HR"H0T MTLLF)15Y#K8L[V)=J,T2(?- MJUF8*47B56Q&;>^R&?5P^CMV&AYY]GBJ.@P>PIJXSZK-2PM<-IZ:\.0/\](Z M;5OBL[!55I%X"5UQ)S9RX0O[,UF55GN7(W=*H[5S%LY"73D$%JY7^IUJ>4-%Z'DC9SP1C5O MG)%G1SY!!1:=K7/"KZG.Q]HSY;;B*C0KG7XK3ZY"R7";9KBUI[YM*;SJY O4 MLDSW)^19PI@::JB%O/CIE0/U>E*P!;IK(S9E"'^(.<+P NNU/G;WBN%48F<4 MG+_7AHC:$7^W]IN(.024C ,\QAA9KFKXAA48K_AV-2<*)=4+7AM<*D-1K-OO MWZCT=SK;.TRIWUXQT)[#HQBO6XEEN#>NQ#>"K?6RZ@;>TUCQ-S@#6F)2K,>1R[* M&_!:R>:%8O.,VK(]L7FCTN[DG\W?*[Y@.,.\#+Y@N[$!?,'P3:\GBYRWL>KY M5Q$'VRE@B2LA#F[Z8= RU.-'U/QAM@Y$V$X"85P5B' +).G&SS$R'R,%3W$E M9,(M/$8C ;7\#3N[1\#"G2DH-Y&A)QY.RHH4!_CJ2W? ;U/W"LB#[*!^:0C4<0G*V0%WOO:U4 MM,1E^98]JB@/-H+EH:'Y-U/M];HQ.KDJL"Q,WFG;AR_ -ZWBRVY.\LFIXII4 MH+,%<;V"&XR>F?'$OI%67DM2.^WRF#2GDMHN)77;DKJ-"ID$244[.GJVUDHR M=,H6_;P*:*<4T"T+:#^IIFA; HI)D/6*"QIE=T=.1;1;BNBV173MPI_51?3" M\M:(1S%3WRN-:!XE=#1E-E,G+K.++Z?OJABJGU0,E2GUSW:FR*.4CQ>Z3P;( M&&^2^UYKEW*_KZ*H S'7O!"*.2YLX&(3ICQG.0 U\8XK1?IK%T0=0$?* =>( M%.,>G^]/9%%1'F99O?T>(SRZYZ>JS+">%<=[A/?A^PZ=ZH^G("?PNV[R/U7; MG@,#HE[U3!?'.CT(GJJ&:8Z:H MKO*;:GJJ/5?JO/@A6RTN9S37LE^IIF1MB(_7"@O_9K:EJ#[TQA.ENH!#/GQ(IR'KNV4"M&Y!I M2UL3Q[!37QD_>MD>^!T%'F$]$J^C6I'AFFLSW&;]Z+>ZOFL?"K^I$'I+[)2T M*;GQ5'<_*W8P'J-+Y=RHA.N1G\>T"C8Z_.%7CQ]OOP7/EZ.3B]_'HYNAS>Y<'EWD:IJ-AZ M$)&Y&%I&$Y+3BME[M:Q1!P3!RK0;U7;G(ULU'?Y5YW0>?H> >._F?\\?YE_U M,3,=$,VO7\^6P=Y=X-0SS[;!.0"&O;+,,?]CS2GN*]5*]VI9(/H%ID+\(%#1 M/(C2+,7F2P<^@;4K?-V*O_"* DM7/@ +-VKU\2^?]1/^";C<"7]1^^4C5AA# MU)94FHRD#D]83"K4AB\RY%%WHBL^R#)O MKJ05(]#2(["#'" M5]R_,]R^]0KNR^EP[X?C5CZDV ;'U9L'UN)Q(,5O,OP<6X]8VW(@8.,YJ6]+ M%RF'CS/#FC,F_]N;$OSQJ[<+S+CX)]AYE&?Z$Q[BSFHUW8)6U6: M@UUS77-MD.RMLVU.^.N<;?C M1W=O$O$$,+-=]CB\H8ZPY.><\//: -C;X.<" +J7H4VXL^L K-?[;=WJ-==N MW=JPW%?JC5V.SRL!K-\!;Z\-8+UIWFYU]FG5#J@C<8O5@N'CFE>K?>L9:O,_ MYVS"@%NTL] 5!QC>/[!'X*$_=7=Z:6KZDZY!I.\#H]]-59N=J@X>$,[Q<\[ MU&XLQ[69J]OTS5-FLHGN.J?ST7S&KB>)-\+RV0MX=&:?,4M4PBY3//MJ7GH# M=;3->!8LJYJXGB' .: RO/"H.PZ6,.>,SI5:4MVV;BI,W!Q4J^DY(@DQ#I[# M+W=/;/%9JASY N*SX*.6\NS0U &,YZ\4YXC.7[EF2&<=+%AHZ\G"YE)R:CS MY$KCYH% 0[^W2N/.SJH]]U'&>86X]QQ&51DB[OV>:SG32YHW7M29E;5X;TQ> MEC27)>SO<;_+NO&:Z!J6CRI+!S6W6!6 *U/I8Q9[;UI#L'T;ATH+5<:8JEOCU39C/VHCLN!*N7YMA&GCEG M_.9Z=MI(UA9Y?@.V#JY2&JW;-W+?^UNWNH;X::, MJM+8"8+7RC/YFR^GOR?7O<0Y1[Q"3$DO8=%-Y%H7H]O,H]#0#1:^.YU4;>LY M_B*6["@W7ZZ^?WO]C#6U2&?1/(->K O8WNB/?WR>^I[(S>#+L'IZ.QS\7AU< MC(:WGQ35>%;GCI2@3PIL(HL\TR_*E''B-)!'A*/RSQK]D^3#B+>.E)\7*?GK M>3(E<3O6IN/H^NRK;OX(.".!!/P',:GDES0.56(LNCB.($4="7Y:?*[=(R\3 M3HY02$ZLQJR54&.V"T#EWB8 E?\4>%&[JB(6Z:SCJRA/#JY M-I7?/),IC;X$M$7P52RD5SS%G)3Z $$8 MIC.5#_A-B:-[(]\?R/<#,-UGW9V"&K)=53<53;?9V+5L1P*_RGM3W:OXD J& MCVDZS:8R<3FP?-?S$72?F$-7^ ZPI!EKOQ)Y'HNY8?\953P&1P/"(8@P<]3 M?3Q5=)<_CX8O.2C_\!,OXW\=*TQ596;K3ZK+E)FACA,>_GHR83B-P+_7)^6# M_E'F[AR\J,K'%BC>C/Z"BS[ C1_PHD"'%#\B!4&G4VWT_T/]Z-<3(9G7]BUJ M52J"EL)ZZ3@>#G&Z90\0,^.^GA/MY6ICI=%4B;WHDB3>!_0(?/5Z#G'=M2=_E\NKBZ*13Z?4[E78[GOM6'%PD,0\6>P.M[ES01]'] MD(L(X3D#%WW084_NX-'AZP/XMDF!-'IU-[8H*)<7(^SF_L=C!0?_^-L(-U;8 M"[/'ND-EM([^HL *L)*1)BLJNH/\Q<,( MW.QEAM+T&8O+I#JM@KJJZB_5J:YIS/P$9.T?G4Q -WS^&3]VHLR9"@(]L:U' MDG%-")_<-;[;.#I %/_@AR0-%6M,]?\:@G;_YAESI6(4'$J(/ M6O0%K/E2$.7:YG<8@OIRYZM'(ET,L"NU!"2DXU0BI"3,]T@$G^770QZK=.L) M.1P:J*Q29]9TFLG ,9O;VY??Q..]1U$4;__>OWU?'A[]S_*\/^^7X[^G0PN-2*/ @^7>1O\78&?/G5HX'A \6G6FNX1"3-,.G'1OK[T<:&ZRU297B%B+ MWG<&_@K6M,UMDM9DB4UQP= NISQ:$CKKDH_F^V8;?+KV,L\V\YU"!^]

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